
<html lang="en"     class="pb-page"  data-request-id="108f63a2-b9a9-450e-8bdd-a165fa692d97"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2011.54.issue-2;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm101251q"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer" /></meta><meta name="dc.Creator" content="Fabrice  Pierre" /></meta><meta name="dc.Creator" content="Peter C.  Chua" /></meta><meta name="dc.Creator" content="Sean E.  O’Brien" /></meta><meta name="dc.Creator" content="Adam  Siddiqui-Jain" /></meta><meta name="dc.Creator" content="Pauline  Bourbon" /></meta><meta name="dc.Creator" content="Mustapha  Haddach" /></meta><meta name="dc.Creator" content="Jerome  Michaux" /></meta><meta name="dc.Creator" content="Johnny  Nagasawa" /></meta><meta name="dc.Creator" content="Michael K.  Schwaebe" /></meta><meta name="dc.Creator" content="Eric  Stefan" /></meta><meta name="dc.Creator" content="Anne  Vialettes" /></meta><meta name="dc.Creator" content="Jeffrey P.  Whitten" /></meta><meta name="dc.Creator" content="Ta Kung  Chen" /></meta><meta name="dc.Creator" content="Levan  Darjania" /></meta><meta name="dc.Creator" content="Ryan  Stansfield" /></meta><meta name="dc.Creator" content="Kenna  Anderes" /></meta><meta name="dc.Creator" content="Josh  Bliesath" /></meta><meta name="dc.Creator" content="Denis  Drygin" /></meta><meta name="dc.Creator" content="Caroline  Ho" /></meta><meta name="dc.Creator" content="May  Omori" /></meta><meta name="dc.Creator" content="Chris  Proffitt" /></meta><meta name="dc.Creator" content="Nicole  Streiner" /></meta><meta name="dc.Creator" content="Katy  Trent" /></meta><meta name="dc.Creator" content="William G.  Rice" /></meta><meta name="dc.Creator" content="David M.  Ryckman" /></meta><meta name="dc.Description" content="Herein we chronicle the discovery of CX-4945 (25n), a first-in-class, orally bioavailable ATP-competitive inhibitor of protein kinase CK2 in clinical trials for cancer. CK2 has long been considered..." /></meta><meta name="Description" content="Herein we chronicle the discovery of CX-4945 (25n), a first-in-class, orally bioavailable ATP-competitive inhibitor of protein kinase CK2 in clinical trials for cancer. CK2 has long been considered..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 21, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101251q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101251q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101251q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101251q" /></link>
        
    
    

<title>Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101251q" /></meta><meta property="og:title" content="Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0012.jpeg" /></meta><meta property="og:description" content="Herein we chronicle the discovery of CX-4945 (25n), a first-in-class, orally bioavailable ATP-competitive inhibitor of protein kinase CK2 in clinical trials for cancer. CK2 has long been considered a prime cancer drug target because of the roles of deregulated and overexpressed CK2 in cancer-promoting prosurvival and antiapoptotic pathways. These biological properties as well as the suitability of CK2’s small ATP binding site for the design of selective inhibitors, led us to fashion novel therapeutic agents for cancer. The optimization leading to 25n (Ki = 0.38 nM) was guided by molecular modeling, suggesting a strong binding of 25n resulting from a combination of hydrophobic interactions, an ionic bridge with Lys68, and hydrogen bonding with the hinge region. 25n was found to be highly selective, orally bioavailable across species (20−51%) and efficacious in xenograft models. The discovery of 25n will allow the therapeutic targeting of CK2 in humans for the first time." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101251q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101251q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101251q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101251q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101251q&amp;href=/doi/10.1021/jm101251q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 635-654</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1012787" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101254z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and SAR of 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice++Pierre">Fabrice Pierre</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+C.++Chua">Peter C. Chua</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean+E.++O%E2%80%99Brien">Sean E. O’Brien</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Siddiqui-Jain">Adam Siddiqui-Jain</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pauline++Bourbon">Pauline Bourbon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mustapha++Haddach">Mustapha Haddach</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerome++Michaux">Jerome Michaux</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johnny++Nagasawa">Johnny Nagasawa</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+K.++Schwaebe">Michael K. Schwaebe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Stefan">Eric Stefan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Vialettes">Anne Vialettes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+P.++Whitten">Jeffrey P. Whitten</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ta+Kung++Chen">Ta Kung Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Levan++Darjania">Levan Darjania</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan++Stansfield">Ryan Stansfield</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenna++Anderes">Kenna Anderes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josh++Bliesath">Josh Bliesath</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denis++Drygin">Denis Drygin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Ho">Caroline Ho</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=May++Omori">May Omori</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chris++Proffitt">Chris Proffitt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicole++Streiner">Nicole Streiner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katy++Trent">Katy Trent</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+G.++Rice">William G. Rice</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Ryckman">David M. Ryckman</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +1 858 875 5113. Fax: 858-875-5101. E-mail: <a href="/cdn-cgi/l/email-protection#c9afb9a0acbbbbac89aab0a5aca7acb9a1a8bba4a8e7aaa6a4"><span class="__cf_email__" data-cfemail="4523352c2037372005263c29202b20352d243728246b262a28">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101251q&amp;href=/doi/10.1021%2Fjm101251q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 635–654</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 21, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 September 2010</li><li><span class="item_label"><b>Published</b> online</span>21 December 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 January 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101251q" title="DOI URL">https://doi.org/10.1021/jm101251q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D635%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFabrice%2BPierre%252C%2BPeter%2BC.%2BChua%252C%2BSean%2BE.%2BO%25E2%2580%2599Brien%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D2%26contentID%3Djm101251q%26title%3DDiscovery%2Band%2BSAR%2Bof%2B5-%25283-Chlorophenylamino%2529benzo%255Bc%255D%255B2%252C6%255Dnaphthyridine-8-carboxylic%2BAcid%2B%2528CX-4945%2529%252C%2Bthe%2BFirst%2BClinical%2BStage%2BInhibitor%2Bof%2BProtein%2BKinase%2BCK2%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D654%26publicationDate%3DJanuary%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101251q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6453</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">191</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101251q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;Pierre&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;C. Chua&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;E. O’Brien&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Siddiqui-Jain&quot;},{&quot;first_name&quot;:&quot;Pauline&quot;,&quot;last_name&quot;:&quot;Bourbon&quot;},{&quot;first_name&quot;:&quot;Mustapha&quot;,&quot;last_name&quot;:&quot;Haddach&quot;},{&quot;first_name&quot;:&quot;Jerome&quot;,&quot;last_name&quot;:&quot;Michaux&quot;},{&quot;first_name&quot;:&quot;Johnny&quot;,&quot;last_name&quot;:&quot;Nagasawa&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;K. Schwaebe&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Stefan&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Vialettes&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;P. Whitten&quot;},{&quot;first_name&quot;:&quot;Ta&quot;,&quot;last_name&quot;:&quot;Kung Chen&quot;},{&quot;first_name&quot;:&quot;Levan&quot;,&quot;last_name&quot;:&quot;Darjania&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;Stansfield&quot;},{&quot;first_name&quot;:&quot;Kenna&quot;,&quot;last_name&quot;:&quot;Anderes&quot;},{&quot;first_name&quot;:&quot;Josh&quot;,&quot;last_name&quot;:&quot;Bliesath&quot;},{&quot;first_name&quot;:&quot;Denis&quot;,&quot;last_name&quot;:&quot;Drygin&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Ho&quot;},{&quot;first_name&quot;:&quot;May&quot;,&quot;last_name&quot;:&quot;Omori&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;Proffitt&quot;},{&quot;first_name&quot;:&quot;Nicole&quot;,&quot;last_name&quot;:&quot;Streiner&quot;},{&quot;first_name&quot;:&quot;Katy&quot;,&quot;last_name&quot;:&quot;Trent&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;G. Rice&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Ryckman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;635-654&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101251q&quot;},&quot;abstract&quot;:&quot;Herein we chronicle the discovery of CX-4945 (25n), a first-in-class, orally bioavailable ATP-competitive inhibitor of protein kinase CK2 in clinical trials for cancer. CK2 has long been considered a prime cancer drug target because of the roles of deregulated and overexpressed CK2 in cancer-promoting prosurvival and antiapoptotic pathways. These biological properties as well as the suitability of CK2’s small ATP binding site for the design of selective inhibitors, led us to fashion novel therapeutic agents for cancer. The optimization leading to 25n (Ki = 0.38 nM) was guided by molecular modeling, suggesting a strong binding of 25n resulting from a combination of hydrophobic interactions, an ionic bridge with Lys68, and hydrogen bonding with the hinge region. 25n was found to be highly selective, orally bioavailable across species (20−51%) and efficacious in xenograft models. The discovery of 25n will allow the therapeutic targeting of CK2 in humans for the first time.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101251q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101251q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101251q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101251q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101251q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101251q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101251q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101251q&amp;href=/doi/10.1021/jm101251q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101251q" /></input><a href="/doi/pdf/10.1021/jm101251q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101251q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101251q%26sid%3Dliteratum%253Aachs%26pmid%3D21174434%26genre%3Darticle%26aulast%3DPierre%26date%3D2011%26atitle%3DDiscovery%2Band%2BSAR%2Bof%2B5-%25283-Chlorophenylamino%2529benzo%255Bc%255D%255B2%252C6%255Dnaphthyridine-8-carboxylic%2BAcid%2B%2528CX-4945%2529%252C%2Bthe%2BFirst%2BClinical%2BStage%2BInhibitor%2Bof%2BProtein%2BKinase%2BCK2%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D2%26spage%3D635%26epage%3D654%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jmcmar.2011.54.issue-2/production/jmcmar.2011.54.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we chronicle the discovery of CX-4945 (<b>25n</b>), a first-in-class, orally bioavailable ATP-competitive inhibitor of protein kinase CK2 in clinical trials for cancer. CK2 has long been considered a prime cancer drug target because of the roles of deregulated and overexpressed CK2 in cancer-promoting prosurvival and antiapoptotic pathways. These biological properties as well as the suitability of CK2’s small ATP binding site for the design of selective inhibitors, led us to fashion novel therapeutic agents for cancer. The optimization leading to <b>25n</b> (<i>K</i><sub>i</sub> = 0.38 nM) was guided by molecular modeling, suggesting a strong binding of <b>25n</b> resulting from a combination of hydrophobic interactions, an ionic bridge with Lys68, and hydrogen bonding with the hinge region. <b>25n</b> was found to be highly selective, orally bioavailable across species (20−51%) and efficacious in xenograft models. The discovery of <b>25n</b> will allow the therapeutic targeting of CK2 in humans for the first time.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinase CK2 is a pleiotropic, highly conserved serine/threonine protein kinase ubiquitously distributed across the compartments of multiple cell types.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> The protein is comprised of a heterotetrameric complex containing two catalytic isoforms (CK2α or CK2α′) and two regulatory β subunits in various combinations. Abundant evidence supports a multifunctional role for CK2 in a number of cellular events contributing to the cancer phenotype. CK2 regulates many antiapoptotic<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and pro-proliferative signaling cascades, including PI3K/Akt<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: PI3K, phosphatidylinositol-3-kinase; Akt, v-akt murine thymoma viral oncogene homologue; NF-κB, nuclear factor κ light-chain enhancer of activated B cells; TBB, 4,5,6,7-tetrabromobenzotriazole; IQA, 2-(5-oxo-5,6-dihydroindolo[1,2-<i>a</i>]quinazolin-7-yl)acetic acid; PTEN, phosphatase and tensin homologue; NaHMDS, sodium bis(trimethylsilyl)amide; PARP, poly(ADP-ribose) polymerase; NAD<sup>+</sup>, nicotinamide adenine dinucleotide; PDK1, 3-phosphoinositide dependent protein kinase; mTOR, mammalian target of rapamycin; FLT3, fms-like tyrosine kinase receptor-3; PIM1, Proviral insertion site in Moloney murine leukemia 1; CDK1, cyclin-dependent kinase 1; NMP, <i>N</i>-methyl-2-pyrrolidone; THF, tetrahydrofuran; HOBt, hydroxybenzotriazole hydrate; DIEA, <i>N</i>,<i>N</i>-diisopropylethylamine; EDCI, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride; PdCl<sub>2</sub>(dppf), 1,1′-bis(diphenylphosphino)ferrocene palladium(II) chloride complexed with dichloromethane; ES, electrospray; EtOAc, ethyl acetate; TFA, trifluoroacetic acid; LCMS, liquid chromatography mass spectrometry; GCMS, gas chromatography mass spectrometry.</p></div> and Wnt signaling cascades, NF-κB transcription, and the DNA damage response (reviewed in refs <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">1</a> and <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a>). Additionally, CK2 has been characterized as a regulator of angiogenesis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">CK2 is constitutively active and does not require phosphorylation by other kinases for activation. Unlike other signaling kinases, where genetic alterations lead to dysregulation of their pathways, no CK2 mutations have been found to date, yet its high expression and activity have been associated with disease states.<a onclick="showRef(event, 'ref5 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref7">(5, 7)</a> Overexpression of CK2 has been well documented in a number of cancers, including head and neck,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> breast,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> colorectal,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> renal,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> lung,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> leukemias,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and prostate,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and has also been linked to poor prognosis and disease progression.<a onclick="showRef(event, 'ref5 ref16'); return false;" href="javascript:void(0);" class="ref ref5 ref16">(5, 16)</a></div><div class="NLM_p">These properties have defined CK2 as a prototypical “non-oncogene target”,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> i.e., a nonmutated gene not directly transformative but which is overexpressed to maintain the cancer phenotype and protect cells from the increased cellular stress resulting from oncogenic activation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The high dependency of cancer cells on nononcogenes for survival has made them an attractive yet underexploited new class of therapeutic targets for the treatment of cancer.</div><div class="NLM_p">Among the possible strategies to modulate CK2, antisense nucleotides directed toward CK2α have scientifically validated CK2 as a target by inducing apoptosis in vivo in a xenograft model of prostate cancer.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> A more practical therapy would involve the oral administration of a small molecule kinase inhibitor. The ATP binding site of CK2 is smaller than most of the other protein kinases due to the presence of unique bulky residues,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> allowing for the design of very selective low molecular weight ATP-competitive inhibitors.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div class="NLM_p">Many ATP-competitive inhibitors of CK2 have already been reported in the literature,<a onclick="showRef(event, 'ref7 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref7 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(7, 23-33)</a> but none of them have reached human clinical trials. Representative structural classes of CK2 inhibitory reagents are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The chlorinated nucleoside <b>1</b> (DRB) was one of the earliest described inhibitors of CK2 with an IC<sub>50</sub> of 15 μM.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Flavonoids such as emodin <b>2</b> displayed greater potency (IC<sub>50</sub> = 2 μM)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> but generally lacked specificity. One of the most studied structural classes of inhibitors include polyhalogenated-heteroaryls such as tetrabromo-benzimidazole <b>3</b> (TBB),<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36-38)</a> which has higher selectivity and potency than many of the other known agents.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These compounds have been widely used as molecular probes to elucidate the functional role of CK2. Although <b>3</b> has been reported to be well tolerated in mice,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the polyhalogenated aromatic nature of this molecule and its analogues raises serious concerns about its potential long-term toxicity in humans.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative structures of known ATP-competitive inhibitors of CK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pharmaceutical industry’s effort to develop CK2 inhibitors has been met with limited success. Vangrevelinghe et al. led the way by discovering the potent and selective CK2 inhibitor <b>6</b> (IQA) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) (IC<sub>50</sub> = 80 nM) by utilizing high throughput docking methodologies.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This molecule demonstrated inhibition of CK2 in cells, and the structural basis for its inhibition has been resolved by X-ray crystallography.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compound <b>6</b> was reported to decompose slowly in aqueous media,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> precluding its use as a drug. A novel series of pyrazolo[1,5-<i>a</i>][1,3,5]triazines exemplified by analogue <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) emerged as a potent class of CK2 inhibitors, with the <i>K</i><sub>i</sub> values of several analogues reported to be below 1 nM.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> These molecules demonstrated cellular antiproliferative activity in the submicromolar range. However, no further data have been published in the literature and the current status of these noteworthy molecules remains undisclosed. A recent publication described the discovery and cellular characterization of a novel molecule <b>5</b>, which induced antiproliferative responses in cell culture, by inhibiting the phosphorylation of the CK2 substrate PTEN at Ser 370.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Additionally, a recent review by Prudent et al.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> discussed an emerging class of inhibitors targeting structural elements located outside of the active site, providing exciting opportunities for the development of allosteric inhibitors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of CK2 inhibitor <b>6</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> PARP inhibitor <b>7</b>,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and lead molecule <b>11c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, we wish to report the discovery of the first-in-class orally available ATP-competitive inhibitor of CK2 <b>25n</b>, currently in clinical trials for the treatment of cancer. The discovery of <b>25n</b> is of considerable importance as it will allow for the evaluation of an entirely novel therapeutic strategy for cancer.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>11a</b>−<b>b</b> were efficiently synthesized (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) via a tandem Suzuki coupling/intramolecular amide formation between methyl 2-bromo-3-thiophene carboxylate <b>9</b> and the commercially available boronic acids <b>10a</b>−<b>b</b>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Functional group interconversions afforded several analogues <b>11c</b>−<b>e</b> bearing various substituents on R2.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0019.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, then MeOH; (b) NaOAc, PdCl<sub>2</sub>(dppf), DMF, 120 °C; (c) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-propanol, DMF, 100 °C; (d) NH<sub>4</sub>OH, 100 °C; (e) LiOH, MeOH, THF, H<sub>2</sub>O, rt; (f) LiAlH<sub>4</sub>, dioxane, 100 °C; (g) POCl<sub>3</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, toluene, reflux; (h) HNR<sup>3</sup>R<sup>4</sup> (for structures of HNR<sup>3</sup>R<sup>4</sup>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), NMP, microwave 120 °C; (i) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, 120 °C; (j) H<sub>2</sub>O<sub>2</sub>, NaOH, NMP, 50 °C; (k) (MeO)<sub>2</sub>CHNMe<sub>2</sub>, 80 °C then AcOH, NH<sub>2</sub>NH<sub>2</sub>, 115 °C.</p></p></figure><div class="NLM_p">Lactam <b>11a</b> was alkylated with 3-bromo-1-propanol to afford a mixture of the <i>N</i>- and <i>O</i>-alkyl analogues <b>12a</b> and <b>12b</b>. After separation by chromatography on silica gel followed by ester hydrolysis, compounds <b>13a</b> and <b>13b</b> were isolated. Their respective structures were assigned on the basis of their proton NMR spectra. The loss of the carbonyl function in the <i>O</i>-alkylated isomer <b>13b</b> resulted in an upfield shift of the nearest thiophene proton, from 7.77 ppm in <b>13a</b> to 7.54 ppm in <b>13b</b>. Lactams <b>11a</b>−<b>b</b> were alternatively reacted with phosphorus oxychloride (POCl<sub>3</sub>) to afford chloroquinolines <b>14a</b>−<b>b</b>. Intermediate <b>14a</b> was further derivatized into various substituted 4-aminothieno[3,2-<i>c</i>]quinoline-7-carboxylic acids <b>17a</b>−<b>p</b> in two steps. The first step involved nucleophilic displacement of the chlorine of <b>14a</b> with various substituted amines. The second step was performed by hydrolysis of the ester function in basic conditions. A tetrazole was introduced on R2 by reacting nitrile <b>16</b> with sodium azide. Alternatively, a nonacidic triazole was also prepared in one pot starting from carboxamide <b>18</b>, obtained by oxidation of the corresponding cyano <b>16</b>.</div><div class="NLM_p">The chemistry described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> extended our previous chemistry to various six-membered ring systems. Various <i>ortho</i>-halogeno esters <b>22a</b>, <b>22e</b>−<b>g</b>, and <b>22i</b> were prepared from their commercially available carboxylic acids <b>21a</b>, <b>21e</b>−<b>g</b>, and <b>21i</b> using standard conditions. Under Suzuki conditions, <i>ortho</i>-halogeno esters <b>22a</b> and <b>22d</b>−<b>i</b> reacted with boronic acids <b>10a</b>−<b>c</b> to form lactams <b>23a</b>−<b>i</b> in one step. These materials were converted to various chloroquinolines <b>24a</b>−<b>i</b> using phosphorus oxychloride.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0020.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, then R<sup>1</sup>OH or H<sub>2</sub>SO<sub>4</sub> (cat.), R<sup>1</sup>OH, reflux; (b) NaOAc, PdCl<sub>2</sub>(dppf), DMF, 120 °C or Cs<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub> (dppf), dioxane, 120 °C; (c) POCl<sub>3</sub> reflux.</p></p></figure><div class="NLM_p">Compound <b>24a</b> was transformed (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) into various substituted benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>25a</b>−<b>t</b> in two steps by reaction with the desired amines followed by ester hydrolysis. Functional group interconversions similar to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> were used to prepare 3-chloroanilines <b>26a</b>−<b>g</b> bearing various substitutions on R2. Nucleophilic displacement of the chlorine by anilines in <b>24d</b>−<b>i</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) and ester hydrolysis provided carboxylates <b>27d</b>−<b>e</b>, <b>27h</b>−<b>i</b>, <b>28d</b>−<b>g</b>, and <b>28i</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0021.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>3</sup>NH<sub>2</sub> (for structure of R<sup>3</sup>NH<sub>2</sub>, see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) or 3-chloroaniline, NMP, microwave 120−160 °C or conventionnal heating at 80 °C; (b) NaOH, H<sub>2</sub>O, EtOH, 50−80 °C; (c) LiAlH<sub>4</sub>, THF, −40 °C to rt; (d) HOBt, EDCI, (<i>i</i>-Pr)<sub>2</sub>NEt, NH<sub>4</sub>Cl, NMP, 70 °C; (e) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, 120 °C; (f) (MeO)<sub>2</sub>CHNMe<sub>2</sub>, 80 °C then AcOH, NH<sub>2</sub>NH<sub>2</sub>, 80 °C.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>N-Ph-R<sup>5</sup>, NMP, microwave 120−160 °C or conventionnal heating at 80 °C; (b) NaOH, H<sub>2</sub>O, EtOH, 50−80 °C.</p></p></figure><div class="NLM_p">The chemistry described in Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a> allowed variations on the position and nature of functional groups on the lower C-ring. Many ortho-substituted halogeno-anilines were prepared from commercially available chemicals (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). The reaction of methyl 3-amino-2-methylbenzoate <b>29</b> with iodination reagent NIS produced a mixture of isomers, the major (86%) component of the mixture being methyl 3-amino-6-iodo-2-methylbenzoate <b>30b</b> and the minor (14%) component being the desired methyl 3-amino-4-iodo-2-methylbenzoate <b>30a.</b> The desired minor product was isolated pure by flash chromatography on silica gel. The structure of this intermediate was unambiguously confirmed by its subsequent reactivity leading to the synthesis of lactam <b>39a</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). The same chemistry tested on the major isomer <b>30b</b> led to a biaryl intermediate that failed to provide any lactam in the presence of NaHMDS. Methyl 5-amino-4-iodo-2-methylbenzoate <b>36</b> was the major isomer resulting from the iodination of methyl 5-amino-2-methylbenzoate <b>35</b> and could be easily isolated by chromatography. Compound <b>37</b> was commercially available, and the bromo aniline <b>32</b> was prepared in one step from the acid <b>31</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS, AcOH, rt, minor isomer isolated by chromatography; (b) H<sub>2</sub>SO<sub>4</sub> (cat.), MeOH, reflux; (c) H<sub>2</sub>, Pd/C, MeOH; (d) NIS, AcOH, rt, major isomer isolated by chromatography.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub> (dppf), dioxane, 120 °C, workup; (b) NaHMDS, THF, rt; (c) POCl<sub>3</sub> reflux, (d) 3-chloroaniline, NMP, microwave 120 °C; (e) NaOH, H<sub>2</sub>O, EtOH, 50−80 °C.</p></p></figure><div class="NLM_p last">Ortho-substituted halogeno-anilines <b>30a</b>, <b>32</b>, and <b>36</b>−<b>37</b> were coupled with boronic acid <b>38</b><a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> to yield 3-(<i>o</i>-aminophenyl)-pyridines intermediates (not shown) which was cyclized into <b>39a</b>−<b>d</b> in the presence of NaHMDS. Finally, conversions to molecules <b>41a</b>−<b>d</b> were carried out via chloroquinolines <b>40a</b>−<b>d</b> using the chemistry described above.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Structure-Based Design and Structure−Activity Relationship (SAR)</h3><div class="NLM_p">During our initial structure-based design efforts to create a pharmaceutically suitable CK2 inhibitor, we noticed an obvious similarity between the CK2 inhibitor <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>)<a onclick="showRef(event, 'ref22 ref40'); return false;" href="javascript:void(0);" class="ref ref22 ref40">(22, 40)</a> and the poly(ADP-ribose) polymerase (PARP) inhibitor <b>7</b> developed by the same group and described elsewhere.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Examination of our own collection of PARP inhibitors as a potential source of novel CK2 inhibitors led us to 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylic acid <b>11c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) because of its relatively close similarity with <b>6</b> and <b>7</b> and, in particular, because of its carboxylic acid group at a position roughly overlaying with that of <b>6</b>. Compound <b>11c</b> was tested in an enzymatic assay using recombinant CK2 along with eight other molecules from our library. Molecule <b>11c</b> was found to inhibit CK2 activity with an IC<sub>50</sub> of 2.1 μM, quickly providing us with a unique lead amenable to further optimization.</div><div class="NLM_p">The inhibitory activity of compounds bearing various substituents on R2, <b>11c</b>, <b>11e</b>, and <b>11d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), suggested that modification of the carboxylic group on R2 offered little potential for increasing activity against CK2, a result consistent with the published SAR of <b>6</b>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Replacement of the acid by a carboxamide in <b>11e</b> or an alcohol in <b>11d</b> suppressed CK2 activity while improving inhibition of PARP.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. CK2 and PARP Inhibitory Activity of Thieno[3,2-<i>c</i>]quinoline Analogues <b>11c</b>−<b>e</b>, <b>13a</b>−<b>b</b>, and <b>17a</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0004.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0005.gif" alt="" id="_i6" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Most PARP inhibitors are designed to compete with the cofactor NAD<sup>+</sup>, and therefore these generally display an essential aryl/heteroaryl substituted amide motif in their structure (highlighted in red in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), which strongly interacts with the PARP protein through three H-bonds.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> A close examination of the published X-ray structure of <b>6</b> cocrystallized with CK2<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) revealed that the lactam CONH motif of <b>6</b> did not form a H-bond with the CK2 protein. This led us to hypothesize that a chemical modification of the same lactam motif in <b>11c</b> could generate molecules with decreased PARP interaction and potentially provide improved selectivity for CK2. Compound <b>11a</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was therefore subjected to chemical modifications to allow the preparation of analogues in which the lactam had been structurally modified.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <b>6</b> bound to maize CK2α (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MO1">1MO1</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (A) 3D representation. Binding of <b>6</b> was largely determined by van der Waals contacts with several hydrophobic residues (in green) of the ATP-binding pocket (mainly Val45, Val53, Ile66, Val95, Phe113, Val116, Met163, and Ile174). The lactam −CONH− moiety of <b>6</b> was not directly involved in binding to the protein. (B) Schematic 2D view. The carboxylate, essential for activity, formed hydrogen bonds with Lys68, the backbone nitrogen of Asp175, and one water molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The data summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (compounds <b>11c</b>, <b>13a</b>−<b>b</b>, and <b>17a</b>) confirmed our hypothesis. O or N-substitution of the lactam decreased inhibition of PARP while preserving significant inhibition of CK2. Interestingly, substituted 4-aminothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>17a</b> displayed greater activity against CK2. The straightforward access to <b>17a</b> from the activated intermediate <b>14a</b> encouraged us to prepare more amino-substituted analogues <b>17b</b>−<b>p</b>, whose enzymatic activities are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Shorter hydroxy alkyl-substituted analogues <b>17b</b> showed moderate activity against CK2. Replacement of the hydroxy residue by a basic amine in <b>17c</b> resulted in a 10-fold increase of inhibition. A similar boost was achieved with phenyl substituted compound <b>17e</b>, leading us into the potency range of <b>6</b>.<a onclick="showRef(event, 'ref22 ref40'); return false;" href="javascript:void(0);" class="ref ref22 ref40">(22, 40)</a> Introduction of a methyl group onto the aniline nitrogen (<b>17f</b>) or in the ortho position of the phenyl ring (<b>17g</b>) induced a notable loss of activity. This may be explained by a decreased planarity of the inhibitors, resulting in less favorable contact interactions within the small CK2 ATP binding site. This observation was also noticed on tertiary amine <b>17d</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. CK2 Inhibitory Activity of Various C-4 and C-7 Substituted Thieno[3,2-<i>c</i>]quinoline Analogues</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0006.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compd</th><th class="colsep0 rowsep0" align="left">−NR<sup>3</sup>R<sup>4</sup></th><th class="colsep0 rowsep0" align="left">R<sup>2</sup></th><th class="colsep0 rowsep0" align="char" char=".">CK2 <br /></br>IC<sub>50</sub>, μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">−NH-(CH<sub>2</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">1.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="left">−NH-(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.102</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="left">pyrrolidino</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">1.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="left">−NH-phenyl</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.092</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17f</b></td><td class="colsep0 rowsep0" align="left">−NMe-phenyl</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">1.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17g</b></td><td class="colsep0 rowsep0" align="left">−NH-(2-Me-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.970</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">−NH-phenyl</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">>2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">−NH-phenyl</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char=".">>2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">−NH-phenyl</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">−NH-phenyl</td><td class="colsep0 rowsep0" align="left"><i>C</i>-(1<i>H</i>-tetrazol-5-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.096</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">−NH-phenyl</td><td class="colsep0 rowsep0" align="left"><i>C-</i>(4<i>H</i>-1,2,4-triazol-3-yl)</td><td class="colsep0 rowsep0" align="char" char=".">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17h</b></td><td class="colsep0 rowsep0" align="left">−NH-(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.516</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17i</b></td><td class="colsep0 rowsep0" align="left">−NH-(4-F-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.219</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17j</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-F-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.068</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17k</b></td><td class="colsep0 rowsep0" align="left">−NH-(4-Cl-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.178</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17l</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-Cl-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17m</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-MeO-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.077</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17n</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-acetylenyl-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17o</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-(PhO)-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.395</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17p</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-(CONHMe)-phenyl)</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.129</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-Cl-phenyl)</td><td class="colsep0 rowsep0" align="left"><i>C</i>-(1<i>H</i>-tetrazol-5-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.129</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">−NH-(3-F-phenyl)</td><td class="colsep0 rowsep0" align="left"><i>C-</i>(1<i>H</i>-tetrazol-5-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.075</td></tr></tbody></table></div></div><div class="NLM_p">Various analogues lacking a carboxylate at C-7 (compounds <b>15</b>, <b>16</b>, <b>18</b>, and <b>20</b>) were inactive, revealing again the importance of an acidic function at that position. Tetrazole <b>19a</b> retained a similar activity, while its nonacidic triazole <b>20</b> counterpart was inactive, in accordance with the previous observation. Bulky moieties such as in <b>17h</b> and <b>17o</b> decreased activity, suggesting that C-4 substituents were interacting with a relatively small hydrophobic pocket. A number of substituted aniline analogues, bearing an acid (<b>17i</b>−<b>p</b>) or a tetrazole (<b>19b</b>−<b>c</b>) at C-7, were prepared (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Anilines substituted at the meta position by small hydrophobic groups showed the greatest inhibition of CK2, leading to the most potent analogues 3-chloroaniline <b>17l</b> (IC<sub>50</sub> = 0.032 μM) and 3-acetylenylaniline <b>17n</b> (IC<sub>50</sub> = 0.028 μM).</div><div class="NLM_p">To improve potency, we considered replacing the thiophene ring with a six-membered ring, equivalent to the structural feature found in <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). For that purpose, our chemistry was successfully extended to ethyl <i>ortho</i>-bromo benzoate <b>22h</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). CK2 assay on the resulting <b>27h</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) revealed a loss of activity when replacing the thiophene by a phenyl ring. On the basis of that observation, we began to explore analogues bearing nitrogen atoms embedded at various places in the A ring (compounds <b>27e</b>, <b>25a</b>, <b>27d</b>, and <b>27i</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), hypothesizing that we might pick up favorable H-bond interactions with the hinge region. This approach proved to be successful and resulted in the discovery of compound <b>25a</b>, which displayed a dramatic boost in activity (>150-fold) over <b>27h</b> and a 15-fold increase in activity over thieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>17e</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of the A Ring on CK2 Inhibitory Activity</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0007.gif" alt="" id="fx4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0008.gif" alt="" id="fx5" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Encouraged by these results and guided by the thieno[3,2-c]quinoline-7-carboxylates SAR (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), we prepared a focused collection of C-5 substituted analogues of <b>25a</b> whose activities are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> (compounds <b>25b</b>−<b>t</b>). All compounds were generally more potent inhibitors of CK2, and their IC<sub>50</sub> values were 10- to 170-fold lower than their thiophene counterparts.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. CK2 Inhibitory Activity of C-5 Substituted Benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>25a</b>−<b>t</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0009.gif" alt="" id="fx6" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compd</th><th class="colsep0 rowsep0" align="left">R<sup>3</sup></th><th class="colsep0 rowsep0" align="char" char=".">CK2 <br /></br>IC<sub>50</sub>, μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="left">−phenyl</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25b</b></td><td class="colsep0 rowsep0" align="left">−(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.025</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25c</b></td><td class="colsep0 rowsep0" align="left">−cyclopentyl</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25d</b></td><td class="colsep0 rowsep0" align="left">−OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25e</b></td><td class="colsep0 rowsep0" align="left">−cyclopropyl</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25f</b></td><td class="colsep0 rowsep0" align="left">−(CH<sub>2</sub>)<sub>2</sub>O-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25g</b></td><td class="colsep0 rowsep0" align="left">−(CH<sub>2</sub>)phenyl</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25h</b></td><td class="colsep0 rowsep0" align="left">−(CH<sub>2</sub>)<sub>2</sub>phenyl</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25i</b></td><td class="colsep0 rowsep0" align="left">−(CH<sub>2</sub>)<sub>3</sub>phenyl</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25j</b></td><td class="colsep0 rowsep0" align="left">−(3-MeO-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25k</b></td><td class="colsep0 rowsep0" align="left">−(3-Cl, 4-F-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25l</b></td><td class="colsep0 rowsep0" align="left">−(3-F-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25m</b></td><td class="colsep0 rowsep0" align="left">−(2-Cl-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25n</b></td><td class="colsep0 rowsep0" align="left">−(3-Cl-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25o</b></td><td class="colsep0 rowsep0" align="left">−(4-Cl-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25p</b></td><td class="colsep0 rowsep0" align="left">−(3-acetylenyl-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25q</b></td><td class="colsep0 rowsep0" align="left">−(3-CN-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25r</b></td><td class="colsep0 rowsep0" align="left">−(4-(PhO)-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.069</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25s</b></td><td class="colsep0 rowsep0" align="left">−(3-(PhO)-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25t</b></td><td class="colsep0 rowsep0" align="left">−(3-(SO<sub>2</sub>NH<sub>2</sub>)-phenyl)</td><td class="colsep0 rowsep0" align="char" char=".">0.043</td></tr></tbody></table></div></div><div class="NLM_p">Compounds bearing small substituents on C-5 (<b>25d</b>) and various substituted aliphatic amino motifs (<b>25b</b>−<b>c</b> and <b>25e</b>−<b>f</b>) achieved good activity, with IC<sub>50</sub> values ranging from 8 to 27 nM. Remarkably, this position of the molecule appeared to tolerate large extended phenyl substituted aliphatic amino groups (<b>25g</b>−<b>i</b>); the phenethylamino substituted analogue <b>25h</b> being the most potent of the series. Derivatives of anilines substituted by small hydrophobic groups in the meta position (<b>25j</b>−<b>l</b>, <b>25n</b>, and <b>25p</b>−<b>q</b>) again demonstrated the greatest inhibition of CK2, 3-chloroaniline <b>25n</b> being the most potent analogue of this novel class of CK2 inhibitors with an IC<sub>50</sub> of 1 nM. Large substituents (<b>25r</b>, <b>25s</b>) or certain polar groups (<b>25t</b>) decreased the activity of the inhibitors by an order of magnitude. The 3-chloroaniline motif was conserved in subsequent molecules to complete the structure−activity relationship studies.</div><div class="NLM_p">The SAR of various 3-chloroanilines in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> highlights the role of the A-ring and the C-ring substituents. Compounds <b>25n</b>, <b>26a</b>, and <b>26c</b>−<b>g</b> confirmed the essential role of the carboxylate on R2 for potent inhibition. Suppressing the carboxylate (<b>26c</b>) or replacing it by a small nonacidic group (<b>26g</b>−<b>26a</b>, <b>26d</b>−<b>e</b>) resulted in over 400-fold loss of activity. Acidic tetrazole <b>26f</b> retained activity but at a somewhat lower level.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. CK2 Inhibitory Activity of Several Chloroanilines Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0011.gif" alt="" id="_i11" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Methyl groups adjacent to the carboxylate had a position dependent effect. On R1 (<b>41a</b>), a methyl group maintained activity at a potent level, while on R3 (<b>41c</b>), it suppressed activity, suggesting an unfavorable interaction with the protein at that position. Molecules <b>41d</b> and <b>41b</b>, in which the carboxylate was moved to adjacent carbons, were much less active, showing that its position on R2 was necessary for potent inhibition.</div><div class="NLM_p last">Molecules <b>28d</b>−<b>f</b> and <b>28i</b> confirmed the optimal position of the ring-A nitrogen atom on A3, implying a discrete interaction of the nitrogen with the protein. The potent activity of pyrimidine analogue <b>28g</b> further strengthened this observation; showing that an additional nitrogen atom within the ring did not negatively affect activity as far as a nitrogen atom was present in A3 for H-binding.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Binding Model</h3><div class="NLM_p">Compound <b>25n</b> was confirmed to be a potent, ATP-competitive inhibitor of CK2 with a <i>K</i><sub>i</sub> = 0.38 ± 0.02 nM against the recombinant human holoenzyme (ααββ). Drawing on analysis of critical interactions and structural overlay with the numerous previously published and publically available structural studies,<a onclick="showRef(event, 'ref22 ref51 ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref22 ref51 ref52 ref53 ref54 ref55">(22, 51-55)</a> we were able to build a binding model that was consistent with the SAR generated by the present CK2 program. No de novo docking or scoring was performed. Each molecule was subjected to in situ minimization using the CHARMm forcefield as implemented in Discovery Studio 2.5.1 from Accelrys, Inc., following manual placement of the compound. The model oriented the compounds within the ATP binding pocket of the kinase (the PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JWH">1JWH</a> of human CK2α was used as the structural template<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a>). Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows the predicted binding of <b>25n</b> to CK2α. The binding model, which was continually revised to be consistent with information derived from recently published X-ray structures and the most recent in-house SAR data, was principally used to prioritize synthesis and rationalize CK2 inhibition data.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0016.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding model of <b>25n</b> (in green) in the ATP-pocket of CK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structural similarity of these compounds to <b>6</b> suggested that the carboxylate group might bind in a similar orientation to <b>6</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The SAR confirmed the importance of the carboxylate group for binding, so we predicted that the carboxylate of <b>25n</b> made analogous ionic interactions with Lys68.</div><div class="NLM_p">The mainly hydrophobic residues in the ATP binding site of CK2α create a small, flat envelope into which ATP and any inhibitor can bind, as outlined by previous works.<a onclick="showRef(event, 'ref22 ref51 ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref22 ref51 ref52 ref53 ref54 ref55">(22, 51-55)</a> The model suggests that the flat tricyclic cores could make large areas of hydrophobic contacts with binding pocket residues. The flat, hydrophobic nature of the tricyclic core is likely to contribute strongly to the high degree of CK2 inhibition observed. The ring-A pyridine nitrogen of <b>25n</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) is perfectly positioned to form a H-bond with the NH of Val116 in the hinge region, analogous to the interactions seen for ATP analogues. The presence of a hydrogen-bond acceptor in the preferred orientation can explain the increased activity of pyridine analogues. It became obvious from this model that displacement of the nitrogen or the carboxylate from their optimal positions resulted in a geometrically unfavorable configuration, translated experimentally by a major loss of activity in the CK2 assay (compounds <b>26c</b>, <b>41d</b>, <b>41b</b>, <b>28i</b>, and <b>28d</b>−<b>f</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). It is unclear why phenyl analogue <b>27h</b> is significantly less potent than thiophene <b>17e</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We can speculate that it may be related to a greater affinity that sulfur-bearing thiophenes (and hence a reorientation to maximize the binding interaction) have for the sulfur group at Met163.</div><div class="NLM_p">The three components of the interaction of <b>25n</b>, large surface hydrophobic interaction, ionic bridge with the Lys68 region, and H-bond with the hinge region, account for the very potent activity of the benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate series. The 3-chloroaniline moiety has proved to maximize potency on both scaffolds, and the chloro group is likely to fit well within a small hydrophobic region, possibly in the glycine rich loop. Interestingly, the 3D conformation of the anilino moiety of our molecules overlay well with anilino substituents of some pyrazolo[1,5-<i>a</i>][1,3,5]triazines inhibitors, previously cocrystallized with CK2 and described by Nie et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">Finally, our model explains the loss of activity of R3-methyl substituted analogue <b>41c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) by suggesting that the methyl group would clash with the gatekeeper residue phe113.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Kinase Selectivity Profile</h3><div class="NLM_p">Compound <b>25n</b> was screened at 0.5 μM against a panel of 238 kinases (Millipore) to assess its selectivity profile. At 0.5 μM, <b>25n</b> showed no major inhibition of the vast majority of tested kinases, including all isoforms of PI3K, Akt, PDK1, and mTOR. IC<sub>50</sub> values were measured against the seven kinases for which it exhibited greater than 90% inhibition at 0.5 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). As anticipated, the molecule displayed an excellent selectivity profile, which is even more remarkable when considering the low molecular weight (349.8 g/mol) of the molecule. In addition, <b>25n</b> was evaluated at a concentration of 10 μM in relevant cell-based assays for FLT3, PIM1, and CDK1 and was found to be functionally inactive against these kinases.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub> Determination for <b>25n</b> against Several Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">kinase</th><th class="colsep0 rowsep0" align="char" char=".">CK2α</th><th class="colsep0 rowsep0" align="char" char=".">CK2α′</th><th class="colsep0 rowsep0" align="char" char=".">DAPK3</th><th class="colsep0 rowsep0" align="char" char=".">FLT3</th><th class="colsep0 rowsep0" align="char" char=".">TBK1</th><th class="colsep0 rowsep0" align="char" char=".">CLK3</th><th class="colsep0 rowsep0" align="char" char=".">HIPK3</th><th class="colsep0 rowsep0" align="char" char=".">PIM1</th><th class="colsep0 rowsep0" align="char" char=".">CDK1/cyclinB</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr></tbody></table></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cellular Characterization</h3><div class="NLM_p">Several of the most potent CK2 inhibitors were tested for their inhibition of the proliferation of various cancer cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The molecules were active against a broad range of cell types, including breast, lung, and prostate cancers in which CK2 has been previously shown to be overexpressed. The cellular biology of the potent inhibitor <b>25n</b> was further investigated. Compound <b>25n</b> was found to potently inhibit endogenous intracellular CK2 activity with an IC<sub>50</sub> of 0.1 μM in Jurkat cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The differences between IC<sub>50</sub> values of <b>25n</b> in the kinase enzyme assay relative to the cell proliferation assay may be due to multiple factors. However, the greatest contributing factor is likely that the ATP concentration in cells (1−10 mM) is far higher than the ATP concentration (15 μM) used in molecular screening assays. Thus, one would expect that higher concentration of ATP-competitive <b>25n</b> is needed to reach the same level of CK2 inhibition in cells.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0017.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Endogenous CK2 activity of <b>25n</b> in Jurkat cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Cell Antiproliferative Activity of Derivatives for Selected Benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" colspan="2" align="char" char="."> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" colspan="4" align="char" char=".">cell viability IC<sub>50</sub>, μM</th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" align="char" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="char" char="."> </th><th class="colsep0 rowsep0" colspan="3" align="char" char=".">prostate</th><th class="colsep0 rowsep0" colspan="2" align="char" char=".">pancreatic</th><th class="colsep0 rowsep0" colspan="2" align="char" char=".">lung</th><th class="colsep0 rowsep0" colspan="2" align="char" char=".">leukemia</th><th class="colsep0 rowsep0" colspan="3" align="char" char=".">breast</th><th class="colsep0 rowsep0" align="char" char=".">colorectal</th><th class="colsep0 rowsep0" align="char" char=".">melanoma</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compd</th><th class="colsep0 rowsep0" align="char" char=".">CK2 IC<sub>50</sub>, μM</th><th class="colsep0 rowsep0" align="char" char=".">PC3</th><th class="colsep0 rowsep0" colspan="2" align="char" char=".">LNCaP</th><th class="colsep0 rowsep0" align="char" char=".">BxPC3</th><th class="colsep0 rowsep0" align="char" char=".">MIA PaCa-2</th><th class="colsep0 rowsep0" align="char" char=".">A549</th><th class="colsep0 rowsep0" align="char" char=".">H1299</th><th class="colsep0 rowsep0" align="char" char=".">Jurkat</th><th class="colsep0 rowsep0" align="char" char=".">K-562</th><th class="colsep0 rowsep0" align="char" char=".">MCF7</th><th class="colsep0 rowsep0" align="char" char=".">Hs578T</th><th class="colsep0 rowsep0" align="char" char=".">MDA-MB-231</th><th class="colsep0 rowsep0" align="char" char=".">HCT-116</th><th class="colsep0 rowsep0" align="char" char=".">A375</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25n</b></td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" colspan="2" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">13.1</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25p</b></td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td><td class="colsep0 rowsep0" colspan="2" align="char" char=".">17.1</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">30.2</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">10.8</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25h</b></td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">23.6</td><td class="colsep0 rowsep0" colspan="2" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">47.0</td><td class="colsep0 rowsep0" align="char" char=".">21.0</td><td class="colsep0 rowsep0" align="char" char=".">11.1</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">16.5</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">13.2</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25q</b></td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">26.4</td><td class="colsep0 rowsep0" colspan="2" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>50</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">22.0</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">41.0</td><td class="colsep0 rowsep0" align="char" char=".">35.6</td><td class="colsep0 rowsep0" align="char" char=".">28.7</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25k</b></td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" colspan="2" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25j</b></td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">17.4</td><td class="colsep0 rowsep0" colspan="2" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">12.9</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25l</b></td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" colspan="2" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">16.7</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr></tbody></table></div></div><div class="NLM_p last">Additional data demonstrating a CK2-inhibition based antiproliferative and antiangiogenic effect of <b>25n</b> will be fully discussed elsewhere.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Briefly, in various cell lines, CK2 inhibition was confirmed by measuring the phosphorylation level of the CK2 specific phosphorylation site on Akt(S129). <b>25n</b> induced dephosphorylation of Akt(S129)<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and a rapid dephosphorylation of the Akt substrate p21(T145). Compound <b>25n</b> induced apoptosis in multiple cancer cell lines as measured by concentration-dependent induction of caspase 3/7 activity. Normal cells failed to show a detectable change in caspase 3/7 activation within the concentration range tested, indicating that cancer cells might be more vulnerable to <b>25n</b> than normal cells.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Pharmacokinetics and Safety</h3><div class="NLM_p">The pharmacokinetic properties of <b>25n</b> were evaluated in multiple species including mouse, rat, and dog (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). The drug exhibited low to moderate clearance and a wide range of volume of distribution across species. Terminal half-life ranged between 5 and 12 h across species, and oral bioavailability was moderate in all species ranging between 20 and 51%. Furthermore, <b>25n</b> showed minimal inhibition of five of the principal cytochrome P450 isoforms (CYP1A2, CYP2C9, CY2C19, CYP2D6, and CYP3A4).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Also, there was no significant inhibition of the hERG channel by this compound (<10% inhibition at 0.1, 1.0, and 10.0 μM) in the patch clamp assay,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and the molecule was considered nonmutagenic based on the Ames assay and also deemed nongenotoxic in the mouse micronucleus test.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetic Parameters for Compound <b>25n</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">species (<i>n</i> = 3)</th><th class="colsep0 rowsep0" align="left" char=".">iv mg/kg</th><th class="colsep0 rowsep0" align="left" char=".">po mg/kg</th><th class="colsep0 rowsep0" align="left" char=".">Cls<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a> L/h/kg</th><th class="colsep0 rowsep0" align="left" char=".">Vss L/kg</th><th class="colsep0 rowsep0" align="left" char="."><i>T</i><sub>1/2</sub> Hr</th><th class="colsep0 rowsep0" align="left" char=".">po <i>C</i><sub>max</sub> ng/mL</th><th class="colsep0 rowsep0" align="left" char=".">po AUC ng·h/mL</th><th class="colsep0 rowsep0" align="left" char=".">%<i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">5<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">25<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">18.1</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">311</td><td class="colsep0 rowsep0" align="char" char=".">2009</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">5.2<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">10.5<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td><td class="colsep0 rowsep0" align="char" char=".">7369</td><td class="colsep0 rowsep0" align="char" char=".">42343</td><td class="colsep0 rowsep0" align="char" char=".">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">1.9<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">8.2<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">2178</td><td class="colsep0 rowsep0" align="char" char=".">5646</td><td class="colsep0 rowsep0" align="char" char=".">51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Abbreviations: Cls, clearance; Vss, volume of distribution at steady state; <i>T</i><sub>1/2</sub>, elimination half-life; <i>C</i><sub>max</sub>, maximum concentration; AUC, area under the curve; %<i>F</i>, bioavailability.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">(<i>n</i> = 4).</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">The sodium salt of <b>25n</b> was administered in a 25 mM sodium phosphate buffer.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Dogs received PO dose via <b>25n</b> sodium salt filled capsules.</p></div></div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Efficacy in Tumor Xenograft Studies</h3><div class="NLM_p">Compound <b>25n</b> was selected for in vivo efficacy in established human prostate PC3 xenograft model in athymic mice (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Mice bearing subcutaneous PC3 tumors were treated with <b>25n</b> (25 mg/kg, 50 mg/kg, and 75 mg/kg, po, bid). <b>25n</b> demonstrated tumor growth inhibition (TGI = 19%, 40%, and 86%, respectively) compared to vehicle treated control, and a dose responsive efficacy was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Last, <b>25n</b> was well tolerated in mice as assessed by minimal changes in body weight during the course of treatment compared to vehicle control. Other efficacy studies in various models further confirmed the tolerability of the drug and will be reported elsewhere.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0018.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo growth inhibitory effect of <b>25n</b> on human prostate cancer PC3 xenografts in nude mice. Compound <b>25n</b> dosed bid at 25 mg/kg (tumor growth inhibition TGI = 19%), 50 mg/kg (TGI = 40%), and 75 mg/kg (TGI = 86%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have discovered a novel family of ATP-competitive inhibitors of CK2 using both structure- and chemistry-based optimization. This work culminated in the discovery of <b>25n</b>, a potent and selective inhibitor of CK2 that is efficacious in animal models of cancer. The SAR information acquired during the lead optimization of this new class of drugs has been used to identify key structural elements necessary to achieve potent CK2 inhibition. As a result, we have established a binding model that rationalizes the multiple components of the strong interaction of <b>25n</b> with the ATP binding pocket, providing valuable information for the design of future classes of small molecule CK2 inhibitors.</div><div class="NLM_p">While being beneficial for selectivity, the small size of the cofactor site of CK2 also predisposes for the discovery of hydrophobic inhibitors with poor drug-like properties. Remarkably, <b>25n</b> attained a favorable balance between potency and pharmacokinetics, a challenging achievement that we believe to be atypical with small molecule CK2 inhibitors.</div><div class="NLM_p">The complexity of the regulation of CK2, its pleiotropy, and the wide distribution of the protein has raised the question of whether CK2 inhibitors can selectively kill cancer cells while sparing normal cells. We have shown that <b>25n</b> was efficacious in xenograft models of cancer and remained very well tolerated. Compound <b>25n</b> (CX-4945) demonstrated an acceptable pharmaceutical profile and is currently being evaluated clinically as a first-in-class CK2 inhibitor for the treatment of cancer.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p last">Beyond cancer, CK2 plays multiple roles in inflammation disorders, neurodegenerative diseases, and viral or parasitic infections.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The discovery of <b>25n</b> and the human pharmacology resulting from the modulation of CK2 may open the door to the discovery of new treatments for diseases in which this protein is dysregulated.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Methods</h4><div class="NLM_p">All solvents and reagents, unless otherwise stated, were reagent grade, commercially available, and used without further purification. All experiments using moisture sensitive reagents were carried out under a dry nitrogen atmosphere. Microwave irradiation was carried out in a CEM Discover series microwave reactor with the Explorer autosampler. Thin layer chromatography was performed Watman Partisil K6F 60 Å silica gel plates (250 μm for analytical or 20 cm × 20 cm, 1000 μm for preparative) with fluorescent indicator and visualized with 254 nm UV light. Flash column chromatography was conducted either under medium pressure using Watman 60 Å, 230−400 mesh ASTM bulk silica gel or on prepacked silica gel cartridges (Biotage). Reverse phase HPLC purification was conducted utilizing mass directed fraction collection employing a Waters Micromass ZQ mass spectrometer with an electrospray probe. Fraction collection was achieved with a Waters 2767 fraction collector driven by a Waters 2525 binary pump. Fractions were collected by mass, UV signal (Waters 2487 dual wave) or a combination of both. The stationary phase is a Phenomenex Luna 5 μm C18 100 Å Axia 21.2 mm × 50 mm column with a mobile phase gradient of 25−95% CH<sub>3</sub>CN or MeOH in H<sub>2</sub>O with 0.1% TFA. Compounds were generally isolated after preparative HPLC by evaporation of the solvents using a Genevac DD-4 evaporator with a fixed rotor. NMR spectra were recorded in CDCl<sub>3</sub>, CD<sub>3</sub>OD, or DMSO-<i>d</i><sub>6</sub> on a Varian Mercury 400 with an AutoX DB PFG probe and Protune accessory operating at 400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C. Trimethyl silane (TMS) was used as internal reference. Chemical shifts (δ) are reported in parts per million (ppm) and coupling constants (<i>J</i>) in hertz (Hz). The following abbreviations are used for multiplicities: s = singlet, br = broad, d = doublet, t = triplet, m = multiplet, dd = doublet of doublet, q = quadruplet, qi = quintuplet, sext = sextuplet. Unless otherwise specified, all final compounds were homogeneous with a purity of ≥95%, as determined by LCMS analysis conducted on a Waters 2695 HPLC/MS system with Micromass ZQ and 2487 UV detectors using a gradient of 10−90% 0.05% TFA in ACN and 0.1% TFA in DI water.</div><div class="NLM_p last">5-Bromopyrimidine-4-carboxylic acid <b>21g</b> was prepared according to a procedure previously described in a patent.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> 4-(Diisopropylcarbamoyl)pyridin-3-ylboronic acid <b>38</b> was prepared using a published procedure.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Compounds <b>8</b>, <b>10a</b>−<b>c</b>, <b>21a</b>, <b>21e</b>−<b>g</b>, <b>21i</b>, <b>22d</b>, <b>22h</b>, <b>29</b>, <b>31</b>, <b>33</b>, <b>37</b>, and the various amines used to prepare analogues described in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> are commercially available.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl 2-Bromothiophene-3-carboxylate (<b>9</b>)</h4><div class="NLM_p last">2-Bromo-3-thiophene carboxylic acid <b>8</b> (1.0 equiv, 12.56 g, 60.66 mmol) was suspended in CH<sub>2</sub>Cl<sub>2</sub> (200 mL). Oxalyl chloride (1.1 equiv, 5.9 mL, 67.16 mmol) and 5 drops of DMF were added, inducing formation of gas. The mixture was stirred overnight at room temperature, and the volatiles were removed in vacuo. The resulting solid was suspended in dry methanol (150 mL) and the mixture heated to reflux. Evaporation of the solvents afforded methyl 2-bromo-3-thiophene carboxylate <b>9</b> (13.16 g, 98%) as a crude brown oil. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> not detected. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 3.88 (s, 3H), 7.23 (d, <i>J</i> = 5.6, 1H), 7.56 (d, <i>J</i> = 5.6, 1H) ppm.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl 4-Oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate (<b>11a</b>)</h4><div class="NLM_p last">In a microwave vial, methyl 2-bromo-3-thiophene carboxylate <b>9</b> (1.0 equiv, 260 mg, 1.18 mmol), 2-amino-4-(methoxycarbonyl)phenylboronic acid hydrochloride <b>10a</b> (1.1 equiv, 300 mg, 1.30 mmol), sodium acetate (3.0 equiv, 292 mg, 3.56 mmol), and PdCl<sub>2</sub> (dppf) (0.05 equiv, 31 mg, 0.059 mmol) were mixed together in anhydrous DMF (2 mL). The mixture was heated in a microwave oven at 120 °C for 10 min. Water was added and the solid filtered and dried. The material was suspended in dichloromethane, filtered, and dried to afford methyl 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>11a</b> as a yellow solid (152 mg, 50%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 260 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 3. 99 (s, 3H), 7.54 (d, <i>J</i> = 5.2, 1H), 7.79 (d, <i>J</i> = 4.8, 1H), 7.86 (d, <i>J</i> = 8.4, 1H), 7.91 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 8.03 (d, <i>J</i> = 1.2, 1H) ppm.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-Oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>11c</b>)</h4><div class="NLM_p last">Methyl 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>11a</b> (1.0 equiv, 618 mg, 2.38 mmol) was suspended in 10 mL of a mixture of methanol, THF, and water (1:1:1, v:v:v). LiOH (2.0 equiv, 114 mg, 4.76 mmol) was added, and the mixture was stirred at room temperature for 2 h. An additional amount of LiOH (114 mg) was added, and the mixture was stirred for an hour. LiOH (50 mg) was added and the mixture stirred for an additional 2 h. Water was added and the solution filtered through a pad of Celite. The pad of Celite was thoroughly washed with aqueous 1 N NaOH. The solution was acidified with 6 N aqueous hydrochloric acid to induce precipitation of the expected material. Filtration and drying afforded <b>11c</b> as a yellow solid (562 mg, 96%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 246 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.61 (d, <i>J</i> = 5.2, 1H), 7.73 (dd, <i>J</i> = 1.6, <i>J</i> = 8.0, 1H), 7.88 (d, <i>J</i> = 5.6, 1H), 7.92 (d, <i>J</i> = 8.4, 1H), 8.02 (d, <i>J</i> = 1.6, 1H), 11.92 (s, 1H), 13.21 (br s, 1H) ppm.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 7-(Hydroxymethyl)thieno[3,2-<i>c</i>]quinolin-4(5<i>H</i>)-one (<b>11d</b>)</h4><div class="NLM_p last">4-Oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylic acid <b>11c</b> (1.0 equiv, 38 mg, 0.155 mmol) was suspended in dioxane (1 mL). LiAlH<sub>4</sub> (7.0 equiv, 40 mg, 1.05 mmol) was added and the mixture stirred at 100 °C for 45 min. Water was added, then methanol and CH<sub>2</sub>Cl<sub>2</sub>. The solid salts were filtered off and washed with methanol and CH<sub>2</sub>Cl<sub>2</sub>. After evaporation of the volatiles in vacuo, the material was dissolved in a mixture of NMP, methanol and water and was purified by preparative HPLC. Genevac evaporation afforded 7-(hydroxymethyl)thieno[3,2-<i>c</i>]quinolin-4(5<i>H</i>)-one <b>11d</b> as an off-white solid (12 mg, 34%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 232 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 4.56 (s, 2H), 7.15 (d, <i>J</i> = 7.6, 1H), 7.39 (br s, 1H), 7.55 (d, <i>J</i> = 5.2, 1H), 7.73 (d, <i>J</i> = 5.2, 1H), 7.76 (d, <i>J</i> = 8.0, 1H), 11.73 (s, 1H) ppm.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-Oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxamide (<b>11e</b>)</h4><div class="NLM_p last">In a closed vessel, methyl 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>11a</b> (44 mg, 0.170 mmol) was suspended in concentrated aqueous ammonia (1 mL). The mixture was stirred at 100 °C overnight. Aqueous 1N NaOH was added and the mixture stirred at room temperature for 2 h. The solid was filtered and dried to provide 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxamide <b>11e</b> as a brown solid (13 mg, 32%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 245 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.51 (br s, 1H), 7.62 (d, <i>J</i> = 4.8, 1H), 7.70 (d, <i>J</i> = 8.4, 1H), 7.87 (d, <i>J</i> = 5.2, 1H), 7.92 (m, 2H), 8.11 (br s, 1H), 11.89 (br s, 1H) ppm.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-Oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carbonitrile (<b>11b</b>)</h4><div class="NLM_p last">In a microwave vial, methyl 2-bromo-3-thiophene carboxylate <b>9</b> (1.0 equiv, 250 mg, 1.13 mmol), 2-amino-3-cyanophenyl boronic acid hydrochloric acid <b>10b</b> (1.1 equiv, 250 mg, 1.24 mmol), sodium acetate (3.0 equiv, 278 mg, 3.39 mmol), and PdCl<sub>2</sub> (dppf) (0.007 equiv, 4.3 mg, 0.0082 mmol) were mixed together in anhydrous DMF (2.5 mL). The mixture was heated in a microwave oven at 120 °C for 10 min. Water was added and the material extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvents removed in vacuo. The resulting solid was sonicated in EtOAc, filtered, and dried to afford 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carbonitrile <b>11b</b> as a tan solid (121 mg, 48%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 227 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.65 (m, 2H), 7.75 (br s, 1H), 7.97 (d, <i>J</i> = 5.2, 1H), 8.06 (d, <i>J</i> = 8.4, 1H), 12.03 (br s, 1H) ppm.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 4-(3-Hydroxypropoxy)thieno[3,2-<i>c</i>]quinoline-7-carboxylate (<b>12b</b>) and Methyl 5-(3-Hydroxypropyl)-4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate (<b>12a</b>)</h4><div class="NLM_p last">Methyl 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>11a</b> (1.0 equiv, 18 mg, 0.069 mmol) was dissolved in anhydrous DMF (0.4 mL). K<sub>2</sub>CO<sub>3</sub> (7.0 equiv, 70 mg, 0.506 mmol) and 3-bromo-1-propanol (16 equiv, 100 μL, 1.144 mmol) were added and the mixture stirred at 100 °C for 1.5 h. After adding water, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvents removed in vacuo. Compounds <b>12a</b> and <b>12b</b> were separated by preparative TLC on silica gel (eluted twice with 30% EtOAc in hexanes, then once with 50% EtOAc in hexanes). The less polar compound was identified as methyl 4-(3-hydroxypropoxy)thieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>12b</b> (12 mg). TLC (50% EtOAc/hexanes) <i>R</i><sub>f</sub> = 0.5. LCMS (ES): 80% pure, <i>m</i>/<i>z</i> 318 [M + H]<sup>+</sup>. The more polar compound was identified as methyl 5-(3-hydroxypropyl)-4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>12a</b> (19 mg). TLC (50% EtOAc/hexanes) <i>R</i><sub>f</sub> = 0.2. LCMS (ES): 80% pure, <i>m</i>/<i>z</i> 318 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 2.08 (qi, <i>J</i> = 6.0, 2H), 3.61 (t, <i>J</i> = 5.2, 2H), 4.62 (t, <i>J</i> = 6.0, 2H), 7.53 (d, <i>J</i> = 5.2, 1H), 7.77 (d, <i>J</i> = 5.2, 1H), 7.93 (d, <i>J</i> = 8.0, 1H), 7.99 (dd, <i>J</i> = 1.2, <i>J</i> = 8.4, 1H), 8.26 (d, <i>J</i> = 0.8, 1H) ppm. Structural assignement was based on NMR spectra of their respective carboxylic acids. The two compounds were used for the following step without any further purification.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-(3-Hydroxypropyl)-4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>13a</b>)</h4><div class="NLM_p last">Methyl 5-(3-hydroxypropyl)-4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>12a</b> (1.0 equiv, 19 mg, 0.060 mmol) was dissolved in a 1:1:1 mixture of THF, methanol, and water (0.5 mL). LiOH (40 mg) was added and the resulting mixture stirred at room temperature for 1.5 h. Water, methanol, and hydrochloric acid were added and the solution purified by preparative HPLC. Genevac evaporation afforded 5-(3-hydroxypropyl)-4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylic acid <b>13a</b> as a white solid (4 mg, 22%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 304 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>/CD<sub>3</sub>OD, 9:1, 400 MHz): δ 2.08 (qi, <i>J</i> = 6.0, 2H), 3.61 (t, <i>J</i> = 5.2, 2H), 4.62 (t, <i>J</i> = 6.0, 2H), 7.53 (d, <i>J</i> = 5.2, 1H), 7.77 (d, <i>J</i> = 5.2, 1H), 7.93 (d, <i>J</i> = 8.0, 1H), 7.99 (dd, <i>J</i> = 1.2, <i>J</i> = 8.4, 1H), 8.26 (d, <i>J</i> = 0.8, 1H) ppm.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-(3-Hydroxypropoxy)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>13b</b>)</h4><div class="NLM_p last">The title compound was prepared according to the procedure used to prepare compound <b>13a</b> starting from methyl 4-(3-hydroxypropoxy)thieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>12b</b>. The title compound <b>13b</b> was isolated as a solid (3 mg, 26%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 304 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>/CD<sub>3</sub>OD, 9:1, 400 MHz): δ 2.04 (qi, <i>J</i> = 6.0, 2H), 3.68 (t, <i>J</i> = 6.0, 2H), 4.69 (t, <i>J</i> = 6.4, 2H), 7.52 (d, <i>J</i> = 4.8, 1H), 7.54 (dd, <i>J</i> = 5.2, <i>J</i> = 1.6, 1H), 7.93 (d, <i>J</i> = 8.4, 1H), 7.97 (dd, <i>J</i> = 7.6, <i>J</i> = 0.8, 1H), 8.49 (d, <i>J</i> = 0.8, 1H) ppm.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Chlorothieno[3,2-<i>c</i>]quinoline-7-carboxylate (<b>14a</b>)</h4><div class="NLM_p last">Methyl 4-oxo-4,5-dihydrothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>11a</b> (1.0 equiv, 1.50 g, 5.79 mmol) was suspended in dry toluene (15 mL). Phosphorus oxychloride (1.2 equiv, 0.64 mL, 6.99 mmol) and DIEA (0.8 equiv, 0.81 mL, 4.65 mmol) were added and the mixture vigorously stirred at 120 °C for 3 h under nitrogen atmosphere. The mixture was hydrolyzed by addition of ice and water. The compound was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4×). The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and the black solution filtered through a pad of Celite. After evaporation of the volatiles in vacuo, the resulting solid was triturated in a mixture of EtOAc and hexanes. Filtration and drying provided methyl 4-chlorothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>14a</b> as a yellow fluffy solid (1.14 g, 71%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 278 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.01 (s, 3H), 7.72 (d, <i>J</i> = 4.8, 1H), 7.74 (d, <i>J</i> = 5.2, 1H), 8.14 (d, <i>J</i> = 8.4, 1H), 8.25 (d, <i>J</i> = 8.4, 1H), 8.85 (d, <i>J</i> = 1.6, 1H) ppm.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-Chlorothieno[3,2-<i>c</i>]quinoline-7-carbonitrile (<b>14b</b>)</h4><div class="NLM_p last">The title compound was prepared according to the procedure used to prepare <b>14a</b> starting from 4-chlorothieno[3,2-<i>c</i>]quinoline-7-carbonitrile <b>11b</b> (1.00 g, 4.42 mmol). The title compound <b>14b</b> was isolated as a brown solid (833 mg, 77%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 245 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.80 (d, <i>J</i> = 4.8, 1H), 8.04 (br d, <i>J</i> = 7.2, 1H), 8.27 (d, <i>J</i> = 5.2, 1H), 8.44 (d, <i>J</i> = 8.4, 1H), 8.63 (br s, 1H) ppm.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl 4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylate (<b>15</b>)</h4><div class="NLM_p last">Methyl 4-chlorothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>14a</b> (1.0 equiv, 60 mg, 0.216 mmol) was mixed with aniline (10.1 equiv, 0.2 mL, 2.19 mmol) and NMP (0.2 mL). The mixture was reacted in a microwave oven at 120 °C for 10 min. Water was added, and the product was extracted with dichloromethane. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed in vacuo. The residue was triturated with dichloromethane, EtOAc, and hexanes to give a solid. After filtration and drying, the title compound <b>15</b> was isolated as a brown solid. (56 mg, 81%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carbonitrile (<b>16</b>)</h4><div class="NLM_p last">4-Chlorothieno[3,2-<i>c</i>]quinoline-7-carbonitrile <b>14b</b> (1.0 equiv, 130 mg, 0.533 mmol), aniline (0.2 mL), and NMP (0.2 mL) were mixed in a microwave vessel. The mixture was heated in a microwave oven at 120 °C for 10 min. Water was added, and the resulting solid was filtered and dried. 4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carbonitrile <b>16</b> was isolated as a gray solid (132 mg, 83%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 302 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.07 (t, <i>J</i> = 7.2, 1H), 7.38 (td, <i>J</i> = 7.6, <i>J</i> = 2.0, 2H), 7.66 (dd, <i>J</i> = 8.0, <i>J</i> = 1.6, 1H), 8.08 (dd, <i>J</i> = 8.8, <i>J</i> = 1.2, 2H), 8.11 (d, <i>J</i> = 4.8, 1H), 8.14 (d, <i>J</i> = 8.4, 1H), 8.19 (d, <i>J</i> = 1.6, 1H), 8.26 (d, <i>J</i> = 5.2, 1H), 9.40 (s, 1H) ppm.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17e</b>)</h4><div class="NLM_p last">Methyl 4-(phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>15</b> (15 mg, 0.045 mmol) was reacted in a mixture of THF (0.5 mL), methanol (0.5 mL), water (0.5 mL), and lithium hydroxide (60 mg) at room temperature overnight. Water was added and the mixture acidified by addition of hydrochloric acid. The volatiles solvents were removed in vacuo, and the resulting solid was filtered and dried. The title compound <b>17e</b> was isolated as an off-white solid (6 mg, 42%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 321 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.28 (br s, 1H), 7.51 (t, <i>J</i> = 6.8, 2H), 7.87 (br s, 2H), 7.93 (d, <i>J</i> = 8.8, 1H), 8.16 (m, 2H), 8.35 (d, <i>J</i> = 5.2, 1H), 8.47 (br s, 1H) ppm.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> General Procedure for the Synthesis of Compounds <b>17a</b>−<b>d</b> and <b>17f</b>−<b>p</b></h4><div id="sec5_1_16_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Synthesis of 4-(3-Hydroxypropylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17a</b>)</h5><div class="NLM_p last">Methyl 4-chlorothieno[3,2-<i>c</i>]quinoline-7-carboxylate <b>14a</b> (7 mg, 0.025 mmol) was mixed with 3-amino-1-propanol (0.1 mL) and NMP (0.1 mL). The mixture was reacted in a microwave oven at 100 °C for 5 min. The mixture was diluted with NMP and purified by preparative HPLC. After evaporation of the solvents in vacuo, the resulting ester was reacted with lithium hydroxide (40 mg, 1.67 mmol) in a 1:1:1 mixture of THF/methanol/water (0.5 mL) at room temperature for 2 h. The resulting mixture was diluted and the compound purified by preparative HPLC. After evaporation of the solvents in vacuo, the title compound <b>17a</b> was isolated as a white solid (4.6 mg, 61%). Alternatively, materials could be isolated in a pure form after dilution of the mixture, acidification by hydrochloric acid and filtration of the resulting precipitate. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 303 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.89 (qi, <i>J</i> = 6.4, 2H), 3.56 (t, <i>J</i> = 6.4, 2H), 3.71 (q, <i>J</i> = 6.0, 2H), 7.86 (br s, 1H), 8.06 (br s, 3H), 8.40 (br s, 1H) ppm.</div></div><div id="sec5_1_16_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 4-(2-Hydroxyethylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17b</b>)</h5><div class="NLM_p last">Yield, 21%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 289 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4-(2-(Dimethylamino)ethylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid, Trifluoroacetate Salt (<b>17c</b>)</h5><div class="NLM_p last">After preparative HPLC, the material was isolated as a TFA salt. Yield, 57%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 316 [M + H]<sup>+</sup>, 271 [M + H − NHMe<sub>2</sub>]<sup>+</sup>.</div></div><div id="sec5_1_16_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 4-(Pyrrolidin-1-yl)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17d</b>)</h5><div class="NLM_p last">Yield, 47%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 299 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.11 (br s, 4H), 3.95 (br s, 2H), 4.20 (br s, 2H), 7.95 (br s, 1H), 8.18 (br s, 3H), 8.82 (br s, 1H), 12.0 (br s, 1H) ppm.</div></div><div id="sec5_1_16_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 4-(Methyl(phenyl)amino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17f</b>)</h5><div class="NLM_p last">Yield, 75%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.68 (s, 3H), 6.12 (d, <i>J</i> = 5, 1H), 7.38 (m, 3H), 7.49 (m, 2H), 7.73 (d, <i>J</i> = 5.2, 1H), 7.95 (d, <i>J</i> = 8.8, 1H), 8.15 (d, <i>J</i> = 8.8, 1H), 8.55 (br s, 1H) ppm.</div></div><div id="sec5_1_16_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 4-(<i>o</i>-Tolylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17g</b>)</h5><div class="NLM_p last">Yield, 90%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.31 (s, 3H), 7.44 (br s, 2H), 7.50 (br s, 1H), 7.55 (m, 1H), 7.98 (br m, 1H), 8.24 (br m, 2H), 8.40 (br s, 1H), 8.56 (br s, 1H) ppm.</div></div><div id="sec5_1_16_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 4-(Phenethylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17h</b>)</h5><div class="NLM_p last">Yield, 56%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 349 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.12 (t, <i>J</i> = 7.6, 2H), 4.01 (br s, 2H) 7.23 (t, <i>J</i> = 6.8, 1H), 7.33 (t, <i>J</i> = 7.6, 2H), 7.39 (d, <i>J</i> = 7.6, 2H), 7.98 (br m, 1H), 8.18 (br m, 2H), 8.34 (br s, 1H), 8.78 (br s, 1H), 10.22 (br s, 1H), 12.83 (br s, 1H), 13.45 (br s, 1H) ppm.</div></div><div id="sec5_1_16_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 4-(4-Fluorophenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17i</b>)</h5><div class="NLM_p last">Yield, 75%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 339 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.38 (br t, <i>J</i> = 7.4, 2H), 7.95 (m, 3H), 8.18 (m, 2H), 8.36 (br d, <i>J</i> = 5.9, 1H), 8.48 (br s, 1H) ppm.</div></div><div id="sec5_1_16_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-(3-Fluorophenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17j</b>)</h5><div class="NLM_p last">Yield, 75%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 339 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.06 (br t, <i>J</i> = 8.0, 1H), 7.51 (q, <i>J</i> = 6, 1H), 7.77 (br d, <i>J</i> = 9.6, 1H), 7.96 (dd, <i>J</i> = 8.0, <i>J</i> = 1.6, 1H), 8.04 (br d, <i>J</i> = 12.8, 1H), 8.16 (s, 1H), 8.17 (d, <i>J</i> = 4.0, 1H), 8.47 (m, 2H) ppm.</div></div><div id="sec5_1_16_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 4-(4-Chlorophenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17k</b>)</h5><div class="NLM_p last">Yield, 100%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 355 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.50 (d, <i>J</i> = 8.0, 2H), 7.92 (d, <i>J</i> = 8.4, 1H), 8.13 (m, 3H), 8.28 (d, <i>J</i> = 5.6, 1H), 8.41(s, 1H), 9.80 (br s, 1H) ppm.</div></div><div id="sec5_1_16_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 4-(3-Chlorophenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17l</b>)</h5><div class="NLM_p last">Yield, 49%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 355 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.20 (br d, <i>J</i> = 8, 1H), 7.47 (t, <i>J</i> = 8, 1H), 7.93 (d, <i>J</i> = 8.4, 1H), 8.05 (d, <i>J</i> = 8, 1H), 8.14 (m, 2H), 8.32 (m, 2H), 8.40 (m, 1H), 9.95 (br s, 1H) ppm.</div></div><div id="sec5_1_16_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 4-(3-Methoxyphenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17m</b>)</h5><div class="NLM_p last">Yield, 87%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 351 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.83 (s, 3H), 6.88 (br s, 1H), 7.42 (m, 2H), 7.62 (br, 1H), 7.96 (br d, <i>J</i> = 9, 2H), 8.19 (br d, <i>J</i> = 8, 2H), 8.38 (br d, <i>J</i> = 4.1, 1H), 8.50 (br s, 1H) ppm.</div></div><div id="sec5_1_16_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 4-(3-Ethynylphenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17n</b>)</h5><div class="NLM_p last">Yield, 59%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 4.23 (s, 1H), 7.26 (br s, 1H), 7.47 (t, <i>J</i> = 7.6, 1H), 7.93 (d, <i>J</i> = 8.4, 1H), 8.13 (m, 3H), 8.22 (s, 1H), 8.31 (d, <i>J</i> = 5.2, 1H), 8.39 (s, 1H), 9.78 (br, 1H) ppm.</div></div><div id="sec5_1_16_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 4-(3-Phenoxyphenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17o</b>)</h5><div class="NLM_p last">Yield, 80%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 413 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 6.91 (br m, 1H), 7.19 (m, 3H), 7.46 (m, 3H), 7.64 (br d, <i>J</i> = 8, 1H), 7.82 (br s, 1H), 7.93 (d, <i>J</i> = 8.8, 1H), 8.13 (d, <i>J</i> = 6, 2H), 8.36 (br s, 1H), 8.48 (br d, <i>J</i> = 4.4, 1H) ppm.</div></div><div id="sec5_1_16_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 4-(3-(Methylcarbamoyl)phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxylic Acid (<b>17p</b>)</h5><div class="NLM_p last">Yield, 49%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 2.83 (d, <i>J</i> = 4, 3H), 7.58 (br t, 1H), 7.71 (br s, 1H), 7.95 (d, <i>J</i> = 8, 1H), 8.17 (m, 2H), 8.33 (br s, 1H), 8.46 (br m, 2H), 8.55 (br s,1H) ppm.</div></div></div><div id="sec5_1_16_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxamide (<b>18</b>)</h4><div class="NLM_p last">4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carbonitrile <b>16</b> (34 mg, 0.113 mmol) was dissolved in NMP (0.3 mL). Aqueous H<sub>2</sub>O<sub>2</sub> (30%, 0.2 mL) was added, followed by addition of 6N NaOH (50 μL). The mixture was stirred at 50 °C for 2 h. An extra amount of 30% aqueous H<sub>2</sub>O<sub>2</sub> (0.3 mL) and 6N NaOH (100 μL) were added to reach 70% conversion in 30 min. Water was added and the solid filtered and dried. The material was further reacted under the same conditions in order to achieve a complete transformation. 4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxamide <b>18</b> was isolated as a solid (30 mg, 83%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 320 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-Phenyl-7-(4<i>H</i>-1,2,4-triazol-3-yl)thieno[3,2-<i>c</i>]quinolin-4-amine (<b>20</b>)</h4><div class="NLM_p last">4-(Phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carboxamide <b>18</b> (28 mg, 0.088 mmol) was suspended in <i>N</i>,<i>N</i>-dimethylformamide dimethylacetal and the mixture stirred at 80 °C under nitrogen atmosphere for 2 h. The volatiles were removed in vacuo. Acetic acid (0.5 mL) and anhydrous hydrazine (0.1 mL) were added, and the mixture was stirred at 115 °C for 1 h. Water and brine were added and the solid was filtered. The material was purified by preparative HPLC. Genevac evaporation and trituration in EtOAc/hexanes afforded the title compound <b>20</b> as an off-white solid (9 mg, 30%). LCMS (ES): 94% pure, <i>m</i>/<i>z</i> 344 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>/CD<sub>3</sub>OD, 9:1, 400 MHz) δ 6.57 (d, <i>J</i> = 4.8, 1H), 7.42−7.44 (m, 3H), 7.47−7.52 (m, 3H), 8.10 (d, <i>J</i> = 8.4, 1H), 8.14 (s, 1H), 8.30 (d, <i>J</i> = 7.2, 1H), 8.39 (s, 1H) ppm.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> General Procedure for the Synthesis of Tetrazole Analogues <b>19a</b>−<b>c</b></h4><div id="sec5_1_17_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> <i>N</i>-Phenyl-7-(1<i>H</i>-tetrazol-5-yl)thieno[3,2-<i>c</i>]quinolin-4-amine (<b>19a</b>)</h5><div class="NLM_p last">4-Chlorothieno[3,2-<i>c</i>]quinoline-7-carbonitrile <b>14b</b> (1.0 equiv, 23 mg, 0.094 mmol), aniline (0.1 mL), and NMP (0.1 mL) were mixed in a microwave vial. The mixture was heated in a microwave oven at 120 °C for 10 min. Water was added and the resulting intermediate 4-(phenylamino)thieno[3,2-<i>c</i>]quinoline-7-carbonitrile <b>16</b> was filtered and dried. This crude material was mixed in a vial with DMF (0.5 mL), NH<sub>4</sub>Cl (50 mg), and NaN<sub>3</sub> (50 mg). The mixture was stirred at 120 °C for 3 h. After addition of water and filtration, <i>N</i>-phenyl-7-(1<i>H</i>-tetrazol-5-yl)thieno[3,2-<i>c</i>]quinolin-4-amine <b>19a</b> was isolated as a beige solid (13 mg, 41%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>, 317 [M + H − N<sub>2</sub>]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.07 (t, <i>J</i> = 7.2, 1H), 7.40 (t, <i>J</i> = 7.6, 2H), 8.00 (dd, <i>J</i> = 1.6, <i>J</i> = 8.4, 1H), 8.04 (d, <i>J</i> = 5.2, 1H), 8.10 (dd, <i>J</i> = 1.2, <i>J</i> = 8.8, 2H), 8.19 (d, <i>J</i> = 8.0, 1H), 8.25 (d, <i>J</i> = 5.6, 1H), 8.43 (d, <i>J</i> = 1.6, 1H), 9.34 (s, 1H) ppm.</div></div><div id="sec5_1_17_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> <i>N</i>-(3-Chlorophenyl)-7-(1<i>H</i>-tetrazol-5-yl)thieno[3,2-<i>c</i>]quinolin-4-amine (<b>19b</b>)</h5><div class="NLM_p last">Yield, 13%. LCMS (ES):>95% pure, <i>m</i>/<i>z</i> 379 [M + H]<sup>+</sup>, 351 [M + H − N<sub>2</sub>]<sup>+</sup>.</div></div><div id="sec5_1_17_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> <i>N</i>-(3-Fluorophenyl)-7-(1<i>H</i>-tetrazol-5-yl)thieno[3,2-<i>c</i>]quinolin-4-amine (<b>19c</b>)</h5><div class="NLM_p last">Yield, 47%. LCMS (ES): > 95% pure, <i>m</i>/<i>z</i> 363 [M + H]<sup>+</sup>, 335 [M + H − N<sub>2</sub>]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 6.89 (td, <i>J</i> = 8.4, <i>J</i> = 2.4, 1H), 7.43 (q, <i>J</i> = 7.9, 1H), 7.85 (dd, <i>J</i> = 1.2, <i>J</i> = 8.0, 1H), 8.06−8.09 (m, 2H), 8.23 (d, <i>J</i> = 8.0, 1H), 8.27 (d, <i>J</i> = 5.6, 1H), 8.33 (dt, <i>J</i> = 2.0, <i>J</i> = 12.4, 1H), 8.51 (d, <i>J</i> = 1.2, 1H), 9.53 (s, 1H) ppm.</div></div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Ethyl 3-Bromoisonicotinate (<b>22a</b>)</h4><div class="NLM_p last">3-Bromoisonicotinic acid <b>21a</b> (3.0 g, 14.9 mmol) in ethanol (100 mL) was treated with concentrated sulfuric acid (5 mL). The mixture was brought to reflux, at which time everything went into solution. After 12 h at reflux, LCMS indicated that the reaction was complete. The reaction mixture was cooled to room temperature and concentrated on a rotary evaporator to a third of its original volume. The mixture was then diluted with 250 mL of ethyl acetate and washed twice with saturated aqueous sodium bicarbonate. Concentration on a rotary evaporator yielded ethyl 3-bromoisonicotinate <b>22a</b> (3.25 g, 95%) as a yellowish oil which was sufficiently pure for subsequent chemical transformations. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 230 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.37 (t, <i>J</i> = 8.0, 3H), 4.39 (q, <i>J</i> = 7.2, 2H), 7.57 (d, <i>J</i> = 5.2, 1H), 8.57 (d, <i>J</i> = 4.8, 1H), 8.04 (s, 1H) ppm.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Methyl 5-Bromopyrimidine-4-carboxylate (<b>22g</b>)</h4><div class="NLM_p last">Crude 5-bromopyrimidine-4-carboxylic acid <b>21g</b> (prepared according to the procedure described in literature<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a>) (1.0 equiv, 6.14 g, 30.2 mmol) was suspended in CH<sub>2</sub>Cl<sub>2</sub> (100 mL). Oxalylchloride (1.1 equiv, 2.9 mL, 33.0 mmol) was added followed by 2 drops of DMF. The mixture was stirred at room temperature overnight, and the volatiles were removed in vacuo. The residue was dissolved in methanol (50 mL) and heated. After evaporation of methanol in vacuo, the compound was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and poured on a prepacked silica gel column. The material was eluted using 20% of ethyl acetate in hexanes. Evaporation of the solvent provided the title compound <b>22g</b> as a light-orange crystalline solid (2.54 g, 39%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 217 [M]<sup>+</sup>, 219 [M + 2]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.04 (s, 3H), 9.02 (s, 1H), 9.21 (s, 1H) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 53.73, 118.31, 155.49, 156.78, 161.52, 163.85 ppm.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Methyl 3-Bromopicolinate (<b>22i</b>)</h4><div class="NLM_p last">3-Bromopicolinic acid <b>21i</b> (1.0 equiv, 5.67 g, 28.08 mmol) was reacted with oxalyl chloride (1.2 equiv, 3.0 mL, 34.39 mmol) in dichloromethane (75 mL). DMF (0.2 mL) was added, and the mixture was stirred for 2 h. The mixture was cooled to 0 °C, and methanol (10 mL) was added. The mixture was diluted with dichloromethane (200 mL). The organic phase was washed with a saturated solution of sodium bicarbonate (2 × 100 mL) and brine (100 mL). The solution was dried over Na<sub>2</sub>SO<sub>4</sub> and the volatiles removed in vacuo to give methyl 3-bromopicolinate <b>22i</b> as a brownish oil (5.82 g, 96%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 4.00 (s, 3H), 7.30 (dd, <i>J</i> = 8.1, <i>J</i> = 4.0, 1H), 8.00 (dd, <i>J</i> = 8.1, <i>J</i> = 1.3, 1H), 8.61 (dd, <i>J</i> = 4.0, <i>J</i> = 1.3, 1H) ppm.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Methyl 2-Bromonicotinate (<b>22e</b>)</h4><div class="NLM_p last">2-Bromopicolinic acid <b>21e</b> (1.0 equiv, 2.51 g, 12.45 mmol) was reacted with oxalyl chloride (1.3 equiv, 1.4 mL, 15.81 mmol) in dichloromethane (40 mL). DMF (0.1 mL) was added, and the mixture was stirred for 2 h. An additional amount of oxalyl chloride (1.4 mL) was added and the reaction stirred for an additional hour. The mixture was cooled to 0 °C, and methanol (5 mL) was added. The mixture was diluted with dichloromethane (200 mL). The organic phase was washed with a saturated solution of sodium bicarbonate (2 × 100 mL) and brine (100 mL). The solution was dried over Na<sub>2</sub>SO<sub>4</sub> and the volatiles removed in vacuo to give methyl 2-bromopicolinate <b>22e</b> as an oil (1.97 g, 73%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 3.95 (s, 3H), 7.32 (dd, <i>J</i> = 7.7, <i>J</i> = 5.1, 1H), 8.17 (dd, <i>J</i> = 7.7, <i>J</i> = 2.2, 1H), 8.60 (dd, <i>J</i> = 5.1, <i>J</i> = 2.0, 1H) ppm.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Ethyl 3-Chloropyrazine-2-carboxylate (<b>22f</b>)</h4><div class="NLM_p last">3-Chloropyrazine-2-carboxylic acid <b>21f</b> (1.0 equiv, 2.08 g, 13.11 mmol) was reacted with oxalyl chloride (1.6 equiv, 1.8 mL, 20.63 mmol) in dichloromethane (75 mL). DMF (0.4 mL) was added, and the mixture was stirred at room temperature overnight. The mixture was concentrated and dissolved in dichloromethane (50 mL). Ethanol (5 mL) was added at 0 °C, and the mixture was stirred for one hour at room temperature. The mixture was diluted with dichloromethane (200 mL). The organic phase was washed with a saturated solution of sodium bicarbonate (2 × 100 mL) and brine (100 mL). The solution was dried over Na<sub>2</sub>SO<sub>4</sub> and the volatiles removed in vacuo. The solution was concentrated and filtered through a plug of silica gel. Evaporation of the solvents gave the title compound <b>22f</b> as an oil (1.65 g, 67%). One spot TLC. LCMS (ES): >80% pure, <i>m</i>/<i>z</i> 187 [M + H]<sup>+</sup>. The material was used for next step without any further purification.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Methyl 5-Oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>23a</b>)</h4><div class="NLM_p last">Ethyl 3-bromoisonicotinate <b>22a</b> (1.15 g, 5.0 mmol), 2-amino-4-methoxycarbonyl-phenylboronic acid hydrochloride <b>10a</b> (1.04 g, 4.5 mmol), sodium acetate (1.64 g, 20 mmol), PdCl<sub>2</sub> (dppf) (182 mg, 0.25 mmol), and dimethylformamide (7.5 mL) were combined in a flask. The flask was evacuated and filled with nitrogen twice and heated to 125 °C with stirring for 12 h or until LCMS indicated the absence of any starting material. The mixture was cooled to room temperature and water (100 mL) was added to form a brown precipitate. The precipitate was filtered to yield 637 mg (56%) of methyl 5-oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>23a</b>. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 255 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.87 (s, 3H), 7.69 (d, <i>J</i> = 8.0, 1H), 7.93 (s, 1H), 8.08 (d, <i>J</i> = 5.2, 1H), 8.60 (d, <i>J</i> = 8.4, 1H), 8.79 (d, <i>J</i> = 5.2, 1H), 9.85 (s, 1H) ppm.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 5-Oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carbonitrile (<b>23b</b>)</h4><div class="NLM_p last">Sodium acetate (410 mg, 5 mmol) and PdCl<sub>2</sub>(dppf) (36 mg, 0.05 mmol) were added to a mixture of ethyl 3-bromoisonicotinate <b>22a</b> (230 mg, 1.0 mmol) and 2-amino-4-cyanophenylboronic acid hydrochloric acid salt <b>10b</b> (179 mg, 0.9 mmol). The mixture was connected to an exit bubbler and heated to 120 °C for 18 h, at which time LCMS analysis indicated that the reaction was done based on the disappearance of starting material. After cooling to room temperature, water was added and the dark solids were filtered and washed with dichloromethane to give 5-oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carbonitrile <b>23b</b> (156 mg, 46%) as a gray solid. LCMS (ES): >90% pure, <i>m</i>/<i>z</i> 222 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.2 (1H, s), 9.96 (1H, s), 8.90 (1H, d, <i>J</i> = 5.1), 8.77 (1H, d, <i>J</i> = 8.2), 8.13 (1H, d, <i>J</i> = 5.1), 7.73 (1H, dd <i>J</i> = 8.2, <i>J</i> = 1.6), 7.70 (1H, d, <i>J</i> = 1.6) ppm.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Benzo[<i>c</i>][2,6]naphthyridin-5(6<i>H</i>)-one (<b>23c</b>)</h4><div class="NLM_p last">Ethyl 3-bromoisonicotinate <b>22a</b> (1.0 equiv, 1.76 g, 7.65 mmol), 2-aminophenylboronic acid hydrochloride <b>10c</b> (1.0 equiv, 1.33 g, 7.67 mmol), and cesium carbonate (2.0 equiv, 4.99 g, 15.31 mmol) were suspended in dioxane (15 mL). The mixture was degassed by bubbling nitrogen for 10 min. PdCl<sub>2</sub> (dppf) (0.05 equiv, 280 mg, 0.383 mmol) was added, and the mixture was stirred at reflux for 2 h. The resulting solid was filtered, washed with methanol, water, and methanol, and dried. Benzo[<i>c</i>][2,6]naphthyridin-5(6<i>H</i>)-one <b>23c</b> was isolated as an off-white solid (823 mg, 55%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 197 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Methyl 6-Oxo-5,6-dihydrophenanthridine-3-carboxylate (<b>23h</b>)</h4><div class="NLM_p last">Ethyl 2-bromobenzoate <b>22h</b> (1.3 equiv, 300 mg, 1.3 mmol) was combined with 2-amino-4-methoxycarbonyl-phenylboronic acid hydrochloride <b>10a</b> (1.0 equiv, 195 mg, 1.0 mmol), sodium acetate (3.9 equiv, 226 mg, 3.9 mmol), PdCl<sub>2</sub> (dppf) (0.025 equiv, 25 mg, 0.025 mmol), and dimethylformamide (2.5 mL). The resulting mixture was reacted in a microwave oven at 120 °C for 10 min. Water was added, and the material was extracted with EtOAc (2×). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered through a plug of silica gel. Trituration with dichloromethane and hexanes provided methyl 6-oxo-5,6-dihydrophenanthridine-3-carboxylate <b>23h</b> as a solid (125 mg, 49%). The crude solid was used for next step without any further characterization and purification.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> General Procedure for the Synthesis of Compounds <b>23d</b>−<b>g</b> and <b>23i</b></h4><div id="sec5_1_27_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> Synthesis of Methyl 5-Oxo-5,6-dihydropyrimido[4,5-<i>c</i>]quinoline-8-carboxylate (<b>23g</b>)</h5><div class="NLM_p last">Methyl 5-bromopyrimidine-4-carboxylate <b>22g</b> (1.0 equiv, 10.0 g, 46.08 mmol) was mixed in a flask with 2-amino-4-methoxycarbonyl-phenylboronic acid hydrochloride <b>10a</b> (1.1 equiv, 11.70 g, 50.56 mmol), cesium carbonate (3.0 equiv, 45.0 g, 138.11 mmol), and PdCl<sub>2</sub> (dppf) (0.015 equiv, 505 mg, 0.69 mmol) in anhydrous dioxane (200 mL). The reaction mixture was degassed by bubbling nitrogen through the suspension of reagents for about 10 min. The reaction was stirred under reflux for 3 h, at which time LCMS monitoring indicated the presence of starting materials. The conversion was completed after adding an extra amount of palladium catalyst (505 mg) and water (200 μL) and further reacting at reflux overnight. After adding water and then brine, the precipitate was filtered and washed with water (200 mL) and methanol (200 mL). The solid was stirred in ethyl acetate for 2 h, filtered, and dried. The title compound <b>23g</b> was isolated as a tan solid (9.39 g, 80%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 256 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.79 (s, 3H), 7.81 (d, <i>J</i> = 8.0, 1H), 8.68 (d, <i>J</i> = 8.8, 1H), 9.49 (s, 1H), 10.19 (s, 1H), 12.37 (s, 1H) ppm.</div></div><div id="sec5_1_27_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> Methyl 5-Oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>23e</b>)</h5><div class="NLM_p last">Yield, 21%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 255 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_27_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> Methyl 5-Oxo-5,6-dihydrobenzo[<i>c</i>][2,7]naphthyridine-8-carboxylate (<b>23d</b>)</h5><div class="NLM_p last">Yield, 90%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 255 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.91 (s, 3H), 7.80 (d, <i>J</i> = 8.8, 1H), 7.99 (s, 1H), 8.45 (d, <i>J</i> = 5.6, 1H), 8.58 (d, <i>J</i> = 8.0, 1H), 8.96 (d, <i>J</i> = 5.6, 1H), 9.45 (br s, 1H), 12.07 (s, 1H) ppm.</div></div><div id="sec5_1_27_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> Methyl 5-Oxo-5,6-dihydropyrazino[2,3-<i>c</i>]quinoline-8-carboxylate (<b>23f</b>)</h5><div class="NLM_p last">Yield, 34%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 256 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.92 (s, 3H), 7.57 (d, <i>J</i> = 8.4, 1H), 8.01 (s, 1H), 8.65 (d, <i>J</i> = 8.4, 1H), 9.03 (d, <i>J</i> = 2.0, 1H), 9.13 (d, <i>J</i> = 1.6, 1H), 12.05 (s, 1H) ppm.</div></div><div id="sec5_1_27_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> Methyl 5-Oxo-5,6-dihydrobenzo[<i>f</i>][1,7]naphthyridine-8-carboxylate (<b>23i</b>)</h5><div class="NLM_p last">Yield, 29%. The crude solid was used for next step without any further purification and characterization.</div></div></div><div id="sec5_1_27_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 2-Amino-3-bromobenzoate (<b>32</b>)</h4><div class="NLM_p last">Commercially available 2-amino-3-bromobenzoic acid <b>31</b> (1.00 g, 4.62 mmol) was mixed with methanol (10 mL) and concentrated sulfuric acid (1 mL). The mixture was stirred at reflux for 31 h. The solvent were evaporated, and saturated aqueous sodium bicarbonate was carefully added. The solid was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvents removed in vacuo to afford methyl 2-amino-3-bromobenzoate <b>32</b> as a semicrystalline solid (976 mg, 91%). LCMS (ES): >85% pure, <i>m</i>/<i>z</i> 230 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 3.88 (s, 3H), 6.34 (br s, 2H), 6.53 (t, <i>J</i> = 8.0, 1H), 7.57 (dd, <i>J</i> = 1.6, <i>J</i> = 7.6, 1H), 7.85 (dd, <i>J</i> = 1.6, <i>J</i> = 8.4, 1H) ppm.</div></div><div id="sec5_1_27_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Methyl 3-Amino-4-iodo-2-methylbenzoate (<b>30a</b>)</h4><div class="NLM_p last">Commercially available methyl 3-amino-2-methylbenzoate <b>29</b> (1.0 equiv, 11.62 g, 70.4 mmol) was suspended in acetic acid (100 mL). <i>N</i>-Iodosuccinimide (1.03 equiv, 16.32 g, 72.0 mmol) was added in several portions. The reaction mixture was stirred at room temperature for 30 min. The solvent was evaporated and the residue diluted with EtOAc (150 mL). The organic phase was washed with a solution of potassium carbonate (100 mL), water (3 × 40 mL), and brine (3 × 40 mL). After drying over Na<sub>2</sub>SO<sub>4</sub>, the solvent was removed by rotary evaporation. The reaction produced a mixture of compounds, the major (86%) component of the mixture being methyl 3-amino-6-iodo-2-methylbenzoate <b>30b</b> (<i>R</i><sub>f</sub> = 0.25, SiO<sub>2</sub>, 25% ethyl acetate in hexanes, GCMS <i>m</i>/<i>z</i> = 291) and the minor (14%) component being the desired methyl 3-amino-4-iodo-2-methylbenzoate <b>30a</b> (<i>R</i><sub>f</sub> = 0.5, SiO<sub>2</sub>, 25% ethyl acetate in hexanes, GCMS <i>m</i>/<i>z</i> = 291). The desired minor product was isolated pure by flash chromatography on silica gel (EtOAc 15% to 25% gradient in hexanes) to afford the title compound <b>30a</b> as a yellow solid (1.23 g, 6%). GCMS: >95% pure, <i>m</i>/<i>z</i> 291. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 2.08 (s, 3H), 3.60 (br s, 2H), 3.94 (s, 3H), 6.45 (d, <i>J</i> = 8.8, 1H), 7.39 (d, <i>J</i> = 8.0, 1H) ppm.</div></div><div id="sec5_1_27_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl 2-Methyl-5-nitrobenzoate (<b>34</b>)</h4><div class="NLM_p last">Commercially available 2-methyl-5-nitrobenzoic acid <b>33</b> (24 g, 132.5 mmol) was dissolved in a mixture of methanol (240 mL) and concentrated sulfuric acid (8 mL). The mixture was stirred at reflux overnight. Upon cooling, the ester crystallized out. The material was isolated by filtration to afford methyl 2-methyl-5-nitrobenzoate <b>34</b> as a white solid (19.0 g, 74%). A second crop of material (4.92 g, 19%) was isolated upon concentration and addition of water to the mother liquor. The crude solid was used for next step without any further characterization and purification.</div></div><div id="sec5_1_27_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Methyl 5-Amino-2-methylbenzoate (<b>35</b>)</h4><div class="NLM_p last">Methyl 2-methyl-5-nitrobenzoate <b>34</b> (5.06 g, 25.95 mmol) was suspended in methanol (100 mL). The mixture was degassed by bubbling nitrogen for 15 min. Pd/C (10% wet Degussa type E101 NE/WW, 260 mg) was added and the mixture stirred under hydrogen atmosphere (balloon) overnight. The suspension was filtered and the solvents evaporated to afford the title compound <b>35</b> as an orange oil (4.18 g, 97%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.45 (s, 3H), 3.45 (br s, 2H), 3.85 (s, 3H), 6.74 (dd, <i>J</i> = 7.4, <i>J</i> = 2.3, 1H), 7.02 (d, <i>J</i> = 7.4, 1H), 7.25 (d, <i>J</i> = 2.5, 1H) ppm.</div></div><div id="sec5_1_27_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Methyl 5-Amino-4-iodo-2-methylbenzoate (<b>36</b>)</h4><div class="NLM_p last">Methyl 5-amino-2-methylbenzoate <b>35</b> (1.0 equiv, 3.75 g, 22.7 mmol) was dissolved in acetic acid (70 mL). <i>N</i>-Iodosuccinimide (1.03 equiv, 5.27 g, 23.4 mmol) was added in small portions over 60 min. The mixture was stirred at room temperature for 30 min. Acetic acid was evaporated. The residue was diluted with ethyl acetate (80 mL) and neutralized with saturated sodium carbonate (80 mL). The organic layer was washed with 1 M sodium thiosulfate (2 × 40 mL) and then water (2 × 40 mL) and brine (2 × 40 mL). The material was purified by flash chromatography on silica gel (gradient 10−30% ethyl acetate in hexanes) to provide methyl 5-amino-4-iodo-2-methylbenzoate <b>36</b> as a yellow−orange solid (3.19 g, 49%). GCMS >95% pure, <i>m</i>/<i>z</i> 291. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.30 (s, 3H), 3.78 (s, 3H), 5.27 (br s, 2H), 7.24 (s, 1H), 7.54 (s, 1H) ppm.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> General Procedure for the Synthesis of Compounds <b>39a</b>−<b>d</b></h4><div id="sec5_1_28_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> Synthesis of Methyl 5-Oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-7-carboxylate (<b>39b</b>)</h5><div class="NLM_p last">Methyl 2-amino-3-bromobenzoate <b>32</b> (1.0 equiv, 652 mg, 2.61 mmol) and 4-(diisopropylcarbamoyl)pyridin-3-ylboronic acid <b>38</b> (prepared according to a procedure described in literature),<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> (1.0 equiv, 600 mg, 2.61 mmol) were combined with cesium carbonate (2.0 equiv, 1.699 g, 5.21 mmol) in dioxane containing 5% of water (6 mL). The mixture was degassed by bubbling nitrogen for 10 min. PdCl<sub>2</sub> (dppf) (0.05 equiv, 95 mg) was added and the reaction stirred at reflux for 2 h. Dioxane was evaporated, water was added, and the material extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvents removed in vacuo. The material was purified by flash chromatography on silica gel (eluent 0.5% methanol in CH<sub>2</sub>Cl<sub>2</sub>) to afford the intermediate methyl 2-amino-3-(4-(diisopropylcarbamoyl)pyridin-3-yl)benzoate as a greenish foam. (LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 356 [M + H]<sup>+</sup>). This material was dissolved under nitrogen atmosphere in anhydrous THF (1.5 mL). A NaHMDS solution (1.0 M in THF, 2.0 equiv, 1.4 mL, 1.4 mmol) was added dropwise from a syringe. The resulting suspension was stirred at room temperature for 1 h. The reaction was quenched by addition of a saturated aqueous solution of ammonium chloride. The solid that formed was filtered and dried. After trituration in methanol and filtration, the title compound was isolated as a gray fluffy solid (93 mg, 14% over two steps). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 255 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.97 (s, 3H), 7.44 (t, <i>J</i> = 7.6, 1H), 8.11 (dd, <i>J</i> = 4,8, <i>J</i> = 0.8, 1H), 8.20 (dd, <i>J</i> = 7.6, <i>J</i> = 1.2, 1H), 8.87 (dd, <i>J</i> = 5.2, 1H), 8.91 (d, <i>J</i> = 7.2, 1H), 9.94 (s, 1H), 11.77 (br s, 1H) ppm.</div></div><div id="sec5_1_28_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> Methyl 7-Methyl-5-oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>39a</b>)</h5><div class="NLM_p last">Yield, 52%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 269 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.60 (s, 3H), 3.88 (s, 3H), 7.60 (d, <i>J</i> = 7, 1H), 8.16 (d, <i>J</i> = 5, 1H), 8.56 (d, <i>J</i> = 7, 1H), 8.88 (d, <i>J</i> = 5, 1H), 9.94 (s, 1H), 11.13 (br s, 1H) ppm.</div></div><div id="sec5_1_28_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> Methyl 9-Methyl-5-oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>39c</b>)</h5><div class="NLM_p last">Yield, 41%. LCMS (ES): 89% pure, <i>m</i>/<i>z</i> 269 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.62 (s, 3H), 3.88 (s, 3H), 7.89 (s, 1H), 8.13 (d, <i>J</i> = 4.8, 1H), 8.58 (s, 1H), 8.87 (d, <i>J</i> = 5.2, 1H), 9.95 (s, 1H), 12.07 (br s, 1H) ppm.</div></div><div id="sec5_1_28_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> Methyl 5-Oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-9-carboxylate (<b>39d</b>)</h5><div class="NLM_p last">Yield, 41%. LCMS (ES): 90% pure, <i>m</i>/<i>z</i> 255 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> General Procedure for the Synthesis of Compounds <b>24a</b>−<b>b</b>, <b>24e</b>−<b>f</b>, and <b>24h</b>−<b>i</b></h4><div id="sec5_1_29_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> Methyl 5-Chlorobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>24a</b>)</h5><div class="NLM_p last">Methyl 5-oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>23a</b> (200 mg, 0.787 mmol) was combined with phosphorus oxychloride (1 mL) and heated to reflux. After 2 h, LCMS indicated the absence of any starting material. The volatiles were removed under reduced pressure. The residue was taken up in dichloromethane (50 mL) and washed twice with saturated aqueous sodium bicarbonate. The organic phase was dried over sodium sulfate and concentrated on a rotary evaporator to give methyl 5-chlorobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>24a</b> (140 mg, 65%) as a grayish solid. An alternate workup consisted in adding acetonitrile after evaporation of phosphorus oxychloride. The material was precipitated by addition of ice and water. Reasonably pure material was obtained after drying in vacuo. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 273 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 4.03 (s, 3H), 8.25 (dd, <i>J</i> = 6.0, <i>J</i> = 1.2, 1H), 8.40 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 8.73 (d, <i>J</i> = 8.8, 1H), 8.82 (d, <i>J</i> = 2.0, 1H), 9.03 (d, <i>J</i> = 5.6, 1H), 10.08 (s, 1H) ppm.</div></div><div id="sec5_1_29_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 5-Chlorobenzo[<i>c</i>][2,6]naphthyridine-8-carbonitrile (<b>24b</b>)</h5><div class="NLM_p last">Yield, 77%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 240 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_29_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> Methyl 6-Chlorophenanthridine-3-carboxylate (<b>24h</b>)</h5><div class="NLM_p last">Yield, 97%. The crude solid was used for next step without any further characterization and purification.</div></div><div id="sec5_1_29_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> Methyl 5-Chlorobenzo[<i>h</i>][1,6]naphthyridine-8-carboxylate (<b>24e</b>)</h5><div class="NLM_p last">Yield, 57%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 273 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_29_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> Methyl 5-Chloropyrazino[2,3-<i>c</i>]quinoline-8-carboxylate (<b>24f</b>)</h5><div class="NLM_p last">Yield, 97%. LCMS (ES): >90% pure, <i>m</i>/<i>z</i> 274 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_29_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> Methyl 5-Chlorobenzo[<i>f</i>][1,7]naphthyridine-8-carboxylate (<b>24i</b>)</h5><div class="NLM_p last">Yield, 80%. LCMS (ES): >85% pure, <i>m</i>/<i>z</i> 273 [M + H]<sup>+</sup>. The material was used for next step without any further purification.</div></div><div id="sec5_1_29_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> Methyl 5-Chlorobenzo[<i>c</i>][2,7]naphthyridine-8-carboxylate (<b>24d</b>)</h5><div class="NLM_p last">A solution of methyl 5-oxo-5,6-dihydrobenzo[<i>c</i>][2,7]naphthyridine-8-carboxylate <b>23d</b> (650 mg, 2.56 mmol) in phosphorus oxychloride (4.0 mL) was heated at 120 °C for 2.5 h. The reaction was concentrated under reduced pressure and diluted with ACN (20 mL) and H<sub>2</sub>O (40 mL). The solution was neutralized with NaOH (3N), and the resulting precipitate was collected by filtration to give the title compound <b>24d</b> (600 mg, 86%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 273 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_29_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> Methyl 5-Chloropyrimido[4,5-<i>c</i>]quinoline-8-carboxylate (<b>24g</b>)</h5><div class="NLM_p last">In a vial, methyl 5-oxo-5,6-dihydropyrimido[4,5-<i>c</i>]quinoline-8-carboxylate <b>23g</b> (1.0 equiv, 151 mg, 0.59 mmol) was mixed in toluene (1 mL) with DIEA (1.5 equiv, 155 μL, 0.89 mmol) and phosphorus oxychloride (5 equiv, 270 μL, 3.0 mmol). The mixture was stirred at 120 °C for 1 h and cooled down to room temperature. After adding ice and water, the compound was extracted with CH<sub>2</sub>Cl<sub>2</sub> (4×). The solution was filtered over Na<sub>2</sub>SO<sub>4</sub> and filtered through a pad of Celite. After evaporation of the volatiles, the material was triturated in a mixture of ethyl acetate and hexanes, filtered, and dried to afford methyl 5-chloropyrimido[4,5-<i>c</i>]quinoline-8-carboxylate <b>24g</b> as a light-brown fluffy solid (115 mg, 71%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 274 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.96 (s, 3H), 8.37 (dd, <i>J</i> = 1.6, <i>J</i> = 8.4, 1H), 8.60 (d, <i>J</i> = 1.6, 1H), 9.15 (d, <i>J</i> = 8.8, 1H), 9.74 (s, 1H), 10.61 (s, 1H) ppm.</div></div><div id="sec5_1_29_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> 5-Chlorobenzo[<i>c</i>][2,6]naphthyridine (<b>24c</b>)</h5><div class="NLM_p last">Benzo[<i>c</i>][2,6]naphthyridin-5(6<i>H</i>)-one <b>23c</b> (1.0 equiv, 813 mg, 4.15 mmol) was mixed with phosphorus oxychloride (5.0 equiv, 2 mL, 21.84 mmol) and acetonitrile (10 mL). The mixture was stirred at reflux for 5 h. The mixture was poured on ice and the resulting solid filtered and dried. 5-Chlorobenzo[<i>c</i>][2,6]naphthyridine <b>24c</b> was isolated as a gray solid (459 mg, 52%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 215 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> General Procedure for the Synthesis of Compounds <b>40a</b>−<b>d</b></h4><div id="sec5_1_30_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> Synthesis of Methyl 5-Chlorobenzo[<i>c</i>][2,6]naphthyridine-7-carboxylate (<b>40b</b>)</h5><div class="NLM_p last">Methyl 5-oxo-5,6-dihydrobenzo[<i>c</i>][2,6]naphthyridine-7-carboxylate <b>39b</b> (1.0 equiv, 85 mg, 0.334 mmol) was stirred in phosphorus oxychloride (2 mL) at 120 °C for 2 h. The solvent was removed in vacuo. Ice and water were added. The resulting solid was filtered and dried to afford the title compound <b>40b</b> as a solid (84 mg, 92%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 273 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_30_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> Methyl 5-Chloro-7-methylbenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>40a</b>)</h5><div class="NLM_p last">Yield, 85%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 287 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.95 (s, 3H), 3.94 (s, 3H), 8.14 (d, <i>J</i> = 7.8, 1H), 8.28 (d, <i>J</i> = 5.7, 1H), 8.98 (d, <i>J</i> = 9, 1H), 9.08 (d, <i>J</i> = 6, 1H), 10.37 (s, 1H) ppm.</div></div><div id="sec5_1_30_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> Methyl 5-Chloro-9-methylbenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>40c</b>)</h5><div class="NLM_p last">Yield, 76%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 287 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.79 (s, 3H), 3.94 (s, 3H), 8.25 (d, <i>J</i> = 5, 1H), 8.45 (s, 1H), 9.02 (s, 1H), 9.07 (d, <i>J</i> = 5, 1H), 10.35 (s 1H) ppm.</div></div><div id="sec5_1_30_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99"> Methyl 5-Chlorobenzo[<i>c</i>][2,6]naphthyridine-9-carboxylate (<b>40d</b>)</h5><div class="NLM_p last">Yield, 50%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 273 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_30_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Methyl 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>26a</b>)</h4><div class="NLM_p last">Methyl 5-chlorobenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>24a</b> (1.0 equiv, 529 mg, 1.94 mmol) was combined with 3-chloroaniline (1.5 equiv, 370 mg, 2.92 mmol) in NMP (4 mL) in a flask, and the mixture was heated to 80 °C for 2 h. The mixture was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated aqueous sodium bicarbonate, and dried over Na<sub>2</sub>SO<sub>4</sub>. The material was purified by flash chromatography (SiO<sub>2</sub>, 1:1 to 9:1 gradient of EtOAc/hexanes) to obtain the title compound <b>26a</b>. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 3.91 (s, 3H), 7.16 (dd, <i>J</i> = 1.2, <i>J</i> = 8.0, 1H), 7.44 (t, <i>J</i> = 8.0, 1H), 7.94 (dd, <i>J</i> = 8.4, <i>J</i> = 2.0, 1H), 8.06 (dd, <i>J</i> = 8.4, <i>J</i> = 1.2, 1H), 8.20−8.22 (m, 2H), 8.82−8.86 (m, 2H), 9.04 (d, <i>J</i> = 5.6, 1H), 10.05 (br s, 1H), 10.21 (s, 1H) ppm.</div></div><div id="sec5_1_30_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> <i>N</i>-(3-Chlorophenyl)benzo[<i>c</i>][2,6]naphthyridin-5-amine (<b>26c</b>)</h4><div class="NLM_p last">5-Chlorobenzo[<i>c</i>][2,6]naphthyridine <b>24c</b> (1.0 equiv, 20 mg, 0.093 mmol) was mixed with 3-chloroaniline (15 equiv, 150 μL, 1.42 mmol) and NMP (0.8 mL). The mixture was stirred at 60 °C overnight. Water was added and the material extracted with dichloromethane. The organic phase was extracted with water (2×) and the solvents evaporated. The material was purified by preparative TLC (SiO<sub>2</sub>, 5% methanol in dichloromethane). The title compound <b>26c</b> was isolated as a solid (19 mg, 68%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 306 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.12 (br d, <i>J</i> = 8.4, 1H), 7.42 (t, <i>J</i> = 8.0, 1H), 7.52 (t, <i>J</i> = 7.2, 1H), 7.70 (t, <i>J</i> = 7.2, 1H), 7.77 (d, <i>J</i> = 7.2, 1H), 8.07 (d, <i>J</i> = 8.0, 1H), 8.34 (s, 1H), 8.58 (d, <i>J</i> = 5.2, 1H), 8.79 (d, <i>J</i> = 8.0, 1H), 8.97 (br s, 1H), 9.62 (s, 1H), 10.18 (br s, 1H) ppm.</div></div><div id="sec5_1_30_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridin-8-yl)methanol (<b>26d</b>)</h4><div class="NLM_p last">Methyl 5-(3-chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>26a</b> (50 mg, 0.137 mmol) was dissolved in THF (4 mL) and the solution cooled to −40 °C. A solution of LiAlH<sub>4</sub> (1.0 M in diethylether, 270 μL, 0.27 mmol) was added, and the reaction mixture was allowed to warm to room temperature. After aqueous workup, the product was purified by flash chromatography on silica gel (ethyl acetate/hexanes gradient from 1:1 to 9:1). The title compound <b>26d</b> was isolated as a solid (46 mg, 100%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 336 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 4.72 (s, 2H), 7.16 (dd, <i>J</i> = 8, <i>J</i> = 1.2, 1H), 7.43−7.49 (m, 2H), 7.75 (s, 1H), 8.05 (br d, <i>J</i> = 8.4, 1H), 8.32 (s, 1H), 8.69 (d, <i>J</i> = 5.6, 1H), 8.74 (d, <i>J</i> = 8.8, 1H), 8.96 (d, <i>J</i> = 6.0, 1H), 9.82 (br s, 1H), 10.18 (s, 1H) ppm.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> General Procedure for the Synthesis of Compounds <b>25a</b>−<b>t</b>, <b>27d</b>−<b>e</b>, <b>27h</b>−<b>i</b>, <b>28d</b>−<b>g</b>, <b>28i</b>, and <b>41a</b>−<b>d</b></h4><div id="sec5_1_31_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i104" class="anchor-spacer"></div><h5 class="article-section__title" id="_i104"> 6-(Phenylamino)phenanthridine-3-carboxylic Acid (<b>27h</b>)</h5><div class="NLM_p">Methyl 6-chlorophenanthridine-3-carboxylate <b>24h</b> (1.0 equiv, 53 mg, 0.20 mmol) was combined with aniline (3 equiv, 57 mg, 0.59 mmol) and <i>N</i>-methyl pyrrolidinone (0.2 mL) in a microwave tube, and the mixture was heated to 120 °C for 10 min, at which time LCMS indicated that the reaction was complete as indicated by the absence of any starting material. 6N NaOH (0.5 mL) was added, and the mixture was stirred at 50 °C for 30 min. The mixture was neutralized with 1N hydrochloric acid. The material was filtered. Purification by preparative HPLC and Genevac evaporation afforded the title compound <b>27h</b> as a solid (28 mg, 45%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 315 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.56−7.70 (m, 5H), 7.99 (t, <i>J</i> = 8.4, 1H), 8.17 (td, <i>J</i> = 8, <i>J</i> = 1.6, 1H), 8.19 (br t, <i>J</i> = 6.8, 1H), 8.49 (d, <i>J</i> = 1.6, 1H), 8.70 (d, <i>J</i> = 8.2, 1H), 8.73 (d, <i>J</i> = 7.2, 1H), 8.86 (d, <i>J</i> = 8, 1H) ppm.</div><div class="NLM_p last">The following compounds were prepared using a similar two-step procedure. The nucleophilic substitutions between various chloro compounds <b>24a</b>, <b>24d</b>−<b>i</b>, and <b>40a</b>−<b>d</b> and various amines was achieved in NMP at temperatures ranging from 80 to 120 °C using microwave (10−15 min) or conventional heating (2 h). The ester hydrolyses were carried out in one pot by adding aqueous (3N or 6N) NaOH to the precedent mixture and heating the solution at 50−80 °C for up to 2 h. Alternatively, the hydrolysis reaction could be accomplished after isolation of the ester by precipitation in water and purification by flash chromatography. The final carboxylic acid materials could be isolated by filtration as pure solids after adding water and neutralizing the solution with an aqueous solution of hydrochloric acid or could be isolated by filtration as sodium carboxylate salts when precipitation occurred during the reaction. An alternate isolation method consisted in diluting the reaction mixture with a mixture of acetonitrile, water, and trifluoroacetic acid. The resulting solutions were submitted to preparative HPLC, providing the pure carboxylic acids after Genevac evaporation. Compounds bearing a basic moiety were isolated as trifluoroacetate salts.</div></div><div id="sec5_1_31_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i105" class="anchor-spacer"></div><h5 class="article-section__title" id="_i105"> 5-(Phenylamino)benzo[<i>h</i>][1,6]naphthyridine-8-carboxylic Acid (<b>27e</b>)</h5><div class="NLM_p last">Yield, 88%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 316 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.10 (t, <i>J</i> = 7.2, 1H), 7.43 (t, <i>J</i> = 7.6, 2H), 7.89 (dd, <i>J</i> = 4.0, <i>J</i> = 8.0, 1H), 7.95 (dd, <i>J</i> = 2, <i>J</i> = 8.4, 1H), 8.10 (d, <i>J</i> = 1.6, 2H), 8.25 (d, <i>J</i> = 1.6, 1H), 8.90 (d, <i>J</i> = 8.4, 1H), 9.14 (dd, <i>J</i> = 1.6, <i>J</i> = 8.4, 1H), 9.21 (dd, <i>J</i> = 1.2, <i>J</i> = 4.4, 1H), 9.54 (s, 1H), 13.16 (s, 1H) ppm.</div></div><div id="sec5_1_31_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> 5-(Phenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid, Trifluoroacetate Salt (<b>25a</b>)</h5><div class="NLM_p last">Yield, 23%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 316 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, CD<sub>3</sub>OD):δ 10.17 (1H, s), 9.67 (1H, br), 8.99 (1H, d, <i>J</i> = 5.9), 8.83 (1H, d, <i>J</i> = 8.6), 8.62 (1H, d, <i>J</i> = 5.9), 8.24 (1H, d, <i>J</i> = 1.6), 8.04 (1H, s), 8.02 (1H, s), 7.93 (1H, dd, <i>J</i> = 8.2, <i>J</i> = 1.6), 7.43 (1H, d, <i>J</i> = 7.4), 7.41 (1H, d, <i>J</i> = 7.4), 7.10 (1H, m) ppm.</div></div><div id="sec5_1_31_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> 5-(Phenylamino)benzo[<i>c</i>][2,7]naphthyridine-8-carboxylic Acid (<b>27d</b>)</h5><div class="NLM_p last">Yield, 72%. LCMS (ES): 82% pure, <i>m</i>/<i>z</i> 316 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.10 (t, <i>J</i> = 7.6, 1H), 7.43 (t, <i>J</i> = 7.6, 2H), 7.93 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 8.09 (d, <i>J</i> = 7.6, 2H), 8.22 (d, <i>J</i> = 1.6, 1H), 8.67 (d, <i>J</i> = 6.0, 1H), 8.71 (d, <i>J</i> = 8.4, 1H), 8.99 (d, <i>J</i> = 5.6, 1H), 9.69 (s, 1H), 10.01 (s, 1H), 13.20 (br s, 1H) ppm.</div></div><div id="sec5_1_31_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i108" class="anchor-spacer"></div><h5 class="article-section__title" id="_i108"> Sodium 5-(Phenylamino)benzo[<i>f</i>][1,7]naphthyridine-8-carboxylate (<b>27i</b>)</h5><div class="NLM_p last">Yield, 10%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 316 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.05 (t, <i>J</i> = 6.8, 1H), 7.42 (t, <i>J</i> = 8, 2H), 7.95 (m, 2H), 8.26 (s, 1H), 8.32 (d, <i>J</i> = 8.0, 2H), 8.46 (d, <i>J</i> = 8.4, 1H), 9.02 (d, <i>J</i> = 4.4, 1H), 9.17 (d, <i>J</i> = 8.4, 1H), 9.73 (s, 1H) ppm.</div></div><div id="sec5_1_31_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i109" class="anchor-spacer"></div><h5 class="article-section__title" id="_i109"> 2-(8-Carboxybenzo[<i>c</i>][2,6]naphthyridin-5-ylamino)-<i>N</i>,<i>N</i>-dimethylethanaminium Trifluoroacetate (<b>25b</b>)</h5><div class="NLM_p last">Yield, 45%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 311 [M + H]<sup>+</sup>, 266 [M + H − NHMe<sub>2</sub>]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.90 (s, 6H), 3.47 (br t, 2H), 3.95 (br s, 2H), 7.88 (dd, <i>J</i> = 8.4, <i>J</i> = 2.0, 1H), 8.24 (m, 2H), 8.41 (br s, 1H), 8.79 (d, <i>J</i> = 8.8, 1H), 8.94 (d, <i>J</i> = 5.2, 1H), 9.49 (br, 1H), 10.12 (s, 1H) ppm.</div></div><div id="sec5_1_31_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i110" class="anchor-spacer"></div><h5 class="article-section__title" id="_i110"> 5-(Cyclopentylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25c</b>)</h5><div class="NLM_p last">Yield, 39%. LCMS (ES): 94% pure, <i>m</i>/<i>z</i> 308 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.62−1.77 (m, 6H), 2.12 (m, 2H), 4.64 (sext, <i>J</i> = 6.8, 1H), 7.70 (br, 1H), 7.84 (m, 1H), 8.16 (br s, 1H), 8.42 (br s, 1H), 8.74 (d, <i>J</i> = 8.0, 1H), 8.89 (m, 1H), 10.07 (s, 1H), 13.0 (br s, 1H) ppm.</div></div><div id="sec5_1_31_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> 5-(Methoxyamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25d</b>)</h5><div class="NLM_p last">Yield, 26%. LCMS (ES): 94% pure, <i>m</i>/<i>z</i> 270 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.92 (s, 3H), 7.55 (d, <i>J</i> = 8.0, 1H), 7.83 (d, <i>J</i> = 5.2, 1H), 8.09 (s, 1H), 8.35 (d, <i>J</i> = 8.4, 1H), 8.58 (d, <i>J</i> = 5.6, 1H), 9.56 (s, 1H), 10.30 (s, 1H), 12.24 (br s, 1H) ppm.</div></div><div id="sec5_1_31_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i112" class="anchor-spacer"></div><h5 class="article-section__title" id="_i112"> 5-(Cyclopropylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25e</b>)</h5><div class="NLM_p last">Yield, 49%. LCMS (ES): 85% pure, <i>m</i>/<i>z</i> 280 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i113" class="anchor-spacer"></div><h5 class="article-section__title" id="_i113"> 5-(2-Isopropoxyethylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25f</b>)</h5><div class="NLM_p last">Yield, 30%. LCMS (ES): 91% pure, <i>m</i>/<i>z</i> 326 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (d, <i>J</i> = 6.0, 6H), 3.61−3.76 (m, 5H), 7.84 (d, <i>J</i> = 8.5, 1H), 8.06 (br, 1H), 8.16 (br s, 1H), 8.30 (d, <i>J</i> = 6.4, 1H), 8.75 (d, <i>J</i> = 8.5, 1H), 8.90 (d, <i>J</i> = 6.4, 1H), 10.08 (s, 1H), 13.10 (br s, 1H) ppm.</div></div><div id="sec5_1_31_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> 5-(Benzylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25g</b>)</h5><div class="NLM_p last">Yield, 69%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 4.87 (s, 2H), 7.23 (t, <i>J</i> = 6.8, 1H), 7.33 (m, 2H), 7.47 (m, 2H), 7.83 (d, <i>J</i> = 8.4, 1H), 8.13 (s, 1H), 8.37 (d, <i>J</i> = 4.4, 1H), 8.73 (d, <i>J</i> = 8.0, 1H), 8.91 (<i>J</i> = 4.8, 1H), 10.08 (s, 1H), 12.20 (br s, 1H) ppm.</div></div><div id="sec5_1_31_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115"> 5-(Phenethylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25h</b>)</h5><div class="NLM_p last">Yield, 33%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 344 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 3.21 (t, <i>J</i> = 6.8, 2H), 4.11 (t, <i>J</i> = 7.2, 2H), 7.21 (m, 1H), 7.31 (m, 2H), 7.37 (m, 2H), 8.20 (dd, <i>J</i> = 8, <i>J</i> = 1.2, 1H), 8.39 (br d, <i>J</i> = 6, 1H), 8.58 (d, <i>J</i> = 1.6, 1H), 8.80 (d, <i>J</i> = 8.4, 1H), 9.02 (d, <i>J</i> = 6, 1H), 10.10 (s, 1H) ppm.</div></div><div id="sec5_1_31_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116"> 5-(3-Phenylpropylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25i</b>)</h5><div class="NLM_p last">Yield, 50%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 358 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.09 (qi, <i>J</i> = 7.2, 2H), 2.77 (t, <i>J</i> = 7.2, 2H), 3.72 (br q, <i>J</i> = 4.8, 2H), 7.18 (m, 1H), 7.28 (m, 4H), 7.91 (d, <i>J</i> = 7.6, 1H), 8.40 (br s, 1H), 8.44 (d, <i>J</i> = 4.0, 1H), 8.78 (d, <i>J</i> = 8.4, 1H), 8.97 (d, <i>J</i> = 5.2, 1H), 10.09 (s, 1H) ppm.</div></div><div id="sec5_1_31_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i117" class="anchor-spacer"></div><h5 class="article-section__title" id="_i117"> 5-(3-Methoxyphenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25j</b>)</h5><div class="NLM_p last">Yield, 48%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, CD<sub>3</sub>OD): δ 3.89 (s, 3H), 7.05 (d, <i>J</i> = 8, 1H), 7.28 (d, <i>J</i> = 7.6, 1H), 7.38 (br s, 1H), 7.52 (t, <i>J</i> = 8, 1H), 8.20 (d, <i>J</i> = 8.8, 1H), 8.51 (s, 1H), 8.56 (d, <i>J</i> = 5.6, 1H), 8.82 (d, <i>J</i> = 8.4, 1H), 9.05 (d, <i>J</i> = 5.6, 1H), 10.16 (s, 1H) ppm.</div></div><div id="sec5_1_31_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i118" class="anchor-spacer"></div><h5 class="article-section__title" id="_i118"> 5-(3-Chloro-4-fluorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25k</b>)</h5><div class="NLM_p last">Yield, 40%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 368 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (t, <i>J</i> = 9.2, 1H), 7.84−7.88 (m, 1H), 8.11 (dd, <i>J</i> = 8.0, <i>J</i> = 1.2, 1H), 8.20 (dd, <i>J</i> = 6.8, <i>J</i> = 2.8, 1H), 8.42 (d, <i>J</i> = 1.6, 1H), 8.48 (d, <i>J</i> = 5.6, 1H), 8.75 (d, <i>J</i> = 8.0, 1H), 8.94 (d, <i>J</i> = 6.0, 1H), 10.11 (s, 1H) ppm.</div></div><div id="sec5_1_31_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i119" class="anchor-spacer"></div><h5 class="article-section__title" id="_i119"> 5-(3-Fluorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25l</b>)</h5><div class="NLM_p last">Yield, 22%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 334 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.90 (td, <i>J</i> = 8.4, <i>J</i> = 2.8, 1H), 7.43 (q, <i>J</i> = 8.4, 1H), 7.87 (d, <i>J</i> = 8.4, 1H), 7.96 (dd, <i>J</i> = 8.4, <i>J</i> = 2.0, 1H), 8.14 (br d, <i>J</i> = 12, 1H), 8.60 (d, <i>J</i> = 5.6, 1H), 8.86 (d, <i>J</i> = 8.4, 1H), 9.00 (d, <i>J</i> = 6,0, 1H), 9.72 (br s, 1H), 10.18 (s, 1H) ppm.</div></div><div id="sec5_1_31_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i120" class="anchor-spacer"></div><h5 class="article-section__title" id="_i120"> 5-(2-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25m</b>)</h5><div class="NLM_p last">Yield, 22%. LCMS (ES): 94% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i121" class="anchor-spacer"></div><h5 class="article-section__title" id="_i121"> Sodium 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>25n</b>)</h5><div class="NLM_p last">Yield, 86%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.10 (dd, <i>J</i> = 7.6, <i>J</i> = 2.0, 1H), 7.43 (t, <i>J</i> = 8.0, 1H), 8.04 (dd, <i>J</i> = 8.4, <i>J</i> = 2.0, 1H), 8.13 (dd, <i>J</i> = 8.0, <i>J</i> = 1.6, 1H), 8.27 (d, <i>J</i> = 1.6, 1H), 8.46 (t, <i>J</i> = 2.0, 1H), 8.65 (d, <i>J</i> = 7.6, 1H), 8.67 (d, <i>J</i> = 8.4, 1H), 8.90 (d, <i>J</i> = 6.0, 1H), 9.75 (s, 1H), 10.2 (s, 1H) ppm. <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 116.0, 116.43, 118.64, 119.19, 119.61, 120.70, 121.53, 125.67, 127.0, 127.56, 129.96, 132.74, 142.12, 142.44, 143.18, 146.38, 147.37, 149.3, 169.25 ppm.</div></div><div id="sec5_1_31_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i122" class="anchor-spacer"></div><h5 class="article-section__title" id="_i122"> 5-(4-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25o</b>)</h5><div class="NLM_p last">Yield, 62%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.48 (d, <i>J</i> = 8.0, 2H), 7.96 (d, <i>J</i> = 7.0, 1H), 8.17 (d, <i>J</i> = 6.4, 2H), 8.27 (s, 1H), 8.61 (d, <i>J</i> = 5.9, 1H), 8.86 (d, <i>J</i> = 8.8, 1H), 9.00 (d, <i>J</i> = 5.9, 1H), 9.69 (s, 1H), 10.19 (s, 1H), 13.20 (br s, 1H) ppm.</div></div><div id="sec5_1_31_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i123" class="anchor-spacer"></div><h5 class="article-section__title" id="_i123"> 5-(3-Ethynylphenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25p</b>)</h5><div class="NLM_p last">Yield, 61%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 340 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 4.21 (s, 1H), 7.21 (d, <i>J</i> = 7.6, 1H), 7.98 (dd, <i>J</i> = 8.4, <i>J</i> = 2.0, 1H), 8.22 (br d, <i>J</i> = 8, 1H), 8.26 (br s, 1H), 8.28 (br s, 1H), 8.63 (d, <i>J</i> = 6, 1H), 8.86 (d, <i>J</i> = 8.8, 1H), 9.00 (d, <i>J</i> = 6, 1H), 9.66 (s, 1H), 10.19 (s, 1H) ppm.</div></div><div id="sec5_1_31_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i124" class="anchor-spacer"></div><h5 class="article-section__title" id="_i124"> 5-(3-Cyanophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid Trifluoroacetate Salt (<b>25q</b>)</h5><div class="NLM_p last">Yield, 30%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 341 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i125" class="anchor-spacer"></div><h5 class="article-section__title" id="_i125"> 5-(4-Phenoxyphenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25r</b>)</h5><div class="NLM_p last">Yield, 54%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 408 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i126" class="anchor-spacer"></div><h5 class="article-section__title" id="_i126"> 5-(3-Phenoxyphenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25s</b>)</h5><div class="NLM_p last">Yield, 70%. LCMS (ES): 90% pure, <i>m</i>/<i>z</i> 408 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i127" class="anchor-spacer"></div><h5 class="article-section__title" id="_i127"> 5-(3-Sulfamoylphenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>25t</b>)</h5><div class="NLM_p last">Yield, 26%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 395 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.43 (s, 2H), 7.56 (d, <i>J</i> = 8.0, 1H), 7.64 (t, <i>J</i> = 7.6, 1H), 7.99 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 8.32 (d, <i>J</i> = 1.6, 1H), 8.40 (d, <i>J</i> = 8.0, 1H), 8.68 (m, 2H), 8.88 (d, <i>J</i> = 8.4, 1H), 9.02 (d, <i>J</i> = 5.6, 1H), 9.89 (s, 1H), 10.20 (s, 1H), 13.20 (br s, 1H) ppm.</div></div><div id="sec5_1_31_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i128" class="anchor-spacer"></div><h5 class="article-section__title" id="_i128"> Sodium 5-(3-Chlorophenylamino)-7-methylbenzo[<i>c</i>][2,6]naphthyridine-8-carboxylate (<b>41a</b>)</h5><div class="NLM_p last">Yield, 46%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.76 (s, 3H), 7.08 (dd, <i>J</i> = 8, <i>J</i> = 2, 1H), 7.41 (t, <i>J</i> = 8.4, 1H), 7.47 (d, <i>J</i> = 8.4, 1H), 8.00 (dd, <i>J</i> = 8.4, <i>J</i> = 2, 1H), 8.45 (d, <i>J</i> = 8.4, 1H), 8.55 (d, <i>J</i> = 5.6, 1H), 8.61 (d, <i>J</i> = 2, 1H), 8.86 (d, <i>J</i> = 2, 1H), 9.66 (s, 1H), 10.08 (s, 1H) ppm.</div></div><div id="sec5_1_31_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i129" class="anchor-spacer"></div><h5 class="article-section__title" id="_i129"> 5-(3-Chlorophenylamino)-9-methylbenzo[<i>c</i>][2,6]naphthyridine-8-carboxylic Acid (<b>41c</b>)</h5><div class="NLM_p last">Yield, 16%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.73 (s, 3H), 7.15 (d, <i>J</i> = 8.0, 1H), 7.45 (t, <i>J</i> = 8.0, 1H), 8.08 (d, <i>J</i> = 6, 1H), 8.20 (s, 1H), 8.29 (br s, 1H), 8.65 (m, 1H), 8.73 (s, 1H), 9.01 (d, <i>J</i> = 6.0, 1H), 9.74 (br s, 1H), 10.22 (br s, 1H) ppm.</div></div><div id="sec5_1_31_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i130" class="anchor-spacer"></div><h5 class="article-section__title" id="_i130"> 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-9-carboxylic Acid (<b>41d</b>)</h5><div class="NLM_p last">Yield, 21%. LCMS (ES): 91% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.19 (d, <i>J</i> = 8.4, 1H), 7.47 (t, <i>J</i> = 8.0, 1H), 7.83 (d, <i>J</i> = 8.8, 1H), 8.09 (d, <i>J</i> = 8.4, 1H), 8.21 (d, <i>J</i> = 8.8, 1H), 8.34 (br s, 1H), 8.69 (d, <i>J</i> = 5.6, 1H), 9.03 (br d, <i>J</i> = 5.6, 1H), 9.29 (s, 1H), 9.90 (br s, 1H), 10.23 (br s, 1H) ppm.</div></div><div id="sec5_1_31_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i131" class="anchor-spacer"></div><h5 class="article-section__title" id="_i131"> 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-7-carboxylic Acid (<b>41b</b>)</h5><div class="NLM_p last">Yield, 9%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i132" class="anchor-spacer"></div><h5 class="article-section__title" id="_i132"> 5-(3-Chlorophenylamino)benzo[<i>f</i>][1,7]naphthyridine-8-carboxylic Acid (<b>28i</b>)</h5><div class="NLM_p last">Yield, 10%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.12 (dd, <i>J</i> = 7, <i>J</i> = 2, 1H), 7.43 (t, <i>J</i> = 7, 1H), 7.97 (dd, <i>J</i> = 7, <i>J</i> = 2, 1H), 8.05 (dd, <i>J</i> = 7, <i>J</i> = 4, 1H), 8.22 (dd, <i>J</i> = 7, <i>J</i> = 2, 1H), 8.32 (d, <i>J</i> = 1.6, 1H), 8.62 (t, <i>J</i> = 2, 1H), 8.72 (d, <i>J</i> = 7, 1H), 9.12 (dd, <i>J</i> = 5, <i>J</i> = 2, 1H), 9.28 (d, <i>J</i> = 7, 1H), 10.12 (s, 1H), 12.25 (br s, 1H) ppm.</div></div><div id="sec5_1_31_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i133" class="anchor-spacer"></div><h5 class="article-section__title" id="_i133"> 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,7]naphthyridine-8-carboxylic Acid (<b>28d</b>)</h5><div class="NLM_p last">Yield, 40%. LCMS (ES): 89% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.15 (dd, <i>J</i> = 8, <i>J</i> = 2, 1H), 7.45 (t, <i>J</i> = 8, 1H), 7.96 (d, <i>J</i> = 8, 1H), 8.08 (d, <i>J</i> = 8, 1H), 8.25 (d, <i>J</i> = 2, 1H), 8.31 (t, <i>J</i> = 2, 1H), 8.70 (d, <i>J</i> = 5.6, 1H), 8.74 (d, <i>J</i> = 8.4, 1H), 9.01 (d, <i>J</i> = 6, 1H), 9.82 (s, 1H), 10.00 (s, 1H), 13.3 (br s, 1H) ppm.</div></div><div id="sec5_1_31_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i134" class="anchor-spacer"></div><h5 class="article-section__title" id="_i134"> 5-(3-Chlorophenylamino)benzo[<i>h</i>][1,6]naphthyridine-8-carboxylic Acid (<b>28e</b>)</h5><div class="NLM_p last">Yield, 18%. LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.11 (d, <i>J</i> = 7.2, 1H),7.42 (t, <i>J</i> = 7.6, 1H), 7.84 (br m, 1H), 7.95 (d, <i>J</i> = 8, 1H), 8.05 (d, <i>J</i> = 7.6, 1H), 8.22 (s, 1H), 8.30 (s, 1H), 8.86 (d, <i>J</i> = 8.4, 1H), 9.06 (d, <i>J</i> = 8, 1H), 9.16 (s, 1H), 9.61 (s, 1H), 13.18 (br s, 1H) ppm.</div></div><div id="sec5_1_31_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i135" class="anchor-spacer"></div><h5 class="article-section__title" id="_i135"> 5-(3-Chlorophenylamino)pyrazino[2,3-<i>c</i>]quinoline-8-carboxylic Acid (<b>28f</b>)</h5><div class="NLM_p last">Yield, 83%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 351 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.14 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 7.44 (t, <i>J</i> = 8.4, 1H), 8.02 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 8.26 (br d, <i>J</i> = 7.6, 1H), 8.32 (br s, 1H), 8.56 (m, 1H), 8.84 (d, <i>J</i> = 8.4, 1H), 9.17 (d, <i>J</i> = 2.4, 1H), 9.33 (d, <i>J</i> = 2.0, 1H), 10.16 (s, 1H), 13.3 (br s, 1H) ppm.</div></div><div id="sec5_1_31_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i136" class="anchor-spacer"></div><h5 class="article-section__title" id="_i136"> 5-(3-Chlorophenylamino)pyrimido[4,5-<i>c</i>]quinoline-8-carboxylic Acid (<b>28g</b>)</h5><div class="NLM_p last">Yield, 83%. LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 351 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.14 (dd, <i>J</i> = 7.6, <i>J</i> = 2.0, 1H), 7.44 (t, <i>J</i> = 8.0, 1H), 8.02 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 8.26 (d, <i>J</i> = 8.0, 1H), 8.32 (d, <i>J</i> = 1.6, 1H), 8.56 (t, <i>J</i> = 2.4, 1H), 8.86 (d, <i>J</i> = 8.4, 1H), 9.66 (s, 1H), 10.18 (s, 1H), 10.44 (s, 1H), 13.33 (br s, 1H) ppm.</div></div><div id="sec5_1_31_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i137" class="anchor-spacer"></div><h5 class="article-section__title" id="_i137"> <i>N</i>-(3-Chlorophenyl)-8-(1<i>H</i>-tetrazol-5-yl)benzo[<i>c</i>][2,6]naphthyridin-5-amine Trifluoroacetate Salt (<b>26f</b>)</h5><div class="NLM_p last">A mixture of the 5-chlorobenzo[<i>c</i>][2,6]naphthyridine-8-carbonitrile <b>24b</b> (25 mg, 0.104 mmol), 3-chloroaniline (50 mg, 0.394 mmol), and NMP (0.2 mL) was heated to 100 °C in a microwave reactor for 20 min. LCMS indicated the absence of starting material. Sodium azide (100 mg, 1.53 mmol), ammonium chloride (100 mg, 1.89 mmol), and DMF (0.2 mL) were added to the crude mixture. The mixture was heated for 18 h at 125 °C, at which time LCMS analysis indicated the absence of any starting material. The mixture was diluted with water and purified by preparative HPLC to give the title compound <b>26f</b> (12 mg, 24%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 374 [M + H]<sup>+</sup>, 346 [M + H − N<sub>2</sub>]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.18 (dd, <i>J</i> = 7.5, <i>J</i> = 1.6, 1H), 7.47 (t, <i>J</i> = 8, 1H), 8.08 (d, <i>J</i> = 7.5, 1H), 8.15 (dd, <i>J</i> = 8.4, <i>J</i> = 1.6, 1H), 8.31 (br s, 1H), 8.43 (d, <i>J</i> = 1.6, 1H), 8.68 (d, <i>J</i> = 6, 1H), 9.00 (d, <i>J</i> = 8.8, 1H), 9.03 (d, <i>J</i> = 6, 1H), 9.83 (br s, 1H), 10.24 (s, 1H) ppm.</div></div><div id="sec5_1_31_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i138" class="anchor-spacer"></div><h5 class="article-section__title" id="_i138"> 5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxamide (<b>26e</b>)</h5><div class="NLM_p last">Sodium 5-(3-chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxylate <b>25n</b> (1.0 equiv, 58 mg, 0.16 mmol) was reacted with HOBt (2.0 equiv, 42 mg, 0.31 mmol), ammonium chloride (7.7 equiv, 65 mg, 1.21 mmol), DIEA (4.0 equiv, 109 μL, 0.63 mmol), and EDCI (2.0 equiv, 60 mg, 0.31 mmol) in NMP (0.5 mL) at 70 °C for 30 min. Water was added, and the resulting precipitate was filtered and washed with water. The crude material was suspended in a mixture of EtOAc and hexanes, filtered, and dried. The title compound <b>26e</b> was isolated as a tan solid (27 mg, 50%). LCMS (ES): >95% pure, <i>m</i>/<i>z</i> 349 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.15 (br d, <i>J</i> = 9.2, 1H), 7.45 (t, <i>J</i> = 8.4, 1H), 7.54 (br s, 1H), 7.97 (dd, <i>J</i> = 1.6, <i>J</i> = 8.4, 1H), 8.11 (dd, <i>J</i> = 1.2, <i>J</i> = 8, 1H), 8.279 (br s, 1H), 8.284 (s, 1H), 8.31 (t, <i>J</i> = 2, 1H), 8.59 (d, <i>J</i> = 6, 1H), 8.85 (d, <i>J</i> = 8.4, 1H), 8.99 (d, <i>J</i> = 6, 1H), 9.67 (s, 1H), 10.20 (s, 1H) ppm.</div></div><div id="sec5_1_31_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i139" class="anchor-spacer"></div><h5 class="article-section__title" id="_i139"> <i>N</i>-(3-Chlorophenyl)-8-(4<i>H</i>-1,2,4-triazol-3-yl)benzo[<i>c</i>][2,6]naphthyridin-5-amine (<b>26g</b>)</h5><div class="NLM_p last">5-(3-Chlorophenylamino)benzo[<i>c</i>][2,6]naphthyridine-8-carboxamide <b>26e</b> (1.0 equiv, 36 mg) was stirred in <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (2 mL) at 80 °C for 4 h. The volatiles were removed in vacuo. Acetic acid (0.5 mL) and hydrazine hydrate (0.1 mL) were added. The mixture was stirred at 80 °C for 1 h. Water was added and the solid filtered and dried. After trituration in a mixture of CH<sub>2</sub>Cl<sub>2</sub> and hexanes, the title compound <b>26g</b> was isolated as a solid (22 mg, 67%). LCMS (ES): 95% pure, <i>m</i>/<i>z</i> 373 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.15 (br d, <i>J</i> = 7.4, 1H), 7.46 (t, <i>J</i> = 8.4, 1H), 8.10 (d, <i>J</i> = 7.5, 1H), 8.15 (d, <i>J</i> = 7.5, 1H), 8.36 (s, 1H), 8.39 (s, 1H), 8.59 (d, <i>J</i> = 5.6, 1H), 8.89 (d, <i>J</i> = 5.6, 1H), 8.97 (d, <i>J</i> = 5.6, 1H), 9.68 (s, 1H), 10.18 (s, 1H) ppm.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i140" class="anchor-spacer"></div><h3 class="article-section__title" id="_i140"> CK2 Kinase Assay</h3><div class="NLM_p last">Test compounds in aqueous solution were added at a volume of 10 μL to a reaction mixture comprising 10 μL of assay dilution buffer (ADB; 20 mM MOPS, pH 7.2, 25 mM β-glycerolphosphate, 5 mM EGTA, 1 mM sodium orthovanadate, and 1 mM dithiothreitol), 10 μL of substrate peptide (RRRDDDSDDD, dissolved in ADB at a concentration of 1 mM), 10 μL of recombinant human CK2 (ααββ-holoenzyme, 25 ng dissolved in ADB; Millipore). Reactions were initiated by the addition of 10 μL of ATP solution (90% 75 mM MgCl<sub>2</sub>, 75 μM ATP (final ATP concentration = 15 μM) dissolved in ADB; 10% [γ-33P]ATP (stock 1 mCi/100 μL; 3000 Ci/mmol (Perkin-Elmer) and maintained for 10 min at 30 °C. The reactions were quenched with 100 μL of 0.75% phosphoric acid and then transferred to and filtered through a phosphocellulose filter plate (Millipore). After washing each well five times with 0.75% phosphoric acid, the plate was dried under vacuum for 5 min and, following the addition of 15 μL of scintillation fluid to each well, the residual radioactivity was measured using a Wallac luminescence counter. The IC<sub>50</sub> values were derived from eight concentrations of test inhibitors.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> <b>25n</b><i>K</i><sub>i</sub> Measurement</h3><div class="NLM_p last">The <i>K</i><sub>i</sub> value (inhibition constant) for <b>25n</b> against recombinant human CK2 (ααββ-holoenzyme) was determined by plotting the IC<sub>50</sub> values of <b>25n</b> determined in the presence of various concentrations of ATP against the concentration of ATP (performed at Millipore). The <i>K</i><sub>i</sub> value is equivalent to the <i>Y</i>-intercept according to the Cheng−Prussoff equation<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [ATP]/<i>K</i><sub>m</sub>), where <i>K</i><sub>i</sub> is the inhibition constant and <i>K</i><sub>m</sub> is the Michaelis constant.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> PARP1 Assay</h3><div class="NLM_p last">PARP assays were conducted using a chemiluminescent PARP1 assay kit (Trevigen). Briefly, reactions were performed in histone-coated strip wells, by adding 10 μL of test compound dissolved in 1× PARP buffer (prepared by mixing 20× PARP buffer diluted with high-purity water) and 15 μL of diluted PARP-HSA enzyme (diluted in 1× PARP buffer, 0.1 unit per well) to 25 μL of PARP1 cocktail (prepared from 10× PARP cocktail and 10× activated DNA, both 2.5 μL per well and 20 μL per well of 1× PARP buffer). The reactions were incubated at ambient temperature for 60 min, and then the liquid was removed. After washing the wells four times with PBS (200 μL), 50 μL of STREP-HRP (horseradish peroxidase) solution (diluted 500-fold in 1× Strep-Diluent) was added, and the reactions were allowed to incubate for 30 min at ambient temperature. The liquid was removed and, after washing the wells four times with PBS (200 μL), 50 μL each of PeroxyGlo A and B (chemiluminescent horseradish peroxidase substrates) were added and the resulting chemiluminescence quantified on the SpectraMax M5 plate reader.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143"> Kinase Selectivity Panel</h3><div class="NLM_p last">The 238 kinase selectivity panel was conducted using the Kinase Profiler service offered by Millipore (Billerica, MA), which utilizes a radiometric filter-binding assay. The % inhibition of each kinase was estimated using 0.5 μM of <b>25n</b> at ATP concentrations equivalent to the <i>K</i><sub>m</sub> value for ATP for each respective human recombinant kinase. The determination of IC<sub>50</sub> values was conducted at similar concentrations of ATP (equivalent to the <i>K</i><sub>m</sub> for ATP) using nine concentrations of <b>25n</b> over a range of 0.0001−1 μM.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> Cell Viability Assay</h3><div class="NLM_p last">Various cell lines were seeded at a density of 3000 cells per well 24 h prior to treatment, in appropriate media, and then treated with indicated concentrations of CK2 inhibitors. Suspension cells were seeded and treated on the same day. Following 4 days of incubation, 20 μL of Alamar Blue (10% of volume/well) was added and the cells were further incubated at 37 °C for 4−5 h. Fluorescence with excitation wavelength at 530−560 nm and emission wavelength at 590 nm was measured.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> Endogenous CK2 Assay</h3><div class="NLM_p last">The human leukemia Jurkat T-cell line were cultured in RPMI 1640 (Cambrex) supplemented with 10% fetal calf serum and 50 ng/mL gentamycin. Before treatment, cells were washed, resuspended at a density of ∼106 cells/mL in medium containing 1% fetal calf serum, and incubated in the presence of <b>25n</b> at 0.01, 0.1, and 1.0 μM for 2 h. Cells were recovered by centrifugation, lysed using a hypotonic buffer (20 mMTris/HCl pH 7.4; 2 mM EDTA; 5 mM EGTA; 10 mM mercaptoethanol; 10 mM NaF; 1 μM okadaic acid; 10% v/v glycerol; 0.05% NP-40; 1% protease inhibitor cocktail) and protein from the cleared lysate was diluted to 1 μg per μL in assay dilution buffer (ADB; 20 mM MOPS, pH 7.2, 25 mM β-glycerolphosphate, 5 mM EGTA, 1 mM sodium orthovanadate, and 1 mM dithiothreitol). To 20 μL of diluted protein was added 10 μL of substrate peptide (RRRDDDSDDD, dissolved in ADB at a concentration of 1 mM) and 10 μL of PKA inhibitor cocktail (Upstate/Millipore). Reactions were initiated by the addition of 10 μL of ATP solution (90% 75 mM MgCl<sub>2</sub>, 500 μL ATP dissolved in ADB; 10% [γ-<sup>32</sup>P]ATP: stock 1 mCi/100 μL; 3000 Ci/mmol (Perkin-Elmer) and maintained for 15 min at 32 °C. The reactions were quenched with 100 μL of 0.75% phosphoric acid and then transferred to and filtered through a phosphocellulose filter plate (Millipore). After washing each well 5 times with 0.75% phosphoric acid, the residual radioactivity was measured using a Wallac luminescence counter.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i146" class="anchor-spacer"></div><h3 class="article-section__title" id="_i146"> In Vivo Pharmacokinetics</h3><div class="NLM_p last">The pharmacokinetic profile of <b>25n</b> was investigated in overnight fasted ICR mice, SD rats, and beagle dogs following a single dose given intravenously (iv) and orally (po). The compound was a sodium salt formulated in phosphate buffer for the mice and rats and as a sodium salt dry powder filled capsule for the dogs. Eight mice (four for each leg), six rats (three for each leg), and six dogs (three for each leg) were treated with <b>25n</b>. Blood samples of each mouse were collected at 0.08, 0.25, 0.50, 1, 2, 4, 6, 8, and 24 h following iv dosing and at 0.25, 0.50, 1, 2, 4, 6, 8, and 24 h following oral dosing. Blood samples of each rat were collected at 0.08, 0.25, 0.50, 1, 2, 4, 6, 8, 12, 24, 36, and 48 h following iv dosing and at 0.25, 0.50, 1, 2, 4, 6, 8, 12, 24, 36, and 48 h following oral dosing. Blood samples of each dog were collected at 0.08, 0.25, 0.50, 1, 2, 4, 6, 8, 12, and 24 h following iv dosing and at 0.25, 0.50, 1, 2, 4, 6, 8, 12, and 24 h following oral dosing. Samples were centrifuged at 8000 rpm for 5 min and the plasma collected and stored at −80 °C until analysis. Samples were analyzed by LC-MS/MS technique. The pharmacokinetic parameters were derived by noncompartmental analysis.</div></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i147" class="anchor-spacer"></div><h3 class="article-section__title" id="_i147"> In Vivo Antitumor Efficacy in PC3 Xenograft</h3><div class="NLM_p last">Tumors were initiated by subcutaneous injection of PC3 tumor cell suspensions into the right hind flank region of each mouse. When tumors reached a designated volume of 150−200 mm<sup>3</sup> mice were randomized and divided into groups of 10 mice per group. The sodium salt of <b>25n</b> was administered as a solution in 25 mM NaH<sub>2</sub>PO<sub>4</sub> buffer, by oral gavage twice daily at 25 mg/kg, 50 mg/kg and 75 mg/kg. Tumor volumes and body weights were measured twice weekly. The length and width of the tumor were measured with calipers and the volume calculated using the following formula: tumor volume = (length × width<sup>2</sup>)/2. Percent tumor growth inhibition (TGI) values were calculated on the final day of the study for <b>25n</b>-treated compared to vehicle-treated mice and were calculated as 100 × {1 − [(TreatedFinal Day − TreatedDay 1)/(ControlFinal Day − ControlDay 1)]}. The significance of the differences between the treated versus vehicle groups were determined using one-way ANOVA (Graphpad Prism).</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice Pierre</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#11776178746363745172687d747f74617970637c703f727e7c"><span class="__cf_email__" data-cfemail="e284928b87909087a2819b8e878c87928a83908f83cc818d8f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter C. Chua</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean E. O’Brien</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Siddiqui-Jain</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pauline Bourbon</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mustapha Haddach</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerome Michaux</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johnny Nagasawa</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael K. Schwaebe</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Stefan</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Vialettes</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey P. Whitten</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ta Kung Chen</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Levan Darjania</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan Stansfield</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenna Anderes</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josh Bliesath</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denis Drygin</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Ho</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">May Omori</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris Proffitt</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicole Streiner</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katy Trent</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William G. Rice</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Ryckman</span> - <span class="hlFld-Affiliation affiliation">Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm101251q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i148">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. John K.C. Lim for reviewing the manuscript and Cosmin Borsan for assistance in recording NMR spectra.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i149">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Duncan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span> </span><span class="NLM_article-title">Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2007&pages=33-47&issue=1&author=J.+S.+Duncanauthor=D.+W.+Litchfield&title=Too+much+of+a+good+thing%3A+the+role+of+protein+kinase+CK2+in+tumorigenesis+and+prospects+for+therapeutic+inhibition+of+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DJ.%2BS.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3DToo%2520much%2520of%2520a%2520good%2520thing%253A%2520the%2520role%2520of%2520protein%2520kinase%2520CK2%2520in%2520tumorigenesis%2520and%2520prospects%2520for%2520therapeutic%2520inhibition%2520of%2520CK2%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2007%26volume%3D1784%26issue%3D1%26spage%3D33%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">One-thousand-and-one substrates of protein kinase CK2?</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=349-368&issue=3&author=F.+Meggioauthor=L.+A.+Pinna&title=One-thousand-and-one+substrates+of+protein+kinase+CK2%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOne-thousand-and-one%2520substrates%2520of%2520protein%2520kinase%2520CK2%253F%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26issue%3D3%26spage%3D349%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Protein kinase CK2: a newcomer in the “druggable kinome”</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1042%2FBST0341303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=17073807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKgtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1303-1306&author=M.+A.+Paganoauthor=L.+Cesaroauthor=F.+Meggioauthor=L.+A.+Pinna&title=Protein+kinase+CK2%3A+a+newcomer+in+the+%E2%80%9Cdruggable+kinome%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: a newcomer in the 'druggable kinome'</span></div><div class="casAuthors">Pagano, M. A.; Cesaro, L.; Meggio, F.; Pinna, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1303-1306</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The acronym CK2 (derived from the misnomer 'casein kinase' 2) denotes one of the most pleiotropic members of the eukaryotic protein kinase superfamily, characterized by an acidic consensus sequence in which a carboxylic acid (or pre-phosphorylated) side chain at position n + 3 relative to the target serine/threonine residue plays a crucial role.  The latest repertoire of CK2 substrates includes approx. 300 proteins, but the anal. of available phosphopeptide databases from different sources suggests that CK2 alone may be responsible for the generation of a much larger proportion (10-20%) of the eukaryotic phosphoproteome.  Although for the time being CK2 is not included among protein kinases whose inhibitors are in clin. practice or in advanced clin. trials, evidence is accumulating that elevated CK2 constitutive activity cooperates to induce a no. of pathol. conditions, including cancer, infectious diseases, neurodegeneration and cardiovascular pathologies.  The development and usage of cell-permeant, selective inhibitors discloses a scenario whereby CK2 plays a global anti-apoptotic role, which under special circumstances may lead to untimely and pathogenic cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoArzdBbGlxIrVg90H21EOLACvtfcHk0lgEiJhEee9YDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKgtb3J&md5=a59049c0ac58609a3fcf8d8dbbca477d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST0341303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0341303%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DCesaro%26aufirst%3DL.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520kinase%2520CK2%253A%2520a%2520newcomer%2520in%2520the%2520%25E2%2580%259Cdruggable%2520kinome%25E2%2580%259D%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D1303%26epage%3D1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ahmad, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Protein kinase CK2—a key suppressor of apoptosis</span> <span class="citation_source-journal">Adv. Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=179-187&author=K.+A.+Ahmadauthor=G.+Wangauthor=G.+Ungerauthor=J.+Slatonauthor=K.+Ahmed&title=Protein+kinase+CK2%E2%80%94a+key+suppressor+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DProtein%2520kinase%2520CK2%25E2%2580%2594a%2520key%2520suppressor%2520of%2520apoptosis%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D2008%26volume%3D48%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 in human diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.2174%2F092986708785132933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=18691045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1870-1886&issue=19&author=B.+Guerraauthor=O.+G.+Issinger&title=Protein+kinase+CK2+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 in human diseases</span></div><div class="casAuthors">Guerra, Barbara; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1870-1886</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 (formerly referred to as casein kinase II) is an evolutionary conserved, ubiquitous protein kinase.  There are two paralog catalytic subunits, i.e. alpha (A1) and alpha' (A2).  The alpha and alpha' subunits are linked to two beta subunits to produce a heterotetrameric structure.  The catalytic alpha subunits are distantly related to the CMGC subfamily of kinases, such as the Cdk kinases.  There are some peculiarities assocd. with protein kinase CK2, which are not found with most other protein kinases: (1) the enzyme is constitutively active, (2) it can use ATP and GTP and (3) it is found elevated in most tumors investigated and rapidly proliferating tissues.  With the elucidation of the structure of the catalytic subunit, it was possible to explain why the enzyme is constitutively active and why it can bind GTP.  Considerable information on the potential roles of CK2 in various disease processes including cancer has been gained in recent years, and the present review may help to further elucidate its aberrant role in many disease states.  Its peculiar structural features may be advantageous in designing tailor-made compds. with the possibility to specifically target this protein kinase.  Since not all the aspects of what has been published on CK2 can be covered in this review, we would like to recommend the following reviews; (1) for general information on CK2 and (2) with a focus on aberrant CK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHAjFIdLj5brVg90H21EOLACvtfcHk0ljIfabQE6LYXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL7N&md5=af6ef98b360211abbb0ce5adcfe439e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F092986708785132933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785132933%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520human%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D19%26spage%3D1870%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kramerov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghizadeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caballero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li Calzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenarh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljubimov, A. V.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2008&pages=177-186&issue=1%E2%88%922&author=A.+A.+Kramerovauthor=M.+Saghizadehauthor=S.+Caballeroauthor=L.+C.+Shawauthor=S.+Li+Calziauthor=M.+Bretnerauthor=M.+Montenarhauthor=L.+A.+Pinnaauthor=M.+B.+Grantauthor=A.+V.+Ljubimov&title=Inhibition+of+protein+kinase+CK2+suppresses+angiogenesis+and+hematopoietic+stem+cell+recruitment+to+retinal+neovascularization+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramerov%26aufirst%3DA.%2BA.%26aulast%3DSaghizadeh%26aufirst%3DM.%26aulast%3DCaballero%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DL.%2BC.%26aulast%3DLi%2BCalzi%26aufirst%3DS.%26aulast%3DBretner%26aufirst%3DM.%26aulast%3DMontenarh%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DLjubimov%26aufirst%3DA.%2BV.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520CK2%2520suppresses%2520angiogenesis%2520and%2520hematopoietic%2520stem%2520cell%2520recruitment%2520to%2520retinal%2520neovascularization%2520sites%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D316%26issue%3D1%25E2%2588%25922%26spage%3D177%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 as a druggable target</span> <span class="citation_source-journal">Mol. Biosyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1039%2Fb805534c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=18704226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVSqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=889-894&issue=9&author=S.+Sarnoauthor=L.+A.+Pinna&title=Protein+kinase+CK2+as+a+druggable+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 as a druggable target</span></div><div class="casAuthors">Sarno, Stefania; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">889-894</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  CK2 is probably the most pleiotropic Ser/Thr protein kinase with hundreds of endogenous substrates already known, which are implicated in a variety of cellular functions.  At variance with most protein kinases whose activity is turned on only in response to specific stimuli, and whose genetic alterations often underlie pathol. situations, CK2 is not susceptible to tight regulation and there are no mutations known to affect its constitutive activity.  Nevertheless an abnormally high level of CK2 is invariably found in tumors, and solid arguments have accumulated suggesting that CK2 plays a global pro-survival function, which under special circumstances creates a cellular environment particularly favorable to the development and potentiation of the tumor phenotype.  Therefore any strategy aimed at attenuating CK2 activity may represent a "master key" for the treatment of different neoplastic diseases.  Waiting for the clarification of the epigenetic mechanisms promoting the rise of CK2 in cells predisposed to develop a tumor phenotype, a useful pharmacol. aid can come from the improvement of a no. of fairly potent and selective CK2 inhibitors already available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEYmgSHCYaLVg90H21EOLACvtfcHk0ljIfabQE6LYXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVSqs7w%253D&md5=64aff474b90d010323dc5a99fce8e424</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2Fb805534c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb805534c%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520kinase%2520CK2%2520as%2520a%2520druggable%2520target%26jtitle%3DMol.%2520Biosyst.%26date%3D2008%26volume%3D4%26issue%3D9%26spage%3D889%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Faust, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubash, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro</span> <span class="citation_source-journal">Head Neck</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1002%2F1097-0347%28200007%2922%3A4%3C341%3A%3AAID-HED5%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=10862016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A280%3ADC%252BD3czos12ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=341-346&issue=4&author=R.+A.+Faustauthor=S.+Tawficauthor=A.+T.+Davisauthor=L.+A.+Bubashauthor=K.+Ahmed&title=Antisense+oligonucleotides+against+protein+kinase+CK2-alpha+inhibit+growth+of+squamous+cell+carcinoma+of+the+head+and+neck+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro</span></div><div class="casAuthors">Faust R A; Tawfic S; Davis A T; Bubash L A; Ahmed K</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-6</span>
        ISSN:<span class="NLM_cas:issn">1043-3074</span>.
    </div><div class="casAbstract">BACKGROUND:  Human squamous cell carcinomas of the head and neck (SCCHN) overexpress the protein kinase CK2, and elevated CK2 activity correlates with aggressive tumor behavior and poor clinical outcome.  We therefore investigated whether interference with CK2 expression would inhibit SCCHN cell growth in vitro.  METHODS:  We targeted the catalytic (alpha) subunit of CK2 using an antisense oligodeoxynucleotide (ODN) strategy.  Human Ca9-22 cells derived from SCCHN were transfected with CK2-alpha sense, nonsense, or antisense ODN; CK2 activity was measured; and the effect on CK2 activity and on cell growth was determined.  RESULTS:  Transfection of Ca9-22 cells with antisense CK2-alpha ODN resulted in significantly decreased CK2 kinase activity associated with nuclear chromatin and in dose-dependent growth inhibition of Ca9-22 cells in vitro.  CONCLUSIONS:  Interference with the protein kinase CK2 signal in SCCHN cells may offer a novel anticancer strategy for this malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzGXahH1HJaHtlzo9xastyfW6udTcc2eZy1VWYlgc7RLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czos12ktg%253D%253D&md5=bad04b421a92ce54696b4693c5bfc800</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2F1097-0347%28200007%2922%3A4%3C341%3A%3AAID-HED5%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0347%2528200007%252922%253A4%253C341%253A%253AAID-HED5%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DFaust%26aufirst%3DR.%2BA.%26aulast%3DTawfic%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DA.%2BT.%26aulast%3DBubash%26aufirst%3DL.%2BA.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DAntisense%2520oligonucleotides%2520against%2520protein%2520kinase%2520CK2-alpha%2520inhibit%2520growth%2520of%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520head%2520and%2520neck%2520in%2520vitro%26jtitle%3DHead%2520Neck%26date%3D2000%26volume%3D22%26issue%3D4%26spage%3D341%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Landesman-Bollag, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romieu-Mourez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardiff, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seldin, D. C.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 in mammary gland tumorigenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">3247</span><span class="NLM_x">–</span> <span class="NLM_lpage">3257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=3247-3257&issue=25&author=E.+Landesman-Bollagauthor=R.+Romieu-Mourezauthor=D.+H.+Songauthor=G.+E.+Sonensheinauthor=R.+D.+Cardiffauthor=D.+C.+Seldin&title=Protein+kinase+CK2+in+mammary+gland+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandesman-Bollag%26aufirst%3DE.%26aulast%3DRomieu-Mourez%26aufirst%3DR.%26aulast%3DSong%26aufirst%3DD.%2BH.%26aulast%3DSonenshein%26aufirst%3DG.%2BE.%26aulast%3DCardiff%26aufirst%3DR.%2BD.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520mammary%2520gland%2520tumorigenesis%26jtitle%3DOncogene%26date%3D2001%26volume%3D20%26issue%3D25%26spage%3D3247%26epage%3D3257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pistorius, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remberger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Differential CKII Activities in Human Colorectal Mucosa, Adenomas and Carcinomas</span> <span class="citation_source-journal">Onkologie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1159%2F000216984" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1991&pages=256-260&issue=3&author=K.+Pistoriusauthor=G.+Seitzauthor=K.+Rembergerauthor=O.+G.+Issinger&title=Differential+CKII+Activities+in+Human+Colorectal+Mucosa%2C+Adenomas+and+Carcinomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1159%2F000216984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000216984%26sid%3Dliteratum%253Aachs%26aulast%3DPistorius%26aufirst%3DK.%26aulast%3DSeitz%26aufirst%3DG.%26aulast%3DRemberger%26aufirst%3DK.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DDifferential%2520CKII%2520Activities%2520in%2520Human%2520Colorectal%2520Mucosa%252C%2520Adenomas%2520and%2520Carcinomas%26jtitle%3DOnkologie%26date%3D1991%26volume%3D14%26issue%3D3%26spage%3D256%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Stalter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becht, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remberger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Asymmetric expression of protein kinase CK2 subunits in human kidney tumors</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1994&pages=141-147&issue=1&author=G.+Stalterauthor=S.+Siemerauthor=E.+Bechtauthor=M.+Zieglerauthor=K.+Rembergerauthor=O.+G.+Issinger&title=Asymmetric+expression+of+protein+kinase+CK2+subunits+in+human+kidney+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStalter%26aufirst%3DG.%26aulast%3DSiemer%26aufirst%3DS.%26aulast%3DBecht%26aufirst%3DE.%26aulast%3DZiegler%26aufirst%3DM.%26aulast%3DRemberger%26aufirst%3DK.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DAsymmetric%2520expression%2520of%2520protein%2520kinase%2520CK2%2520subunits%2520in%2520human%2520kidney%2520tumors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1994%26volume%3D202%26issue%3D1%26spage%3D141%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">O-charoenrat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span> </span><span class="NLM_article-title">Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5792</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1158%2F1078-0432.CCR-03-0317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=15355908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlyjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=5792-5803&issue=17&author=P.+O-charoenratauthor=V.+Ruschauthor=S.+G.+Talbotauthor=I.+Sarkariaauthor=A.+Vialeauthor=N.+Socciauthor=I.+Ngaiauthor=P.+Raoauthor=B.+Singh&title=Casein+kinase+II+alpha+subunit+and+C1-inhibitor+are+independent+predictors+of+outcome+in+patients+with+squamous+cell+carcinoma+of+the+lung"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung</span></div><div class="casAuthors">O-Charoenrat, Pornchai; Rusch, Valerie; Talbot, Simon G.; Sarkaria, Inderpal; Viale, Agnes; Socci, Nicholas; Ngai, Ivan; Rao, Pulivarthi; Singh, Bhuvanesh</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5792-5803</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Gene expression profiling has been shown to be a valuable tool for prognostication and identification of cancer-assocd. genes in human malignancies.  The authors aimed to identify potential prognostic marker(s) in non-small cell lung cancers using global gene expression profiles.  Twenty-one previously untreated patients with non-small cell lung cancer were analyzed using the Affymetrix GeneChip high-d. oligonucleotide array and comparative genomic hybridization.  Identified candidate genes were validated in an independent cohort of 45 patients using quant. real-time reverse transcription-PCR and Western blot analyses.  Follow-up data for these patients was collected and used to assess outcome correlations.  Hierarchical clustering anal. yielded three distinct subgroups based on gene expression profiling.  Cluster I consisted of 4 patients with adenocarcinoma and 1 with squamous cell carcinoma (squamous cell carcinoma); clusters II and III consisted of 6 and 10 patients with squamous cell carcinoma, resp.  Outcome anal. was performed on the cluster groups contg. solely squamous cell carcinoma, revealing significant differences in disease-specific survival rates.  Moreover, patients having a combination of advanced Tumor-Node-Metastasis stage and assigned to the poor prognosis cluster group (cluster II) had significantly poorer outcomes.  Comparative genomic hybridization anal. showed recurrent chromosomal losses at 1p, 3p, 17, 19, and 22 and gains/amplifications at 3q, 5p, and 8q, which did not vary significantly between the cluster groups.  The authors internally and externally validated a subset of 11 cluster II (poor prognosis)-specific genes having corresponding chromosomal aberrations identified by comparative genomic hybridization as prognostic markers in an independent cohort of patients with lung squamous cell carcinoma identifying CSNK2A1 and C1-Inh as independent predictors of outcome.  CSNK2A1 and C1-Inh are independent predictors of survival in lung squamous cell carcinoma patients and may be useful as prognostic markers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeFyuVlgBO7Vg90H21EOLACvtfcHk0ljRIh_fmXDsVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlyjs7k%253D&md5=0a96c1b8922106fef2f3ce02eb3a71dd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0317%26sid%3Dliteratum%253Aachs%26aulast%3DO-charoenrat%26aufirst%3DP.%26aulast%3DRusch%26aufirst%3DV.%26aulast%3DTalbot%26aufirst%3DS.%2BG.%26aulast%3DSarkaria%26aufirst%3DI.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DSocci%26aufirst%3DN.%26aulast%3DNgai%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26atitle%3DCasein%2520kinase%2520II%2520alpha%2520subunit%2520and%2520C1-inhibitor%2520are%2520independent%2520predictors%2520of%2520outcome%2520in%2520patients%2520with%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520lung%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26issue%3D17%26spage%3D5792%26epage%3D5803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, Y. H.</span><span> </span><span class="NLM_article-title">Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1158%2F1078-0432.CCR-06-1602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=17289898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1019-1028&issue=3&author=J.+S.+Kimauthor=J.+I.+Eomauthor=J.+W.+Cheongauthor=A.+J.+Choiauthor=J.+K.+Leeauthor=W.+I.+Yangauthor=Y.+H.+Min&title=Protein+kinase+CK2alpha+as+an+unfavorable+prognostic+marker+and+novel+therapeutic+target+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia</span></div><div class="casAuthors">Kim, Jin Seok; Eom, Ju In; Cheong, June-Won; Choi, Ae Jin; Lee, Jin Koo; Yang, Woo Ick; Min, Yoo Hong</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1019-1028</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Introduction: Protein kinase CK2 is implicated in cellular proliferation and transformation.  However, the clin. and biol. significances of CK2 have not been elucidated in acute myeloid leukemia (AML).  Exptl. Design: We evaluated the biol. significances of catalytic subunit of CK2 (CK2α) expression in leukemia cell lines and primary leukemic blasts obtained from AML patients.  Results: In this study, the expression of CK2α was elevated in a substantial proportion of AML.  In AML patients with normal karyotype, the disease-free survival and overall survival rates were significantly lower in the CK2α-high compared with the CK2α-low AML cases (P = 0.0252 and P = 0.0392, resp.).  An induced overexpression of CK2α increased the levels of Ser473 phosphorylated (p)-Akt/protein kinase B (PKB), p-PDK1, pFKHR, p-BAD, Bcl-2, Bcl-xL, Mcl-1, and XIAP.  Treatment of U937 cell line and primary AML blasts with selective CK2 inhibitor, tetrabromobenzotriazole or apigenin, reduced the levels of these mols. in a dose-dependent manner.  CK2α small interfering RNA treatment also resulted in a down-regulation of p-Akt/PKB and Bcl-2 in U937 cells.  Apigenin-induced cell death was preferentially obsd. in the CK2α-high leukemia cell lines, HL-60 and NB4, which was accompanied by cytoplasmic release of SMAC/DIABLO and proteolytic cleavage of procaspase-9, procaspase-3, procaspase-8, and poly(ADP)ribose polymerase.  An induced overexpression of CK2α potentially enhanced the sensitivity of U937 cells to the apigenin-induced cell death.  Apigenin-induced cell death was significantly higher in CK2α-high AML compared with CK2α-low AML (P < 0.0001) or normal bone marrow samples (P < 0.0001).  Conclusion: These findings strongly suggest protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7fx3ZX_P4UrVg90H21EOLACvtfcHk0liP03BE2Mc0AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7c%253D&md5=bc56dacc8f3ad4ba702623b09dcb4bd3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1602%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DEom%26aufirst%3DJ.%2BI.%26aulast%3DCheong%26aufirst%3DJ.%2BW.%26aulast%3DChoi%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DYang%26aufirst%3DW.%2BI.%26aulast%3DMin%26aufirst%3DY.%2BH.%26atitle%3DProtein%2520kinase%2520CK2alpha%2520as%2520an%2520unfavorable%2520prognostic%2520marker%2520and%2520novel%2520therapeutic%2520target%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D3%26spage%3D1019%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Yenice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goueli, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=11-16&issue=1&author=S.+Yeniceauthor=A.+T.+Davisauthor=S.+A.+Goueliauthor=A.+Akdasauthor=C.+Limasauthor=K.+Ahmed&title=Nuclear+casein+kinase+2+%28CK-2%29+activity+in+human+normal%2C+benign+hyperplastic%2C+and+cancerous+prostate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYenice%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DA.%2BT.%26aulast%3DGoueli%26aufirst%3DS.%2BA.%26aulast%3DAkdas%26aufirst%3DA.%26aulast%3DLimas%26aufirst%3DC.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DNuclear%2520casein%2520kinase%25202%2520%2528CK-2%2529%2520activity%2520in%2520human%2520normal%252C%2520benign%2520hyperplastic%252C%2520and%2520cancerous%2520prostate%26jtitle%3DProstate%26date%3D1994%26volume%3D24%26issue%3D1%26spage%3D11%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Laramas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filhol, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringeisen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Descotes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">928</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2007&pages=928-934&issue=5&author=M.+Laramasauthor=D.+Pasquierauthor=O.+Filholauthor=F.+Ringeisenauthor=J.+L.+Descotesauthor=C.+Cochet&title=Nuclear+localization+of+protein+kinase+CK2+catalytic+subunit+%28CK2alpha%29+is+associated+with+poor+prognostic+factors+in+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaramas%26aufirst%3DM.%26aulast%3DPasquier%26aufirst%3DD.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DRingeisen%26aufirst%3DF.%26aulast%3DDescotes%26aufirst%3DJ.%2BL.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNuclear%2520localization%2520of%2520protein%2520kinase%2520CK2%2520catalytic%2520subunit%2520%2528CK2alpha%2529%2520is%2520associated%2520with%2520poor%2520prognostic%2520factors%2520in%2520human%2520prostate%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2007%26volume%3D43%26issue%3D5%26spage%3D928%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tawfic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 signal in neoplasia</span> <span class="citation_source-journal">Histol. Histopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=11332713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Smtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=573-582&issue=2&author=S.+Tawficauthor=S.+Yuauthor=H.+Wangauthor=R.+Faustauthor=A.+Davisauthor=K.+Ahmed&title=Protein+kinase+CK2+signal+in+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 signal in neoplasia</span></div><div class="casAuthors">Tawfic, S.; Yu, S.; Wang, H.; Faust, R.; Davis, A.; Ahmed, K.</div><div class="citationInfo"><span class="NLM_cas:title">Histology and Histopathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-582</span>CODEN:
                <span class="NLM_cas:coden">HIHIES</span>;
        ISSN:<span class="NLM_cas:issn">0213-3911</span>.
    
            (<span class="NLM_cas:orgname">Histology and Histopathology</span>)
        </div><div class="casAbstract">A review with many refs.  Protein kinase CK2 (previously known as casein kinase II) is a protein Ser/Thr kinase that was implicated in cell growth and proliferation.  The focus of this review is on the apparent role of CK2 in cancer.  Studies from several labs. have shown a dysregulated expression of the kinase in tumors.  Nuclear matrix and chromatin appear to be key sites for signaling of the CK2 activity in relation to cell growth.  Several types of growth stimuli produce a common downstream response in CK2 by enhancing its nuclear shuttling.  The neoplastic change is also assocd. with changes in intracellular localization of the kinase so that a higher nuclear localization is obsd. in tumor cells compared with normal cells.  Exptl. studies suggest that dysregulated expression of the α subunit of CK2 imparts an oncogenic potential in the cells such that in cooperation with certain oncogenes it produces a profound enhancement of the tumor phenotype.  Recent studies have provided evidence that overexpression of CK2 in tumor cells is not simply a reflection of tumor cell proliferation alone but addnl. may reflect the pathobiol. characteristics of the tumor.  Of considerable interest is the possibility that CK2 dysregulation in tumors may influence the apoptotic activity in those cells.  Approaches to interfering with the CK2 signal may provide a useful means for inducing tumor cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqD8HQSFNesLVg90H21EOLACvtfcHk0liP03BE2Mc0AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Smtbc%253D&md5=ec11e4e8878d533bf62b64e3a4a054e8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTawfic%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DFaust%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DProtein%2520kinase%2520CK2%2520signal%2520in%2520neoplasia%26jtitle%3DHistol.%2520Histopathol.%26date%3D2001%26volume%3D16%26issue%3D2%26spage%3D573%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Addiction to protein kinase CK2: a common denominator of diverse cancer cells?</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=499-504&issue=3&author=M.+Ruzzeneauthor=L.+A.+Pinna&title=Addiction+to+protein+kinase+CK2%3A+a+common+denominator+of+diverse+cancer+cells%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DAddiction%2520to%2520protein%2520kinase%2520CK2%253A%2520a%2520common%2520denominator%2520of%2520diverse%2520cancer%2520cells%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26issue%3D3%26spage%3D499%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solimini, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">Principles of cancer therapy: oncogene and non-oncogene addiction</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1016%2Fj.cell.2009.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19269363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=823-837&issue=5&author=J.+Luoauthor=N.+L.+Soliminiauthor=S.+J.+Elledge&title=Principles+of+cancer+therapy%3A+oncogene+and+non-oncogene+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of cancer therapy: oncogene and non-oncogene addiction</span></div><div class="casAuthors">Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-837</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Cancer is a complex collection of distinct genetic diseases united by common hallmarks.  Here, we expand upon the classic hallmarks to include the stress phenotypes of tumorigenesis.  We describe a conceptual framework of how oncogene and non-oncogene addictions contribute to these hallmarks and how they can be exploited through stress sensitization and stress overload to selectively kill cancer cells.  In particular, we present evidence for a large class of non-oncogenes that are essential for cancer cell survival and present attractive drug targets.  Finally, we discuss the path ahead to therapeutic discovery and provide theor. considerations for combining orthogonal cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrH3NH_D9W6LVg90H21EOLACvtfcHk0lgkUYdbc96NMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSnsLw%253D&md5=dfbc7a874dcad44f8af947083dab8c33</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DSolimini%26aufirst%3DN.%2BL.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DPrinciples%2520of%2520cancer%2520therapy%253A%2520oncogene%2520and%2520non-oncogene%2520addiction%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D5%26spage%3D823%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Slaton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloper, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=15634760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotVOq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=712-721&issue=12&author=J.+W.+Slatonauthor=G.+M.+Ungerauthor=D.+T.+Sloperauthor=A.+T.+Davisauthor=K.+Ahmed&title=Induction+of+apoptosis+by+antisense+CK2+in+human+prostate+cancer+xenograft+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Apoptosis by Antisense CK2 in Human Prostate Cancer Xenograft Model</span></div><div class="casAuthors">Slaton, Joel W.; Unger, Gretchen M.; Sloper, Daniel T.; Davis, Alan T.; Ahmed, Khalil</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">712-721</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein serine/threonine kinase CK2 (formerly casein kinase 2) is a ubiquitous protein kinase that plays key roles in cell growth, proliferation, and survival.  We have shown previously that its mol. down-regulation induces apoptosis in cancer cells in culture.  Here, we have employed a xenograft model of prostate cancer to extend these studies to det. whether antisense CK2α evokes a similar response in vivo.  A single dose of antisense CK2α oligodeoxynucleotide given directly into the PC3-LN4 xenograft tumor in nude mouse induced a dose- and time-dependent tumor cell death in vivo.  The tumor was completely resolved at the higher tested dose of the antisense.  Cell death was due to apoptosis and correlated with a potent down-regulation of the CK2α message and loss of CK2 from the nuclear matrix in the xenograft tissue as well as in cancer cells in culture.  These observations accorded with several of the earlier studies indicating that loss of CK2 from the nuclear matrix is assocd. with induction of apoptosis.  Comparison of the effects of antisense CK2α oligodeoxynucleotide on cancer vs. normal or noncancer cells showed that the concn. of antisense CK2α that elicited extensive apoptosis in tumor cells in culture or xenograft tumors in vivo had a relatively small or minimal effect on noncancer cells in culture or on normal prostate gland subjected to orthotropic injection of antisense oligodeoxynucleotide in vivo.  The basis for the difference in sensitivity of cancer vs. noncancer cells to antisense CK2α is unknown at this time; however, this differential response under similar conditions of treatment may be significant in considering the potential feasibility of targeting the CK2 signal for induction of apoptosis in cancer cells in vivo.  Although much further work will be needed to establish the feasibility of targeting CK2 for cancer therapy, to our knowledge, this is the first report to provide important new evidence as an initial "proof of principle" for the potential application of antisense CK2α in cancer therapy, paving the way for future detailed studies of approaches to targeting CK2 in vivo to induce cancer cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR4RbEBGDZ67Vg90H21EOLACvtfcHk0lgkUYdbc96NMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotVOq&md5=e98d44f29959efc3df971da3ef9bc272</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlaton%26aufirst%3DJ.%2BW.%26aulast%3DUnger%26aufirst%3DG.%2BM.%26aulast%3DSloper%26aufirst%3DD.%2BT.%26aulast%3DDavis%26aufirst%3DA.%2BT.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DInduction%2520of%2520apoptosis%2520by%2520antisense%2520CK2%2520in%2520human%2520prostate%2520cancer%2520xenograft%2520model%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2004%26volume%3D2%26issue%3D12%26spage%3D712%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Trembley, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kren, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Emergence of protein kinase CK2 as a key target in cancer therapy</span> <span class="citation_source-journal">Biofactors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=187-195&issue=3&author=J.+H.+Trembleyauthor=Z.+Chenauthor=G.+Ungerauthor=J.+Slatonauthor=B.+T.+Krenauthor=C.+Van+Waesauthor=K.+Ahmed&title=Emergence+of+protein+kinase+CK2+as+a+key+target+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrembley%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DKren%26aufirst%3DB.%2BT.%26aulast%3DVan%2BWaes%26aufirst%3DC.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DEmergence%2520of%2520protein%2520kinase%2520CK2%2520as%2520a%2520key%2520target%2520in%2520cancer%2520therapy%26jtitle%3DBiofactors%26date%3D2010%26volume%3D36%26issue%3D3%26spage%3D187%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzeszko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">The selectivity of inhibitors of protein kinase CK2. An update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2008&pages=353-365&issue=3&author=M.+A.+Paganoauthor=J.+Bainauthor=Z.+Kazimierczukauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=G.+Di+Mairaauthor=M.+Elliottauthor=A.+Orzeszkoauthor=G.+Cozzaauthor=F.+Meggioauthor=L.+A.+Pinna&title=The+selectivity+of+inhibitors+of+protein+kinase+CK2.+An+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520selectivity%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520CK2.%2520An%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D415%26issue%3D3%26spage%3D353%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Moliner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-<i>a</i>)quinazolin-7-yl]acetic acid (IQA)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=639-646&issue=3&author=S.+Sarnoauthor=E.+de+Molinerauthor=M.+Ruzzeneauthor=M.+A.+Paganoauthor=R.+Battistuttaauthor=J.+Bainauthor=D.+Fabbroauthor=J.+Schoepferauthor=M.+Elliottauthor=P.+Furetauthor=F.+Meggioauthor=G.+Zanottiauthor=L.+A.+Pinna&title=Biochemical+and+three-dimensional-structural+study+of+the+specific+inhibition+of+protein+kinase+CK2+by+%5B5-oxo-5%2C6-dihydroindolo-%281%2C2-a%29quinazolin-7-yl%5Dacetic+acid+%28IQA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3Dde%2BMoliner%26aufirst%3DE.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DBiochemical%2520and%2520three-dimensional-structural%2520study%2520of%2520the%2520specific%2520inhibition%2520of%2520protein%2520kinase%2520CK2%2520by%2520%255B5-oxo-5%252C6-dihydroindolo-%25281%252C2-a%2529quinazolin-7-yl%255Dacetic%2520acid%2520%2528IQA%2529%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D374%26issue%3D3%26spage%3D639%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lopez-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moucadel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouawad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=3171-3185&author=M.+Lopez-Ramosauthor=R.+Prudentauthor=V.+Moucadelauthor=C.+F.+Sautelauthor=C.+Baretteauthor=L.+Lafanechereauthor=L.+Mouawadauthor=D.+Griersonauthor=F.+Schmidtauthor=J.+C.+Florentauthor=P.+Filippakopoulosauthor=A.+N.+Bullockauthor=S.+Knappauthor=J.+B.+Reiserauthor=C.+Cochet&title=New+potent+dual+inhibitors+of+CK2+and+Pim+kinases%3A+discovery+and+structural+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Ramos%26aufirst%3DM.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DMouawad%26aufirst%3DL.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DFlorent%26aufirst%3DJ.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DReiser%26aufirst%3DJ.%2BB.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNew%2520potent%2520dual%2520inhibitors%2520of%2520CK2%2520and%2520Pim%2520kinases%253A%2520discovery%2520and%2520structural%2520insights%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D3171%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Sandholt, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Resorufin: a lead for a new protein kinase CK2 inhibitor</span> <span class="citation_source-journal">Anticancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=238-248&issue=4&author=I.+S.+Sandholtauthor=B.+B.+Olsenauthor=B.+Guerraauthor=O.+G.+Issinger&title=Resorufin%3A+a+lead+for+a+new+protein+kinase+CK2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandholt%26aufirst%3DI.%2BS.%26aulast%3DOlsen%26aufirst%3DB.%2BB.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DResorufin%253A%2520a%2520lead%2520for%2520a%2520new%2520protein%2520kinase%2520CK2%2520inhibitor%26jtitle%3DAnticancer%2520Drugs%26date%3D2009%26volume%3D20%26issue%3D4%26spage%3D238%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nakaniwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span> </span><span class="NLM_article-title">Structure of human protein kinase CK2alpha2 with a potent indazole-derivative inhibitor</span> <span class="citation_source-journal">Acta Crystallogr., Sect F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1107%2FS1744309108043194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19193990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=75-79&issue=2&author=T.+Nakaniwaauthor=T.+Kinoshitaauthor=Y.+Sekiguchiauthor=T.+Tadaauthor=I.+Nakanishiauthor=K.+Kitauraauthor=Y.+Suzukiauthor=H.+Ohnoauthor=A.+Hirasawaauthor=G.+Tsujimoto&title=Structure+of+human+protein+kinase+CK2alpha2+with+a+potent+indazole-derivative+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human protein kinase CK2α2 with a potent indazole-derivative inhibitor</span></div><div class="casAuthors">Nakaniwa, Tetsuko; Kinoshita, Takayoshi; Sekiguchi, Yusuke; Tada, Toshiji; Nakanishi, Isao; Kitaura, Kazuo; Suzuki, Yamato; Ohno, Hiroaki; Hirasawa, Akira; Tsujimoto, Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-79</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Casein kinase 2 (CK2) is a serine/threonine kinase that functions as a heterotetramer composed of two catalytic subunits (CK2α1 or CK2α2) and two regulatory subunits (CK2β).  The two isoenzymes CK2α1 and CK2α2 play distinguishable roles in healthy subjects and in patients with diseases such as cancer, resp.  In order to develop novel CK2α1-selective inhibitors, the crystal structure of human CK2α2 (hCK2α2) complexed with a potent CK2α inhibitor which binds to the active site of hCK2α2 was detd. and compared with that of human CK2α1.  While the two isoenzymes exhibited a high similarity with regard to the active site, the largest structural difference between the isoforms occurred in the β4-β5 loop responsible for the CK2α-CK2β interface.  The top of the N-terminal segment interacted with the β4-β5 loop via a hydrogen bond in hCK2α2 but not in hCK2α1.  Thus, the CK2α-CK2β interface is a likely target candidate for the prodn. of selective CK2α1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfg1zyw6VxVbVg90H21EOLACvtfcHk0lhq05d4VPa8fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCktrY%253D&md5=4dffcee1b2fb45186f77ef5e0c13cc99</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS1744309108043194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309108043194%26sid%3Dliteratum%253Aachs%26aulast%3DNakaniwa%26aufirst%3DT.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DSekiguchi%26aufirst%3DY.%26aulast%3DTada%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DKitaura%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DStructure%2520of%2520human%2520protein%2520kinase%2520CK2alpha2%2520with%2520a%2520potent%2520indazole-derivative%2520inhibitor%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2009%26volume%3D65%26issue%3D2%26spage%3D75%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Najda-Bernatowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzeszko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopanska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muszynska, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span> </span><span class="NLM_article-title">Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide-potential inhibitors of human protein kinase CK2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1573</span><span class="NLM_x">–</span> <span class="NLM_lpage">1578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1573-1578&issue=4&author=A.+Najda-Bernatowiczauthor=M.+Lebskaauthor=A.+Orzeszkoauthor=K.+Kopanskaauthor=E.+Krzywinskaauthor=G.+Muszynskaauthor=M.+Bretner&title=Synthesis+of+new+analogs+of+benzotriazole%2C+benzimidazole+and+phthalimide-potential+inhibitors+of+human+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNajda-Bernatowicz%26aufirst%3DA.%26aulast%3DLebska%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DKopanska%26aufirst%3DK.%26aulast%3DKrzywinska%26aufirst%3DE.%26aulast%3DMuszynska%26aufirst%3DG.%26aulast%3DBretner%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520new%2520analogs%2520of%2520benzotriazole%252C%2520benzimidazole%2520and%2520phthalimide-potential%2520inhibitors%2520of%2520human%2520protein%2520kinase%2520CK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D4%26spage%3D1573%26epage%3D1578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hung, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablons, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, L.</span><span> </span><span class="NLM_article-title">Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=135&issue=1&author=M.+S.+Hungauthor=Z.+Xuauthor=Y.+C.+Linauthor=J.+H.+Maoauthor=C.+T.+Yangauthor=P.+J.+Changauthor=D.+M.+Jablonsauthor=L.+You&title=Identification+of+hematein+as+a+novel+inhibitor+of+protein+kinase+CK2+from+a+natural+product+library"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DM.%2BS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DMao%26aufirst%3DJ.%2BH.%26aulast%3DYang%26aufirst%3DC.%2BT.%26aulast%3DChang%26aufirst%3DP.%2BJ.%26aulast%3DJablons%26aufirst%3DD.%2BM.%26aulast%3DYou%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520hematein%2520as%2520a%2520novel%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%2520from%2520a%2520natural%2520product%2520library%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Gianoncelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzeszko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">7281</span><span class="NLM_x">–</span> <span class="NLM_lpage">7289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7281-7289&issue=20&author=A.+Gianoncelliauthor=G.+Cozzaauthor=A.+Orzeszkoauthor=F.+Meggioauthor=Z.+Kazimierczukauthor=L.+A.+Pinna&title=Tetraiodobenzimidazoles+are+potent+inhibitors+of+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DTetraiodobenzimidazoles%2520are%2520potent%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D20%26spage%3D7281%26epage%3D7289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papinutto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianoncelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagotto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Quinalizarin as a potent, selective and cell permeable inhibitor of protein kinase CK2</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=387-395&issue=3&author=G.+Cozzaauthor=M.+Mazzoranaauthor=E.+Papinuttoauthor=J.+Bainauthor=M.+Elliottauthor=G.+Di+Mairaauthor=A.+Gianoncelliauthor=M.+A.+Paganoauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=R.+Battistuttaauthor=F.+Meggioauthor=S.+Moroauthor=G.+Zagottoauthor=L.+A.+Pinna&title=Quinalizarin+as+a+potent%2C+selective+and+cell+permeable+inhibitor+of+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DQuinalizarin%2520as%2520a%2520potent%252C%2520selective%2520and%2520cell%2520permeable%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26issue%3D3%26spage%3D387%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1002%2Fardp.200700269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=18763715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=554-561&issue=9&author=Y.+Suzukiauthor=J.+Cluzeauauthor=T.+Haraauthor=A.+Hirasawaauthor=G.+Tsujimotoauthor=S.+Oishiauthor=H.+Ohnoauthor=N.+Fujii&title=Structure%E2%88%92activity+relationships+of+pyrazine-based+CK2+inhibitors%3A+synthesis+and+evaluation+of+2%2C6-disubstituted+pyrazines+and+4%2C6-disubstituted+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines</span></div><div class="casAuthors">Suzuki, Yamato; Cluzeau, Jerome; Hara, Takafumi; Hirasawa, Akira; Tsujimoto, Gozoh; Oishi, Shinya; Ohno, Hiroaki; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">554-561</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Structually related to the known CK2 inhibitors, 2,6-disubstituted pyrazine and 4,6-disubstituted pyrimidine derivs. were synthesized and their inhibitory activities toward CK2α and CK2α' were evaluated.  Structure-activity relationship study has revealed that several pyrazine derivs. bearing a (pyrrol-3-yl)acetic acid and a monosubstituted aniline possess potent inhibitory activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY4qRwDY7y2rVg90H21EOLACvtfcHk0ljawjF-zWLC1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtb%252FK&md5=c1a1a1ca84ff4172b58ef88d9365e58b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700269%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DCluzeau%26aufirst%3DJ.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520pyrazine-based%2520CK2%2520inhibitors%253A%2520synthesis%2520and%2520evaluation%2520of%25202%252C6-disubstituted%2520pyrazines%2520and%25204%252C6-disubstituted%2520pyrimidines%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2008%26volume%3D341%26issue%3D9%26spage%3D554%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moucadel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouawad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">Salicylaldehyde derivatives as new protein kinase CK2 inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1780</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1412</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1780&publication_year=2008&pages=1412-1420&issue=12&author=R.+Prudentauthor=M.+Lopez-Ramosauthor=V.+Moucadelauthor=C.+Baretteauthor=D.+Griersonauthor=L.+Mouawadauthor=J.+C.+Florentauthor=L.+Lafanechereauthor=F.+Schmidtauthor=C.+Cochet&title=Salicylaldehyde+derivatives+as+new+protein+kinase+CK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DLopez-Ramos%26aufirst%3DM.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DMouawad%26aufirst%3DL.%26aulast%3DFlorent%26aufirst%3DJ.%2BC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DSalicylaldehyde%2520derivatives%2520as%2520new%2520protein%2520kinase%2520CK2%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1780%26issue%3D12%26spage%3D1412%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">How druggable is protein kinase CK2?</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1002%2Fmed.20164" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=419-462&issue=3&author=G.+Cozzaauthor=A.+Bortolatoauthor=S.+Moro&title=How+druggable+is+protein+kinase+CK2%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fmed.20164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20164%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DHow%2520druggable%2520is%2520protein%2520kinase%2520CK2%253F%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D30%26issue%3D3%26spage%3D419%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frascella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucchini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Development and exploitation of CK2 inhibitors</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2005&pages=69-76&issue=1%E2%88%922&author=S.+Sarnoauthor=M.+Ruzzeneauthor=P.+Frascellaauthor=M.+A.+Paganoauthor=F.+Meggioauthor=A.+Zambonauthor=M.+Mazzoranaauthor=G.+Di+Mairaauthor=V.+Lucchiniauthor=L.+A.+Pinna&title=Development+and+exploitation+of+CK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DFrascella%26aufirst%3DP.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZambon%26aufirst%3DA.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DLucchini%26aufirst%3DV.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DDevelopment%2520and%2520exploitation%2520of%2520CK2%2520inhibitors%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D274%26issue%3D1%25E2%2588%25922%26spage%3D69%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zandomeni, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandomeni, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shugar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinmann, R.</span><span> </span><span class="NLM_article-title">Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-<span class="smallcaps smallerCapital">d</span>-ribofuranosylbenzimidazole of specific RNA polymerase II transcription</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">3414</span><span class="NLM_x">–</span> <span class="NLM_lpage">3419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=3414-3419&author=R.+Z.+Zandomeniauthor=M.+C.+Zandomeniauthor=D.+Shugarauthor=R.+Weinmann&title=Casein+kinase+type+II+is+involved+in+the+inhibition+by+5%2C6-dichloro-1-beta-d-ribofuranosylbenzimidazole+of+specific+RNA+polymerase+II+transcription"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZandomeni%26aufirst%3DR.%2BZ.%26aulast%3DZandomeni%26aufirst%3DM.%2BC.%26aulast%3DShugar%26aufirst%3DD.%26aulast%3DWeinmann%26aufirst%3DR.%26atitle%3DCasein%2520kinase%2520type%2520II%2520is%2520involved%2520in%2520the%2520inhibition%2520by%25205%252C6-dichloro-1-beta-d-ribofuranosylbenzimidazole%2520of%2520specific%2520RNA%2520polymerase%2520II%2520transcription%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D3414%26epage%3D3419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Yim, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span> </span><span class="NLM_article-title">Emodin, an anthraquinone derivative isolated from the rhizomes of <i>Rheum palmatum</i>, selectively inhibits the activity of casein kinase II as a competitive inhibitor</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=9-13&author=H.+L.+Yimauthor=Y.+H.+Leeauthor=C.+H.+Leeauthor=S.+K.+Lee&title=Emodin%2C+an+anthraquinone+derivative+isolated+from+the+rhizomes+of+Rheum+palmatum%2C+selectively+inhibits+the+activity+of+casein+kinase+II+as+a+competitive+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYim%26aufirst%3DH.%2BL.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BK.%26atitle%3DEmodin%252C%2520an%2520anthraquinone%2520derivative%2520isolated%2520from%2520the%2520rhizomes%2520of%2520Rheum%2520palmatum%252C%2520selectively%2520inhibits%2520the%2520activity%2520of%2520casein%2520kinase%2520II%2520as%2520a%2520competitive%2520inhibitor%26jtitle%3DPlanta%2520Med.%26date%3D1999%26volume%3D65%26spage%3D9%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrzejewska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">6239</span><span class="NLM_x">–</span> <span class="NLM_lpage">6247</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049854a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6239-6247&issue=25&author=M.+A.+Paganoauthor=M.+Andrzejewskaauthor=M.+Ruzzeneauthor=S.+Sarnoauthor=L.+Cesaroauthor=J.+Bainauthor=M.+Elliottauthor=F.+Meggioauthor=Z.+Kazimierczukauthor=L.+A.+Pinna&title=Optimization+of+protein+kinase+CK2+inhibitors+derived+from+4%2C5%2C6%2C7-tetrabromobenzimidazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm049854a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049854a%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DAndrzejewska%26aufirst%3DM.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DCesaro%26aufirst%3DL.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOptimization%2520of%2520protein%2520kinase%2520CK2%2520inhibitors%2520derived%2520from%25204%252C5%252C6%252C7-tetrabromobenzimidazole%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D25%26spage%3D6239%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2002&pages=41-47&issue=1&author=M.+Ruzzeneauthor=D.+Penzoauthor=L.+A.+Pinna&title=Protein+kinase+CK2+inhibitor+4%2C5%2C6%2C7-tetrabromobenzotriazole+%28TBB%29+induces+apoptosis+and+caspase-dependent+degradation+of+haematopoietic+lineage+cell-specific+protein+1+%28HS1%29+in+Jurkat+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPenzo%26aufirst%3DD.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520kinase%2520CK2%2520inhibitor%25204%252C5%252C6%252C7-tetrabromobenzotriazole%2520%2528TBB%2529%2520induces%2520apoptosis%2520and%2520caspase-dependent%2520degradation%2520of%2520haematopoietic%2520lineage%2520cell-specific%2520protein%25201%2520%2528HS1%2529%2520in%2520Jurkat%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D364%26issue%3D1%26spage%3D41%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zastapilo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szyszka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shugar, D.</span><span> </span><span class="NLM_article-title">Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=129-133&issue=1&author=P.+Zienauthor=M.+Bretnerauthor=K.+Zastapiloauthor=R.+Szyszkaauthor=D.+Shugar&title=Selectivity+of+4%2C5%2C6%2C7-tetrabromobenzimidazole+as+an+ATP-competitive+potent+inhibitor+of+protein+kinase+CK2+from+various+sources"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZien%26aufirst%3DP.%26aulast%3DBretner%26aufirst%3DM.%26aulast%3DZastapilo%26aufirst%3DK.%26aulast%3DSzyszka%26aufirst%3DR.%26aulast%3DShugar%26aufirst%3DD.%26atitle%3DSelectivity%2520of%25204%252C5%252C6%252C7-tetrabromobenzimidazole%2520as%2520an%2520ATP-competitive%2520potent%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%2520from%2520various%2520sources%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D306%26issue%3D1%26spage%3D129%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">DePierre, J. W.</span>, <span> </span><span class="NLM_article-title">Mammalian Toxicity of Organic Compounds of Bromine and Iodine</span>. In  <span class="citation_source-book">Organic Bromine and Iodine Compounds</span>, <span class="NLM_contrib-group">Neilson, A. H.</span>, Ed.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin-Heidelberg-New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3R</span>, pp  <span class="NLM_fpage">221</span>− <span class="NLM_lpage">232</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1007%2F978-3-540-37055-0_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=221-232&author=J.+W.+DePierreauthor=A.+H.+Neilson&title=Organic+Bromine+and+Iodine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-37055-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-37055-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DDePierre%26aufirst%3DJ.%2BW.%26atitle%3DMammalian%2520Toxicity%2520of%2520Organic%2520Compounds%2520of%2520Bromine%2520and%2520Iodine%26btitle%3DOrganic%2520Bromine%2520and%2520Iodine%2520Compounds%26aulast%3DNeilson%26aufirst%3DA.%2BH.%26pub%3DSpringer-Verlag%26date%3D2003%26volume%3D3R%26spage%3D221%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Vangrevelinghe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2656</span><span class="NLM_x">–</span> <span class="NLM_lpage">2662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030827e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2656-2662&issue=13&author=E.+Vangrevelingheauthor=K.+Zimmermannauthor=J.+Schoepferauthor=R.+Portmannauthor=D.+Fabbroauthor=P.+Furet&title=Discovery+of+a+potent+and+selective+protein+kinase+CK2+inhibitor+by+high-throughput+docking"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm030827e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030827e%26sid%3Dliteratum%253Aachs%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DPortmann%26aufirst%3DR.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520protein%2520kinase%2520CK2%2520inhibitor%2520by%2520high-throughput%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D13%26spage%3D2656%26epage%3D2662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Nie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perretta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Averill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis, and study of pyrazolo[1,5-<i>a</i>][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4191</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4191-4195&issue=15&author=Z.+Nieauthor=C.+Perrettaauthor=P.+Ericksonauthor=S.+Margosiakauthor=R.+Almassyauthor=J.+Luauthor=A.+Averillauthor=K.+M.+Yagerauthor=S.+Chu&title=Structure-based+design%2C+synthesis%2C+and+study+of+pyrazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+derivatives+as+potent+inhibitors+of+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DZ.%26aulast%3DPerretta%26aufirst%3DC.%26aulast%3DErickson%26aufirst%3DP.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DAverill%26aufirst%3DA.%26aulast%3DYager%26aufirst%3DK.%2BM.%26aulast%3DChu%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520study%2520of%2520pyrazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D15%26spage%3D4191%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Nie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perretta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Averill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-<i>a</i>] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=619-623&issue=2&author=Z.+Nieauthor=C.+Perrettaauthor=P.+Ericksonauthor=S.+Margosiakauthor=J.+Luauthor=A.+Averillauthor=R.+Almassyauthor=S.+Chu&title=Structure-based+design+and+synthesis+of+novel+macrocyclic+pyrazolo%5B1%2C5-a%5D+%5B1%2C3%2C5%5Dtriazine+compounds+as+potent+inhibitors+of+protein+kinase+CK2+and+their+anticancer+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DZ.%26aulast%3DPerretta%26aufirst%3DC.%26aulast%3DErickson%26aufirst%3DP.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DAverill%26aufirst%3DA.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DChu%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520novel%2520macrocyclic%2520pyrazolo%255B1%252C5-a%255D%2520%255B1%252C3%252C5%255Dtriazine%2520compounds%2520as%2520potent%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%2520and%2520their%2520anticancer%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D2%26spage%3D619%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgraf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pornillos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyanat-Yazdi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2009&pages=159-167&issue=1%E2%88%922&author=D.+Zhuauthor=J.+Henselauthor=R.+Hilgrafauthor=M.+Abbasianauthor=O.+Pornillosauthor=G.+Deyanat-Yazdiauthor=X.+H.+Huaauthor=S.+Cox&title=Inhibition+of+protein+kinase+CK2+expression+and+activity+blocks+tumor+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DHensel%26aufirst%3DJ.%26aulast%3DHilgraf%26aufirst%3DR.%26aulast%3DAbbasian%26aufirst%3DM.%26aulast%3DPornillos%26aufirst%3DO.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DHua%26aufirst%3DX.%2BH.%26aulast%3DCox%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520CK2%2520expression%2520and%2520activity%2520blocks%2520tumor%2520cell%2520growth%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2009%26volume%3D333%26issue%3D1%25E2%2588%25922%26spage%3D159%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">New protein kinase CK2 inhibitors: jumping out of the catalytic box</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1016%2Fj.chembiol.2009.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19246001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFagtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=112-20&issue=2&author=R.+Prudentauthor=C.+Cochet&title=New+protein+kinase+CK2+inhibitors%3A+jumping+out+of+the+catalytic+box"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">New Protein Kinase CK2 Inhibitors: Jumping out of the Catalytic Box</span></div><div class="casAuthors">Prudent, Renaud; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-120</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Protein kinases are central components of signal transduction cascades often dysregulated in cancer, and they represent some of the most promising drug targets.  However, the target selectivity is a major concern because most described kinase inhibitors target the highly conserved ATP-binding pocket.  Recently, new classes of inhibitors that do not compete with ATP and exhibit different mechanisms of action have been described.  Overexpression of protein kinase CK2 is an unfavorable prognostic marker in several cancers.  Consequently, CK2 has emerged as a relevant therapeutic target.  Several classes of ATP-competitive inhibitors have been identified, showing variable effectiveness.  The mol. architecture of this multisubunit enzyme could offer alternative strategies to inhibit CK2 functions, and this review illustrates these emerging possibilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhT6P1wNSadrVg90H21EOLACvtfcHk0ljoqm1PrvIpAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFagtb4%253D&md5=06c71497d578a82b136893cde423b436</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNew%2520protein%2520kinase%2520CK2%2520inhibitors%253A%2520jumping%2520out%2520of%2520the%2520catalytic%2520box%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26issue%3D2%26spage%3D112%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=493-498&author=R.+Prudentauthor=C.+Sautelauthor=C.+Cochet&title=Structure-based+discovery+of+small+molecules+targeting+different+surfaces+of+protein-kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DSautel%26aufirst%3DC.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DStructure-based%2520discovery%2520of%2520small%2520molecules%2520targeting%2520different%2520surfaces%2520of%2520protein-kinase%2520CK2%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D3%26spage%3D493%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Hodgetts, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershaw, M. T.</span><span> </span><span class="NLM_article-title">Synthesis of 2-aryl-oxazolo[4,5-<i>c</i>]quinoline-4(5<i>H</i>)-ones and 2-aryl-thiazolo[4,5-<i>c</i>]quinoline-4(5<i>H</i>)-ones</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0350285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2911-2914&issue=16&author=K.+J.+Hodgettsauthor=M.+T.+Kershaw&title=Synthesis+of+2-aryl-oxazolo%5B4%2C5-c%5Dquinoline-4%285H%29-ones+and+2-aryl-thiazolo%5B4%2C5-c%5Dquinoline-4%285H%29-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol0350285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0350285%26sid%3Dliteratum%253Aachs%26aulast%3DHodgetts%26aufirst%3DK.%2BJ.%26aulast%3DKershaw%26aufirst%3DM.%2BT.%26atitle%3DSynthesis%2520of%25202-aryl-oxazolo%255B4%252C5-c%255Dquinoline-4%25285H%2529-ones%2520and%25202-aryl-thiazolo%255B4%252C5-c%255Dquinoline-4%25285H%2529-ones%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26issue%3D16%26spage%3D2911%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Alessi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larkin, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snieckus, V.</span><span> </span><span class="NLM_article-title">Directed ortho metalation-boronation and Suzuki−Miyaura cross coupling of pyridine derivatives: a one-pot protocol to substituted azabiaryls</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0620359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=1588-1594&issue=5&author=M.+Alessiauthor=A.+L.+Larkinauthor=K.+A.+Ogilvieauthor=L.+A.+Greenauthor=S.+Laiauthor=S.+Lopezauthor=V.+Snieckus&title=Directed+ortho+metalation-boronation+and+Suzuki%E2%88%92Miyaura+cross+coupling+of+pyridine+derivatives%3A+a+one-pot+protocol+to+substituted+azabiaryls"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo0620359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0620359%26sid%3Dliteratum%253Aachs%26aulast%3DAlessi%26aufirst%3DM.%26aulast%3DLarkin%26aufirst%3DA.%2BL.%26aulast%3DOgilvie%26aufirst%3DK.%2BA.%26aulast%3DGreen%26aufirst%3DL.%2BA.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DLopez%26aufirst%3DS.%26aulast%3DSnieckus%26aufirst%3DV.%26atitle%3DDirected%2520ortho%2520metalation-boronation%2520and%2520Suzuki%25E2%2588%2592Miyaura%2520cross%2520coupling%2520of%2520pyridine%2520derivatives%253A%2520a%2520one-pot%2520protocol%2520to%2520substituted%2520azabiaryls%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D5%26spage%3D1588%26epage%3D1594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Rodgers, J.; Robinson, D.; Arvanitis, A.; Masduskuie, T.; Shepard, S.; Storace, L.; Wang, H.; Rafalski, M.; Jalluri, R.; Combs, A.; Crawley, M.</span>, <span> </span><span class="NLM_article-title">Tetracylclic Inhibitors of Janus Kinases</span>. PCT patent application WO2005/105814, <span class="NLM_day">10</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+Rodgers&author=D.+Robinson&author=A.+Arvanitis&author=T.+Masduskuie&author=S.+Shepard&author=L.+Storace&author=H.+Wang&author=M.+Rafalski&author=R.+Jalluri&author=A.+Combs&author=M.+Crawley&title=Tetracylclic+Inhibitors+of+Janus+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DJ.%26atitle%3DTetracylclic%2520Inhibitors%2520of%2520Janus%2520Kinases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Jagtap, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=421-440&issue=5&author=P.+Jagtapauthor=C.+Szabo&title=Poly%28ADP-ribose%29+polymerase+and+the+therapeutic+effects+of+its+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520and%2520the%2520therapeutic%2520effects%2520of%2520its%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26issue%3D5%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Cepeda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuertesa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonsoa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quevedob, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotoa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, J.</span><span> </span><span class="NLM_article-title">Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=39-55&author=V.+Cepedaauthor=M.+Fuertesaauthor=J.+Castillacauthor=C.+Alonsoaauthor=C.+Quevedobauthor=M.+Sotoaauthor=J.+P%C3%A9rez&title=Poly%28ADP-Ribose%29+Polymerase-1+%28PARP-1%29+Inhibitors+in+Cancer+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCepeda%26aufirst%3DV.%26aulast%3DFuertesa%26aufirst%3DM.%26aulast%3DCastillac%26aufirst%3DJ.%26aulast%3DAlonsoa%26aufirst%3DC.%26aulast%3DQuevedob%26aufirst%3DC.%26aulast%3DSotoa%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez%26aufirst%3DJ.%26atitle%3DPoly%2528ADP-Ribose%2529%2520Polymerase-1%2520%2528PARP-1%2529%2520Inhibitors%2520in%2520Cancer%2520Chemotherapy%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D39%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Niefind, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermakowa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5320</span><span class="NLM_x">–</span> <span class="NLM_lpage">5331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5320-5331&issue=19&author=K.+Niefindauthor=B.+Guerraauthor=I.+Ermakowaauthor=O.+G.+Issinger&title=Crystal+structure+of+human+protein+kinase+CK2%3A+insights+into+basic+properties+of+the+CK2+holoenzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DErmakowa%26aufirst%3DI.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520human%2520protein%2520kinase%2520CK2%253A%2520insights%2520into%2520basic%2520properties%2520of%2520the%2520CK2%2520holoenzyme%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26issue%3D19%26spage%3D5320%26epage%3D5331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistutta, R.</span><span> </span><span class="NLM_article-title">A structural insight into CK2 inhibition</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2008&pages=57-62&issue=1%E2%88%922&author=M.+Mazzoranaauthor=L.+A.+Pinnaauthor=R.+Battistutta&title=A+structural+insight+into+CK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DA%2520structural%2520insight%2520into%2520CK2%2520inhibition%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D316%26issue%3D1%25E2%2588%25922%26spage%3D57%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Battistutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">The ATP-Binding Site of Protein Kinase CK2 Holds a Positive Electrostatic Area and Conserved Water Molecules</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1804</span><span class="NLM_x">–</span> <span class="NLM_lpage">1809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1804-1809&issue=15&author=R.+Battistuttaauthor=M.+Mazzoranaauthor=L.+Cendronauthor=A.+Bortolatoauthor=S.+Sarnoauthor=Z.+Kazimierczukauthor=G.+Zanottiauthor=S.+Moroauthor=L.+A.+Pinna&title=The+ATP-Binding+Site+of+Protein+Kinase+CK2+Holds+a+Positive+Electrostatic+Area+and+Conserved+Water+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520ATP-Binding%2520Site%2520of%2520Protein%2520Kinase%2520CK2%2520Holds%2520a%2520Positive%2520Electrostatic%2520Area%2520and%2520Conserved%2520Water%2520Molecules%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26issue%3D15%26spage%3D1804%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Niefind, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Protein kinase CK2: From structures to insights</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">11−12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1007%2Fs00018-009-9149-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19387553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1800-1816&issue=11%E2%88%9212&author=K.+Niefindauthor=J.+Raafauthor=O.+G.+Issinger&title=Protein+kinase+CK2%3A+From+structures+to+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: From structures to insights</span></div><div class="casAuthors">Niefind, K.; Raaf, J.; Issinger, O.-G.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1800-1816</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Within the last decade, 40 crystal structures corresponding to protein kinase CK2 (former name 'casein kinase 2'), to its catalytic subunit CK2α, and to its regulatory subunit CK2β, were published.  Together they provide a valuable, yet by far not complete basis to rationalize the biochem. features of the enzyme, such as its constitutive activity, acidophilic substrate specificity, dual-cosubstrate specificity, and its heterotetrameric quaternary structure.  Comprehensive sets of structural superimpositions reveal that both CK2α and CK2β are relatively rigid mols.  In CK2β the crit. region of CK2α recruitment is pre-formed in the unbound state.  In CK2α the activation segment, a key element of protein kinase regulation, adapts invariably the typical conformation of the active enzymes.  Recent structures of human CK2α have revealed a surprising plasticity in the ATP-binding region, suggesting an alternative mode of activity control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5HGNXeL_wnbVg90H21EOLACvtfcHk0liafRqROFhUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs78%253D&md5=b34be6e4939fd050c6b4abea24dc5dcf</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9149-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9149-8%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DProtein%2520kinase%2520CK2%253A%2520From%2520structures%2520to%2520insights%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26issue%3D11%25E2%2588%259212%26spage%3D1800%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Battistutta, R.</span><span> </span><span class="NLM_article-title">Structural bases of protein kinase CK2 inhibition</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">11−12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1868</span><span class="NLM_x">–</span> <span class="NLM_lpage">1889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1007%2Fs00018-009-9155-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19387547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1868-1889&issue=11%E2%88%9212&author=R.+Battistutta&title=Structural+bases+of+protein+kinase+CK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases of protein kinase CK2 inhibition</span></div><div class="casAuthors">Battistutta, R.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1868-1889</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is involved in many fundamental aspects of normal cell life, but it is also able to establish favorable conditions for tumorigenesis.  CK2 is elevated in various cancers, it is a potent suppressor of apoptosis, it strongly promotes cell survival, it strengthens the multi-drug resistant phenotype, and can be considered a valuable drug target for cancer therapy.  Here, the structural bases of CK2 inhibition deduced from the anal. of crystal structures of CK2α-inhibitor complexes are presented and discussed.  The best ATP-competitive inhibitors show an adequate hydrophobic character, an excellent shape complementarity with the unique active site of CK2, and the ability to establish polar interactions with both the hinge region and the pos. electrostatic area near the conserved water W1 and the Lys-68-Glu-81 salt bridge.  The state of the art of non-ATP-competitive inhibitors is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2bH__CP4zI7Vg90H21EOLACvtfcHk0lgsTvaQYH1d6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7k%253D&md5=ec7844e7e74b8c51e4f3bd13487e4002</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9155-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9155-x%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DStructural%2520bases%2520of%2520protein%2520kinase%2520CK2%2520inhibition%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26issue%3D11%25E2%2588%259212%26spage%3D1868%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Siddiqui-Jain, A.; Drygin, D.; Streiner, N.; Chua, P.; Pierre, F.; O’Brien, S.; Bliesath, J.; Omori, M.; Huser, N.; Ho, C.; Proffitt, C.; Schwaebe, M.; Ryckman, D.; Rice, W. G.; Anderes, K.</span><span> </span><span class="NLM_article-title">CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span>),  <span class="NLM_fpage">10288</span>− <span class="NLM_lpage">10298</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10288-10298&issue=24&author=A.+Siddiqui-Jain&author=D.+Drygin&author=N.+Streiner&author=P.+Chua&author=F.+Pierre&author=S.+O%E2%80%99Brien&author=J.+Bliesath&author=M.+Omori&author=N.+Huser&author=C.+Ho&author=C.+Proffitt&author=M.+Schwaebe&author=D.+Ryckman&author=W.+G.+Rice&author=K.+Anderes&title=CX-4945%2C+an+Orally+Bioavailable+Selective+Inhibitor+of+Protein+Kinase+CK2%2C+Inhibits+Prosurvival+and+Angiogenic+Signaling+and+Exhibits+Antitumor+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26atitle%3DCX-4945%252C%2520an%2520Orally%2520Bioavailable%2520Selective%2520Inhibitor%2520of%2520Protein%2520Kinase%2520CK2%252C%2520Inhibits%2520Prosurvival%2520and%2520Angiogenic%2520Signaling%2520and%2520Exhibits%2520Antitumor%2520Efficacy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D24%26spage%3D10288%26epage%3D10298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustolon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1038%2Fsj.cdd.4401604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=15818404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=668-677&issue=6&author=G.+Di+Mairaauthor=M.+Salviauthor=G.+Arrigoniauthor=O.+Marinauthor=S.+Sarnoauthor=F.+Brustolonauthor=L.+A.+Pinnaauthor=M.+Ruzzene&title=Protein+kinase+CK2+phosphorylates+and+upregulates+Akt%2FPKB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span></div><div class="casAuthors">Di Maira, G.; Salvi, M.; Arrigoni, G.; Marin, O.; Sarno, S.; Brustolon, F.; Pinna, L. A.; Ruzzene, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-677</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment of Jurkat cells with specific inhibitors of protein kinase CK2 induces apoptosis.  Here we provide evidence that the antiapoptotic effect of CK2 can be at least partially mediated by upregulation of the Akt/PKB pathway.  Such a conclusion is based on the following observations: (1) inhibition of CK2 by cell treatment with two structurally unrelated CK2 inhibitors induces downregulation of Akt/PKB, as judged from decreased phosphorylation of its physiol. targets, and immunoppt. kinase assay; (2) similar results are obsd. upon redn. of CK2 catalytic subunit by the RNA-interference technique; (3) Akt/PKB Ser129 is phosphorylated by CK2 in vitro and in vivo; (4) such a phosphorylation of activated Akt/PKB correlates with a further increase in catalytic activity.  These data disclose an unanticipated mechanism by which constitutive phosphorylation by CK2 may be required for maximal activation of Akt/PKB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEFAKQPYl_7Vg90H21EOLACvtfcHk0lgsTvaQYH1d6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D&md5=04f583a966bd2ed26f315a2395370db9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401604%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DArrigoni%26aufirst%3DG.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DBrustolon%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26atitle%3DProtein%2520kinase%2520CK2%2520phosphorylates%2520and%2520upregulates%2520Akt%252FPKB%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26issue%3D6%26spage%3D668%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><div class="note"><p class="first last">Tested at MicroConstants, San Diego, CA</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tested+at+MicroConstants%2C+San+Diego%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><div class="note"><p class="first last">Tested at CEREP, Seattle, WA</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tested+at+CEREP%2C+Seattle%2C+WA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Lim, J. K.; Padgett, C. S.; Marschke, R. F.; Northfelt, D. W.; Andreopoulou, E.; Von Hoff, D. D.; Anderes, K.; Chen, T. K.; O’Brien, S.</span>, <span> </span><span class="NLM_article-title">Utility of Clinical Biomarkers for Detecting Protein Kinase CK2 Inhibition: A Report from the Phase I Trial of CX-4945</span>. <span class="NLM_conf-name">AACR 101st Annual Meeting</span>, <span class="NLM_conf-loc">Washington, DC</span>, <span class="NLM_conf-date">April 17−21, 2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lim%2C+J.+K.%3B+Padgett%2C+C.+S.%3B+Marschke%2C+R.+F.%3B+Northfelt%2C+D.+W.%3B+Andreopoulou%2C+E.%3B+Von+Hoff%2C+D.+D.%3B+Anderes%2C+K.%3B+Chen%2C+T.+K.%3B+O%E2%80%99Brien%2C+S.%2C+Utility+of+Clinical+Biomarkers+for+Detecting+Protein+Kinase+CK2+Inhibition%3A+A+Report+from+the+Phase+I+Trial+of+CX-4945.+AACR+101st+Annual+Meeting%2C+Washington%2C+DC%2C+April+17%E2%88%9221%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DJ.%2BK.%26atitle%3DUtility%2520of%2520Clinical%2520Biomarkers%2520for%2520Detecting%2520Protein%2520Kinase%2520CK2%2520Inhibition%253A%2520A%2520Report%2520from%2520the%2520Phase%2520I%2520Trial%2520of%2520CX-4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Barreau, M.; Cotrel, C.; Jeanmart, C.</span><span> </span><span class="NLM_article-title">1,2-Dithiole derivatives</span>. U.S. Patent US4,110,450, <span class="NLM_month">Aug</span><span class="NLM_day">29</span>,<span class="NLM_x"> </span><span class="NLM_year">1978</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1978&author=M.+Barreau&author=C.+Cotrel&author=C.+Jeanmart&title=1%2C2-Dithiole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarreau%26aufirst%3DM.%26atitle%3D1%252C2-Dithiole%2520derivatives%26date%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&issue=23&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26issue%3D23%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 191 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yuanjiang Wang, Zhaodan Lv, Feihong Chen, Xing Wang, <span class="NLM_string-name hlFld-ContribAuthor">Shaohua Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine Derivatives as Highly Selective CK2 Inhibitors with Potent Cancer Cell Stemness Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5082-5098. <a href="https://doi.org/10.1021/acs.jmedchem.1c00131" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00131%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B5-%2525283-Chlorophenylamino%252529benzo%25255Bc%25255D%25255B2%25252C6%25255Dnaphthyridine%252BDerivatives%252Bas%252BHighly%252BSelective%252BCK2%252BInhibitors%252Bwith%252BPotent%252BCancer%252BCell%252BStemness%252BInhibition%26aulast%3DWang%26aufirst%3DYuanjiang%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23012021%26date%3D09042021%26volume%3D64%26issue%3D8%26spage%3D5082%26epage%3D5098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuanjiang Wang, Xinyi Wang, Gang Xu, <span class="NLM_string-name hlFld-ContribAuthor">Shaohua Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Novel CK2-Specific Pt(II) Compound Reverses Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 4163-4178. <a href="https://doi.org/10.1021/acs.jmedchem.1c00079" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00079%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BCK2-Specific%252BPt%252528II%252529%252BCompound%252BReverses%252BCisplatin-Induced%252BResistance%252Bby%252BInhibiting%252BCancer%252BCell%252BStemness%252Band%252BSuppressing%252BDNA%252BDamage%252BRepair%252Bin%252BNon-small%252BCell%252BLung%252BCancer%252BTreatments%26aulast%3DWang%26aufirst%3DYuanjiang%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16012021%26date%3D30032021%26volume%3D64%26issue%3D7%26spage%3D4163%26epage%3D4178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhimin Ying, Jie Cen, Feng Luo, You Wu, Shuangrong Liu, Wenteng Chen, Jiaan Shao, <span class="NLM_string-name hlFld-ContribAuthor">Yongping Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate-Tuned Domino Annulation for Selective Synthesis of Poly-substituted Benzo[f]imidazo[2,1-a][2,7]naphthyridines and 3-Azaheterocyclic Substituted 2-Arylquinolines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (6)
                                     , 4747-4755. <a href="https://doi.org/10.1021/acs.joc.1c00112" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00112%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSubstrate-Tuned%252BDomino%252BAnnulation%252Bfor%252BSelective%252BSynthesis%252Bof%252BPoly-substituted%252BBenzo%25255Bf%25255Dimidazo%25255B2%25252C1-a%25255D%25255B2%25252C7%25255Dnaphthyridines%252Band%252B3-Azaheterocyclic%252BSubstituted%252B2-Arylquinolines%26aulast%3DYing%26aufirst%3DZhimin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D14012021%26date%3D25022021%26volume%3D86%26issue%3D6%26spage%3D4747%26epage%3D4755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Honorata Czapinska, Maria Winiewska-Szajewska, Anna Szymaniec-Rutkowska, Anna Piasecka, Matthias Bochtler, <span class="NLM_string-name hlFld-ContribAuthor">Jarosław Poznański</span>. </span><span class="cited-content_cbyCitation_article-title">Halogen Atoms in the Protein–Ligand System. Structural and Thermodynamic Studies of the Binding of Bromobenzotriazoles by the Catalytic Subunit of Human Protein Kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2021,</strong> <em>125 </em>
                                    (10)
                                     , 2491-2503. <a href="https://doi.org/10.1021/acs.jpcb.0c10264" title="DOI URL">https://doi.org/10.1021/acs.jpcb.0c10264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.0c10264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.0c10264%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DHalogen%252BAtoms%252Bin%252Bthe%252BProtein%2525E2%252580%252593Ligand%252BSystem.%252BStructural%252Band%252BThermodynamic%252BStudies%252Bof%252Bthe%252BBinding%252Bof%252BBromobenzotriazoles%252Bby%252Bthe%252BCatalytic%252BSubunit%252Bof%252BHuman%252BProtein%252BKinase%252BCK2%26aulast%3DCzapinska%26aufirst%3DHonorata%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D13112020%26date%3D01032021%26date%3D09032021%26volume%3D125%26issue%3D10%26spage%3D2491%26epage%3D2503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laura Goracci, Jenny Desantis, Aurora Valeri, Beatrice Castellani, Michela Eleuteri, <span class="NLM_string-name hlFld-ContribAuthor">Gabriele Cruciani</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11615-11638. <a href="https://doi.org/10.1021/acs.jmedchem.0c00793" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00793%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnderstanding%252Bthe%252BMetabolism%252Bof%252BProteolysis%252BTargeting%252BChimeras%252B%252528PROTACs%252529%25253A%252BThe%252BNext%252BStep%252Btoward%252BPharmaceutical%252BApplications%26aulast%3DGoracci%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11052020%26date%3D07102020%26volume%3D63%26issue%3D20%26spage%3D11615%26epage%3D11638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ming-Shu Wang, Hong-Chuang Xu, Yi Gong, Ren-Yu Qu, Lin-Sheng Zhuo, <span class="NLM_string-name hlFld-ContribAuthor">Wei Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Arylation of 2,7-Naphthyridin-1(2H)-one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (9)
                                     , 457-467. <a href="https://doi.org/10.1021/acscombsci.0c00074" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00074%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BArylation%252Bof%252B2%25252C7-Naphthyridin-1%2525282H%252529-one%252Bwith%252BDiaryliodonium%252BSalts%252Band%252BDiscovery%252Bof%252Ba%252BNew%252BSelective%252BMET%25252FAXL%252BKinase%252BInhibitor%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03052020%26date%3D22062020%26date%3D10072020%26date%3D26062020%26volume%3D22%26issue%3D9%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dirk Lindenblatt, Anna Nickelsen, Violetta M. Applegate, Joachim Jose, <span class="NLM_string-name hlFld-ContribAuthor">Karsten Niefind</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7766-7772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00587" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00587%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Band%252BMechanistic%252BBasis%252Bof%252Bthe%252BInhibitory%252BPotency%252Bof%252BSelected%252B2-Aminothiazole%252BCompounds%252Bon%252BProtein%252BKinase%252BCK2%26aulast%3DLindenblatt%26aufirst%3DDirk%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09042020%26date%3D14072020%26date%3D26062020%26volume%3D63%26issue%3D14%26spage%3D7766%26epage%3D7772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Loganathan Rangasamy, Irene Ortín, José María Zapico, Claire Coderch, Ana Ramos, <span class="NLM_string-name hlFld-ContribAuthor">Beatriz de Pascual-Teresa</span>. </span><span class="cited-content_cbyCitation_article-title">New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 713-719. <a href="https://doi.org/10.1021/acsmedchemlett.9b00561" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00561%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252BDual%252BCK2%25252FHDAC1%252BInhibitors%252Bwith%252BNanomolar%252BInhibitory%252BActivity%252Bagainst%252BBoth%252BEnzymes%26aulast%3DRangasamy%26aufirst%3DLoganathan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30112019%26date%3D07042020%26date%3D10042020%26date%3D07042020%26volume%3D11%26issue%3D5%26spage%3D713%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span> and <span class="hlFld-ContribAuthor ">Demetri T.  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3552-3579. <a href="https://doi.org/10.1021/acs.jmedchem.6b01807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BNecessary%252BNitrogen%252BAtom%25253A%252BA%252BVersatile%252BHigh-Impact%252BDesign%252BElement%252Bfor%252BMultiparameter%252BOptimization%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D09122016%26date%3D08022017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palanisamy  Deepa</span>  . </span><span class="cited-content_cbyCitation_article-title">An Overview of the Factors Influencing CK2 Ligands and the Impact of Crystal Waters: A Theoretical Study. </span><span class="cited-content_cbyCitation_journal-name">Crystal Growth & Design</span><span> <strong>2017,</strong> <em>17 </em>
                                    (3)
                                     , 1299-1315. <a href="https://doi.org/10.1021/acs.cgd.6b01711" title="DOI URL">https://doi.org/10.1021/acs.cgd.6b01711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.cgd.6b01711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.cgd.6b01711%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystal%2520Growth%2520%2526%2520Design%26atitle%3DAn%252BOverview%252Bof%252Bthe%252BFactors%252BInfluencing%252BCK2%252BLigands%252Band%252Bthe%252BImpact%252Bof%252BCrystal%252BWaters%25253A%252BA%252BTheoretical%252BStudy%26aulast%3DDeepa%26aufirst%3DPalanisamy%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2017%26date%3D24112016%26date%3D05012017%26date%3D07022017%26date%3D01032017%26date%3D18012017%26volume%3D17%26issue%3D3%26spage%3D1299%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E.  Dowling</span>, <span class="hlFld-ContribAuthor ">Marat  Alimzhanov</span>, <span class="hlFld-ContribAuthor ">Larry  Bao</span>, <span class="hlFld-ContribAuthor ">Claudio  Chuaqui</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Denz</span>, <span class="hlFld-ContribAuthor ">Emma  Jenkins</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Larsen</span>, <span class="hlFld-ContribAuthor ">Paul D.  Lyne</span>, <span class="hlFld-ContribAuthor ">Timothy  Pontz</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Geoff A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Lindsay  Snow</span>, <span class="hlFld-ContribAuthor ">Nichole  O’Connell</span>, and <span class="hlFld-ContribAuthor ">Andrew D.  Ferguson</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 300-305. <a href="https://doi.org/10.1021/acsmedchemlett.5b00452" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00452</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00452%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Band%252BSelective%252BCK2%252BKinase%252BInhibitors%252Bwith%252BEffects%252Bon%252BWnt%252BPathway%252BSignaling%252Bin%252BVivo%26aulast%3DDowling%26aufirst%3DJames%2BE.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D23112015%26date%3D20012016%26date%3D29012016%26date%3D10032016%26date%3D20012016%26volume%3D7%26issue%3D3%26spage%3D300%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ewelina  Haraburda</span>, <span class="hlFld-ContribAuthor ">Agustí  Lledó</span>, <span class="hlFld-ContribAuthor ">Anna  Roglans</span>, and <span class="hlFld-ContribAuthor ">Anna  Pla-Quintana</span>  . </span><span class="cited-content_cbyCitation_article-title">Dehydrogenative [2 + 2 + 2] Cycloaddition of Cyano-yne-allene Substrates: Convenient Access to 2,6-Naphthyridine Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (12)
                                     , 2882-2885. <a href="https://doi.org/10.1021/acs.orglett.5b01554" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b01554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b01554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b01554%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDehydrogenative%252B%25255B2%252B%25252B%252B2%252B%25252B%252B2%25255D%252BCycloaddition%252Bof%252BCyano-yne-allene%252BSubstrates%25253A%252BConvenient%252BAccess%252Bto%252B2%25252C6-Naphthyridine%252BScaffolds%26aulast%3DHaraburda%26aufirst%3DEwelina%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27032015%26date%3D11062015%26date%3D19062015%26volume%3D17%26issue%3D12%26spage%3D2882%26epage%3D2885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Wang</span>, <span class="hlFld-ContribAuthor ">Lijun  Xue</span>, <span class="hlFld-ContribAuthor ">Yiyi  He</span>, <span class="hlFld-ContribAuthor ">Licong  Weng</span>, and <span class="hlFld-ContribAuthor ">Ling  Fang</span>  . </span><span class="cited-content_cbyCitation_article-title">Access to Functionalized 3H-Pyrrolo[2,3-c]quinolin-4(5H)-ones and Thieno[2,3-c]quinolin-4(5H)-ones via Domino Reaction of 4-Alkynyl-3-bromoquinolin-2(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (20)
                                     , 9628-9638. <a href="https://doi.org/10.1021/jo501753p" title="DOI URL">https://doi.org/10.1021/jo501753p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo501753p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo501753p%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAccess%252Bto%252BFunctionalized%252B3H-Pyrrolo%25255B2%25252C3-c%25255Dquinolin-4%2525285H%252529-ones%252Band%252BThieno%25255B2%25252C3-c%25255Dquinolin-4%2525285H%252529-ones%252Bvia%252BDomino%252BReaction%252Bof%252B4-Alkynyl-3-bromoquinolin-2%2525281H%252529-ones%26aulast%3DWang%26aufirst%3DZhiyong%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D31072014%26date%3D03102014%26date%3D17102014%26date%3D22092014%26volume%3D79%26issue%3D20%26spage%3D9628%26epage%3D9638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Jianmin  Jia</span>, <span class="hlFld-ContribAuthor ">Xiaoke  Guo</span>, <span class="hlFld-ContribAuthor ">Jingjie  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Taotao  Feng</span>, <span class="hlFld-ContribAuthor ">Hongxi  Chu</span>, <span class="hlFld-ContribAuthor ">You  Zhou</span>, <span class="hlFld-ContribAuthor ">Shenglie  Zhang</span>, <span class="hlFld-ContribAuthor ">Zongliang  Liu</span>, and <span class="hlFld-ContribAuthor ">Qidong  You</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Design of Tricyclic Scaffolds as Protein Kinase CK2 (CK2) Inhibitors through a Combination of Shape-Based Virtual Screening and Structure-Based Molecular Modification. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (8)
                                     , 2093-2102. <a href="https://doi.org/10.1021/ci400114f" title="DOI URL">https://doi.org/10.1021/ci400114f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400114f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400114f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Band%252BDesign%252Bof%252BTricyclic%252BScaffolds%252Bas%252BProtein%252BKinase%252BCK2%252B%252528CK2%252529%252BInhibitors%252Bthrough%252Ba%252BCombination%252Bof%252BShape-Based%252BVirtual%252BScreening%252Band%252BStructure-Based%252BMolecular%252BModification%26aulast%3DSun%26aufirst%3DHaopeng%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D18022013%26date%3D12082013%26date%3D26082013%26date%3D16072013%26volume%3D53%26issue%3D8%26spage%3D2093%26epage%3D2102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E.  Dowling</span>, <span class="hlFld-ContribAuthor ">Marat  Alimzhanov</span>, <span class="hlFld-ContribAuthor ">Larry  Bao</span>, <span class="hlFld-ContribAuthor ">Michael H.  Block</span>, <span class="hlFld-ContribAuthor ">Claudio  Chuaqui</span>, <span class="hlFld-ContribAuthor ">Emma L.  Cooke</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Denz</span>, <span class="hlFld-ContribAuthor ">Alex  Hird</span>, <span class="hlFld-ContribAuthor ">Shan  Huang</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Larsen</span>, <span class="hlFld-ContribAuthor ">Bo  Peng</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Pontz</span>, <span class="hlFld-ContribAuthor ">Caroline  Rivard-Costa</span>, <span class="hlFld-ContribAuthor ">Jamal Carlos  Saeh</span>, <span class="hlFld-ContribAuthor ">Kumar  Thakur</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, and <span class="hlFld-ContribAuthor ">Paul D.  Lyne</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (8)
                                     , 800-805. <a href="https://doi.org/10.1021/ml400197u" title="DOI URL">https://doi.org/10.1021/ml400197u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400197u%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Band%252BProperty%252BBased%252BDesign%252Bof%252BPyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252BInhibitors%252Bof%252BCK2%252BKinase%252Bwith%252BActivity%252Bin%252BVivo%26aulast%3DDowling%26aufirst%3DJames%2BE.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D23052013%26date%3D03072013%26date%3D15072013%26date%3D08082013%26date%3D03072013%26volume%3D4%26issue%3D8%26spage%3D800%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Xing-Ye  Mu</span>, <span class="hlFld-ContribAuthor ">Yu-Ling  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, and <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Combinatorial Synthesis of Fused Tetracyclic Heterocycles Containing [1,6]Naphthyridine Derivatives under Catalyst Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2013,</strong> <em>15 </em>
                                    (5)
                                     , 267-272. <a href="https://doi.org/10.1021/co400020w" title="DOI URL">https://doi.org/10.1021/co400020w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co400020w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco400020w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DCombinatorial%252BSynthesis%252Bof%252BFused%252BTetracyclic%252BHeterocycles%252BContaining%252B%25255B1%25252C6%25255DNaphthyridine%252BDerivatives%252Bunder%252BCatalyst%252BFree%252BConditions%26aulast%3DLi%26aufirst%3DChao%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15022013%26date%3D08042013%26date%3D26042013%26date%3D13052013%26date%3D12042013%26volume%3D15%26issue%3D5%26spage%3D267%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Fan</span>, <span class="hlFld-ContribAuthor ">Qin  Ye</span>, <span class="hlFld-ContribAuthor ">Hai-Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>, <span class="hlFld-ContribAuthor ">Shu-Liang  Wang</span>, and <span class="hlFld-ContribAuthor ">Shu-Jiang  Tu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Double [3 + 2 + 1] Heteroannulation for Forming Unprecedented Dipyrazolo-Fused 2,6-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (9)
                                     , 2258-2261. <a href="https://doi.org/10.1021/ol4008266" title="DOI URL">https://doi.org/10.1021/ol4008266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol4008266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol4008266%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNovel%252BDouble%252B%25255B3%252B%25252B%252B2%252B%25252B%252B1%25255D%252BHeteroannulation%252Bfor%252BForming%252BUnprecedented%252BDipyrazolo-Fused%252B2%25252C6-Naphthyridines%26aulast%3DFan%26aufirst%3DWei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26032013%26date%3D18042013%26date%3D03052013%26volume%3D15%26issue%3D9%26spage%3D2258%26epage%3D2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tania  Tahtouh</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Panagis  Filippakopoulos</span>, <span class="hlFld-ContribAuthor ">Meera  Soundararajan</span>, <span class="hlFld-ContribAuthor ">Guillaume  Burgy</span>, <span class="hlFld-ContribAuthor ">Emilie  Durieu</span>, <span class="hlFld-ContribAuthor ">Claude  Cochet</span>, <span class="hlFld-ContribAuthor ">Ralf S.  Schmid</span>, <span class="hlFld-ContribAuthor ">Donald C.  Lo</span>, <span class="hlFld-ContribAuthor ">Florent  Delhommel</span>, <span class="hlFld-ContribAuthor ">Anselm E.  Oberholzer</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Pearl</span>, <span class="hlFld-ContribAuthor ">François  Carreaux</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Bazureau</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, and <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>  . </span><span class="cited-content_cbyCitation_article-title">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (21)
                                     , 9312-9330. <a href="https://doi.org/10.1021/jm301034u" title="DOI URL">https://doi.org/10.1021/jm301034u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301034u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelectivity%25252C%252BCocrystal%252BStructures%25252C%252Band%252BNeuroprotective%252BProperties%252Bof%252BLeucettines%25252C%252Ba%252BFamily%252Bof%252BProtein%252BKinase%252BInhibitors%252BDerived%252Bfrom%252Bthe%252BMarine%252BSponge%252BAlkaloid%252BLeucettamine%252BB%26aulast%3DTahtouh%26aufirst%3DTania%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15072012%26date%3D08102012%26date%3D08112012%26date%3D21092012%26volume%3D55%26issue%3D21%26spage%3D9312%26epage%3D9330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E.  Dowling</span>, <span class="hlFld-ContribAuthor ">Claudio  Chuaqui</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Pontz</span>, <span class="hlFld-ContribAuthor ">Paul D.  Lyne</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Larsen</span>, <span class="hlFld-ContribAuthor ">Michael H.  Block</span>, <span class="hlFld-ContribAuthor ">Huawei  Chen</span>, <span class="hlFld-ContribAuthor ">Nancy  Su</span>, <span class="hlFld-ContribAuthor ">Allan  Wu</span>, <span class="hlFld-ContribAuthor ">Daniel  Russell</span>, <span class="hlFld-ContribAuthor ">Hannah  Pollard</span>, <span class="hlFld-ContribAuthor ">John W.  Lee</span>, <span class="hlFld-ContribAuthor ">Bo  Peng</span>, <span class="hlFld-ContribAuthor ">Kumar  Thakur</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Patrick  Brassil</span>, <span class="hlFld-ContribAuthor ">Vicki  Racicot</span>, <span class="hlFld-ContribAuthor ">Larry  Bao</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Denz</span>, and <span class="hlFld-ContribAuthor ">Emma  Cooke</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (4)
                                     , 278-283. <a href="https://doi.org/10.1021/ml200257n" title="DOI URL">https://doi.org/10.1021/ml200257n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200257n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200257n%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Band%252BSelective%252BInhibitors%252Bof%252BCK2%252BKinase%252BIdentified%252Bthrough%252BStructure-Guided%252BHybridization%26aulast%3DDowling%26aufirst%3DJames%2BE.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D27102011%26date%3D24012012%26date%3D10022012%26date%3D12042012%26date%3D24012012%26volume%3D3%26issue%3D4%26spage%3D278%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zengye  Hou</span>, <span class="hlFld-ContribAuthor ">Isao  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Takei</span>, <span class="hlFld-ContribAuthor ">Misato  Yasue</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Misu</span>, <span class="hlFld-ContribAuthor ">Yamato  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shinya  Nakamura</span>, <span class="hlFld-ContribAuthor ">Tatsuhide  Kure</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Ohno</span>, <span class="hlFld-ContribAuthor ">Katsumi  Murata</span>, <span class="hlFld-ContribAuthor ">Kazuo  Kitaura</span>, <span class="hlFld-ContribAuthor ">Akira  Hirasawa</span>, <span class="hlFld-ContribAuthor ">Gozoh  Tsujimoto</span>, <span class="hlFld-ContribAuthor ">Shinya  Oishi</span>, and <span class="hlFld-ContribAuthor ">Nobutaka  Fujii</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Novel Potent Protein Kinase CK2 (CK2) Inhibitors with Phenyl-azole Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2899-2903. <a href="https://doi.org/10.1021/jm2015167" title="DOI URL">https://doi.org/10.1021/jm2015167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2015167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2015167%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BNovel%252BPotent%252BProtein%252BKinase%252BCK2%252B%252528CK2%252529%252BInhibitors%252Bwith%252BPhenyl-azole%252BScaffolds%26aulast%3DHou%26aufirst%3DZengye%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D09112011%26date%3D07032012%26date%3D22032012%26date%3D17022012%26volume%3D55%26issue%3D6%26spage%3D2899%26epage%3D2903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Battistutta</span>, <span class="hlFld-ContribAuthor ">Giorgio  Cozza</span>, <span class="hlFld-ContribAuthor ">Fabrice  Pierre</span>, <span class="hlFld-ContribAuthor ">Elena  Papinutto</span>, <span class="hlFld-ContribAuthor ">Graziano  Lolli</span>, <span class="hlFld-ContribAuthor ">Stefania  Sarno</span>, <span class="hlFld-ContribAuthor ">Sean E.  O’Brien</span>, <span class="hlFld-ContribAuthor ">Adam  Siddiqui-Jain</span>, <span class="hlFld-ContribAuthor ">Mustapha  Haddach</span>, <span class="hlFld-ContribAuthor ">Kenna  Anderes</span>, <span class="hlFld-ContribAuthor ">David M.  Ryckman</span>, <span class="hlFld-ContribAuthor ">Flavio  Meggio</span>, and <span class="hlFld-ContribAuthor ">Lorenzo A.  Pinna</span>  . </span><span class="cited-content_cbyCitation_article-title">Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2011,</strong> <em>50 </em>
                                    (39)
                                     , 8478-8488. <a href="https://doi.org/10.1021/bi2008382" title="DOI URL">https://doi.org/10.1021/bi2008382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi2008382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi2008382%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DUnprecedented%252BSelectivity%252Band%252BStructural%252BDeterminants%252Bof%252Ba%252BNew%252BClass%252Bof%252BProtein%252BKinase%252BCK2%252BInhibitors%252Bin%252BClinical%252BTrials%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DBattistutta%26aufirst%3DRoberto%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D31052011%26date%3D25082011%26date%3D07092011%26date%3D04102011%26date%3D26082011%26volume%3D50%26issue%3D39%26spage%3D8478%26epage%3D8488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Claudio  D’Amore</span>, <span class="hlFld-ContribAuthor ">Stefania  Sarno</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>, <span class="hlFld-ContribAuthor ">Maria  Ruzzene</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinase CK2: a potential therapeutic target for diverse human diseases. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-021-00567-7" title="DOI URL">https://doi.org/10.1038/s41392-021-00567-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-021-00567-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-021-00567-7%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DProtein%252Bkinase%252BCK2%25253A%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Bdiverse%252Bhuman%252Bdiseases%26aulast%3DBorgo%26aufirst%3DChristian%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katrina  Kildey</span>, <span class="hlFld-ContribAuthor ">Neha S.  Gandhi</span>, <span class="hlFld-ContribAuthor ">Katherine B.  Sahin</span>, <span class="hlFld-ContribAuthor ">Esha T.  Shah</span>, <span class="hlFld-ContribAuthor ">Eric  Boittier</span>, <span class="hlFld-ContribAuthor ">Pascal H. G.  Duijf</span>, <span class="hlFld-ContribAuthor ">Christopher  Molloy</span>, <span class="hlFld-ContribAuthor ">Joshua T.  Burgess</span>, <span class="hlFld-ContribAuthor ">Sam  Beard</span>, <span class="hlFld-ContribAuthor ">Emma  Bolderson</span>, <span class="hlFld-ContribAuthor ">Amila  Suraweera</span>, <span class="hlFld-ContribAuthor ">Derek J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  O’Byrne</span>, <span class="hlFld-ContribAuthor ">Mark N.  Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Communications Biology</span><span> <strong>2021,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42003-021-02136-8" title="DOI URL">https://doi.org/10.1038/s42003-021-02136-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42003-021-02136-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42003-021-02136-8%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Biology%26atitle%3DElevating%252BCDCA3%252Blevels%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%252Benhances%252Bsensitivity%252Bto%252Bplatinum-based%252Bchemotherapy%26aulast%3DKildey%26aufirst%3DKatrina%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Claudio  D’Amore</span>, <span class="hlFld-ContribAuthor ">Luca  Cesaro</span>, <span class="hlFld-ContribAuthor ">Stefania  Sarno</span>, <span class="hlFld-ContribAuthor ">Lorenzo A.  Pinna</span>, <span class="hlFld-ContribAuthor ">Maria  Ruzzene</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>. </span><span class="cited-content_cbyCitation_article-title">How can a traffic light properly work if it is always green? The paradox of CK2 signaling. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Biochemistry and Molecular Biology</span><span> <strong>2021,</strong> <em>56 </em>
                                    (4)
                                     , 321-359. <a href="https://doi.org/10.1080/10409238.2021.1908951" title="DOI URL">https://doi.org/10.1080/10409238.2021.1908951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10409238.2021.1908951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10409238.2021.1908951%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DHow%252Bcan%252Ba%252Btraffic%252Blight%252Bproperly%252Bwork%252Bif%252Bit%252Bis%252Balways%252Bgreen%25253F%252BThe%252Bparadox%252Bof%252BCK2%252Bsignaling%26aulast%3DBorgo%26aufirst%3DChristian%26date%3D2021%26date%3D2021%26volume%3D56%26issue%3D4%26spage%3D321%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Kumawat</span>, <span class="hlFld-ContribAuthor ">Sadanandam  Namsani</span>, <span class="hlFld-ContribAuthor ">Debabrata  Pramanik</span>, <span class="hlFld-ContribAuthor ">Sudip  Roy</span>, <span class="hlFld-ContribAuthor ">Jayant K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>2 </em>, 1-12. <a href="https://doi.org/10.1080/07391102.2021.1937319" title="DOI URL">https://doi.org/10.1080/07391102.2021.1937319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1937319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1937319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIntegrated%252Bdocking%252Band%252Benhanced%252Bsampling-based%252Bselection%252Bof%252Brepurposing%252Bdrugs%252Bfor%252BSARS-CoV-2%252Bby%252Btargeting%252Bhost%252Bdependent%252Bfactors%26aulast%3DKumawat%26aufirst%3DAmit%26date%3D2021%26date%3D2021%26volume%3D2%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ehab  El-Awaad</span>, <span class="hlFld-ContribAuthor ">Robin  Birus</span>, <span class="hlFld-ContribAuthor ">Christelle  Marminon</span>, <span class="hlFld-ContribAuthor ">Zouhair  Bouaziz</span>, <span class="hlFld-ContribAuthor ">Laurens  Ballentin</span>, <span class="hlFld-ContribAuthor ">Dagmar  Aichele</span>, <span class="hlFld-ContribAuthor ">Marc  Le Borgne</span>, <span class="hlFld-ContribAuthor ">Joachim  Jose</span>. </span><span class="cited-content_cbyCitation_article-title">Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-b]indole Derivative, Discovered as CK2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (6)
                                     , 542. <a href="https://doi.org/10.3390/ph14060542" title="DOI URL">https://doi.org/10.3390/ph14060542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14060542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14060542%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DBroad-Spectrum%252BAnticancer%252BActivity%252Band%252BPharmacokinetic%252BProperties%252Bof%252Ba%252BPrenyloxy-Substituted%252BIndeno%25255B1%25252C2-b%25255Dindole%252BDerivative%25252C%252BDiscovered%252Bas%252BCK2%252BInhibitor%26aulast%3DEl-Awaad%26aufirst%3DEhab%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D6%26spage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Penghui  Dong</span>, <span class="hlFld-ContribAuthor ">Kashif  Majeed</span>, <span class="hlFld-ContribAuthor ">Lingna  Wang</span>, <span class="hlFld-ContribAuthor ">Zijian  Guo</span>, <span class="hlFld-ContribAuthor ">Fengtao  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Transition metal-free approach to azafluoranthene scaffolds by aldol condensation/[1+2+3] annulation tandem reaction of isocyanoacetates with 8-(alkynyl)-1-naphthaldehydes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (39)
                                     , 4855-4858. <a href="https://doi.org/10.1039/D1CC01015H" title="DOI URL">https://doi.org/10.1039/D1CC01015H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC01015H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC01015H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTransition%252Bmetal-free%252Bapproach%252Bto%252Bazafluoranthene%252Bscaffolds%252Bby%252Baldol%252Bcondensation%25252F%25255B1%25252B2%25252B3%25255D%252Bannulation%252Btandem%252Breaction%252Bof%252Bisocyanoacetates%252Bwith%252B8-%252528alkynyl%252529-1-naphthaldehydes%26aulast%3DDong%26aufirst%3DPenghui%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D39%26spage%3D4855%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janeen H.  Trembley</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Betsy T.  Kren</span>, <span class="hlFld-ContribAuthor ">Amy A.  Gravely</span>, <span class="hlFld-ContribAuthor ">Emiro  Caicedo-Granados</span>, <span class="hlFld-ContribAuthor ">Mark A.  Klein</span>, <span class="hlFld-ContribAuthor ">Khalil  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (5)
                                     , 571. <a href="https://doi.org/10.3390/biomedicines9050571" title="DOI URL">https://doi.org/10.3390/biomedicines9050571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9050571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9050571%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DCX-4945%252Band%252BsiRNA-Mediated%252BKnockdown%252Bof%252BCK2%252BImproves%252BCisplatin%252BResponse%252Bin%252BHPV%252528%25252B%252529%252Band%252BHPV%252528%2525E2%252588%252592%252529%252BHNSCC%252BCell%252BLines%26aulast%3DTrembley%26aufirst%3DJaneen%2BH.%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D5%26spage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyasha  De</span>, <span class="hlFld-ContribAuthor ">Ishita  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Bhargavi  Karna</span>, <span class="hlFld-ContribAuthor ">Nirmal  Mazumder</span>. </span><span class="cited-content_cbyCitation_article-title">Brief review on repurposed drugs and vaccines for possible treatment of COVID-19. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2021,</strong> <em>898 </em>, 173977. <a href="https://doi.org/10.1016/j.ejphar.2021.173977" title="DOI URL">https://doi.org/10.1016/j.ejphar.2021.173977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2021.173977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2021.173977%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DBrief%252Breview%252Bon%252Brepurposed%252Bdrugs%252Band%252Bvaccines%252Bfor%252Bpossible%252Btreatment%252Bof%252BCOVID-19%26aulast%3DDe%26aufirst%3DPriyasha%26date%3D2021%26volume%3D898%26spage%3D173977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Baier</span>, <span class="hlFld-ContribAuthor ">Anne  Kokel</span>, <span class="hlFld-ContribAuthor ">William  Horton</span>, <span class="hlFld-ContribAuthor ">Ewa  Gizińska</span>, <span class="hlFld-ContribAuthor ">Garima  Pandey</span>, <span class="hlFld-ContribAuthor ">Ryszard  Szyszka</span>, <span class="hlFld-ContribAuthor ">Béla  Török</span>, <span class="hlFld-ContribAuthor ">Marianna  Török</span>. </span><span class="cited-content_cbyCitation_article-title">Organofluorine Hydrazone Derivatives as Multifunctional Anti‐Alzheimer's Agents with CK2 Inhibitory and Antioxidant Features. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>6 </em><a href="https://doi.org/10.1002/cmdc.202100047" title="DOI URL">https://doi.org/10.1002/cmdc.202100047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100047%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DOrganofluorine%252BHydrazone%252BDerivatives%252Bas%252BMultifunctional%252BAnti%2525E2%252580%252590Alzheimer%252527s%252BAgents%252Bwith%252BCK2%252BInhibitory%252Band%252BAntioxidant%252BFeatures%26aulast%3DBaier%26aufirst%3DAndrea%26date%3D2021%26date%3D2021%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhanusha  Yesudhas</span>, <span class="hlFld-ContribAuthor ">Ambuj  Srivastava</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Infection</span><span> <strong>2021,</strong> <em>49 </em>
                                    (2)
                                     , 199-213. <a href="https://doi.org/10.1007/s15010-020-01516-2" title="DOI URL">https://doi.org/10.1007/s15010-020-01516-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s15010-020-01516-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs15010-020-01516-2%26sid%3Dliteratum%253Aachs%26jtitle%3DInfection%26atitle%3DCOVID-19%252Boutbreak%25253A%252Bhistory%25252C%252Bmechanism%25252C%252Btransmission%25252C%252Bstructural%252Bstudies%252Band%252Btherapeutics%26aulast%3DYesudhas%26aufirst%3DDhanusha%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3D2%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleanor L.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Jessica  Iegre</span>, <span class="hlFld-ContribAuthor ">Paul D.  Brear</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Zhabina</span>, <span class="hlFld-ContribAuthor ">Marko  Hyvönen</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1977. <a href="https://doi.org/10.3390/molecules26071977" title="DOI URL">https://doi.org/10.3390/molecules26071977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071977%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDownfalls%252Bof%252BChemical%252BProbes%252BActing%252Bat%252Bthe%252BKinase%252BATP-Site%25253A%252BCK2%252Bas%252Ba%252BCase%252BStudy%26aulast%3DAtkinson%26aufirst%3DEleanor%2BL.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  D'Amore</span>, <span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>. </span><span class="cited-content_cbyCitation_article-title">A mutational approach to dissect the functional role of the putative CFTR “PTM-CODE”. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cystic Fibrosis</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.1016/j.jcf.2021.03.010" title="DOI URL">https://doi.org/10.1016/j.jcf.2021.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jcf.2021.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jcf.2021.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cystic%2520Fibrosis%26atitle%3DA%252Bmutational%252Bapproach%252Bto%252Bdissect%252Bthe%252Bfunctional%252Brole%252Bof%252Bthe%252Bputative%252BCFTR%252B%2525E2%252580%25259CPTM-CODE%2525E2%252580%25259D%26aulast%3DD%2527Amore%26aufirst%3DClaudio%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seungbeom  Lee</span>, <span class="hlFld-ContribAuthor ">Jisu  Kim</span>, <span class="hlFld-ContribAuthor ">Jeyun  Jo</span>, <span class="hlFld-ContribAuthor ">Jae Won  Chang</span>, <span class="hlFld-ContribAuthor ">Jaehoon  Sim</span>, <span class="hlFld-ContribAuthor ">Hwayoung  Yun</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in development of hetero-bivalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113318. <a href="https://doi.org/10.1016/j.ejmech.2021.113318" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113318%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bdevelopment%252Bof%252Bhetero-bivalent%252Bkinase%252Binhibitors%26aulast%3DLee%26aufirst%3DSeungbeom%26date%3D2021%26volume%3D216%26spage%3D113318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">David H.  Drewry</span>, <span class="hlFld-ContribAuthor ">Julie E.  Pickett</span>, <span class="hlFld-ContribAuthor ">Amelie  Tjaden</span>, <span class="hlFld-ContribAuthor ">Andreas  Krämer</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Laszlo  Gyenis</span>, <span class="hlFld-ContribAuthor ">Daniel  Menyhart</span>, <span class="hlFld-ContribAuthor ">David W.  Litchfield</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Alison D.  Axtman</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a potent and selective chemical probe for the pleiotropic kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (4)
                                     , 546-558.e10. <a href="https://doi.org/10.1016/j.chembiol.2020.12.013" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DDevelopment%252Bof%252Ba%252Bpotent%252Band%252Bselective%252Bchemical%252Bprobe%252Bfor%252Bthe%252Bpleiotropic%252Bkinase%252BCK2%26aulast%3DWells%26aufirst%3DCarrow%2BI.%26date%3D2021%26volume%3D28%26issue%3D4%26spage%3D546%26epage%3D558.e10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Luca  Cesaro</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Hirota</span>, <span class="hlFld-ContribAuthor ">Keiko  Kuwata</span>, <span class="hlFld-ContribAuthor ">Claudio  D’Amore</span>, <span class="hlFld-ContribAuthor ">Thomas  Ruppert</span>, <span class="hlFld-ContribAuthor ">Renata  Blatnik</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>, <span class="hlFld-ContribAuthor ">Lorenzo A.  Pinna</span>. </span><span class="cited-content_cbyCitation_article-title">Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113217. <a href="https://doi.org/10.1016/j.ejmech.2021.113217" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113217%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComparing%252Bthe%252Befficacy%252Band%252Bselectivity%252Bof%252BCk2%252Binhibitors.%252BA%252Bphosphoproteomics%252Bapproach%26aulast%3DBorgo%26aufirst%3DChristian%26date%3D2021%26volume%3D214%26spage%3D113217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Giacosa</span>, <span class="hlFld-ContribAuthor ">Catherine  Pillet</span>, <span class="hlFld-ContribAuthor ">Irinka  Séraudie</span>, <span class="hlFld-ContribAuthor ">Laurent  Guyon</span>, <span class="hlFld-ContribAuthor ">Yann  Wallez</span>, <span class="hlFld-ContribAuthor ">Caroline  Roelants</span>, <span class="hlFld-ContribAuthor ">Christophe  Battail</span>, <span class="hlFld-ContribAuthor ">Bertrand  Evrard</span>, <span class="hlFld-ContribAuthor ">Frédéric  Chalmel</span>, <span class="hlFld-ContribAuthor ">Caroline  Barette</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Soleilhac</span>, <span class="hlFld-ContribAuthor ">Marie-Odile  Fauvarque</span>, <span class="hlFld-ContribAuthor ">Quentin  Franquet</span>, <span class="hlFld-ContribAuthor ">Clément  Sarrazin</span>, <span class="hlFld-ContribAuthor ">Nicolas  Peilleron</span>, <span class="hlFld-ContribAuthor ">Gaëlle  Fiard</span>, <span class="hlFld-ContribAuthor ">Jean-Alexandre  Long</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Descotes</span>, <span class="hlFld-ContribAuthor ">Claude  Cochet</span>, <span class="hlFld-ContribAuthor ">Odile  Filhol</span>. </span><span class="cited-content_cbyCitation_article-title">Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 576. <a href="https://doi.org/10.3390/cancers13030576" title="DOI URL">https://doi.org/10.3390/cancers13030576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13030576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13030576%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCooperative%252BBlockade%252Bof%252BCK2%252Band%252BATM%252BKinases%252BDrives%252BApoptosis%252Bin%252BVHL-Deficient%252BRenal%252BCarcinoma%252BCells%252Bthrough%252BROS%252BOverproduction%26aulast%3DGiacosa%26aufirst%3DSofia%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Maria  Ruzzene</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinase CK2 inhibition as a pharmacological strategy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 23-46. <a href="https://doi.org/10.1016/bs.apcsb.2020.09.003" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2020.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2020.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2020.09.003%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%252Bkinase%252BCK2%252Binhibition%252Bas%252Ba%252Bpharmacological%252Bstrategy%26aulast%3DBorgo%26aufirst%3DChristian%26date%3D2021%26spage%3D23%26epage%3D46%26pub%3DElsevier%26atitle%3DProtein%252BKinases%252Bin%252BDrug%252BDiscovery%26date%3D2021%26volume%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe‐Peng  Deng</span>, <span class="hlFld-ContribAuthor ">Da‐Gang  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Csp
              2
              –H functionalization of aldehydes with triplet O
              2
              catalyzed by NHPI: A density functional theory investigation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physical Organic Chemistry</span><span> <strong>2020,</strong> <em>33 </em>
                                    (12)
                                     <a href="https://doi.org/10.1002/poc.4112" title="DOI URL">https://doi.org/10.1002/poc.4112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/poc.4112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpoc.4112%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physical%2520Organic%2520Chemistry%26atitle%3DMechanisms%252Bof%252BCsp%252B2%252B%2525E2%252580%252593H%252Bfunctionalization%252Bof%252Baldehydes%252Bwith%252Btriplet%252BO%252B2%252Bcatalyzed%252Bby%252BNHPI%25253A%252BA%252Bdensity%252Bfunctional%252Btheory%252Binvestigation%26aulast%3DDeng%26aufirst%3DZhe%25E2%2580%2590Peng%26date%3D2020%26date%3D2020%26volume%3D33%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  D’Amore</span>, <span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Stefania  Sarno</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>. </span><span class="cited-content_cbyCitation_article-title">Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance. </span><span class="cited-content_cbyCitation_journal-name">Cellular Oncology</span><span> <strong>2020,</strong> <em>43 </em>
                                    (6)
                                     , 1003-1016. <a href="https://doi.org/10.1007/s13402-020-00566-w" title="DOI URL">https://doi.org/10.1007/s13402-020-00566-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13402-020-00566-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13402-020-00566-w%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Oncology%26atitle%3DRole%252Bof%252BCK2%252Binhibitor%252BCX-4945%252Bin%252Banti-cancer%252Bcombination%252Btherapy%252B%2525E2%252580%252593%252Bpotential%252Bclinical%252Brelevance%26aulast%3DD%25E2%2580%2599Amore%26aufirst%3DClaudio%26date%3D2020%26date%3D2020%26volume%3D43%26issue%3D6%26spage%3D1003%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Krämer</span>, <span class="hlFld-ContribAuthor ">Christian Georg  Kurz</span>, <span class="hlFld-ContribAuthor ">Benedict-Tilman  Berger</span>, <span class="hlFld-ContribAuthor ">Ibrahim Ethem  Celik</span>, <span class="hlFld-ContribAuthor ">Amelie  Tjaden</span>, <span class="hlFld-ContribAuthor ">Francesco Aleksy  Greco</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Thomas  Hanke</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112770. <a href="https://doi.org/10.1016/j.ejmech.2020.112770" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112770%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Blead%252Bto%252Bthe%252Bidentification%252Bof%252Ba%252Bhighly%252Bselective%252Bcasein%252Bkinase%252B2%252Binhibitor%26aulast%3DKr%25C3%25A4mer%26aufirst%3DAndreas%26date%3D2020%26volume%3D208%26spage%3D112770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Richter</span>, <span class="hlFld-ContribAuthor ">Sina  Sender</span>, <span class="hlFld-ContribAuthor ">Annemarie  Lenz</span>, <span class="hlFld-ContribAuthor ">Rico  Schwarz</span>, <span class="hlFld-ContribAuthor ">Burkhard  Hinz</span>, <span class="hlFld-ContribAuthor ">Gudrun  Knuebel</span>, <span class="hlFld-ContribAuthor ">Anett  Sekora</span>, <span class="hlFld-ContribAuthor ">Hugo  Murua Escobar</span>, <span class="hlFld-ContribAuthor ">Christian  Junghanss</span>, <span class="hlFld-ContribAuthor ">Catrin  Roolf</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-020-6650-9" title="DOI URL">https://doi.org/10.1186/s12885-020-6650-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-020-6650-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-020-6650-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DInfluence%252Bof%252BCasein%252Bkinase%252BII%252Binhibitor%252BCX-4945%252Bon%252BBCL6-mediated%252Bapoptotic%252Bsignaling%252Bin%252BB-ALL%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DRichter%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chitrala  Teja</span>, <span class="hlFld-ContribAuthor ">Fazlur‐Rahman  Nawaz Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Thienoquinolines (Quinoline‐fused heterocycle). </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 1889-1900. <a href="https://doi.org/10.1002/ajoc.202000427" title="DOI URL">https://doi.org/10.1002/ajoc.202000427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000427%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BThienoquinolines%252B%252528Quinoline%2525E2%252580%252590fused%252Bheterocycle%252529%26aulast%3DTeja%26aufirst%3DChitrala%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D1889%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steve P.H.  Alexander</span>, <span class="hlFld-ContribAuthor ">Jane F.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Anthony P.  Davenport</span>, <span class="hlFld-ContribAuthor ">Jamie A.  Davies</span>, <span class="hlFld-ContribAuthor ">Elena  Faccenda</span>, <span class="hlFld-ContribAuthor ">Simon D.  Harding</span>, <span class="hlFld-ContribAuthor ">Francesca  Levi‐Schaffer</span>, <span class="hlFld-ContribAuthor ">Janet J.  Maguire</span>, <span class="hlFld-ContribAuthor ">Adam J.  Pawson</span>, <span class="hlFld-ContribAuthor ">Christopher  Southan</span>, <span class="hlFld-ContribAuthor ">Michael  Spedding</span>. </span><span class="cited-content_cbyCitation_article-title">A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (21)
                                     , 4942-4966. <a href="https://doi.org/10.1111/bph.15094" title="DOI URL">https://doi.org/10.1111/bph.15094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15094%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Brational%252Broadmap%252Bfor%252BSARS%2525E2%252580%252590CoV%2525E2%252580%2525902%25252FCOVID%2525E2%252580%25259019%252Bpharmacotherapeutic%252Bresearch%252Band%252Bdevelopment%25253A%252BIUPHAR%252BReview%252B29%26aulast%3DAlexander%26aufirst%3DSteve%2BP.H.%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D21%26spage%3D4942%26epage%3D4966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Dalle Vedove</span>, <span class="hlFld-ContribAuthor ">Francesca  Zonta</span>, <span class="hlFld-ContribAuthor ">Enrico  Zanforlin</span>, <span class="hlFld-ContribAuthor ">Nicola  Demitri</span>, <span class="hlFld-ContribAuthor ">Giovanni  Ribaudo</span>, <span class="hlFld-ContribAuthor ">Giulia  Cazzanelli</span>, <span class="hlFld-ContribAuthor ">Alberto  Ongaro</span>, <span class="hlFld-ContribAuthor ">Stefania  Sarno</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Zagotto</span>, <span class="hlFld-ContribAuthor ">Roberto  Battistutta</span>, <span class="hlFld-ContribAuthor ">Maria  Ruzzene</span>, <span class="hlFld-ContribAuthor ">Graziano  Lolli</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of selective CK2 inhibitors targeting its open hinge conformation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112267. <a href="https://doi.org/10.1016/j.ejmech.2020.112267" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112267%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252Bclass%252Bof%252Bselective%252BCK2%252Binhibitors%252Btargeting%252Bits%252Bopen%252Bhinge%252Bconformation%26aulast%3DDalle%2BVedove%26aufirst%3DAndrea%26date%3D2020%26volume%3D195%26spage%3D112267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasser  Perera</span>, <span class="hlFld-ContribAuthor ">Alice  Melão</span>, <span class="hlFld-ContribAuthor ">Ailyn C.  Ramón</span>, <span class="hlFld-ContribAuthor ">Dania  Vázquez</span>, <span class="hlFld-ContribAuthor ">Daniel  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Silvio E.  Perea</span>, <span class="hlFld-ContribAuthor ">João T.  Barata</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1377. <a href="https://doi.org/10.3390/cancers12061377" title="DOI URL">https://doi.org/10.3390/cancers12061377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061377%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DClinical-Grade%252BPeptide-Based%252BInhibition%252Bof%252BCK2%252BBlocks%252BViability%252Band%252BProliferation%252Bof%252BT-ALL%252BCells%252Band%252BCounteracts%252BIL-7%252BStimulation%252Band%252BStromal%252BSupport%26aulast%3DPerera%26aufirst%3DYasser%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Om  Basukala</span>, <span class="hlFld-ContribAuthor ">Vanessa  Sarabia-Vega</span>, <span class="hlFld-ContribAuthor ">Lawrence  Banks</span>. </span><span class="cited-content_cbyCitation_article-title">Human papillomavirus oncoproteins and post-translational modifications: generating multifunctional hubs for overriding cellular homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2020,</strong> <em>401 </em>
                                    (5)
                                     , 585-599. <a href="https://doi.org/10.1515/hsz-2019-0408" title="DOI URL">https://doi.org/10.1515/hsz-2019-0408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2019-0408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2019-0408%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DHuman%252Bpapillomavirus%252Boncoproteins%252Band%252Bpost-translational%252Bmodifications%25253A%252Bgenerating%252Bmultifunctional%252Bhubs%252Bfor%252Boverriding%252Bcellular%252Bhomeostasis%26aulast%3DBasukala%26aufirst%3DOm%26date%3D2020%26date%3D2020%26volume%3D401%26issue%3D5%26spage%3D585%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Regina  Martínez</span>, <span class="hlFld-ContribAuthor ">Bruno  Di Geronimo</span>, <span class="hlFld-ContribAuthor ">Miryam  Pastor</span>, <span class="hlFld-ContribAuthor ">José María  Zapico</span>, <span class="hlFld-ContribAuthor ">Claire  Coderch</span>, <span class="hlFld-ContribAuthor ">Rostyslav  Panchuk</span>, <span class="hlFld-ContribAuthor ">Nadia  Skorokhyd</span>, <span class="hlFld-ContribAuthor ">Maciej  Maslyk</span>, <span class="hlFld-ContribAuthor ">Ana  Ramos</span>, <span class="hlFld-ContribAuthor ">Beatriz  de Pascual-Teresa</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1497. <a href="https://doi.org/10.3390/molecules25071497" title="DOI URL">https://doi.org/10.3390/molecules25071497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071497%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMultitarget%252BAnticancer%252BAgents%252BBased%252Bon%252BHistone%252BDeacetylase%252Band%252BProtein%252BKinase%252BCK2%252BInhibitors%26aulast%3DMart%25C3%25ADnez%26aufirst%3DRegina%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Li</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhongxiang  Qin</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>, <span class="hlFld-ContribAuthor ">Rong  Xiang</span>, <span class="hlFld-ContribAuthor ">Yan  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103547. <a href="https://doi.org/10.1016/j.bioorg.2019.103547" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103547%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Boptimization%252Bof%252Borally%252Bspleen%252Btyrosine%252Bkinase%252B%252528SYK%252529%252Binhibitors%252Bfor%252Btreatment%252Bof%252Bsolid%252Btumor%26aulast%3DWang%26aufirst%3DCheng%26date%3D2020%26volume%3D95%26spage%3D103547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masato  Tsuyuguchi</span>, <span class="hlFld-ContribAuthor ">Tetsuko  Nakaniwa</span>, <span class="hlFld-ContribAuthor ">Akira  Hirasawa</span>, <span class="hlFld-ContribAuthor ">Isao  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Kinoshita</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights for producing CK2α1-specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126837. <a href="https://doi.org/10.1016/j.bmcl.2019.126837" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126837%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252Binsights%252Bfor%252Bproducing%252BCK2%2525CE%2525B11-specific%252Binhibitors%26aulast%3DTsuyuguchi%26aufirst%3DMasato%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eslam  Pourbasheer</span>, <span class="hlFld-ContribAuthor ">Reza  Aalizadeh</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Ganjali</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR study of CK2 inhibitors by GA-MLR and GA-SVM methods. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2019,</strong> <em>12 </em>
                                    (8)
                                     , 2141-2149. <a href="https://doi.org/10.1016/j.arabjc.2014.12.021" title="DOI URL">https://doi.org/10.1016/j.arabjc.2014.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2014.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2014.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DQSAR%252Bstudy%252Bof%252BCK2%252Binhibitors%252Bby%252BGA-MLR%252Band%252BGA-SVM%252Bmethods%26aulast%3DPourbasheer%26aufirst%3DEslam%26date%3D2019%26volume%3D12%26issue%3D8%26spage%3D2141%26epage%3D2149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Jain</span>, <span class="hlFld-ContribAuthor ">Vikash  Chandra</span>, <span class="hlFld-ContribAuthor ">Pankaj  Kumar Jain</span>, <span class="hlFld-ContribAuthor ">Kamla  Pathak</span>, <span class="hlFld-ContribAuthor ">Devendra  Pathak</span>, <span class="hlFld-ContribAuthor ">Ankur  Vaidya</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review on current developments of quinoline-based anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2019,</strong> <em>12 </em>
                                    (8)
                                     , 4920-4946. <a href="https://doi.org/10.1016/j.arabjc.2016.10.009" title="DOI URL">https://doi.org/10.1016/j.arabjc.2016.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2016.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2016.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DComprehensive%252Breview%252Bon%252Bcurrent%252Bdevelopments%252Bof%252Bquinoline-based%252Banticancer%252Bagents%26aulast%3DJain%26aufirst%3DShweta%26date%3D2019%26volume%3D12%26issue%3D8%26spage%3D4920%26epage%3D4946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiyan  Sun</span>, <span class="hlFld-ContribAuthor ">Linsheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Huan  Dong</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nengfang  She</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 8-Amino-Substituted 2-Phenyl-2,7-Naphthyridinone Derivatives as New c-Kit/VEGFR-2 Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (24)
                                     , 4461. <a href="https://doi.org/10.3390/molecules24244461" title="DOI URL">https://doi.org/10.3390/molecules24244461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24244461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24244461%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252B8-Amino-Substituted%252B2-Phenyl-2%25252C7-Naphthyridinone%252BDerivatives%252Bas%252BNew%252Bc-Kit%25252FVEGFR-2%252BKinase%252BInhibitors%26aulast%3DSun%26aufirst%3DHaiyan%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D24%26spage%3D4461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laure-Elie  Carloni</span>, <span class="hlFld-ContribAuthor ">Stefan  Mohnani</span>, <span class="hlFld-ContribAuthor ">Davide  Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3,5-Disubstituted Isoxazoles through a 1,3-Dipolar Cycloaddition Reaction between Alkynes and Nitrile Oxides Generated from
              O
              -Silylated Hydroxamic Acids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (44)
                                     , 7322-7334. <a href="https://doi.org/10.1002/ejoc.201901045" title="DOI URL">https://doi.org/10.1002/ejoc.201901045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B3%25252C5-Disubstituted%252BIsoxazoles%252Bthrough%252Ba%252B1%25252C3-Dipolar%252BCycloaddition%252BReaction%252Bbetween%252BAlkynes%252Band%252BNitrile%252BOxides%252BGenerated%252Bfrom%252BO%252B-Silylated%252BHydroxamic%252BAcids%26aulast%3DCarloni%26aufirst%3DLaure-Elie%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D44%26spage%3D7322%26epage%3D7334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuting  Qiao</span>, <span class="hlFld-ContribAuthor ">Tingkai  Chen</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Hongzhi  Lin</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Qinglong  Guo</span>, <span class="hlFld-ContribAuthor ">Zongliang  Liu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule modulators targeting protein kinase CK1 and CK2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111581. <a href="https://doi.org/10.1016/j.ejmech.2019.111581" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111581%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecule%252Bmodulators%252Btargeting%252Bprotein%252Bkinase%252BCK1%252Band%252BCK2%26aulast%3DQiao%26aufirst%3DYuting%26date%3D2019%26volume%3D181%26spage%3D111581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Di Maira</span>, <span class="hlFld-ContribAuthor ">Alessandra  Gentilini</span>, <span class="hlFld-ContribAuthor ">Mirella  Pastore</span>, <span class="hlFld-ContribAuthor ">Alessandra  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Benedetta  Piombanti</span>, <span class="hlFld-ContribAuthor ">Chiara  Raggi</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Rovida</span>, <span class="hlFld-ContribAuthor ">Monika  Lewinska</span>, <span class="hlFld-ContribAuthor ">Jesper B.  Andersen</span>, <span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>, <span class="hlFld-ContribAuthor ">Daniele  Ottaviani</span>, <span class="hlFld-ContribAuthor ">Maria  Ruzzene</span>, <span class="hlFld-ContribAuthor ">Fabio  Marra</span>. </span><span class="cited-content_cbyCitation_article-title">The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Oncogenesis</span><span> <strong>2019,</strong> <em>8 </em>
                                    (11)
                                     <a href="https://doi.org/10.1038/s41389-019-0171-x" title="DOI URL">https://doi.org/10.1038/s41389-019-0171-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41389-019-0171-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41389-019-0171-x%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogenesis%26atitle%3DThe%252Bprotein%252Bkinase%252BCK2%252Bcontributes%252Bto%252Bthe%252Bmalignant%252Bphenotype%252Bof%252Bcholangiocarcinoma%252Bcells%26aulast%3DDi%2BMaira%26aufirst%3DGiovanni%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Agnew</span>, <span class="hlFld-ContribAuthor ">Lijun  Liu</span>, <span class="hlFld-ContribAuthor ">Shu  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Liang  You</span>, <span class="hlFld-ContribAuthor ">Wayland  Yeung</span>, <span class="hlFld-ContribAuthor ">Natarajan  Kannan</span>, <span class="hlFld-ContribAuthor ">David  Jablons</span>, <span class="hlFld-ContribAuthor ">Natalia  Jura</span>. </span><span class="cited-content_cbyCitation_article-title">The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (37)
                                     , 13545-13559. <a href="https://doi.org/10.1074/jbc.RA119.009725" title="DOI URL">https://doi.org/10.1074/jbc.RA119.009725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.009725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.009725%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DThe%252Bcrystal%252Bstructure%252Bof%252Bthe%252Bprotein%252Bkinase%252BHIPK2%252Breveals%252Ba%252Bunique%252Barchitecture%252Bof%252Bits%252BCMGC-insert%252Bregion%26aulast%3DAgnew%26aufirst%3DChristopher%26date%3D2019%26volume%3D294%26issue%3D37%26spage%3D13545%26epage%3D13559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Denan  Sun</span>, <span class="hlFld-ContribAuthor ">Jiping  Du</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Jingbo  Lan</span>, <span class="hlFld-ContribAuthor ">Di  Wu</span>, <span class="hlFld-ContribAuthor ">Jingsong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Transient directing ligand- and solvent-controlled C–H/C–H cross-coupling/quaternization cyclization/dequaternization of benzaldehydes with thiophenes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (52)
                                     , 7518-7521. <a href="https://doi.org/10.1039/C9CC04017J" title="DOI URL">https://doi.org/10.1039/C9CC04017J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC04017J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC04017J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTransient%252Bdirecting%252Bligand-%252Band%252Bsolvent-controlled%252BC%2525E2%252580%252593H%25252FC%2525E2%252580%252593H%252Bcross-coupling%25252Fquaternization%252Bcyclization%25252Fdequaternization%252Bof%252Bbenzaldehydes%252Bwith%252Bthiophenes%26aulast%3DSun%26aufirst%3DDenan%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D52%26spage%3D7518%26epage%3D7521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  D'Amore</span>, <span class="hlFld-ContribAuthor ">Valentina  Salizzato</span>, <span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Luca  Cesaro</span>, <span class="hlFld-ContribAuthor ">Lorenzo A.  Pinna</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>. </span><span class="cited-content_cbyCitation_article-title">A Journey through the Cytoskeleton with Protein Kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Current Protein & Peptide Science</span><span> <strong>2019,</strong> <em>20 </em>
                                    (6)
                                     , 547-562. <a href="https://doi.org/10.2174/1389203720666190119124846" title="DOI URL">https://doi.org/10.2174/1389203720666190119124846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389203720666190119124846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389203720666190119124846%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Protein%2520%2526%2520Peptide%2520Science%26atitle%3DA%252BJourney%252Bthrough%252Bthe%252BCytoskeleton%252Bwith%252BProtein%252BKinase%252BCK2%26aulast%3DD%2527Amore%26aufirst%3DClaudio%26date%3D2019%26volume%3D20%26issue%3D6%26spage%3D547%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Skierka</span>, <span class="hlFld-ContribAuthor ">Paweł  Wilamowski</span>, <span class="hlFld-ContribAuthor ">Monika  Wielechowska</span>, <span class="hlFld-ContribAuthor ">Dominik  Cysewski</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Senkara</span>, <span class="hlFld-ContribAuthor ">Patrycja  Wińska</span>, <span class="hlFld-ContribAuthor ">Maria  Bretner</span>, <span class="hlFld-ContribAuthor ">Joanna  Cieśla</span>. </span><span class="cited-content_cbyCitation_article-title">Human dihydrofolate reductase is a substrate of protein kinase CK2α. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2019,</strong> <em>513 </em>
                                    (2)
                                     , 368-373. <a href="https://doi.org/10.1016/j.bbrc.2019.03.186" title="DOI URL">https://doi.org/10.1016/j.bbrc.2019.03.186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2019.03.186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2019.03.186%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DHuman%252Bdihydrofolate%252Breductase%252Bis%252Ba%252Bsubstrate%252Bof%252Bprotein%252Bkinase%252BCK2%2525CE%2525B1%26aulast%3DSkierka%26aufirst%3DKatarzyna%26date%3D2019%26volume%3D513%26issue%3D2%26spage%3D368%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arielis  Rodríguez-Ulloa</span>, <span class="hlFld-ContribAuthor ">Yassel  Ramos</span>, <span class="hlFld-ContribAuthor ">Aniel  Sánchez-Puente</span>, <span class="hlFld-ContribAuthor ">Yasser  Perera</span>, <span class="hlFld-ContribAuthor ">Alexis  Musacchio-Lasa</span>, <span class="hlFld-ContribAuthor ">Jorge  Fernández-de-Cossio</span>, <span class="hlFld-ContribAuthor ">Gabriel  Padrón</span>, <span class="hlFld-ContribAuthor ">Luis J.G.  López</span>, <span class="hlFld-ContribAuthor ">Vladimir  Besada</span>, <span class="hlFld-ContribAuthor ">Silvio E.  Perea</span>. </span><span class="cited-content_cbyCitation_article-title">The Combination of the CIGB-300 Anticancer Peptide and Cisplatin Modulates Proteins Related to Cell Survival, DNA Repair and Metastasis in a Lung Cancer Cell Line Model. </span><span class="cited-content_cbyCitation_journal-name">Current Proteomics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (4)
                                     , 338-349. <a href="https://doi.org/10.2174/1570164616666190126104325" title="DOI URL">https://doi.org/10.2174/1570164616666190126104325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570164616666190126104325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570164616666190126104325%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Proteomics%26atitle%3DThe%252BCombination%252Bof%252Bthe%252BCIGB-300%252BAnticancer%252BPeptide%252Band%252BCisplatin%252BModulates%252BProteins%252BRelated%252Bto%252BCell%252BSurvival%25252C%252BDNA%252BRepair%252Band%252BMetastasis%252Bin%252Ba%252BLung%252BCancer%252BCell%252BLine%252BModel%26aulast%3DRodr%25C3%25ADguez-Ulloa%26aufirst%3DArielis%26date%3D2019%26volume%3D16%26issue%3D4%26spage%3D338%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norihiko  Nakazawa</span>, <span class="hlFld-ContribAuthor ">Orie  Arakawa</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ebe</span>, <span class="hlFld-ContribAuthor ">Mitsuhiro  Yanagida</span>. </span><span class="cited-content_cbyCitation_article-title">Casein kinase II–dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (10)
                                     , 3772-3782. <a href="https://doi.org/10.1074/jbc.RA118.004955" title="DOI URL">https://doi.org/10.1074/jbc.RA118.004955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.004955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.004955%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DCasein%252Bkinase%252BII%2525E2%252580%252593dependent%252Bphosphorylation%252Bof%252BDNA%252Btopoisomerase%252BII%252Bsuppresses%252Bthe%252Beffect%252Bof%252Ba%252Bcatalytic%252Btopo%252BII%252Binhibitor%25252C%252BICRF-193%25252C%252Bin%252Bfission%252Byeast%26aulast%3DNakazawa%26aufirst%3DNorihiko%26date%3D2019%26volume%3D294%26issue%3D10%26spage%3D3772%26epage%3D3782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kais  Zakharia</span>, <span class="hlFld-ContribAuthor ">Katsuyuki  Miyabe</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Dehai  Wu</span>, <span class="hlFld-ContribAuthor ">Catherine D.  Moser</span>, <span class="hlFld-ContribAuthor ">Mitesh J.  Borad</span>, <span class="hlFld-ContribAuthor ">Lewis R.  Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 143-153. <a href="https://doi.org/10.1016/j.tranon.2018.09.005" title="DOI URL">https://doi.org/10.1016/j.tranon.2018.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tranon.2018.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tranon.2018.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DPreclinical%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEvidence%252Bof%252Ban%252BAntitumor%252BEffect%252Bof%252BCX-4945%25252C%252Ba%252BCasein%252BKinase%252BII%252BInhibitor%25252C%252Bin%252BCholangiocarcinoma%26aulast%3DZakharia%26aufirst%3DKais%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zibo  Zhao</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Volk</span>, <span class="hlFld-ContribAuthor ">Noah W.  Birch</span>, <span class="hlFld-ContribAuthor ">Kristen L.  Stoltz</span>, <span class="hlFld-ContribAuthor ">Elizabeth T.  Bartom</span>, <span class="hlFld-ContribAuthor ">Stacy A.  Marshall</span>, <span class="hlFld-ContribAuthor ">Emily J.  Rendleman</span>, <span class="hlFld-ContribAuthor ">Carson M.  Nestler</span>, <span class="hlFld-ContribAuthor ">Joseph  Shilati</span>, <span class="hlFld-ContribAuthor ">Gary E.  Schiltz</span>, <span class="hlFld-ContribAuthor ">John D.  Crispino</span>, <span class="hlFld-ContribAuthor ">Ali  Shilatifard</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia. </span><span class="cited-content_cbyCitation_journal-name">Genes & Development</span><span> <strong>2019,</strong> <em>33 </em>
                                    (1-2)
                                     , 61-74. <a href="https://doi.org/10.1101/gad.319830.118" title="DOI URL">https://doi.org/10.1101/gad.319830.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/gad.319830.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fgad.319830.118%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%2520%2526%2520Development%26atitle%3DRegulation%252Bof%252BMLL%25252FCOMPASS%252Bstability%252Bthrough%252Bits%252Bproteolytic%252Bcleavage%252Bby%252Btaspase1%252Bas%252Ba%252Bpossible%252Bapproach%252Bfor%252Bclinical%252Btherapy%252Bof%252Bleukemia%26aulast%3DZhao%26aufirst%3DZibo%26date%3D2019%26date%3D2018%26volume%3D33%26issue%3D1-2%26spage%3D61%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Feihong  Chen</span>, <span class="hlFld-ContribAuthor ">Nannan  Liu</span>, <span class="hlFld-ContribAuthor ">Xinyi  Wang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin–proteasome pathway. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 536-544. <a href="https://doi.org/10.1016/j.bioorg.2018.09.005" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DChemically%252Binduced%252Bdegradation%252Bof%252BCK2%252Bby%252Bproteolysis%252Btargeting%252Bchimeras%252Bbased%252Bon%252Ba%252Bubiquitin%2525E2%252580%252593proteasome%252Bpathway%26aulast%3DChen%26aufirst%3DHong%26date%3D2018%26volume%3D81%26spage%3D536%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulia P.  Bogza</span>, <span class="hlFld-ContribAuthor ">Alexey A.  Rastrepin</span>, <span class="hlFld-ContribAuthor ">Victoria V.  Nider</span>, <span class="hlFld-ContribAuthor ">Tatyana Yu  Zheleznova</span>, <span class="hlFld-ContribAuthor ">Anton J.  Stasyuk</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Kurowska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Laba</span>, <span class="hlFld-ContribAuthor ">Evgeny B.  Ulyankin</span>, <span class="hlFld-ContribAuthor ">Wojciech  Domagala</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Fisyuk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and optical properties of 2-functionally substituted 4,5-dihydrothieno[3,2-c]quinolines. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2018,</strong> <em>159 </em>, 419-428. <a href="https://doi.org/10.1016/j.dyepig.2018.06.031" title="DOI URL">https://doi.org/10.1016/j.dyepig.2018.06.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2018.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2018.06.031%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3DSynthesis%252Band%252Boptical%252Bproperties%252Bof%252B2-functionally%252Bsubstituted%252B4%25252C5-dihydrothieno%25255B3%25252C2-c%25255Dquinolines%26aulast%3DBogza%26aufirst%3DYulia%2BP.%26date%3D2018%26volume%3D159%26spage%3D419%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. D.  Tsoy</span>, <span class="hlFld-ContribAuthor ">N. A.  Kruglova</span>, <span class="hlFld-ContribAuthor ">A. V.  Filatov</span>. </span><span class="cited-content_cbyCitation_article-title">Lymphocyte Phosphatase-Associated Phosphoprotein Is a Substrate of Protein Kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry (Moscow)</span><span> <strong>2018,</strong> <em>83 </em>
                                    (11)
                                     , 1380-1387. <a href="https://doi.org/10.1134/S0006297918110081" title="DOI URL">https://doi.org/10.1134/S0006297918110081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S0006297918110081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS0006297918110081%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520%2528Moscow%2529%26atitle%3DLymphocyte%252BPhosphatase-Associated%252BPhosphoprotein%252BIs%252Ba%252BSubstrate%252Bof%252BProtein%252BKinase%252BCK2%26aulast%3DTsoy%26aufirst%3DT.%2BD.%26date%3D2018%26date%3D2018%26volume%3D83%26issue%3D11%26spage%3D1380%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jürgen  Vahter</span>, <span class="hlFld-ContribAuthor ">Kaido  Viht</span>, <span class="hlFld-ContribAuthor ">Asko  Uri</span>, <span class="hlFld-ContribAuthor ">Ganesh babu  Manoharan</span>, <span class="hlFld-ContribAuthor ">Erki  Enkvist</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (18)
                                     , 5062-5068. <a href="https://doi.org/10.1016/j.bmc.2018.09.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThiazole-%252Band%252Bselenazole-comprising%252Bhigh-affinity%252Binhibitors%252Bpossess%252Bbright%252Bmicrosecond-scale%252Bphotoluminescence%252Bin%252Bcomplex%252Bwith%252Bprotein%252Bkinase%252BCK2%26aulast%3DVahter%26aufirst%3DJ%25C3%25BCrgen%26date%3D2018%26volume%3D26%26issue%3D18%26spage%3D5062%26epage%3D5068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beata  Jonik-Nowak</span>, <span class="hlFld-ContribAuthor ">Thomas  Menneteau</span>, <span class="hlFld-ContribAuthor ">Didier  Fesquet</span>, <span class="hlFld-ContribAuthor ">Véronique  Baldin</span>, <span class="hlFld-ContribAuthor ">Catherine  Bonne-Andrea</span>, <span class="hlFld-ContribAuthor ">Francisca  Méchali</span>, <span class="hlFld-ContribAuthor ">Bertrand  Fabre</span>, <span class="hlFld-ContribAuthor ">Prisca  Boisguerin</span>, <span class="hlFld-ContribAuthor ">Sylvain  de Rossi</span>, <span class="hlFld-ContribAuthor ">Corinne  Henriquet</span>, <span class="hlFld-ContribAuthor ">Martine  Pugnière</span>, <span class="hlFld-ContribAuthor ">Manuelle  Ducoux-Petit</span>, <span class="hlFld-ContribAuthor ">Odile  Burlet-Schiltz</span>, <span class="hlFld-ContribAuthor ">Angus I.  Lamond</span>, <span class="hlFld-ContribAuthor ">Philippe  Fort</span>, <span class="hlFld-ContribAuthor ">Séverine  Boulon</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  Bousquet</span>, <span class="hlFld-ContribAuthor ">Olivier  Coux</span>. </span><span class="cited-content_cbyCitation_article-title">PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (28)
                                     , E6477-E6486. <a href="https://doi.org/10.1073/pnas.1722299115" title="DOI URL">https://doi.org/10.1073/pnas.1722299115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1722299115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1722299115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DPIP30%25252FFAM192A%252Bis%252Ba%252Bnovel%252Bregulator%252Bof%252Bthe%252Bnuclear%252Bproteasome%252Bactivator%252BPA28%2525CE%2525B3%26aulast%3DJonik-Nowak%26aufirst%3DBeata%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D28%26spage%3DE6477%26epage%3DE6486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Afsaneh  Taheri Kal Koshvandi</span>, <span class="hlFld-ContribAuthor ">Majid M.  Heravi</span>, <span class="hlFld-ContribAuthor ">Tayebeh  Momeni</span>. </span><span class="cited-content_cbyCitation_article-title">Current Applications of Suzuki–Miyaura Coupling Reaction in The Total Synthesis of Natural Products: An update. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2018,</strong> <em>32 </em>
                                    (3)
                                     , e4210. <a href="https://doi.org/10.1002/aoc.4210" title="DOI URL">https://doi.org/10.1002/aoc.4210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.4210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.4210%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DCurrent%252BApplications%252Bof%252BSuzuki%2525E2%252580%252593Miyaura%252BCoupling%252BReaction%252Bin%252BThe%252BTotal%252BSynthesis%252Bof%252BNatural%252BProducts%25253A%252BAn%252Bupdate%26aulast%3DTaheri%2BKal%2BKoshvandi%26aufirst%3DAfsaneh%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D3%26spage%3De4210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashutosh  Srivastava</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Hirota</span>, <span class="hlFld-ContribAuthor ">Stephan  Irle</span>, <span class="hlFld-ContribAuthor ">Florence  Tama</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2018,</strong> <em>86 </em>
                                    (3)
                                     , 344-353. <a href="https://doi.org/10.1002/prot.25444" title="DOI URL">https://doi.org/10.1002/prot.25444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.25444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.25444%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DConformational%252Bdynamics%252Bof%252Bhuman%252Bprotein%252Bkinase%252BCK2%2525CE%2525B1%252Band%252Bits%252Beffect%252Bon%252Bfunction%252Band%252Binhibition%26aulast%3DSrivastava%26aufirst%3DAshutosh%26date%3D2018%26date%3D2017%26volume%3D86%26issue%3D3%26spage%3D344%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Monika  Janeczko</span>, <span class="hlFld-ContribAuthor ">Oleg M.  Demchuk</span>, <span class="hlFld-ContribAuthor ">Anna  Boguszewska-Czubara</span>, <span class="hlFld-ContribAuthor ">Hieronim  Golczyk</span>, <span class="hlFld-ContribAuthor ">Anna  Sierosławska</span>, <span class="hlFld-ContribAuthor ">Anna  Rymuszka</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Martyna</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>. </span><span class="cited-content_cbyCitation_article-title">A representative of arylcyanomethylenequinone oximes effectively inhibits growth and formation of hyphae in Candida albicans and influences the activity of protein kinases in vitro. </span><span class="cited-content_cbyCitation_journal-name">Saudi Pharmaceutical Journal</span><span> <strong>2018,</strong> <em>26 </em>
                                    (2)
                                     , 244-252. <a href="https://doi.org/10.1016/j.jsps.2017.12.004" title="DOI URL">https://doi.org/10.1016/j.jsps.2017.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsps.2017.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsps.2017.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DSaudi%2520Pharmaceutical%2520Journal%26atitle%3DA%252Brepresentative%252Bof%252Barylcyanomethylenequinone%252Boximes%252Beffectively%252Binhibits%252Bgrowth%252Band%252Bformation%252Bof%252Bhyphae%252Bin%252BCandida%252Balbicans%252Band%252Binfluences%252Bthe%252Bactivity%252Bof%252Bprotein%252Bkinases%252Bin%252Bvitro%26aulast%3DMas%25C5%2582yk%26aufirst%3DMaciej%26date%3D2018%26volume%3D26%26issue%3D2%26spage%3D244%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunfang  Hu</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenjing  Gao</span>, <span class="hlFld-ContribAuthor ">Guisheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Tongxin  Liu</span>, <span class="hlFld-ContribAuthor ">Qingfeng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">PIFA-promoted intramolecular oxidative C(aryl)-H amidation reaction: Synthesis of quinolino[3,4- b ]quinoxalin-6(5 H )-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (6)
                                     , 665-671. <a href="https://doi.org/10.1016/j.tet.2017.12.016" title="DOI URL">https://doi.org/10.1016/j.tet.2017.12.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.12.016%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DPIFA-promoted%252Bintramolecular%252Boxidative%252BC%252528aryl%252529-H%252Bamidation%252Breaction%25253A%252BSynthesis%252Bof%252Bquinolino%25255B3%25252C4-%252Bb%252B%25255Dquinoxalin-6%2525285%252BH%252B%252529-ones%26aulast%3DHu%26aufirst%3DChunfang%26date%3D2018%26volume%3D74%26issue%3D6%26spage%3D665%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob P.  Turowec</span>, <span class="hlFld-ContribAuthor ">Nicole A.  St. Denis</span>, <span class="hlFld-ContribAuthor ">David W.  Litchfield</span>. </span><span class="cited-content_cbyCitation_article-title">Casein Kinase II. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 708-717. <a href="https://doi.org/10.1007/978-3-319-67199-4_110" title="DOI URL">https://doi.org/10.1007/978-3-319-67199-4_110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-67199-4_110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-67199-4_110%26sid%3Dliteratum%253Aachs%26atitle%3DCasein%252BKinase%252BII%26aulast%3DTurowec%26aufirst%3DJacob%2BP.%26date%3D2018%26date%3D2018%26spage%3D708%26epage%3D717%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEncyclopedia%252Bof%252BSignaling%252BMolecules%26aulast%3DChoi%26aufirst%3DSangdun%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Iegre</span>, <span class="hlFld-ContribAuthor ">Paul  Brear</span>, <span class="hlFld-ContribAuthor ">Claudia  De Fusco</span>, <span class="hlFld-ContribAuthor ">Masao  Yoshida</span>, <span class="hlFld-ContribAuthor ">Sophie L.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Maxim  Rossmann</span>, <span class="hlFld-ContribAuthor ">Laura  Carro</span>, <span class="hlFld-ContribAuthor ">Hannah F.  Sore</span>, <span class="hlFld-ContribAuthor ">Marko  Hyvönen</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">Second-generation CK2α inhibitors targeting the αD pocket. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 3041-3049. <a href="https://doi.org/10.1039/C7SC05122K" title="DOI URL">https://doi.org/10.1039/C7SC05122K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7SC05122K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7SC05122K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DSecond-generation%252BCK2%2525CE%2525B1%252Binhibitors%252Btargeting%252Bthe%252B%2525CE%2525B1D%252Bpocket%26aulast%3DIegre%26aufirst%3DJessica%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11%26spage%3D3041%26epage%3D3049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvio E.  Perea</span>, <span class="hlFld-ContribAuthor ">Idania  Baladrón</span>, <span class="hlFld-ContribAuthor ">Carmen  Valenzuela</span>, <span class="hlFld-ContribAuthor ">Yasser  Perera</span>. </span><span class="cited-content_cbyCitation_article-title">CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Oncology</span><span> <strong>2018,</strong> <em>45 </em>
                                    (1-2)
                                     , 58-67. <a href="https://doi.org/10.1053/j.seminoncol.2018.04.006" title="DOI URL">https://doi.org/10.1053/j.seminoncol.2018.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.seminoncol.2018.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.seminoncol.2018.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Oncology%26atitle%3DCIGB-300%25253A%252BA%252Bpeptide-based%252Bdrug%252Bthat%252Bimpairs%252Bthe%252BProtein%252BKinase%252BCK2-mediated%252Bphosphorylation%26aulast%3DPerea%26aufirst%3DSilvio%2BE.%26date%3D2018%26volume%3D45%26issue%3D1-2%26spage%3D58%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuliang  Guo</span>, <span class="hlFld-ContribAuthor ">Qingyu  Xing</span>, <span class="hlFld-ContribAuthor ">Kunhua  Lei</span>, <span class="hlFld-ContribAuthor ">Daisy  Zhang-Negrerie</span>, <span class="hlFld-ContribAuthor ">Yunfei  Du</span>, <span class="hlFld-ContribAuthor ">Kang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">A Tandem Ring Opening/Closure Reaction in A BF
              3
              -Mediated Rearrangement of Spirooxindoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (24)
                                     , 4393-4398. <a href="https://doi.org/10.1002/adsc.201700728" title="DOI URL">https://doi.org/10.1002/adsc.201700728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201700728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201700728%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DA%252BTandem%252BRing%252BOpening%25252FClosure%252BReaction%252Bin%252BA%252BBF%252B3%252B-Mediated%252BRearrangement%252Bof%252BSpirooxindoles%26aulast%3DGuo%26aufirst%3DXuliang%26date%3D2017%26date%3D2017%26volume%3D359%26issue%3D24%26spage%3D4393%26epage%3D4398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-ming  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiang-kai  Dong</span>, <span class="hlFld-ContribAuthor ">Kun  Song</span>, <span class="hlFld-ContribAuthor ">Tong-dan  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-kang  Huang</span>, <span class="hlFld-ContribAuthor ">Jing-miao  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiu-yan  Yang</span>, <span class="hlFld-ContribAuthor ">Ying  Shen</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2017,</strong> <em>38 </em>
                                    (12)
                                     , 1691-1698. <a href="https://doi.org/10.1038/aps.2017.55" title="DOI URL">https://doi.org/10.1038/aps.2017.55</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.55%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DA%252Bnovel%252Ballosteric%252Bsite%252Bin%252Bcasein%252Bkinase%252B2%2525CE%2525B1%252Bdiscovered%252Busing%252Bcombining%252Bbioinformatics%252Band%252Bbiochemistry%252Bmethods%26aulast%3DJiang%26aufirst%3DHai-ming%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D12%26spage%3D1691%26epage%3D1698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benoît  Bestgen</span>, <span class="hlFld-ContribAuthor ">Zakia  Belaid-Choucair</span>, <span class="hlFld-ContribAuthor ">Thierry  Lomberget</span>, <span class="hlFld-ContribAuthor ">Marc  Le Borgne</span>, <span class="hlFld-ContribAuthor ">Odile  Filhol</span>, <span class="hlFld-ContribAuthor ">Claude  Cochet</span>. </span><span class="cited-content_cbyCitation_article-title">In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2017,</strong> <em>10 </em>
                                    (4)
                                     , 16. <a href="https://doi.org/10.3390/ph10010016" title="DOI URL">https://doi.org/10.3390/ph10010016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph10010016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph10010016%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DIn%252BSearch%252Bof%252BSmall%252BMolecule%252BInhibitors%252BTargeting%252Bthe%252BFlexible%252BCK2%252BSubunit%252BInterface%26aulast%3DBestgen%26aufirst%3DBeno%25C3%25AEt%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  Schwind</span>, <span class="hlFld-ContribAuthor ">Sarah  Schetting</span>, <span class="hlFld-ContribAuthor ">Mathias  Montenarh</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Protein Kinase CK2 Prevents Adipogenic Differentiation of Mesenchymal Stem Cells Like C3H/10T1/2 Cells. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2017,</strong> <em>10 </em>
                                    (4)
                                     , 22. <a href="https://doi.org/10.3390/ph10010022" title="DOI URL">https://doi.org/10.3390/ph10010022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph10010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph10010022%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DInhibition%252Bof%252BProtein%252BKinase%252BCK2%252BPrevents%252BAdipogenic%252BDifferentiation%252Bof%252BMesenchymal%252BStem%252BCells%252BLike%252BC3H%25252F10T1%25252F2%252BCells%26aulast%3DSchwind%26aufirst%3DLisa%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Ferrer-Font</span>, <span class="hlFld-ContribAuthor ">Lucia  Villamañan</span>, <span class="hlFld-ContribAuthor ">Nuria  Arias-Ramos</span>, <span class="hlFld-ContribAuthor ">Jordi  Vilardell</span>, <span class="hlFld-ContribAuthor ">Maria  Plana</span>, <span class="hlFld-ContribAuthor ">Maria  Ruzzene</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Pinna</span>, <span class="hlFld-ContribAuthor ">Emilio  Itarte</span>, <span class="hlFld-ContribAuthor ">Carles  Arús</span>, <span class="hlFld-ContribAuthor ">Ana  Candiota</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2017,</strong> <em>10 </em>
                                    (4)
                                     , 24. <a href="https://doi.org/10.3390/ph10010024" title="DOI URL">https://doi.org/10.3390/ph10010024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph10010024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph10010024%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DTargeting%252BProtein%252BKinase%252BCK2%25253A%252BEvaluating%252BCX-4945%252BPotential%252Bfor%252BGL261%252BGlioblastoma%252BTherapy%252Bin%252BImmunocompetent%252BMice%26aulast%3DFerrer-Font%26aufirst%3DLaura%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janeen  Trembley</span>, <span class="hlFld-ContribAuthor ">Betsy  Kren</span>, <span class="hlFld-ContribAuthor ">Md.  Abedin</span>, <span class="hlFld-ContribAuthor ">Rachel  Vogel</span>, <span class="hlFld-ContribAuthor ">Claire  Cannon</span>, <span class="hlFld-ContribAuthor ">Gretchen  Unger</span>, <span class="hlFld-ContribAuthor ">Khalil  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2017,</strong> <em>10 </em>
                                    (4)
                                     , 25. <a href="https://doi.org/10.3390/ph10010025" title="DOI URL">https://doi.org/10.3390/ph10010025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph10010025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph10010025%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DCK2%252BMolecular%252BTargeting%2525E2%252580%252594Tumor%252BCell-Specific%252BDelivery%252Bof%252BRNAi%252Bin%252BVarious%252BModels%252Bof%252BCancer%26aulast%3DTrembley%26aufirst%3DJaneen%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D4%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thu Lan  Nguyen</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Yann  Hérault</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 1183-1199. <a href="https://doi.org/10.1080/13543776.2017.1360285" title="DOI URL">https://doi.org/10.1080/13543776.2017.1360285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1360285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1360285%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DDual-specificity%252Btyrosine%252Bphosphorylation-regulated%252Bkinase%252B1A%252B%252528DYRK1A%252529%252Binhibitors%25253A%252Ba%252Bsurvey%252Bof%252Brecent%252Bpatent%252Bliterature%26aulast%3DNguyen%26aufirst%3DThu%2BLan%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D1183%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. N.  Zinchenko</span>, <span class="hlFld-ContribAuthor ">L. V.  Muzychka</span>, <span class="hlFld-ContribAuthor ">O. B.  Smolii</span>, <span class="hlFld-ContribAuthor ">V. G.  Bdzhola</span>, <span class="hlFld-ContribAuthor ">M. V.  Protopopov</span>, <span class="hlFld-ContribAuthor ">S. M.  Yarmoluk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel amino-substituted derivatives of pyrido[2,3-d]pyrimidine as inhibitors of protein kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Biopolymers and Cell</span><span> <strong>2017,</strong> <em>33 </em>
                                    (5)
                                     , 367-378. <a href="https://doi.org/10.7124/bc.000960" title="DOI URL">https://doi.org/10.7124/bc.000960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7124/bc.000960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7124%2Fbc.000960%26sid%3Dliteratum%253Aachs%26jtitle%3DBiopolymers%2520and%2520Cell%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bamino-substituted%252Bderivatives%252Bof%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidine%252Bas%252Binhibitors%252Bof%252Bprotein%252Bkinase%252BCK2%26aulast%3DZinchenko%26aufirst%3DA.%2BN.%26date%3D2017%26volume%3D33%26issue%3D5%26spage%3D367%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagi Reddy  Modugu</span>, <span class="hlFld-ContribAuthor ">Praveen Kumar  Pittala</span>. </span><span class="cited-content_cbyCitation_article-title">p-TSA-catalyzed facile and efficient one-pot eco-friendly synthesis of novel isoxazolyl amino furo[3,2-c]quinolinone derivatives in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (40)
                                     , 3859-3863. <a href="https://doi.org/10.1016/j.tetlet.2017.08.062" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.08.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.08.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.08.062%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3Dp-TSA-catalyzed%252Bfacile%252Band%252Befficient%252Bone-pot%252Beco-friendly%252Bsynthesis%252Bof%252Bnovel%252Bisoxazolyl%252Bamino%252Bfuro%25255B3%25252C2-c%25255Dquinolinone%252Bderivatives%252Bin%252Baqueous%252Bmedium%26aulast%3DModugu%26aufirst%3DNagi%2BReddy%26date%3D2017%26volume%3D58%26issue%3D40%26spage%3D3859%26epage%3D3863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salam H.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Mark J.  Turner</span>, <span class="hlFld-ContribAuthor ">Vinciane  Saint-Criq</span>, <span class="hlFld-ContribAuthor ">James  Garnett</span>, <span class="hlFld-ContribAuthor ">Iram J.  Haq</span>, <span class="hlFld-ContribAuthor ">Malcolm  Brodlie</span>, <span class="hlFld-ContribAuthor ">Chris  Ward</span>, <span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>, <span class="hlFld-ContribAuthor ">Andrea  Venerando</span>, <span class="hlFld-ContribAuthor ">Michael A.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">CK2 is a key regulator of SLC4A2-mediated Cl−/HCO3 − exchange in human airway epithelia. </span><span class="cited-content_cbyCitation_journal-name">Pflügers Archiv - European Journal of Physiology</span><span> <strong>2017,</strong> <em>469 </em>
                                    (9)
                                     , 1073-1091. <a href="https://doi.org/10.1007/s00424-017-1981-3" title="DOI URL">https://doi.org/10.1007/s00424-017-1981-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00424-017-1981-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00424-017-1981-3%26sid%3Dliteratum%253Aachs%26jtitle%3DPfl%25C3%25BCgers%2520Archiv%2520-%2520European%2520Journal%2520of%2520Physiology%26atitle%3DCK2%252Bis%252Ba%252Bkey%252Bregulator%252Bof%252BSLC4A2-mediated%252BCl%2525E2%252588%252592%25252FHCO3%252B%2525E2%252588%252592%252Bexchange%252Bin%252Bhuman%252Bairway%252Bepithelia%26aulast%3DIbrahim%26aufirst%3DSalam%2BH.%26date%3D2017%26date%3D2017%26volume%3D469%26issue%3D9%26spage%3D1073%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Zhou</span>, <span class="hlFld-ContribAuthor ">Na  Zhang</span>, <span class="hlFld-ContribAuthor ">Shan  Tang</span>, <span class="hlFld-ContribAuthor ">Xiaoqian  Qi</span>, <span class="hlFld-ContribAuthor ">Lijiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhong</span>, <span class="hlFld-ContribAuthor ">Yongzhen  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (5)
                                     , 840. <a href="https://doi.org/10.3390/molecules22050840" title="DOI URL">https://doi.org/10.3390/molecules22050840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22050840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22050840%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DExploring%252Bthe%252BPivotal%252BRole%252Bof%252Bthe%252BCK2%252BHinge%252BRegion%252BSub-Pocket%252Bin%252BBinding%252Bwith%252BTricyclic%252BQuinolone%252BAnalogues%252Bby%252BComputational%252BAnalysis%26aulast%3DZhou%26aufirst%3DYue%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D5%26spage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jürgen  Vahter</span>, <span class="hlFld-ContribAuthor ">Kaido  Viht</span>, <span class="hlFld-ContribAuthor ">Asko  Uri</span>, <span class="hlFld-ContribAuthor ">Erki  Enkvist</span>. </span><span class="cited-content_cbyCitation_article-title">Oligo-aspartic acid conjugates with benzo[ c ][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (7)
                                     , 2277-2284. <a href="https://doi.org/10.1016/j.bmc.2017.02.055" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.02.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.02.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.02.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOligo-aspartic%252Bacid%252Bconjugates%252Bwith%252Bbenzo%25255B%252Bc%252B%25255D%25255B2%25252C6%25255Dnaphthyridine-8-carboxylic%252Bacid%252Bscaffold%252Bas%252Bpicomolar%252Binhibitors%252Bof%252BCK2%26aulast%3DVahter%26aufirst%3DJ%25C3%25BCrgen%26date%3D2017%26volume%3D25%26issue%3D7%26spage%3D2277%26epage%3D2284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emre  Hoplamaz</span>, <span class="hlFld-ContribAuthor ">Selbi  Keskin</span>, <span class="hlFld-ContribAuthor ">Metin  Balci</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of Benzo[
              h
              ][1,6]-naphthyridines and Chromenopyrazinones through Alkyne Cyclization. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (11)
                                     , 1489-1497. <a href="https://doi.org/10.1002/ejoc.201601661" title="DOI URL">https://doi.org/10.1002/ejoc.201601661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201601661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201601661%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BSynthesis%252Bof%252BBenzo%25255B%252Bh%252B%25255D%25255B1%25252C6%25255D-naphthyridines%252Band%252BChromenopyrazinones%252Bthrough%252BAlkyne%252BCyclization%26aulast%3DHoplamaz%26aufirst%3DEmre%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D11%26spage%3D1489%26epage%3D1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2017,</strong> <em>37 </em>
                                    (2)
                                     , 314-367. <a href="https://doi.org/10.1002/med.21409" title="DOI URL">https://doi.org/10.1002/med.21409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21409%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DApproved%252Band%252BExperimental%252BSmall-Molecule%252BOncology%252BKinase%252BInhibitor%252BDrugs%25253A%252BA%252BMid-2016%252BOverview%26aulast%3DFischer%26aufirst%3DPeter%2BM.%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D2%26spage%3D314%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Borgo</span>, <span class="hlFld-ContribAuthor ">Cinzia  Franchin</span>, <span class="hlFld-ContribAuthor ">Stefano  Scalco</span>, <span class="hlFld-ContribAuthor ">Valentina  Bosello-Travain</span>, <span class="hlFld-ContribAuthor ">Arianna  Donella-Deana</span>, <span class="hlFld-ContribAuthor ">Giorgio  Arrigoni</span>, <span class="hlFld-ContribAuthor ">Mauro  Salvi</span>, <span class="hlFld-ContribAuthor ">Lorenzo A.  Pinna</span>. </span><span class="cited-content_cbyCitation_article-title">Generation and quantitative proteomics analysis of CK2α/α’(−/−) cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep42409" title="DOI URL">https://doi.org/10.1038/srep42409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep42409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep42409%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DGeneration%252Band%252Bquantitative%252Bproteomics%252Banalysis%252Bof%252BCK2%2525CE%2525B1%25252F%2525CE%2525B1%2525E2%252580%252599%252528%2525E2%252588%252592%25252F%2525E2%252588%252592%252529%252Bcells%26aulast%3DBorgo%26aufirst%3DChristian%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adhiyaman Kottai Munusamy  Magesh Selva Kumar</span>, <span class="hlFld-ContribAuthor ">Paul  Dhivya</span>, <span class="hlFld-ContribAuthor ">Subramanian Parameswaran  Rajendran</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of Fused [1,6]Naphthyridine Derivatives via Three-Component Reaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Chinese Chemical Society</span><span> <strong>2017,</strong> <em>64 </em>
                                    (2)
                                     , 138-142. <a href="https://doi.org/10.1002/jccs.201600196" title="DOI URL">https://doi.org/10.1002/jccs.201600196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jccs.201600196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjccs.201600196%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Chinese%2520Chemical%2520Society%26atitle%3DOne-Pot%252BSynthesis%252Bof%252BFused%252B%25255B1%25252C6%25255DNaphthyridine%252BDerivatives%252Bvia%252BThree-Component%252BReaction%26aulast%3DMagesh%2BSelva%2BKumar%26aufirst%3DAdhiyaman%2BKottai%2BMunusamy%26date%3D2017%26date%3D2016%26volume%3D64%26issue%3D2%26spage%3D138%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sateesh Kumar  Arepalli</span>, <span class="hlFld-ContribAuthor ">Byeongwoo  Park</span>, <span class="hlFld-ContribAuthor ">Jae-Kyung  Jung</span>, <span class="hlFld-ContribAuthor ">Kiho  Lee</span>, <span class="hlFld-ContribAuthor ">Heesoon  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">A facile one-pot regioselective synthesis of functionalized novel benzo[f]chromeno[4,3-b][1,7]naphthyridines and benzo[f][1,7]naphthyridines via an imino Diels-Alder reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (5)
                                     , 449-454. <a href="https://doi.org/10.1016/j.tetlet.2016.12.050" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.12.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.12.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.12.050%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bfacile%252Bone-pot%252Bregioselective%252Bsynthesis%252Bof%252Bfunctionalized%252Bnovel%252Bbenzo%25255Bf%25255Dchromeno%25255B4%25252C3-b%25255D%25255B1%25252C7%25255Dnaphthyridines%252Band%252Bbenzo%25255Bf%25255D%25255B1%25252C7%25255Dnaphthyridines%252Bvia%252Ban%252Bimino%252BDiels-Alder%252Breaction%26aulast%3DArepalli%26aufirst%3DSateesh%2BKumar%26date%3D2017%26volume%3D58%26issue%3D5%26spage%3D449%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob P.  Turowec</span>, <span class="hlFld-ContribAuthor ">Nicole A.  St. Denis</span>, <span class="hlFld-ContribAuthor ">David W.  Litchfield</span>. </span><span class="cited-content_cbyCitation_article-title">Casein Kinase II. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-10. <a href="https://doi.org/10.1007/978-1-4614-6438-9_110-1" title="DOI URL">https://doi.org/10.1007/978-1-4614-6438-9_110-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-6438-9_110-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-6438-9_110-1%26sid%3Dliteratum%253Aachs%26atitle%3DCasein%252BKinase%252BII%26aulast%3DTurowec%26aufirst%3DJacob%2BP.%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D10%26pub%3DSpringer%2520New%2520York%26atitle%3DEncyclopedia%252Bof%252BSignaling%252BMolecules%26aulast%3DChoi%26aufirst%3DSangdun%26date%3D2017%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrika  Gowda</span>, <span class="hlFld-ContribAuthor ">Chunhua  Song</span>, <span class="hlFld-ContribAuthor ">Malika  Kapadia</span>, <span class="hlFld-ContribAuthor ">Jonathon L.  Payne</span>, <span class="hlFld-ContribAuthor ">Tommy  Hu</span>, <span class="hlFld-ContribAuthor ">Yali  Ding</span>, <span class="hlFld-ContribAuthor ">Sinisa  Dovat</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros. </span><span class="cited-content_cbyCitation_journal-name">Advances in Biological Regulation</span><span> <strong>2017,</strong> <em>63 </em>, 71-80. <a href="https://doi.org/10.1016/j.jbior.2016.09.003" title="DOI URL">https://doi.org/10.1016/j.jbior.2016.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbior.2016.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbior.2016.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520in%2520Biological%2520Regulation%26atitle%3DRegulation%252Bof%252Bcellular%252Bproliferation%252Bin%252Bacute%252Blymphoblastic%252Bleukemia%252Bby%252BCasein%252BKinase%252BII%252B%252528CK2%252529%252Band%252BIkaros%26aulast%3DGowda%26aufirst%3DChandrika%26date%3D2017%26volume%3D63%26spage%3D71%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kalpana  Mishra</span>, <span class="hlFld-ContribAuthor ">Jay Bahadur  Singh</span>, <span class="hlFld-ContribAuthor ">Tanu  Gupta</span>, <span class="hlFld-ContribAuthor ">Radhey M.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Ag(
              i
              )-Catalyzed one-pot synthesis of 4-fluorobenzo[b][1,6] naphthyridines and 4-fluoroisoquinolines via iminofluorination of alkynes with Selectfluor. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (9)
                                     , 1794-1798. <a href="https://doi.org/10.1039/C7QO00346C" title="DOI URL">https://doi.org/10.1039/C7QO00346C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00346C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00346C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DAg%252528%252Bi%252B%252529-Catalyzed%252Bone-pot%252Bsynthesis%252Bof%252B4-fluorobenzo%25255Bb%25255D%25255B1%25252C6%25255D%252Bnaphthyridines%252Band%252B4-fluoroisoquinolines%252Bvia%252Biminofluorination%252Bof%252Balkynes%252Bwith%252BSelectfluor%26aulast%3DMishra%26aufirst%3DKalpana%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D9%26spage%3D1794%26epage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mukesh C.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Rationalization of physicochemical characters and structural determinants of benzimidazole analogues as casein kinase 2 inhibitors: computational approach. </span><span class="cited-content_cbyCitation_journal-name">Network Modeling Analysis in Health Informatics and Bioinformatics</span><span> <strong>2016,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s13721-016-0139-0" title="DOI URL">https://doi.org/10.1007/s13721-016-0139-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13721-016-0139-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13721-016-0139-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNetwork%2520Modeling%2520Analysis%2520in%2520Health%2520Informatics%2520and%2520Bioinformatics%26atitle%3DRationalization%252Bof%252Bphysicochemical%252Bcharacters%252Band%252Bstructural%252Bdeterminants%252Bof%252Bbenzimidazole%252Banalogues%252Bas%252Bcasein%252Bkinase%252B2%252Binhibitors%25253A%252Bcomputational%252Bapproach%26aulast%3DSharma%26aufirst%3DMukesh%2BC.%26date%3D2016%26date%3D2016%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Tampellini</span>, <span class="hlFld-ContribAuthor ">A.  La Salvia</span>, <span class="hlFld-ContribAuthor ">G. V.  Scagliotti</span>. </span><span class="cited-content_cbyCitation_article-title">Novel investigational therapies for treating biliary tract carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2016,</strong> <em>25 </em>
                                    (12)
                                     , 1423-1436. <a href="https://doi.org/10.1080/13543784.2016.1252330" title="DOI URL">https://doi.org/10.1080/13543784.2016.1252330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2016.1252330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2016.1252330%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DNovel%252Binvestigational%252Btherapies%252Bfor%252Btreating%252Bbiliary%252Btract%252Bcarcinoma%26aulast%3DTampellini%26aufirst%3DM.%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D12%26spage%3D1423%26epage%3D1436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea F. N.  Rosenberger</span>, <span class="hlFld-ContribAuthor ">Tjado H. J.  Morrema</span>, <span class="hlFld-ContribAuthor ">Wouter H.  Gerritsen</span>, <span class="hlFld-ContribAuthor ">Elise S.  van Haastert</span>, <span class="hlFld-ContribAuthor ">Hripsime  Snkhchyan</span>, <span class="hlFld-ContribAuthor ">Riet  Hilhorst</span>, <span class="hlFld-ContribAuthor ">Annemieke J. M.  Rozemuller</span>, <span class="hlFld-ContribAuthor ">Philip  Scheltens</span>, <span class="hlFld-ContribAuthor ">Saskia M.  van der Vies</span>, <span class="hlFld-ContribAuthor ">Jeroen J. M.  Hoozemans</span>. </span><span class="cited-content_cbyCitation_article-title">Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2016,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-015-0470-x" title="DOI URL">https://doi.org/10.1186/s12974-015-0470-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-015-0470-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-015-0470-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DIncreased%252Boccurrence%252Bof%252Bprotein%252Bkinase%252BCK2%252Bin%252Bastrocytes%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bpathology%26aulast%3DRosenberger%26aufirst%3DAndrea%2BF.%2BN.%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anatolii R.  Syniugin</span>, <span class="hlFld-ContribAuthor ">Olga V.  Ostrynska</span>, <span class="hlFld-ContribAuthor ">Maksym O.  Chekanov</span>, <span class="hlFld-ContribAuthor ">Galyna P.  Volynets</span>, <span class="hlFld-ContribAuthor ">Sergiy A.  Starosyla</span>, <span class="hlFld-ContribAuthor ">Volodymyr G.  Bdzhola</span>, <span class="hlFld-ContribAuthor ">Sergiy M.  Yarmoluk</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (sup4)
                                     , 160-169. <a href="https://doi.org/10.1080/14756366.2016.1222584" title="DOI URL">https://doi.org/10.1080/14756366.2016.1222584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1222584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1222584%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B3-quinoline%252Bcarboxylic%252Bacids%252Bas%252Bnew%252Binhibitors%252Bof%252Bprotein%252Bkinase%252BCK2%26aulast%3DSyniugin%26aufirst%3DAnatolii%2BR.%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3Dsup4%26spage%3D160%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm101251q&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-2%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm101251q&amp;citedByCount=191&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative structures of known ATP-competitive inhibitors of CK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of CK2 inhibitor <b>6</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> PARP inhibitor <b>7</b>,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and lead molecule <b>11c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0019.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, then MeOH; (b) NaOAc, PdCl<sub>2</sub>(dppf), DMF, 120 °C; (c) K<sub>2</sub>CO<sub>3</sub>, 3-bromo-1-propanol, DMF, 100 °C; (d) NH<sub>4</sub>OH, 100 °C; (e) LiOH, MeOH, THF, H<sub>2</sub>O, rt; (f) LiAlH<sub>4</sub>, dioxane, 100 °C; (g) POCl<sub>3</sub>, (<i>i</i>-Pr)<sub>2</sub>NEt, toluene, reflux; (h) HNR<sup>3</sup>R<sup>4</sup> (for structures of HNR<sup>3</sup>R<sup>4</sup>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), NMP, microwave 120 °C; (i) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, 120 °C; (j) H<sub>2</sub>O<sub>2</sub>, NaOH, NMP, 50 °C; (k) (MeO)<sub>2</sub>CHNMe<sub>2</sub>, 80 °C then AcOH, NH<sub>2</sub>NH<sub>2</sub>, 115 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0020.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, then R<sup>1</sup>OH or H<sub>2</sub>SO<sub>4</sub> (cat.), R<sup>1</sup>OH, reflux; (b) NaOAc, PdCl<sub>2</sub>(dppf), DMF, 120 °C or Cs<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub> (dppf), dioxane, 120 °C; (c) POCl<sub>3</sub> reflux.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0021.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>3</sup>NH<sub>2</sub> (for structure of R<sup>3</sup>NH<sub>2</sub>, see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) or 3-chloroaniline, NMP, microwave 120−160 °C or conventionnal heating at 80 °C; (b) NaOH, H<sub>2</sub>O, EtOH, 50−80 °C; (c) LiAlH<sub>4</sub>, THF, −40 °C to rt; (d) HOBt, EDCI, (<i>i</i>-Pr)<sub>2</sub>NEt, NH<sub>4</sub>Cl, NMP, 70 °C; (e) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, 120 °C; (f) (MeO)<sub>2</sub>CHNMe<sub>2</sub>, 80 °C then AcOH, NH<sub>2</sub>NH<sub>2</sub>, 80 °C.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>N-Ph-R<sup>5</sup>, NMP, microwave 120−160 °C or conventionnal heating at 80 °C; (b) NaOH, H<sub>2</sub>O, EtOH, 50−80 °C.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS, AcOH, rt, minor isomer isolated by chromatography; (b) H<sub>2</sub>SO<sub>4</sub> (cat.), MeOH, reflux; (c) H<sub>2</sub>, Pd/C, MeOH; (d) NIS, AcOH, rt, major isomer isolated by chromatography.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub> (dppf), dioxane, 120 °C, workup; (b) NaHMDS, THF, rt; (c) POCl<sub>3</sub> reflux, (d) 3-chloroaniline, NMP, microwave 120 °C; (e) NaOH, H<sub>2</sub>O, EtOH, 50−80 °C.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <b>6</b> bound to maize CK2α (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MO1">1MO1</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (A) 3D representation. Binding of <b>6</b> was largely determined by van der Waals contacts with several hydrophobic residues (in green) of the ATP-binding pocket (mainly Val45, Val53, Ile66, Val95, Phe113, Val116, Met163, and Ile174). The lactam −CONH− moiety of <b>6</b> was not directly involved in binding to the protein. (B) Schematic 2D view. The carboxylate, essential for activity, formed hydrogen bonds with Lys68, the backbone nitrogen of Asp175, and one water molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0016.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding model of <b>25n</b> (in green) in the ATP-pocket of CK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0017.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Endogenous CK2 activity of <b>25n</b> in Jurkat cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/medium/jm-2010-01251q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0018.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo growth inhibitory effect of <b>25n</b> on human prostate cancer PC3 xenografts in nude mice. Compound <b>25n</b> dosed bid at 25 mg/kg (tumor growth inhibition TGI = 19%), 50 mg/kg (TGI = 40%), and 75 mg/kg (TGI = 86%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-2/jm101251q/production/images/large/jm-2010-01251q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101251q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i149">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Duncan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span> </span><span class="NLM_article-title">Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2007&pages=33-47&issue=1&author=J.+S.+Duncanauthor=D.+W.+Litchfield&title=Too+much+of+a+good+thing%3A+the+role+of+protein+kinase+CK2+in+tumorigenesis+and+prospects+for+therapeutic+inhibition+of+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DJ.%2BS.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3DToo%2520much%2520of%2520a%2520good%2520thing%253A%2520the%2520role%2520of%2520protein%2520kinase%2520CK2%2520in%2520tumorigenesis%2520and%2520prospects%2520for%2520therapeutic%2520inhibition%2520of%2520CK2%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2007%26volume%3D1784%26issue%3D1%26spage%3D33%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">One-thousand-and-one substrates of protein kinase CK2?</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=349-368&issue=3&author=F.+Meggioauthor=L.+A.+Pinna&title=One-thousand-and-one+substrates+of+protein+kinase+CK2%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOne-thousand-and-one%2520substrates%2520of%2520protein%2520kinase%2520CK2%253F%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26issue%3D3%26spage%3D349%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Protein kinase CK2: a newcomer in the “druggable kinome”</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1042%2FBST0341303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=17073807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKgtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1303-1306&author=M.+A.+Paganoauthor=L.+Cesaroauthor=F.+Meggioauthor=L.+A.+Pinna&title=Protein+kinase+CK2%3A+a+newcomer+in+the+%E2%80%9Cdruggable+kinome%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: a newcomer in the 'druggable kinome'</span></div><div class="casAuthors">Pagano, M. A.; Cesaro, L.; Meggio, F.; Pinna, L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1303-1306</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The acronym CK2 (derived from the misnomer 'casein kinase' 2) denotes one of the most pleiotropic members of the eukaryotic protein kinase superfamily, characterized by an acidic consensus sequence in which a carboxylic acid (or pre-phosphorylated) side chain at position n + 3 relative to the target serine/threonine residue plays a crucial role.  The latest repertoire of CK2 substrates includes approx. 300 proteins, but the anal. of available phosphopeptide databases from different sources suggests that CK2 alone may be responsible for the generation of a much larger proportion (10-20%) of the eukaryotic phosphoproteome.  Although for the time being CK2 is not included among protein kinases whose inhibitors are in clin. practice or in advanced clin. trials, evidence is accumulating that elevated CK2 constitutive activity cooperates to induce a no. of pathol. conditions, including cancer, infectious diseases, neurodegeneration and cardiovascular pathologies.  The development and usage of cell-permeant, selective inhibitors discloses a scenario whereby CK2 plays a global anti-apoptotic role, which under special circumstances may lead to untimely and pathogenic cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoArzdBbGlxIrVg90H21EOLACvtfcHk0ljZ_FNX9ZF3Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKgtb3J&md5=a59049c0ac58609a3fcf8d8dbbca477d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2FBST0341303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0341303%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DCesaro%26aufirst%3DL.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520kinase%2520CK2%253A%2520a%2520newcomer%2520in%2520the%2520%25E2%2580%259Cdruggable%2520kinome%25E2%2580%259D%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2006%26volume%3D34%26spage%3D1303%26epage%3D1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ahmad, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Protein kinase CK2—a key suppressor of apoptosis</span> <span class="citation_source-journal">Adv. Enzyme Regul.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=179-187&author=K.+A.+Ahmadauthor=G.+Wangauthor=G.+Ungerauthor=J.+Slatonauthor=K.+Ahmed&title=Protein+kinase+CK2%E2%80%94a+key+suppressor+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DProtein%2520kinase%2520CK2%25E2%2580%2594a%2520key%2520suppressor%2520of%2520apoptosis%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D2008%26volume%3D48%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 in human diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.2174%2F092986708785132933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=18691045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1870-1886&issue=19&author=B.+Guerraauthor=O.+G.+Issinger&title=Protein+kinase+CK2+in+human+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 in human diseases</span></div><div class="casAuthors">Guerra, Barbara; Issinger, Olaf-Georg</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1870-1886</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 (formerly referred to as casein kinase II) is an evolutionary conserved, ubiquitous protein kinase.  There are two paralog catalytic subunits, i.e. alpha (A1) and alpha' (A2).  The alpha and alpha' subunits are linked to two beta subunits to produce a heterotetrameric structure.  The catalytic alpha subunits are distantly related to the CMGC subfamily of kinases, such as the Cdk kinases.  There are some peculiarities assocd. with protein kinase CK2, which are not found with most other protein kinases: (1) the enzyme is constitutively active, (2) it can use ATP and GTP and (3) it is found elevated in most tumors investigated and rapidly proliferating tissues.  With the elucidation of the structure of the catalytic subunit, it was possible to explain why the enzyme is constitutively active and why it can bind GTP.  Considerable information on the potential roles of CK2 in various disease processes including cancer has been gained in recent years, and the present review may help to further elucidate its aberrant role in many disease states.  Its peculiar structural features may be advantageous in designing tailor-made compds. with the possibility to specifically target this protein kinase.  Since not all the aspects of what has been published on CK2 can be covered in this review, we would like to recommend the following reviews; (1) for general information on CK2 and (2) with a focus on aberrant CK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHAjFIdLj5brVg90H21EOLACvtfcHk0ljZ_FNX9ZF3Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrsL7N&md5=af6ef98b360211abbb0ce5adcfe439e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F092986708785132933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785132933%26sid%3Dliteratum%253Aachs%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520human%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D19%26spage%3D1870%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kramerov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghizadeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caballero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li Calzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenarh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljubimov, A. V.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2008&pages=177-186&issue=1%E2%88%922&author=A.+A.+Kramerovauthor=M.+Saghizadehauthor=S.+Caballeroauthor=L.+C.+Shawauthor=S.+Li+Calziauthor=M.+Bretnerauthor=M.+Montenarhauthor=L.+A.+Pinnaauthor=M.+B.+Grantauthor=A.+V.+Ljubimov&title=Inhibition+of+protein+kinase+CK2+suppresses+angiogenesis+and+hematopoietic+stem+cell+recruitment+to+retinal+neovascularization+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramerov%26aufirst%3DA.%2BA.%26aulast%3DSaghizadeh%26aufirst%3DM.%26aulast%3DCaballero%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DL.%2BC.%26aulast%3DLi%2BCalzi%26aufirst%3DS.%26aulast%3DBretner%26aufirst%3DM.%26aulast%3DMontenarh%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DLjubimov%26aufirst%3DA.%2BV.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520CK2%2520suppresses%2520angiogenesis%2520and%2520hematopoietic%2520stem%2520cell%2520recruitment%2520to%2520retinal%2520neovascularization%2520sites%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D316%26issue%3D1%25E2%2588%25922%26spage%3D177%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 as a druggable target</span> <span class="citation_source-journal">Mol. Biosyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1039%2Fb805534c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=18704226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVSqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=889-894&issue=9&author=S.+Sarnoauthor=L.+A.+Pinna&title=Protein+kinase+CK2+as+a+druggable+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 as a druggable target</span></div><div class="casAuthors">Sarno, Stefania; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">889-894</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  CK2 is probably the most pleiotropic Ser/Thr protein kinase with hundreds of endogenous substrates already known, which are implicated in a variety of cellular functions.  At variance with most protein kinases whose activity is turned on only in response to specific stimuli, and whose genetic alterations often underlie pathol. situations, CK2 is not susceptible to tight regulation and there are no mutations known to affect its constitutive activity.  Nevertheless an abnormally high level of CK2 is invariably found in tumors, and solid arguments have accumulated suggesting that CK2 plays a global pro-survival function, which under special circumstances creates a cellular environment particularly favorable to the development and potentiation of the tumor phenotype.  Therefore any strategy aimed at attenuating CK2 activity may represent a "master key" for the treatment of different neoplastic diseases.  Waiting for the clarification of the epigenetic mechanisms promoting the rise of CK2 in cells predisposed to develop a tumor phenotype, a useful pharmacol. aid can come from the improvement of a no. of fairly potent and selective CK2 inhibitors already available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEYmgSHCYaLVg90H21EOLACvtfcHk0lj2Qym2MREj1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVSqs7w%253D&md5=64aff474b90d010323dc5a99fce8e424</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2Fb805534c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb805534c%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520kinase%2520CK2%2520as%2520a%2520druggable%2520target%26jtitle%3DMol.%2520Biosyst.%26date%3D2008%26volume%3D4%26issue%3D9%26spage%3D889%26epage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Faust, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubash, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro</span> <span class="citation_source-journal">Head Neck</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1002%2F1097-0347%28200007%2922%3A4%3C341%3A%3AAID-HED5%3E3.0.CO%3B2-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=10862016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A280%3ADC%252BD3czos12ktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=341-346&issue=4&author=R.+A.+Faustauthor=S.+Tawficauthor=A.+T.+Davisauthor=L.+A.+Bubashauthor=K.+Ahmed&title=Antisense+oligonucleotides+against+protein+kinase+CK2-alpha+inhibit+growth+of+squamous+cell+carcinoma+of+the+head+and+neck+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro</span></div><div class="casAuthors">Faust R A; Tawfic S; Davis A T; Bubash L A; Ahmed K</div><div class="citationInfo"><span class="NLM_cas:title">Head & neck</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-6</span>
        ISSN:<span class="NLM_cas:issn">1043-3074</span>.
    </div><div class="casAbstract">BACKGROUND:  Human squamous cell carcinomas of the head and neck (SCCHN) overexpress the protein kinase CK2, and elevated CK2 activity correlates with aggressive tumor behavior and poor clinical outcome.  We therefore investigated whether interference with CK2 expression would inhibit SCCHN cell growth in vitro.  METHODS:  We targeted the catalytic (alpha) subunit of CK2 using an antisense oligodeoxynucleotide (ODN) strategy.  Human Ca9-22 cells derived from SCCHN were transfected with CK2-alpha sense, nonsense, or antisense ODN; CK2 activity was measured; and the effect on CK2 activity and on cell growth was determined.  RESULTS:  Transfection of Ca9-22 cells with antisense CK2-alpha ODN resulted in significantly decreased CK2 kinase activity associated with nuclear chromatin and in dose-dependent growth inhibition of Ca9-22 cells in vitro.  CONCLUSIONS:  Interference with the protein kinase CK2 signal in SCCHN cells may offer a novel anticancer strategy for this malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzGXahH1HJaHtlzo9xastyfW6udTcc2eYZ1RcfAXfZFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czos12ktg%253D%253D&md5=bad04b421a92ce54696b4693c5bfc800</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2F1097-0347%28200007%2922%3A4%3C341%3A%3AAID-HED5%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0347%2528200007%252922%253A4%253C341%253A%253AAID-HED5%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DFaust%26aufirst%3DR.%2BA.%26aulast%3DTawfic%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DA.%2BT.%26aulast%3DBubash%26aufirst%3DL.%2BA.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DAntisense%2520oligonucleotides%2520against%2520protein%2520kinase%2520CK2-alpha%2520inhibit%2520growth%2520of%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520head%2520and%2520neck%2520in%2520vitro%26jtitle%3DHead%2520Neck%26date%3D2000%26volume%3D22%26issue%3D4%26spage%3D341%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Landesman-Bollag, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romieu-Mourez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardiff, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seldin, D. C.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 in mammary gland tumorigenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">3247</span><span class="NLM_x">–</span> <span class="NLM_lpage">3257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=3247-3257&issue=25&author=E.+Landesman-Bollagauthor=R.+Romieu-Mourezauthor=D.+H.+Songauthor=G.+E.+Sonensheinauthor=R.+D.+Cardiffauthor=D.+C.+Seldin&title=Protein+kinase+CK2+in+mammary+gland+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandesman-Bollag%26aufirst%3DE.%26aulast%3DRomieu-Mourez%26aufirst%3DR.%26aulast%3DSong%26aufirst%3DD.%2BH.%26aulast%3DSonenshein%26aufirst%3DG.%2BE.%26aulast%3DCardiff%26aufirst%3DR.%2BD.%26aulast%3DSeldin%26aufirst%3DD.%2BC.%26atitle%3DProtein%2520kinase%2520CK2%2520in%2520mammary%2520gland%2520tumorigenesis%26jtitle%3DOncogene%26date%3D2001%26volume%3D20%26issue%3D25%26spage%3D3247%26epage%3D3257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pistorius, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remberger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Differential CKII Activities in Human Colorectal Mucosa, Adenomas and Carcinomas</span> <span class="citation_source-journal">Onkologie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1159%2F000216984" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1991&pages=256-260&issue=3&author=K.+Pistoriusauthor=G.+Seitzauthor=K.+Rembergerauthor=O.+G.+Issinger&title=Differential+CKII+Activities+in+Human+Colorectal+Mucosa%2C+Adenomas+and+Carcinomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1159%2F000216984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000216984%26sid%3Dliteratum%253Aachs%26aulast%3DPistorius%26aufirst%3DK.%26aulast%3DSeitz%26aufirst%3DG.%26aulast%3DRemberger%26aufirst%3DK.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DDifferential%2520CKII%2520Activities%2520in%2520Human%2520Colorectal%2520Mucosa%252C%2520Adenomas%2520and%2520Carcinomas%26jtitle%3DOnkologie%26date%3D1991%26volume%3D14%26issue%3D3%26spage%3D256%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Stalter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becht, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remberger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Asymmetric expression of protein kinase CK2 subunits in human kidney tumors</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1994&pages=141-147&issue=1&author=G.+Stalterauthor=S.+Siemerauthor=E.+Bechtauthor=M.+Zieglerauthor=K.+Rembergerauthor=O.+G.+Issinger&title=Asymmetric+expression+of+protein+kinase+CK2+subunits+in+human+kidney+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStalter%26aufirst%3DG.%26aulast%3DSiemer%26aufirst%3DS.%26aulast%3DBecht%26aufirst%3DE.%26aulast%3DZiegler%26aufirst%3DM.%26aulast%3DRemberger%26aufirst%3DK.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DAsymmetric%2520expression%2520of%2520protein%2520kinase%2520CK2%2520subunits%2520in%2520human%2520kidney%2520tumors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1994%26volume%3D202%26issue%3D1%26spage%3D141%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">O-charoenrat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span> </span><span class="NLM_article-title">Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5792</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1158%2F1078-0432.CCR-03-0317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=15355908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlyjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=5792-5803&issue=17&author=P.+O-charoenratauthor=V.+Ruschauthor=S.+G.+Talbotauthor=I.+Sarkariaauthor=A.+Vialeauthor=N.+Socciauthor=I.+Ngaiauthor=P.+Raoauthor=B.+Singh&title=Casein+kinase+II+alpha+subunit+and+C1-inhibitor+are+independent+predictors+of+outcome+in+patients+with+squamous+cell+carcinoma+of+the+lung"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung</span></div><div class="casAuthors">O-Charoenrat, Pornchai; Rusch, Valerie; Talbot, Simon G.; Sarkaria, Inderpal; Viale, Agnes; Socci, Nicholas; Ngai, Ivan; Rao, Pulivarthi; Singh, Bhuvanesh</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5792-5803</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Gene expression profiling has been shown to be a valuable tool for prognostication and identification of cancer-assocd. genes in human malignancies.  The authors aimed to identify potential prognostic marker(s) in non-small cell lung cancers using global gene expression profiles.  Twenty-one previously untreated patients with non-small cell lung cancer were analyzed using the Affymetrix GeneChip high-d. oligonucleotide array and comparative genomic hybridization.  Identified candidate genes were validated in an independent cohort of 45 patients using quant. real-time reverse transcription-PCR and Western blot analyses.  Follow-up data for these patients was collected and used to assess outcome correlations.  Hierarchical clustering anal. yielded three distinct subgroups based on gene expression profiling.  Cluster I consisted of 4 patients with adenocarcinoma and 1 with squamous cell carcinoma (squamous cell carcinoma); clusters II and III consisted of 6 and 10 patients with squamous cell carcinoma, resp.  Outcome anal. was performed on the cluster groups contg. solely squamous cell carcinoma, revealing significant differences in disease-specific survival rates.  Moreover, patients having a combination of advanced Tumor-Node-Metastasis stage and assigned to the poor prognosis cluster group (cluster II) had significantly poorer outcomes.  Comparative genomic hybridization anal. showed recurrent chromosomal losses at 1p, 3p, 17, 19, and 22 and gains/amplifications at 3q, 5p, and 8q, which did not vary significantly between the cluster groups.  The authors internally and externally validated a subset of 11 cluster II (poor prognosis)-specific genes having corresponding chromosomal aberrations identified by comparative genomic hybridization as prognostic markers in an independent cohort of patients with lung squamous cell carcinoma identifying CSNK2A1 and C1-Inh as independent predictors of outcome.  CSNK2A1 and C1-Inh are independent predictors of survival in lung squamous cell carcinoma patients and may be useful as prognostic markers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeFyuVlgBO7Vg90H21EOLACvtfcHk0liguJ_UYacHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlyjs7k%253D&md5=0a96c1b8922106fef2f3ce02eb3a71dd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0317%26sid%3Dliteratum%253Aachs%26aulast%3DO-charoenrat%26aufirst%3DP.%26aulast%3DRusch%26aufirst%3DV.%26aulast%3DTalbot%26aufirst%3DS.%2BG.%26aulast%3DSarkaria%26aufirst%3DI.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DSocci%26aufirst%3DN.%26aulast%3DNgai%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26atitle%3DCasein%2520kinase%2520II%2520alpha%2520subunit%2520and%2520C1-inhibitor%2520are%2520independent%2520predictors%2520of%2520outcome%2520in%2520patients%2520with%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520lung%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26issue%3D17%26spage%3D5792%26epage%3D5803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kim, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, Y. H.</span><span> </span><span class="NLM_article-title">Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1158%2F1078-0432.CCR-06-1602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=17289898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1019-1028&issue=3&author=J.+S.+Kimauthor=J.+I.+Eomauthor=J.+W.+Cheongauthor=A.+J.+Choiauthor=J.+K.+Leeauthor=W.+I.+Yangauthor=Y.+H.+Min&title=Protein+kinase+CK2alpha+as+an+unfavorable+prognostic+marker+and+novel+therapeutic+target+in+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia</span></div><div class="casAuthors">Kim, Jin Seok; Eom, Ju In; Cheong, June-Won; Choi, Ae Jin; Lee, Jin Koo; Yang, Woo Ick; Min, Yoo Hong</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1019-1028</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Introduction: Protein kinase CK2 is implicated in cellular proliferation and transformation.  However, the clin. and biol. significances of CK2 have not been elucidated in acute myeloid leukemia (AML).  Exptl. Design: We evaluated the biol. significances of catalytic subunit of CK2 (CK2α) expression in leukemia cell lines and primary leukemic blasts obtained from AML patients.  Results: In this study, the expression of CK2α was elevated in a substantial proportion of AML.  In AML patients with normal karyotype, the disease-free survival and overall survival rates were significantly lower in the CK2α-high compared with the CK2α-low AML cases (P = 0.0252 and P = 0.0392, resp.).  An induced overexpression of CK2α increased the levels of Ser473 phosphorylated (p)-Akt/protein kinase B (PKB), p-PDK1, pFKHR, p-BAD, Bcl-2, Bcl-xL, Mcl-1, and XIAP.  Treatment of U937 cell line and primary AML blasts with selective CK2 inhibitor, tetrabromobenzotriazole or apigenin, reduced the levels of these mols. in a dose-dependent manner.  CK2α small interfering RNA treatment also resulted in a down-regulation of p-Akt/PKB and Bcl-2 in U937 cells.  Apigenin-induced cell death was preferentially obsd. in the CK2α-high leukemia cell lines, HL-60 and NB4, which was accompanied by cytoplasmic release of SMAC/DIABLO and proteolytic cleavage of procaspase-9, procaspase-3, procaspase-8, and poly(ADP)ribose polymerase.  An induced overexpression of CK2α potentially enhanced the sensitivity of U937 cells to the apigenin-induced cell death.  Apigenin-induced cell death was significantly higher in CK2α-high AML compared with CK2α-low AML (P < 0.0001) or normal bone marrow samples (P < 0.0001).  Conclusion: These findings strongly suggest protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7fx3ZX_P4UrVg90H21EOLACvtfcHk0liguJ_UYacHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7c%253D&md5=bc56dacc8f3ad4ba702623b09dcb4bd3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1602%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DEom%26aufirst%3DJ.%2BI.%26aulast%3DCheong%26aufirst%3DJ.%2BW.%26aulast%3DChoi%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DYang%26aufirst%3DW.%2BI.%26aulast%3DMin%26aufirst%3DY.%2BH.%26atitle%3DProtein%2520kinase%2520CK2alpha%2520as%2520an%2520unfavorable%2520prognostic%2520marker%2520and%2520novel%2520therapeutic%2520target%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D3%26spage%3D1019%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Yenice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goueli, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1994&pages=11-16&issue=1&author=S.+Yeniceauthor=A.+T.+Davisauthor=S.+A.+Goueliauthor=A.+Akdasauthor=C.+Limasauthor=K.+Ahmed&title=Nuclear+casein+kinase+2+%28CK-2%29+activity+in+human+normal%2C+benign+hyperplastic%2C+and+cancerous+prostate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYenice%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DA.%2BT.%26aulast%3DGoueli%26aufirst%3DS.%2BA.%26aulast%3DAkdas%26aufirst%3DA.%26aulast%3DLimas%26aufirst%3DC.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DNuclear%2520casein%2520kinase%25202%2520%2528CK-2%2529%2520activity%2520in%2520human%2520normal%252C%2520benign%2520hyperplastic%252C%2520and%2520cancerous%2520prostate%26jtitle%3DProstate%26date%3D1994%26volume%3D24%26issue%3D1%26spage%3D11%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Laramas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filhol, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringeisen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Descotes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">928</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2007&pages=928-934&issue=5&author=M.+Laramasauthor=D.+Pasquierauthor=O.+Filholauthor=F.+Ringeisenauthor=J.+L.+Descotesauthor=C.+Cochet&title=Nuclear+localization+of+protein+kinase+CK2+catalytic+subunit+%28CK2alpha%29+is+associated+with+poor+prognostic+factors+in+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaramas%26aufirst%3DM.%26aulast%3DPasquier%26aufirst%3DD.%26aulast%3DFilhol%26aufirst%3DO.%26aulast%3DRingeisen%26aufirst%3DF.%26aulast%3DDescotes%26aufirst%3DJ.%2BL.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNuclear%2520localization%2520of%2520protein%2520kinase%2520CK2%2520catalytic%2520subunit%2520%2528CK2alpha%2529%2520is%2520associated%2520with%2520poor%2520prognostic%2520factors%2520in%2520human%2520prostate%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2007%26volume%3D43%26issue%3D5%26spage%3D928%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tawfic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 signal in neoplasia</span> <span class="citation_source-journal">Histol. Histopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=11332713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Smtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=573-582&issue=2&author=S.+Tawficauthor=S.+Yuauthor=H.+Wangauthor=R.+Faustauthor=A.+Davisauthor=K.+Ahmed&title=Protein+kinase+CK2+signal+in+neoplasia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 signal in neoplasia</span></div><div class="casAuthors">Tawfic, S.; Yu, S.; Wang, H.; Faust, R.; Davis, A.; Ahmed, K.</div><div class="citationInfo"><span class="NLM_cas:title">Histology and Histopathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-582</span>CODEN:
                <span class="NLM_cas:coden">HIHIES</span>;
        ISSN:<span class="NLM_cas:issn">0213-3911</span>.
    
            (<span class="NLM_cas:orgname">Histology and Histopathology</span>)
        </div><div class="casAbstract">A review with many refs.  Protein kinase CK2 (previously known as casein kinase II) is a protein Ser/Thr kinase that was implicated in cell growth and proliferation.  The focus of this review is on the apparent role of CK2 in cancer.  Studies from several labs. have shown a dysregulated expression of the kinase in tumors.  Nuclear matrix and chromatin appear to be key sites for signaling of the CK2 activity in relation to cell growth.  Several types of growth stimuli produce a common downstream response in CK2 by enhancing its nuclear shuttling.  The neoplastic change is also assocd. with changes in intracellular localization of the kinase so that a higher nuclear localization is obsd. in tumor cells compared with normal cells.  Exptl. studies suggest that dysregulated expression of the α subunit of CK2 imparts an oncogenic potential in the cells such that in cooperation with certain oncogenes it produces a profound enhancement of the tumor phenotype.  Recent studies have provided evidence that overexpression of CK2 in tumor cells is not simply a reflection of tumor cell proliferation alone but addnl. may reflect the pathobiol. characteristics of the tumor.  Of considerable interest is the possibility that CK2 dysregulation in tumors may influence the apoptotic activity in those cells.  Approaches to interfering with the CK2 signal may provide a useful means for inducing tumor cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqD8HQSFNesLVg90H21EOLACvtfcHk0li5J8ZC1hoI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Smtbc%253D&md5=ec11e4e8878d533bf62b64e3a4a054e8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTawfic%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DFaust%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DProtein%2520kinase%2520CK2%2520signal%2520in%2520neoplasia%26jtitle%3DHistol.%2520Histopathol.%26date%3D2001%26volume%3D16%26issue%3D2%26spage%3D573%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Addiction to protein kinase CK2: a common denominator of diverse cancer cells?</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=499-504&issue=3&author=M.+Ruzzeneauthor=L.+A.+Pinna&title=Addiction+to+protein+kinase+CK2%3A+a+common+denominator+of+diverse+cancer+cells%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DAddiction%2520to%2520protein%2520kinase%2520CK2%253A%2520a%2520common%2520denominator%2520of%2520diverse%2520cancer%2520cells%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26issue%3D3%26spage%3D499%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solimini, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">Principles of cancer therapy: oncogene and non-oncogene addiction</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1016%2Fj.cell.2009.02.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19269363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=823-837&issue=5&author=J.+Luoauthor=N.+L.+Soliminiauthor=S.+J.+Elledge&title=Principles+of+cancer+therapy%3A+oncogene+and+non-oncogene+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of cancer therapy: oncogene and non-oncogene addiction</span></div><div class="casAuthors">Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">823-837</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Cancer is a complex collection of distinct genetic diseases united by common hallmarks.  Here, we expand upon the classic hallmarks to include the stress phenotypes of tumorigenesis.  We describe a conceptual framework of how oncogene and non-oncogene addictions contribute to these hallmarks and how they can be exploited through stress sensitization and stress overload to selectively kill cancer cells.  In particular, we present evidence for a large class of non-oncogenes that are essential for cancer cell survival and present attractive drug targets.  Finally, we discuss the path ahead to therapeutic discovery and provide theor. considerations for combining orthogonal cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrH3NH_D9W6LVg90H21EOLACvtfcHk0li5J8ZC1hoI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSnsLw%253D&md5=dfbc7a874dcad44f8af947083dab8c33</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DSolimini%26aufirst%3DN.%2BL.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DPrinciples%2520of%2520cancer%2520therapy%253A%2520oncogene%2520and%2520non-oncogene%2520addiction%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D5%26spage%3D823%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Slaton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloper, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=15634760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotVOq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=712-721&issue=12&author=J.+W.+Slatonauthor=G.+M.+Ungerauthor=D.+T.+Sloperauthor=A.+T.+Davisauthor=K.+Ahmed&title=Induction+of+apoptosis+by+antisense+CK2+in+human+prostate+cancer+xenograft+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Apoptosis by Antisense CK2 in Human Prostate Cancer Xenograft Model</span></div><div class="casAuthors">Slaton, Joel W.; Unger, Gretchen M.; Sloper, Daniel T.; Davis, Alan T.; Ahmed, Khalil</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">712-721</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Protein serine/threonine kinase CK2 (formerly casein kinase 2) is a ubiquitous protein kinase that plays key roles in cell growth, proliferation, and survival.  We have shown previously that its mol. down-regulation induces apoptosis in cancer cells in culture.  Here, we have employed a xenograft model of prostate cancer to extend these studies to det. whether antisense CK2α evokes a similar response in vivo.  A single dose of antisense CK2α oligodeoxynucleotide given directly into the PC3-LN4 xenograft tumor in nude mouse induced a dose- and time-dependent tumor cell death in vivo.  The tumor was completely resolved at the higher tested dose of the antisense.  Cell death was due to apoptosis and correlated with a potent down-regulation of the CK2α message and loss of CK2 from the nuclear matrix in the xenograft tissue as well as in cancer cells in culture.  These observations accorded with several of the earlier studies indicating that loss of CK2 from the nuclear matrix is assocd. with induction of apoptosis.  Comparison of the effects of antisense CK2α oligodeoxynucleotide on cancer vs. normal or noncancer cells showed that the concn. of antisense CK2α that elicited extensive apoptosis in tumor cells in culture or xenograft tumors in vivo had a relatively small or minimal effect on noncancer cells in culture or on normal prostate gland subjected to orthotropic injection of antisense oligodeoxynucleotide in vivo.  The basis for the difference in sensitivity of cancer vs. noncancer cells to antisense CK2α is unknown at this time; however, this differential response under similar conditions of treatment may be significant in considering the potential feasibility of targeting the CK2 signal for induction of apoptosis in cancer cells in vivo.  Although much further work will be needed to establish the feasibility of targeting CK2 for cancer therapy, to our knowledge, this is the first report to provide important new evidence as an initial "proof of principle" for the potential application of antisense CK2α in cancer therapy, paving the way for future detailed studies of approaches to targeting CK2 in vivo to induce cancer cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR4RbEBGDZ67Vg90H21EOLACvtfcHk0livk1GGZlfxSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotVOq&md5=e98d44f29959efc3df971da3ef9bc272</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlaton%26aufirst%3DJ.%2BW.%26aulast%3DUnger%26aufirst%3DG.%2BM.%26aulast%3DSloper%26aufirst%3DD.%2BT.%26aulast%3DDavis%26aufirst%3DA.%2BT.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DInduction%2520of%2520apoptosis%2520by%2520antisense%2520CK2%2520in%2520human%2520prostate%2520cancer%2520xenograft%2520model%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2004%26volume%3D2%26issue%3D12%26spage%3D712%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Trembley, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kren, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, K.</span><span> </span><span class="NLM_article-title">Emergence of protein kinase CK2 as a key target in cancer therapy</span> <span class="citation_source-journal">Biofactors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2010&pages=187-195&issue=3&author=J.+H.+Trembleyauthor=Z.+Chenauthor=G.+Ungerauthor=J.+Slatonauthor=B.+T.+Krenauthor=C.+Van+Waesauthor=K.+Ahmed&title=Emergence+of+protein+kinase+CK2+as+a+key+target+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrembley%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DUnger%26aufirst%3DG.%26aulast%3DSlaton%26aufirst%3DJ.%26aulast%3DKren%26aufirst%3DB.%2BT.%26aulast%3DVan%2BWaes%26aufirst%3DC.%26aulast%3DAhmed%26aufirst%3DK.%26atitle%3DEmergence%2520of%2520protein%2520kinase%2520CK2%2520as%2520a%2520key%2520target%2520in%2520cancer%2520therapy%26jtitle%3DBiofactors%26date%3D2010%26volume%3D36%26issue%3D3%26spage%3D187%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzeszko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">The selectivity of inhibitors of protein kinase CK2. An update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2008&pages=353-365&issue=3&author=M.+A.+Paganoauthor=J.+Bainauthor=Z.+Kazimierczukauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=G.+Di+Mairaauthor=M.+Elliottauthor=A.+Orzeszkoauthor=G.+Cozzaauthor=F.+Meggioauthor=L.+A.+Pinna&title=The+selectivity+of+inhibitors+of+protein+kinase+CK2.+An+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520selectivity%2520of%2520inhibitors%2520of%2520protein%2520kinase%2520CK2.%2520An%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D415%26issue%3D3%26spage%3D353%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Moliner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-<i>a</i>)quinazolin-7-yl]acetic acid (IQA)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=639-646&issue=3&author=S.+Sarnoauthor=E.+de+Molinerauthor=M.+Ruzzeneauthor=M.+A.+Paganoauthor=R.+Battistuttaauthor=J.+Bainauthor=D.+Fabbroauthor=J.+Schoepferauthor=M.+Elliottauthor=P.+Furetauthor=F.+Meggioauthor=G.+Zanottiauthor=L.+A.+Pinna&title=Biochemical+and+three-dimensional-structural+study+of+the+specific+inhibition+of+protein+kinase+CK2+by+%5B5-oxo-5%2C6-dihydroindolo-%281%2C2-a%29quinazolin-7-yl%5Dacetic+acid+%28IQA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3Dde%2BMoliner%26aufirst%3DE.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DBiochemical%2520and%2520three-dimensional-structural%2520study%2520of%2520the%2520specific%2520inhibition%2520of%2520protein%2520kinase%2520CK2%2520by%2520%255B5-oxo-5%252C6-dihydroindolo-%25281%252C2-a%2529quinazolin-7-yl%255Dacetic%2520acid%2520%2528IQA%2529%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D374%26issue%3D3%26spage%3D639%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lopez-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moucadel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouawad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=3171-3185&author=M.+Lopez-Ramosauthor=R.+Prudentauthor=V.+Moucadelauthor=C.+F.+Sautelauthor=C.+Baretteauthor=L.+Lafanechereauthor=L.+Mouawadauthor=D.+Griersonauthor=F.+Schmidtauthor=J.+C.+Florentauthor=P.+Filippakopoulosauthor=A.+N.+Bullockauthor=S.+Knappauthor=J.+B.+Reiserauthor=C.+Cochet&title=New+potent+dual+inhibitors+of+CK2+and+Pim+kinases%3A+discovery+and+structural+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Ramos%26aufirst%3DM.%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DSautel%26aufirst%3DC.%2BF.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DMouawad%26aufirst%3DL.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DFlorent%26aufirst%3DJ.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DReiser%26aufirst%3DJ.%2BB.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNew%2520potent%2520dual%2520inhibitors%2520of%2520CK2%2520and%2520Pim%2520kinases%253A%2520discovery%2520and%2520structural%2520insights%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D3171%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Sandholt, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Resorufin: a lead for a new protein kinase CK2 inhibitor</span> <span class="citation_source-journal">Anticancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=238-248&issue=4&author=I.+S.+Sandholtauthor=B.+B.+Olsenauthor=B.+Guerraauthor=O.+G.+Issinger&title=Resorufin%3A+a+lead+for+a+new+protein+kinase+CK2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandholt%26aufirst%3DI.%2BS.%26aulast%3DOlsen%26aufirst%3DB.%2BB.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DResorufin%253A%2520a%2520lead%2520for%2520a%2520new%2520protein%2520kinase%2520CK2%2520inhibitor%26jtitle%3DAnticancer%2520Drugs%26date%3D2009%26volume%3D20%26issue%3D4%26spage%3D238%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nakaniwa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span> </span><span class="NLM_article-title">Structure of human protein kinase CK2alpha2 with a potent indazole-derivative inhibitor</span> <span class="citation_source-journal">Acta Crystallogr., Sect F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1107%2FS1744309108043194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19193990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=75-79&issue=2&author=T.+Nakaniwaauthor=T.+Kinoshitaauthor=Y.+Sekiguchiauthor=T.+Tadaauthor=I.+Nakanishiauthor=K.+Kitauraauthor=Y.+Suzukiauthor=H.+Ohnoauthor=A.+Hirasawaauthor=G.+Tsujimoto&title=Structure+of+human+protein+kinase+CK2alpha2+with+a+potent+indazole-derivative+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human protein kinase CK2α2 with a potent indazole-derivative inhibitor</span></div><div class="casAuthors">Nakaniwa, Tetsuko; Kinoshita, Takayoshi; Sekiguchi, Yusuke; Tada, Toshiji; Nakanishi, Isao; Kitaura, Kazuo; Suzuki, Yamato; Ohno, Hiroaki; Hirasawa, Akira; Tsujimoto, Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-79</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Casein kinase 2 (CK2) is a serine/threonine kinase that functions as a heterotetramer composed of two catalytic subunits (CK2α1 or CK2α2) and two regulatory subunits (CK2β).  The two isoenzymes CK2α1 and CK2α2 play distinguishable roles in healthy subjects and in patients with diseases such as cancer, resp.  In order to develop novel CK2α1-selective inhibitors, the crystal structure of human CK2α2 (hCK2α2) complexed with a potent CK2α inhibitor which binds to the active site of hCK2α2 was detd. and compared with that of human CK2α1.  While the two isoenzymes exhibited a high similarity with regard to the active site, the largest structural difference between the isoforms occurred in the β4-β5 loop responsible for the CK2α-CK2β interface.  The top of the N-terminal segment interacted with the β4-β5 loop via a hydrogen bond in hCK2α2 but not in hCK2α1.  Thus, the CK2α-CK2β interface is a likely target candidate for the prodn. of selective CK2α1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfg1zyw6VxVbVg90H21EOLACvtfcHk0lg-MFiF0SmO-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCktrY%253D&md5=4dffcee1b2fb45186f77ef5e0c13cc99</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS1744309108043194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309108043194%26sid%3Dliteratum%253Aachs%26aulast%3DNakaniwa%26aufirst%3DT.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DSekiguchi%26aufirst%3DY.%26aulast%3DTada%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DI.%26aulast%3DKitaura%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DStructure%2520of%2520human%2520protein%2520kinase%2520CK2alpha2%2520with%2520a%2520potent%2520indazole-derivative%2520inhibitor%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2009%26volume%3D65%26issue%3D2%26spage%3D75%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Najda-Bernatowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzeszko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopanska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzywinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muszynska, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span> </span><span class="NLM_article-title">Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide-potential inhibitors of human protein kinase CK2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1573</span><span class="NLM_x">–</span> <span class="NLM_lpage">1578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=1573-1578&issue=4&author=A.+Najda-Bernatowiczauthor=M.+Lebskaauthor=A.+Orzeszkoauthor=K.+Kopanskaauthor=E.+Krzywinskaauthor=G.+Muszynskaauthor=M.+Bretner&title=Synthesis+of+new+analogs+of+benzotriazole%2C+benzimidazole+and+phthalimide-potential+inhibitors+of+human+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNajda-Bernatowicz%26aufirst%3DA.%26aulast%3DLebska%26aufirst%3DM.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DKopanska%26aufirst%3DK.%26aulast%3DKrzywinska%26aufirst%3DE.%26aulast%3DMuszynska%26aufirst%3DG.%26aulast%3DBretner%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520new%2520analogs%2520of%2520benzotriazole%252C%2520benzimidazole%2520and%2520phthalimide-potential%2520inhibitors%2520of%2520human%2520protein%2520kinase%2520CK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D4%26spage%3D1573%26epage%3D1578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hung, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablons, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, L.</span><span> </span><span class="NLM_article-title">Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=135&issue=1&author=M.+S.+Hungauthor=Z.+Xuauthor=Y.+C.+Linauthor=J.+H.+Maoauthor=C.+T.+Yangauthor=P.+J.+Changauthor=D.+M.+Jablonsauthor=L.+You&title=Identification+of+hematein+as+a+novel+inhibitor+of+protein+kinase+CK2+from+a+natural+product+library"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DM.%2BS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DMao%26aufirst%3DJ.%2BH.%26aulast%3DYang%26aufirst%3DC.%2BT.%26aulast%3DChang%26aufirst%3DP.%2BJ.%26aulast%3DJablons%26aufirst%3DD.%2BM.%26aulast%3DYou%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520hematein%2520as%2520a%2520novel%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%2520from%2520a%2520natural%2520product%2520library%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Gianoncelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orzeszko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">7281</span><span class="NLM_x">–</span> <span class="NLM_lpage">7289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7281-7289&issue=20&author=A.+Gianoncelliauthor=G.+Cozzaauthor=A.+Orzeszkoauthor=F.+Meggioauthor=Z.+Kazimierczukauthor=L.+A.+Pinna&title=Tetraiodobenzimidazoles+are+potent+inhibitors+of+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DTetraiodobenzimidazoles%2520are%2520potent%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D20%26spage%3D7281%26epage%3D7289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papinutto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianoncelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagotto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Quinalizarin as a potent, selective and cell permeable inhibitor of protein kinase CK2</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=387-395&issue=3&author=G.+Cozzaauthor=M.+Mazzoranaauthor=E.+Papinuttoauthor=J.+Bainauthor=M.+Elliottauthor=G.+Di+Mairaauthor=A.+Gianoncelliauthor=M.+A.+Paganoauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=R.+Battistuttaauthor=F.+Meggioauthor=S.+Moroauthor=G.+Zagottoauthor=L.+A.+Pinna&title=Quinalizarin+as+a+potent%2C+selective+and+cell+permeable+inhibitor+of+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPapinutto%26aufirst%3DE.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DGianoncelli%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DQuinalizarin%2520as%2520a%2520potent%252C%2520selective%2520and%2520cell%2520permeable%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26issue%3D3%26spage%3D387%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines</span> <span class="citation_source-journal">Arch. Pharm. (Weinheim, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1002%2Fardp.200700269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=18763715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2008&pages=554-561&issue=9&author=Y.+Suzukiauthor=J.+Cluzeauauthor=T.+Haraauthor=A.+Hirasawaauthor=G.+Tsujimotoauthor=S.+Oishiauthor=H.+Ohnoauthor=N.+Fujii&title=Structure%E2%88%92activity+relationships+of+pyrazine-based+CK2+inhibitors%3A+synthesis+and+evaluation+of+2%2C6-disubstituted+pyrazines+and+4%2C6-disubstituted+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines</span></div><div class="casAuthors">Suzuki, Yamato; Cluzeau, Jerome; Hara, Takafumi; Hirasawa, Akira; Tsujimoto, Gozoh; Oishi, Shinya; Ohno, Hiroaki; Fujii, Nobutaka</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">554-561</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Structually related to the known CK2 inhibitors, 2,6-disubstituted pyrazine and 4,6-disubstituted pyrimidine derivs. were synthesized and their inhibitory activities toward CK2α and CK2α' were evaluated.  Structure-activity relationship study has revealed that several pyrazine derivs. bearing a (pyrrol-3-yl)acetic acid and a monosubstituted aniline possess potent inhibitory activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY4qRwDY7y2rVg90H21EOLACvtfcHk0ljWXXqji2O3sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2jtb%252FK&md5=c1a1a1ca84ff4172b58ef88d9365e58b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fardp.200700269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200700269%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DCluzeau%26aufirst%3DJ.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520pyrazine-based%2520CK2%2520inhibitors%253A%2520synthesis%2520and%2520evaluation%2520of%25202%252C6-disubstituted%2520pyrazines%2520and%25204%252C6-disubstituted%2520pyrimidines%26jtitle%3DArch.%2520Pharm.%2520%2528Weinheim%252C%2520Ger.%2529%26date%3D2008%26volume%3D341%26issue%3D9%26spage%3D554%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Ramos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moucadel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grierson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouawad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florent, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafanechere, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">Salicylaldehyde derivatives as new protein kinase CK2 inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1780</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1412</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1780&publication_year=2008&pages=1412-1420&issue=12&author=R.+Prudentauthor=M.+Lopez-Ramosauthor=V.+Moucadelauthor=C.+Baretteauthor=D.+Griersonauthor=L.+Mouawadauthor=J.+C.+Florentauthor=L.+Lafanechereauthor=F.+Schmidtauthor=C.+Cochet&title=Salicylaldehyde+derivatives+as+new+protein+kinase+CK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DLopez-Ramos%26aufirst%3DM.%26aulast%3DMoucadel%26aufirst%3DV.%26aulast%3DBarette%26aufirst%3DC.%26aulast%3DGrierson%26aufirst%3DD.%26aulast%3DMouawad%26aufirst%3DL.%26aulast%3DFlorent%26aufirst%3DJ.%2BC.%26aulast%3DLafanechere%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DSalicylaldehyde%2520derivatives%2520as%2520new%2520protein%2520kinase%2520CK2%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1780%26issue%3D12%26spage%3D1412%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span> </span><span class="NLM_article-title">How druggable is protein kinase CK2?</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1002%2Fmed.20164" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=419-462&issue=3&author=G.+Cozzaauthor=A.+Bortolatoauthor=S.+Moro&title=How+druggable+is+protein+kinase+CK2%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fmed.20164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20164%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DMoro%26aufirst%3DS.%26atitle%3DHow%2520druggable%2520is%2520protein%2520kinase%2520CK2%253F%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D30%26issue%3D3%26spage%3D419%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frascella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucchini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Development and exploitation of CK2 inhibitors</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2005&pages=69-76&issue=1%E2%88%922&author=S.+Sarnoauthor=M.+Ruzzeneauthor=P.+Frascellaauthor=M.+A.+Paganoauthor=F.+Meggioauthor=A.+Zambonauthor=M.+Mazzoranaauthor=G.+Di+Mairaauthor=V.+Lucchiniauthor=L.+A.+Pinna&title=Development+and+exploitation+of+CK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DFrascella%26aufirst%3DP.%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DZambon%26aufirst%3DA.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DLucchini%26aufirst%3DV.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DDevelopment%2520and%2520exploitation%2520of%2520CK2%2520inhibitors%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D274%26issue%3D1%25E2%2588%25922%26spage%3D69%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zandomeni, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandomeni, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shugar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinmann, R.</span><span> </span><span class="NLM_article-title">Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-<span class="smallcaps smallerCapital">d</span>-ribofuranosylbenzimidazole of specific RNA polymerase II transcription</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">3414</span><span class="NLM_x">–</span> <span class="NLM_lpage">3419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=3414-3419&author=R.+Z.+Zandomeniauthor=M.+C.+Zandomeniauthor=D.+Shugarauthor=R.+Weinmann&title=Casein+kinase+type+II+is+involved+in+the+inhibition+by+5%2C6-dichloro-1-beta-d-ribofuranosylbenzimidazole+of+specific+RNA+polymerase+II+transcription"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZandomeni%26aufirst%3DR.%2BZ.%26aulast%3DZandomeni%26aufirst%3DM.%2BC.%26aulast%3DShugar%26aufirst%3DD.%26aulast%3DWeinmann%26aufirst%3DR.%26atitle%3DCasein%2520kinase%2520type%2520II%2520is%2520involved%2520in%2520the%2520inhibition%2520by%25205%252C6-dichloro-1-beta-d-ribofuranosylbenzimidazole%2520of%2520specific%2520RNA%2520polymerase%2520II%2520transcription%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D3414%26epage%3D3419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Yim, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span> </span><span class="NLM_article-title">Emodin, an anthraquinone derivative isolated from the rhizomes of <i>Rheum palmatum</i>, selectively inhibits the activity of casein kinase II as a competitive inhibitor</span> <span class="citation_source-journal">Planta Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=9-13&author=H.+L.+Yimauthor=Y.+H.+Leeauthor=C.+H.+Leeauthor=S.+K.+Lee&title=Emodin%2C+an+anthraquinone+derivative+isolated+from+the+rhizomes+of+Rheum+palmatum%2C+selectively+inhibits+the+activity+of+casein+kinase+II+as+a+competitive+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYim%26aufirst%3DH.%2BL.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BK.%26atitle%3DEmodin%252C%2520an%2520anthraquinone%2520derivative%2520isolated%2520from%2520the%2520rhizomes%2520of%2520Rheum%2520palmatum%252C%2520selectively%2520inhibits%2520the%2520activity%2520of%2520casein%2520kinase%2520II%2520as%2520a%2520competitive%2520inhibitor%26jtitle%3DPlanta%2520Med.%26date%3D1999%26volume%3D65%26spage%3D9%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Pagano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrzejewska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">6239</span><span class="NLM_x">–</span> <span class="NLM_lpage">6247</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049854a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6239-6247&issue=25&author=M.+A.+Paganoauthor=M.+Andrzejewskaauthor=M.+Ruzzeneauthor=S.+Sarnoauthor=L.+Cesaroauthor=J.+Bainauthor=M.+Elliottauthor=F.+Meggioauthor=Z.+Kazimierczukauthor=L.+A.+Pinna&title=Optimization+of+protein+kinase+CK2+inhibitors+derived+from+4%2C5%2C6%2C7-tetrabromobenzimidazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm049854a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049854a%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DM.%2BA.%26aulast%3DAndrzejewska%26aufirst%3DM.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DCesaro%26aufirst%3DL.%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DMeggio%26aufirst%3DF.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DOptimization%2520of%2520protein%2520kinase%2520CK2%2520inhibitors%2520derived%2520from%25204%252C5%252C6%252C7-tetrabromobenzimidazole%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D25%26spage%3D6239%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2002&pages=41-47&issue=1&author=M.+Ruzzeneauthor=D.+Penzoauthor=L.+A.+Pinna&title=Protein+kinase+CK2+inhibitor+4%2C5%2C6%2C7-tetrabromobenzotriazole+%28TBB%29+induces+apoptosis+and+caspase-dependent+degradation+of+haematopoietic+lineage+cell-specific+protein+1+%28HS1%29+in+Jurkat+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DPenzo%26aufirst%3DD.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DProtein%2520kinase%2520CK2%2520inhibitor%25204%252C5%252C6%252C7-tetrabromobenzotriazole%2520%2528TBB%2529%2520induces%2520apoptosis%2520and%2520caspase-dependent%2520degradation%2520of%2520haematopoietic%2520lineage%2520cell-specific%2520protein%25201%2520%2528HS1%2529%2520in%2520Jurkat%2520cells%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D364%26issue%3D1%26spage%3D41%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zastapilo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szyszka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shugar, D.</span><span> </span><span class="NLM_article-title">Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=129-133&issue=1&author=P.+Zienauthor=M.+Bretnerauthor=K.+Zastapiloauthor=R.+Szyszkaauthor=D.+Shugar&title=Selectivity+of+4%2C5%2C6%2C7-tetrabromobenzimidazole+as+an+ATP-competitive+potent+inhibitor+of+protein+kinase+CK2+from+various+sources"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZien%26aufirst%3DP.%26aulast%3DBretner%26aufirst%3DM.%26aulast%3DZastapilo%26aufirst%3DK.%26aulast%3DSzyszka%26aufirst%3DR.%26aulast%3DShugar%26aufirst%3DD.%26atitle%3DSelectivity%2520of%25204%252C5%252C6%252C7-tetrabromobenzimidazole%2520as%2520an%2520ATP-competitive%2520potent%2520inhibitor%2520of%2520protein%2520kinase%2520CK2%2520from%2520various%2520sources%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D306%26issue%3D1%26spage%3D129%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">DePierre, J. W.</span>, <span> </span><span class="NLM_article-title">Mammalian Toxicity of Organic Compounds of Bromine and Iodine</span>. In  <span class="citation_source-book">Organic Bromine and Iodine Compounds</span>, <span class="NLM_contrib-group">Neilson, A. H.</span>, Ed.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin-Heidelberg-New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3R</span>, pp  <span class="NLM_fpage">221</span>− <span class="NLM_lpage">232</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1007%2F978-3-540-37055-0_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=221-232&author=J.+W.+DePierreauthor=A.+H.+Neilson&title=Organic+Bromine+and+Iodine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-37055-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-37055-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DDePierre%26aufirst%3DJ.%2BW.%26atitle%3DMammalian%2520Toxicity%2520of%2520Organic%2520Compounds%2520of%2520Bromine%2520and%2520Iodine%26btitle%3DOrganic%2520Bromine%2520and%2520Iodine%2520Compounds%26aulast%3DNeilson%26aufirst%3DA.%2BH.%26pub%3DSpringer-Verlag%26date%3D2003%26volume%3D3R%26spage%3D221%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Vangrevelinghe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2656</span><span class="NLM_x">–</span> <span class="NLM_lpage">2662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030827e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2656-2662&issue=13&author=E.+Vangrevelingheauthor=K.+Zimmermannauthor=J.+Schoepferauthor=R.+Portmannauthor=D.+Fabbroauthor=P.+Furet&title=Discovery+of+a+potent+and+selective+protein+kinase+CK2+inhibitor+by+high-throughput+docking"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm030827e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030827e%26sid%3Dliteratum%253Aachs%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DPortmann%26aufirst%3DR.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520protein%2520kinase%2520CK2%2520inhibitor%2520by%2520high-throughput%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D13%26spage%3D2656%26epage%3D2662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Nie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perretta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Averill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis, and study of pyrazolo[1,5-<i>a</i>][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4191</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4191-4195&issue=15&author=Z.+Nieauthor=C.+Perrettaauthor=P.+Ericksonauthor=S.+Margosiakauthor=R.+Almassyauthor=J.+Luauthor=A.+Averillauthor=K.+M.+Yagerauthor=S.+Chu&title=Structure-based+design%2C+synthesis%2C+and+study+of+pyrazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+derivatives+as+potent+inhibitors+of+protein+kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DZ.%26aulast%3DPerretta%26aufirst%3DC.%26aulast%3DErickson%26aufirst%3DP.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DAverill%26aufirst%3DA.%26aulast%3DYager%26aufirst%3DK.%2BM.%26aulast%3DChu%26aufirst%3DS.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520study%2520of%2520pyrazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D15%26spage%3D4191%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Nie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perretta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Averill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almassy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S.</span><span> </span><span class="NLM_article-title">Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-<i>a</i>] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=619-623&issue=2&author=Z.+Nieauthor=C.+Perrettaauthor=P.+Ericksonauthor=S.+Margosiakauthor=J.+Luauthor=A.+Averillauthor=R.+Almassyauthor=S.+Chu&title=Structure-based+design+and+synthesis+of+novel+macrocyclic+pyrazolo%5B1%2C5-a%5D+%5B1%2C3%2C5%5Dtriazine+compounds+as+potent+inhibitors+of+protein+kinase+CK2+and+their+anticancer+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNie%26aufirst%3DZ.%26aulast%3DPerretta%26aufirst%3DC.%26aulast%3DErickson%26aufirst%3DP.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DAverill%26aufirst%3DA.%26aulast%3DAlmassy%26aufirst%3DR.%26aulast%3DChu%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520novel%2520macrocyclic%2520pyrazolo%255B1%252C5-a%255D%2520%255B1%252C3%252C5%255Dtriazine%2520compounds%2520as%2520potent%2520inhibitors%2520of%2520protein%2520kinase%2520CK2%2520and%2520their%2520anticancer%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D2%26spage%3D619%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgraf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pornillos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyanat-Yazdi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span> </span><span class="NLM_article-title">Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2009&pages=159-167&issue=1%E2%88%922&author=D.+Zhuauthor=J.+Henselauthor=R.+Hilgrafauthor=M.+Abbasianauthor=O.+Pornillosauthor=G.+Deyanat-Yazdiauthor=X.+H.+Huaauthor=S.+Cox&title=Inhibition+of+protein+kinase+CK2+expression+and+activity+blocks+tumor+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DHensel%26aufirst%3DJ.%26aulast%3DHilgraf%26aufirst%3DR.%26aulast%3DAbbasian%26aufirst%3DM.%26aulast%3DPornillos%26aufirst%3DO.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DHua%26aufirst%3DX.%2BH.%26aulast%3DCox%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520protein%2520kinase%2520CK2%2520expression%2520and%2520activity%2520blocks%2520tumor%2520cell%2520growth%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2009%26volume%3D333%26issue%3D1%25E2%2588%25922%26spage%3D159%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">New protein kinase CK2 inhibitors: jumping out of the catalytic box</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1016%2Fj.chembiol.2009.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19246001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFagtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=112-20&issue=2&author=R.+Prudentauthor=C.+Cochet&title=New+protein+kinase+CK2+inhibitors%3A+jumping+out+of+the+catalytic+box"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">New Protein Kinase CK2 Inhibitors: Jumping out of the Catalytic Box</span></div><div class="casAuthors">Prudent, Renaud; Cochet, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-120</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Protein kinases are central components of signal transduction cascades often dysregulated in cancer, and they represent some of the most promising drug targets.  However, the target selectivity is a major concern because most described kinase inhibitors target the highly conserved ATP-binding pocket.  Recently, new classes of inhibitors that do not compete with ATP and exhibit different mechanisms of action have been described.  Overexpression of protein kinase CK2 is an unfavorable prognostic marker in several cancers.  Consequently, CK2 has emerged as a relevant therapeutic target.  Several classes of ATP-competitive inhibitors have been identified, showing variable effectiveness.  The mol. architecture of this multisubunit enzyme could offer alternative strategies to inhibit CK2 functions, and this review illustrates these emerging possibilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhT6P1wNSadrVg90H21EOLACvtfcHk0lh68Oj2FfX_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFagtb4%253D&md5=06c71497d578a82b136893cde423b436</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DNew%2520protein%2520kinase%2520CK2%2520inhibitors%253A%2520jumping%2520out%2520of%2520the%2520catalytic%2520box%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26issue%3D2%26spage%3D112%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Prudent, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochet, C.</span><span> </span><span class="NLM_article-title">Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=493-498&author=R.+Prudentauthor=C.+Sautelauthor=C.+Cochet&title=Structure-based+discovery+of+small+molecules+targeting+different+surfaces+of+protein-kinase+CK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudent%26aufirst%3DR.%26aulast%3DSautel%26aufirst%3DC.%26aulast%3DCochet%26aufirst%3DC.%26atitle%3DStructure-based%2520discovery%2520of%2520small%2520molecules%2520targeting%2520different%2520surfaces%2520of%2520protein-kinase%2520CK2%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D3%26spage%3D493%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Hodgetts, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershaw, M. T.</span><span> </span><span class="NLM_article-title">Synthesis of 2-aryl-oxazolo[4,5-<i>c</i>]quinoline-4(5<i>H</i>)-ones and 2-aryl-thiazolo[4,5-<i>c</i>]quinoline-4(5<i>H</i>)-ones</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2911</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0350285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2911-2914&issue=16&author=K.+J.+Hodgettsauthor=M.+T.+Kershaw&title=Synthesis+of+2-aryl-oxazolo%5B4%2C5-c%5Dquinoline-4%285H%29-ones+and+2-aryl-thiazolo%5B4%2C5-c%5Dquinoline-4%285H%29-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol0350285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0350285%26sid%3Dliteratum%253Aachs%26aulast%3DHodgetts%26aufirst%3DK.%2BJ.%26aulast%3DKershaw%26aufirst%3DM.%2BT.%26atitle%3DSynthesis%2520of%25202-aryl-oxazolo%255B4%252C5-c%255Dquinoline-4%25285H%2529-ones%2520and%25202-aryl-thiazolo%255B4%252C5-c%255Dquinoline-4%25285H%2529-ones%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26issue%3D16%26spage%3D2911%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Alessi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larkin, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snieckus, V.</span><span> </span><span class="NLM_article-title">Directed ortho metalation-boronation and Suzuki−Miyaura cross coupling of pyridine derivatives: a one-pot protocol to substituted azabiaryls</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0620359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=1588-1594&issue=5&author=M.+Alessiauthor=A.+L.+Larkinauthor=K.+A.+Ogilvieauthor=L.+A.+Greenauthor=S.+Laiauthor=S.+Lopezauthor=V.+Snieckus&title=Directed+ortho+metalation-boronation+and+Suzuki%E2%88%92Miyaura+cross+coupling+of+pyridine+derivatives%3A+a+one-pot+protocol+to+substituted+azabiaryls"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo0620359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0620359%26sid%3Dliteratum%253Aachs%26aulast%3DAlessi%26aufirst%3DM.%26aulast%3DLarkin%26aufirst%3DA.%2BL.%26aulast%3DOgilvie%26aufirst%3DK.%2BA.%26aulast%3DGreen%26aufirst%3DL.%2BA.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DLopez%26aufirst%3DS.%26aulast%3DSnieckus%26aufirst%3DV.%26atitle%3DDirected%2520ortho%2520metalation-boronation%2520and%2520Suzuki%25E2%2588%2592Miyaura%2520cross%2520coupling%2520of%2520pyridine%2520derivatives%253A%2520a%2520one-pot%2520protocol%2520to%2520substituted%2520azabiaryls%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D5%26spage%3D1588%26epage%3D1594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Rodgers, J.; Robinson, D.; Arvanitis, A.; Masduskuie, T.; Shepard, S.; Storace, L.; Wang, H.; Rafalski, M.; Jalluri, R.; Combs, A.; Crawley, M.</span>, <span> </span><span class="NLM_article-title">Tetracylclic Inhibitors of Janus Kinases</span>. PCT patent application WO2005/105814, <span class="NLM_day">10</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=J.+Rodgers&author=D.+Robinson&author=A.+Arvanitis&author=T.+Masduskuie&author=S.+Shepard&author=L.+Storace&author=H.+Wang&author=M.+Rafalski&author=R.+Jalluri&author=A.+Combs&author=M.+Crawley&title=Tetracylclic+Inhibitors+of+Janus+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DJ.%26atitle%3DTetracylclic%2520Inhibitors%2520of%2520Janus%2520Kinases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Jagtap, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, C.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=421-440&issue=5&author=P.+Jagtapauthor=C.+Szabo&title=Poly%28ADP-ribose%29+polymerase+and+the+therapeutic+effects+of+its+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DSzabo%26aufirst%3DC.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase%2520and%2520the%2520therapeutic%2520effects%2520of%2520its%2520inhibitors%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26issue%3D5%26spage%3D421%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Cepeda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuertesa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonsoa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quevedob, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotoa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, J.</span><span> </span><span class="NLM_article-title">Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=39-55&author=V.+Cepedaauthor=M.+Fuertesaauthor=J.+Castillacauthor=C.+Alonsoaauthor=C.+Quevedobauthor=M.+Sotoaauthor=J.+P%C3%A9rez&title=Poly%28ADP-Ribose%29+Polymerase-1+%28PARP-1%29+Inhibitors+in+Cancer+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCepeda%26aufirst%3DV.%26aulast%3DFuertesa%26aufirst%3DM.%26aulast%3DCastillac%26aufirst%3DJ.%26aulast%3DAlonsoa%26aufirst%3DC.%26aulast%3DQuevedob%26aufirst%3DC.%26aulast%3DSotoa%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez%26aufirst%3DJ.%26atitle%3DPoly%2528ADP-Ribose%2529%2520Polymerase-1%2520%2528PARP-1%2529%2520Inhibitors%2520in%2520Cancer%2520Chemotherapy%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D39%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Niefind, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermakowa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5320</span><span class="NLM_x">–</span> <span class="NLM_lpage">5331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5320-5331&issue=19&author=K.+Niefindauthor=B.+Guerraauthor=I.+Ermakowaauthor=O.+G.+Issinger&title=Crystal+structure+of+human+protein+kinase+CK2%3A+insights+into+basic+properties+of+the+CK2+holoenzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DGuerra%26aufirst%3DB.%26aulast%3DErmakowa%26aufirst%3DI.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DCrystal%2520structure%2520of%2520human%2520protein%2520kinase%2520CK2%253A%2520insights%2520into%2520basic%2520properties%2520of%2520the%2520CK2%2520holoenzyme%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26issue%3D19%26spage%3D5320%26epage%3D5331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistutta, R.</span><span> </span><span class="NLM_article-title">A structural insight into CK2 inhibition</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">1−2</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2008&pages=57-62&issue=1%E2%88%922&author=M.+Mazzoranaauthor=L.+A.+Pinnaauthor=R.+Battistutta&title=A+structural+insight+into+CK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DA%2520structural%2520insight%2520into%2520CK2%2520inhibition%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D316%26issue%3D1%25E2%2588%25922%26spage%3D57%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Battistutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzorana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazimierczuk, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">The ATP-Binding Site of Protein Kinase CK2 Holds a Positive Electrostatic Area and Conserved Water Molecules</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1804</span><span class="NLM_x">–</span> <span class="NLM_lpage">1809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1804-1809&issue=15&author=R.+Battistuttaauthor=M.+Mazzoranaauthor=L.+Cendronauthor=A.+Bortolatoauthor=S.+Sarnoauthor=Z.+Kazimierczukauthor=G.+Zanottiauthor=S.+Moroauthor=L.+A.+Pinna&title=The+ATP-Binding+Site+of+Protein+Kinase+CK2+Holds+a+Positive+Electrostatic+Area+and+Conserved+Water+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26aulast%3DMazzorana%26aufirst%3DM.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DThe%2520ATP-Binding%2520Site%2520of%2520Protein%2520Kinase%2520CK2%2520Holds%2520a%2520Positive%2520Electrostatic%2520Area%2520and%2520Conserved%2520Water%2520Molecules%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26issue%3D15%26spage%3D1804%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Niefind, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issinger, O. G.</span><span> </span><span class="NLM_article-title">Protein kinase CK2: From structures to insights</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">11−12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1007%2Fs00018-009-9149-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19387553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1800-1816&issue=11%E2%88%9212&author=K.+Niefindauthor=J.+Raafauthor=O.+G.+Issinger&title=Protein+kinase+CK2%3A+From+structures+to+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2: From structures to insights</span></div><div class="casAuthors">Niefind, K.; Raaf, J.; Issinger, O.-G.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1800-1816</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Within the last decade, 40 crystal structures corresponding to protein kinase CK2 (former name 'casein kinase 2'), to its catalytic subunit CK2α, and to its regulatory subunit CK2β, were published.  Together they provide a valuable, yet by far not complete basis to rationalize the biochem. features of the enzyme, such as its constitutive activity, acidophilic substrate specificity, dual-cosubstrate specificity, and its heterotetrameric quaternary structure.  Comprehensive sets of structural superimpositions reveal that both CK2α and CK2β are relatively rigid mols.  In CK2β the crit. region of CK2α recruitment is pre-formed in the unbound state.  In CK2α the activation segment, a key element of protein kinase regulation, adapts invariably the typical conformation of the active enzymes.  Recent structures of human CK2α have revealed a surprising plasticity in the ATP-binding region, suggesting an alternative mode of activity control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5HGNXeL_wnbVg90H21EOLACvtfcHk0liQ-jyhVmxAsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs78%253D&md5=b34be6e4939fd050c6b4abea24dc5dcf</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9149-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9149-8%26sid%3Dliteratum%253Aachs%26aulast%3DNiefind%26aufirst%3DK.%26aulast%3DRaaf%26aufirst%3DJ.%26aulast%3DIssinger%26aufirst%3DO.%2BG.%26atitle%3DProtein%2520kinase%2520CK2%253A%2520From%2520structures%2520to%2520insights%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26issue%3D11%25E2%2588%259212%26spage%3D1800%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Battistutta, R.</span><span> </span><span class="NLM_article-title">Structural bases of protein kinase CK2 inhibition</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">11−12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1868</span><span class="NLM_x">–</span> <span class="NLM_lpage">1889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1007%2Fs00018-009-9155-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=19387547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=1868-1889&issue=11%E2%88%9212&author=R.+Battistutta&title=Structural+bases+of+protein+kinase+CK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases of protein kinase CK2 inhibition</span></div><div class="casAuthors">Battistutta, R.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1868-1889</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Protein kinase CK2 is involved in many fundamental aspects of normal cell life, but it is also able to establish favorable conditions for tumorigenesis.  CK2 is elevated in various cancers, it is a potent suppressor of apoptosis, it strongly promotes cell survival, it strengthens the multi-drug resistant phenotype, and can be considered a valuable drug target for cancer therapy.  Here, the structural bases of CK2 inhibition deduced from the anal. of crystal structures of CK2α-inhibitor complexes are presented and discussed.  The best ATP-competitive inhibitors show an adequate hydrophobic character, an excellent shape complementarity with the unique active site of CK2, and the ability to establish polar interactions with both the hinge region and the pos. electrostatic area near the conserved water W1 and the Lys-68-Glu-81 salt bridge.  The state of the art of non-ATP-competitive inhibitors is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2bH__CP4zI7Vg90H21EOLACvtfcHk0liQ-jyhVmxAsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsVGjs7k%253D&md5=ec7844e7e74b8c51e4f3bd13487e4002</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-9155-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-9155-x%26sid%3Dliteratum%253Aachs%26aulast%3DBattistutta%26aufirst%3DR.%26atitle%3DStructural%2520bases%2520of%2520protein%2520kinase%2520CK2%2520inhibition%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2009%26volume%3D66%26issue%3D11%25E2%2588%259212%26spage%3D1868%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Siddiqui-Jain, A.; Drygin, D.; Streiner, N.; Chua, P.; Pierre, F.; O’Brien, S.; Bliesath, J.; Omori, M.; Huser, N.; Ho, C.; Proffitt, C.; Schwaebe, M.; Ryckman, D.; Rice, W. G.; Anderes, K.</span><span> </span><span class="NLM_article-title">CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy</span>.  <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span>),  <span class="NLM_fpage">10288</span>− <span class="NLM_lpage">10298</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10288-10298&issue=24&author=A.+Siddiqui-Jain&author=D.+Drygin&author=N.+Streiner&author=P.+Chua&author=F.+Pierre&author=S.+O%E2%80%99Brien&author=J.+Bliesath&author=M.+Omori&author=N.+Huser&author=C.+Ho&author=C.+Proffitt&author=M.+Schwaebe&author=D.+Ryckman&author=W.+G.+Rice&author=K.+Anderes&title=CX-4945%2C+an+Orally+Bioavailable+Selective+Inhibitor+of+Protein+Kinase+CK2%2C+Inhibits+Prosurvival+and+Angiogenic+Signaling+and+Exhibits+Antitumor+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui-Jain%26aufirst%3DA.%26atitle%3DCX-4945%252C%2520an%2520Orally%2520Bioavailable%2520Selective%2520Inhibitor%2520of%2520Protein%2520Kinase%2520CK2%252C%2520Inhibits%2520Prosurvival%2520and%2520Angiogenic%2520Signaling%2520and%2520Exhibits%2520Antitumor%2520Efficacy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D24%26spage%3D10288%26epage%3D10298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Di Maira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustolon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span> </span><span class="NLM_article-title">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm101251q&amp;key=10.1038%2Fsj.cdd.4401604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm101251q&amp;key=15818404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm101251q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=668-677&issue=6&author=G.+Di+Mairaauthor=M.+Salviauthor=G.+Arrigoniauthor=O.+Marinauthor=S.+Sarnoauthor=F.+Brustolonauthor=L.+A.+Pinnaauthor=M.+Ruzzene&title=Protein+kinase+CK2+phosphorylates+and+upregulates+Akt%2FPKB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase CK2 phosphorylates and upregulates Akt/PKB</span></div><div class="casAuthors">Di Maira, G.; Salvi, M.; Arrigoni, G.; Marin, O.; Sarno, S.; Brustolon, F.; Pinna, L. A.; Ruzzene, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">668-677</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment of Jurkat cells with specific inhibitors of protein kinase CK2 induces apoptosis.  Here we provide evidence that the antiapoptotic effect of CK2 can be at least partially mediated by upregulation of the Akt/PKB pathway.  Such a conclusion is based on the following observations: (1) inhibition of CK2 by cell treatment with two structurally unrelated CK2 inhibitors induces downregulation of Akt/PKB, as judged from decreased phosphorylation of its physiol. targets, and immunoppt. kinase assay; (2) similar results are obsd. upon redn. of CK2 catalytic subunit by the RNA-interference technique; (3) Akt/PKB Ser129 is phosphorylated by CK2 in vitro and in vivo; (4) such a phosphorylation of activated Akt/PKB correlates with a further increase in catalytic activity.  These data disclose an unanticipated mechanism by which constitutive phosphorylation by CK2 may be required for maximal activation of Akt/PKB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEFAKQPYl_7Vg90H21EOLACvtfcHk0liQ-jyhVmxAsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Smu74%253D&md5=04f583a966bd2ed26f315a2395370db9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401604%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMaira%26aufirst%3DG.%26aulast%3DSalvi%26aufirst%3DM.%26aulast%3DArrigoni%26aufirst%3DG.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DBrustolon%26aufirst%3DF.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DRuzzene%26aufirst%3DM.%26atitle%3DProtein%2520kinase%2520CK2%2520phosphorylates%2520and%2520upregulates%2520Akt%252FPKB%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2005%26volume%3D12%26issue%3D6%26spage%3D668%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><div class="note"><p class="first last">Tested at MicroConstants, San Diego, CA</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tested+at+MicroConstants%2C+San+Diego%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><div class="note"><p class="first last">Tested at CEREP, Seattle, WA</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tested+at+CEREP%2C+Seattle%2C+WA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Lim, J. K.; Padgett, C. S.; Marschke, R. F.; Northfelt, D. W.; Andreopoulou, E.; Von Hoff, D. D.; Anderes, K.; Chen, T. K.; O’Brien, S.</span>, <span> </span><span class="NLM_article-title">Utility of Clinical Biomarkers for Detecting Protein Kinase CK2 Inhibition: A Report from the Phase I Trial of CX-4945</span>. <span class="NLM_conf-name">AACR 101st Annual Meeting</span>, <span class="NLM_conf-loc">Washington, DC</span>, <span class="NLM_conf-date">April 17−21, 2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lim%2C+J.+K.%3B+Padgett%2C+C.+S.%3B+Marschke%2C+R.+F.%3B+Northfelt%2C+D.+W.%3B+Andreopoulou%2C+E.%3B+Von+Hoff%2C+D.+D.%3B+Anderes%2C+K.%3B+Chen%2C+T.+K.%3B+O%E2%80%99Brien%2C+S.%2C+Utility+of+Clinical+Biomarkers+for+Detecting+Protein+Kinase+CK2+Inhibition%3A+A+Report+from+the+Phase+I+Trial+of+CX-4945.+AACR+101st+Annual+Meeting%2C+Washington%2C+DC%2C+April+17%E2%88%9221%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DJ.%2BK.%26atitle%3DUtility%2520of%2520Clinical%2520Biomarkers%2520for%2520Detecting%2520Protein%2520Kinase%2520CK2%2520Inhibition%253A%2520A%2520Report%2520from%2520the%2520Phase%2520I%2520Trial%2520of%2520CX-4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Barreau, M.; Cotrel, C.; Jeanmart, C.</span><span> </span><span class="NLM_article-title">1,2-Dithiole derivatives</span>. U.S. Patent US4,110,450, <span class="NLM_month">Aug</span><span class="NLM_day">29</span>,<span class="NLM_x"> </span><span class="NLM_year">1978</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1978&author=M.+Barreau&author=C.+Cotrel&author=C.+Jeanmart&title=1%2C2-Dithiole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarreau%26aufirst%3DM.%26atitle%3D1%252C2-Dithiole%2520derivatives%26date%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzymatic reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&issue=23&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzymatic+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzymatic%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26issue%3D23%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MO1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MO1','PDB','1MO1'); return false;">PDB: 1MO1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JWH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1JWH','PDB','1JWH'); return false;">PDB: 1JWH</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101251q&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-2%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm101251q" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101251q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a1c4f1c7b3db8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
